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Abstract 
This PhD thesis aims to extend the current quantitative microbial risk 
assessment for minimally heated chilled foods by including information on 
variability of non-proteolytic Clostridium botulinum at strain level. The research 
on strain variability covers practical experiments as well as literature surveys and 
focuses on heat resistance properties of non-proteolytic C. botulinum spores, 
variability in growth at chill temperatures and variability in growth and neurotoxin 
formation in the presence of different carbohydrates. A strain classification 
pattern was developed and compared with published literature information on the 
genetic variation of non-proteolytic C. botulinum. Results for the growth at chill 
temperatures and from the carbohydrate study provide strong evidence of 
significant variability for strains of non-proteolytic C. botulinum that is associated 
with the type of neurotoxin formed. Although a literature review on heat 
resistance did not show correlation between the decimal reduction time and toxin 
type for non-proteolytic C. botulinum it provides a strong quantitative support for 
modelling of the thermal properties of the spores. Insights on strain variability 
were included in a modular quantitative microbial risk assessment (QMRA) for    
a model dairy-based chilled dessert using a Monte Carlo simulation technique. 
The model considered four steps in product manufacture that either reduced or 
increased the hazard associated with non-proteolytic C. botulinum: spore load in 
raw material, thermal inactivation of spores, distribution of spores in retail units 
and population kinetics for non-proteolytic C. botulinum during multi-stage 
storage regimes. The replacement of a commonly applied assumption on strain 
homogeneity with strain specific characteristics of non-proteolytic C. botulinum 
revealed that inclusion of information on strain variability has an important impact 
on estimated risks. The QMRA indicated that, for a minimally heated dairy-based 
dessert, a greater hazard was associated with type E strains than with those of 
type B and F. The findings in this thesis provide important information relating to 
food safety and public health and could be used by risk managers for verification 
of microbiological criteria for particular products originating from geographical 
locations with higher prevalence of type E non-proteolytic C. botulinum strains. 
This approach illustrates a step forward by including population details into to 
risk assessment which may become a significant element in the assessment of 
complex foodborne hazards.  
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1. Introduction 
Dynamic social and economic changes over the last few decades have led to 
new trends in food production. These trends meet consumers demand for 
minimally processed, healthy products with limited chemical preservatives at an 
affordable price and little time needed for preparation prior to consumption. The 
production of this type of product presents many challenges for industry to 
overcome. These challenges are not limited to structural or business 
management, but most importantly, the implementation of an effective food 
safety and quality system that provides consumers with high sensory and high 
nutritional products without adverse health effects. This is particularly challenging 
due to the number of potential biological hazards arising at all stages in the food 
chain (McClure, 2008). Although the traditional approach to food safety has 
protected consumers for many decades, the increasing complexity of the food 
supply chain, combined with a strong sensitivity to controlling factors (e.g. in 
case of chilled products correct storage at refrigeration temperature through the 
entire shelf life), requires a sophisticated method for the assessment and control 
of microbiological hazards. Such method is a Quantitative Microbial Risk 
Assessment (QMRA) – a relatively new tool that allows for the optimal utilisation 
of available information to improve the efficiency and control of steps involved in 
the manufacture of minimally heated chilled foods, leading to better assessment 
and control of the corresponding hazards. One important potential hazard in 
these foods is non-proteolytic C. botulinum, a highly dangerous pathogen (Peck, 
1997). Foodborne botulism outbreaks associated with this microorganism in 
commercially processed foods are rare, however in the case of minimally heated 
chilled foods there is the potential for many persons to become ill (with 109 packs 
sold each year in UK), so that associated risk has great public health importance. 
The health effects and medical and economic costs attributable to botulism 
outbreaks linked with commercially produced foods can be high (Setlow and 
Johnson, 1997). QMRAs have previously been presented for non-proteolytic     
C. botulinum in minimally heated chilled foods (Carlin et al., 2000; Barker et al., 
2002; Barker et al., 2005a; Malakar et al., 2011; Hudson and Lake, 2012). The 
risks were based on an assumption of homogeneous behaviour for the pathogen 
in all elements of the food chain and all aspects of the pathogen response in 
many parts of the modular risk assessment. Nevertheless, a number of 
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published studies (see section 5.1.6) have revealed a high level of variability for 
non-proteolytic C. botulinum strains. The variability is known to be important 
during the interpretation of risk assessment in terms of decision making that can 
lead to underestimation of risk. Therefore, it is crucial to test the significance of 
strain variability in the risk assessment process for non-proteolytic C. botulinum 
for minimally heated chilled food.  
 
1.1 C. botulinum – low frequency, high impact risk 
In 2011 there were upwards of 70,000 cases of foodborne disease in reported 
outbreaks in the European Union, resulting in more than 7,000 hospitalisations 
and 93 deaths. The most commonly reported causative agents were Salmonella 
spp., bacterial toxins, Campylobacter, viruses and Escherichia coli. The 
clostridial toxins were responsible for 165 outbreaks of which 35 cases were 
reported to be caused by C. botulinum (28 hospitalised and 1 death) 
(EFSA/ECDC, 2013). It should be noted that since foodborne botulism and other 
forms of foodborne disease are under reported in different European countries, 
these numbers are likely to be an underestimate of the real position. According 
to studies of Scallan et al. (2011) under reporting factor for C. botulinum is equal 
to 1.1 and 2.0 for under diagnosis. Although C. botulinum is a relatively rare 
source of foodborne disease, it has serious health (extensive convalescence and 
high fatality rate in comparison to other foodborne pathogens) and commercial 
consequences (reputation and financial loss) and requires a sophisticated 
method of control and prevention. 
 
1.1.1 Characteristics of C. botulinum 
C. botulinum is a group of Gram-positive, rod-shaped organisms (Figure 1.1) that 
was isolated for the first time in 1895 by Emile van Ermengem (Erbguth, 2004). 
The bacteria form heat-resistant spores, which are widely distributed in the 
environment (e.g. soils, sediments of coastal waters, fruits, vegetables, viscera 
of fish, mammals and shellfish) (Dodds, 1993a; Dodds, 1993b; Carlin et al., 
2004; Lindström et al., 2009; Carlin, 2011; Malakar et al., 2013) and are able to 
germinate under anaerobic conditions. Germination leads to growth and 
potentially the production of a potent botulinum neurotoxin which is the cause of 
neuroparalytic disease with a high mortality rate (~10% cases) (Peck, 2006).  
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Figure 1.1 Scanning Electron Microscope photograph of non-proteolytic            
C. botulinum strain Eklund 17B 
Source: Cross and Carter (2013) 
 
Based on cultural, biochemical and physiological properties this species is 
classified into four (I – IV) distinct genetic and phenotypic groups with different 
pathogenicity for humans and animals. The groups have the ability to produce 
antigenically different neurotoxins. There are seven distinct botulinum 
neurotoxins, A through G (Table 1.1). Most strains of C. botulinum produce toxin 
of a single antigenic type, although dual-neurotoxin-forming strains have been 
reported. In this case, a predominant amount of one toxin is formed and              
a smaller amount of a second toxin e.g. Bf (Peck, 2010). Additionally, some 
strains of C. baratii and C. butyricum also form botulinum neurotoxin (Peck, 
2009). 
 
Group I C. botulinum (proteolytic C. botulinum) and Group II C. botulinum (non-
proteolytic C. botulinum) strains form type A, B, E or F neurotoxins and are 
responsible for foodborne botulism (see below). These groups differ in 
biodiversity, with Group I C. botulinum consisting of more closely related strains 
than Group II C. botulinum (Keto-Timonen et al., 2005; Hill et al., 2007; Stringer 
et al., 2013). Section 5.1.6 includes an extensive description of inter-strain 
variability of non-proteolytic C. botulinum. 
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Group of neurotoxigenic C. botulinum 
 
Characteristic 
Group I 
proteolytic  
C. botulinum 
Group II 
non-proteolytic  
C. botulinum 
Group III 
 
Group IV 
 
Toxins formed A, B, F B, E, F C, D G 
Genome size (Mb) 3.86 – 4.26 3.66 – 3.80 2.96  
Minimum temp. for growth 10.0 – 12.0°C 2.5 – 3.0°C 15.0°C  
Optimum temp. for growth 37.0°C 25.0°C 40.0°C 37.0°C 
Minimum pH for growth 4.6 5.0 5.1  
NaCl concentration 
preventing growth 
10% 5%  6.5% 
Minimum aw for growth
a) 0.94/0.93 0.97/0.94   
Spore heat resistanceb) 121°C/0.2 82°C/2.4 104°C/0.9 104°C/1.2 
Spore radiation resistance 
b) 
2.0 – 4.5 kGy 1.0 – 2.0 kGy   
Ferment glucosec) + + + - 
Ferment fructose V + V - 
Ferment maltose V + V - 
Ferment sucrose - + - - 
Lipase production + + + - 
Proteolysis + - - + 
Disease host human human animal  
Similar atoxic organism C. 
sporogenes 
no species 
specified 
C. novyi 
C.subtermi-
nale 
Table 1.1 Physiological properties of four groups of C. botulinum that form 
botulinum toxin 
Source: Data from Hatheway (1993), Peck (2009), Peck (2010), Peck et al. (2011) 
a) aw (water activity) – amount of water available for microbial growth; 
b) expressed in      
a form of D-value at a given temperature (the concept of D-value (in minutes) is 
described in Chapter 2); c) + positive for all strains, - negative for all strains, V variable 
response; an empty cell indicates that data were not available 
 
Spores of non-proteolytic C. botulinum are less heat resistant than those of 
proteolytic C. botulinum, and have different growth requirements. Non-proteolytic 
C. botulinum is able to grow and produce toxins at refrigeration temperature 
(minimum growth temperature 2.5 – 3.0°C, optimum of 25.0°C), whereas growth 
of proteolytic C. botulinum has not been reported at or below 10.0°C and strains 
have an optimal growth temperature ~37.0°C. A pH below 5.0 or NaCl 
concentration above 5% prevents growth and neurotoxin formation by non-
proteolytic C. botulinum, whereas growth of proteolytic C. botulinum is not 
observed at pH below 4.6 or at a NaCl concentration above 10%. These 
differences in characteristics of proteolytic and non-proteolytic C. botulinum 
influence the types of foods implicated in foodborne botulism outbreaks (Table 
1.2). Dried or vacuum-packed fish and fermented marine products are often 
associated with non-proteolytic C. botulinum (Lund and Peck, 2000; Lindström et 
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al., 2006) and low acid canned foods are often associated with proteolytic         
C. botulinum (Peck, 2010). Strains of Group III C. botulinum, that form types C 
and D neurotoxin, cause most of the cases of botulism in animals, mainly birds, 
cattle and horses (Kelch et al., 2000).  
 
Although C. botulinum strains have been isolated throughout the world, the type 
of isolated strain tends to be associated with geographical location. For example 
strains that produce type A toxin are frequently detected in soils from the 
Western USA and Argentina. Type B strains are most common in soils of 
Eastern USA and sediments in Britain, Ireland and Iceland, whereas type E 
strains are found in sediments and coastal soils of Nordic countries, the Baltic 
Sea, Alaska, Northern Canada and Japan. Type F strains are of relatively low 
prevalence in the environment (Dodds, 1993b). Such a heterogeneous 
distribution of strains in different geographic areas means that information 
regarding the origin of food components has a crucial importance in the 
calculation of the risk associated with C. botulinum (see section 5). 
 
1.1.2 Characteristics of botulism 
Botulism is a serious but rare illness that causes flaccid paralysis of muscles. It 
occurs from ingestion of preformed botulinum neurotoxin or germination and 
growth of spores present in tissues and subsequent growth and neurotoxin 
formation. There are four major forms of botulism: 
 
Foodborne botulism 
This is most frequently caused by neurotoxins of type A, B, E or occasionally F. 
The onset of botulism generally occurs 12 to 72 hours after exposure to 
preformed toxin. Classic neurologic symptoms of botulism include blurred vision, 
double vision, dry mouth and muscle weakness. Other symptoms may include 
vomiting, nausea, abdominal cramps or diarrhoea (Lindström and Korkeala, 
2006). Untreated, symptoms may include flaccid paralysis of arms, legs, trunk 
and respiratory muscles. Flaccid paralysis is caused by the neurotoxin blocking 
release of the neurotransmitter acetylcholine at the motor nerve terminals of the 
neuromuscular junctions, leading to a bilateral descending paralysis, starting with 
the head and neck. Severe cases may involve a long hospital stay with an 
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extensive period of convalescence that may take months or even years. In 
extremely severe cases, death may result from cardiac or respiratory muscle 
failure (Lund and Peck, 2000; Peck, 2010). Botulism has been caused by           
a diverse range of food products (Table 1.2), often home-prepared, but 
occasionally commercial foods are implicated (see section 1.1.3). 
 
Wound botulism 
This form of botulism is analogous to tetanus. It occurs when a wound becomes 
contaminated with spores, which then lead to growth and toxin production. The 
symptoms are similar to those in foodborne botulism, however the incubation 
period is typically much longer ranging from 4 to 14 days (Lindström and 
Korkeala, 2006; Reller et al., 2006). The first cases of wound botulism were 
reported in the 1940s and 1950s in the USA (Davis et al., 1951), and most of the 
time were associated with traumatic wound or post-operative injures. Since 2000 
the number of reported wound botulism cases has increased and it is now mainly 
associated with intravenous drug abuse. The country with the highest number of 
reported cases is the USA with ~13 cases each year (CDC, 2011a). A few cases 
are reported each year in the UK (Akbulut et al., 2005), Germany (Galldiks et al., 
2007), Sweden (Artin et al., 2007) and France (Roblot et al., 2006). Occasionally 
wound botulism can occur in a small-scale epidemic often associated with          
a batch of contaminated heroin (Dhaked et al., 2010). 
 
Infant botulism 
Infant botulism occurs in children less than 52 weeks old when ingested spores 
germinate, grow and produce toxin in the gastrointestinal track. The first clinical 
symptoms include constipation that lasts for several days, poor feeding and 
progressive descending neurological deterioration (Brett et al., 2005). Outbreak 
investigations show that infant botulism is often associated with honey 
consumption. Many countries recommend that honey jars should be labelled with 
a statement indicating that the product is not suitable for infants less than 12 
months old (Lund and Peck, 2000). Other vehicles previously reported as 
responsible for infant botulism include infant formula (Brett et al., 2005), corn 
syrup (Spika et al., 1989) and dust (Nevas et al., 2005).  
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Adult infectious botulism  
Sporadic cases occur when C. botulinum colonises the adult’s gut following 
extensive gastrointestinal surgery or intensive antibiotic therapy (Sobel, 2005). 
 
There are also two other forms of botulism: inhalation and iatrogenic. To date 
few cases of inhalation botulism have been reported – these result from 
inhalation of toxin by laboratory personnel (Holzer, 1962). Although this form of 
botulism occurs very rarely it is of public health importance as it could include the 
use of C. botulinum neurotoxin as a biological weapon (Arnon et al., 2001; Peck, 
2010). Iatrogenic botulism is the most recently described form of botulism. It 
occurs as an adverse effect associated with the therapeutic or cosmetic use of 
botulinum neurotoxin (Coban et al., 2010; Ghasemi et al., 2012). 
 
1.1.3 Epidemiology of foodborne botulism 
In all European Union countries, plus Iceland and Norway, botulism is a statutory 
notifiable disease although the effectiveness of reporting is variable. The 
effective reporting of foodborne botulism is further complicated by the possibility 
of misdiagnosis including a number of other conditions including, anxiety, 
Guillain-Barré syndrome, myasthenia gravis, intoxication, stroke, and more rarely 
polio, tick paralysis and viral infection of the central nervous system (HPA, 2008). 
Nevertheless, if botulism is confirmed then due to its serious health effects, 
epidemiologists conduct a thorough investigation of the botulism outbreak 
including the identification of the contaminated product and factors supporting 
spore survival and subsequent growth and neurotoxin formation. Botulism 
outbreaks summarised in Table 1.2 indicate that botulism has been reported 
throughout the world, affecting from one to several victims, with various health 
effects and some fatal. In general, based on the number of reported cases, 
countries can be classified as those with no reported cases (e.g. Belgium – no 
reported case in the last 30 years), rare (e.g. UK – less than one per year in the 
last 30 years) or those where cases are more frequent. The last category 
includes countries where botulism outbreaks are reported more than once in      
a year, e.g. Poland with 22 cases reported in 2012 (PZH, 2012), Italy and 
Romania with 23 and 32 in 2008, respectively (ECDC, 2010). In the majority of 
cases, botulism is caused by type A, B, E or F toxins produced by proteolytic    
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C. botulinum or non-proteolytic C. botulinum, with rare cases also due to 
neurotoxigenic C. butyricum or C. baratii (Peck, 2002; Lindström and Korkeala, 
2006). Since proteolytic C. botulinum and non-proteolytic C. botulinum possess 
different physiological properties (Table 1.1), the range of food involved in 
botulism outbreaks is great and can be divided into three main categories: those 
associated with home-preservation (meats, vegetables or fishes), commercial 
production or food served in restaurants. Foods involved in outbreaks originating 
from catering facilities or commercial productions occur relatively rarely (Table 
1.2), however due to the potential for many persons to become ill, and the 
severity of the illness, such outbreaks are always thoroughly investigated. Such 
an investigation can result in changes in product composition and/or in the 
manufacturing process, as well as increase in awareness of the hazard amongst 
the population. 
Chapter 1 
27 
Year Country Product Toxin type 
Cases 
(deaths) 
Factors Reference 
Proteolytic C. botulinum 
1985 Canada Restaurant, chopped garlic in oil B 36 
Anaerobic garlic storage, 
temperature abuse, no controlling 
factors i.e. acid or salt 
Leclair et al. (2013) 
1985 Canada Home-canned mushrooms B 1 Unknown Leclair et al. (2013) 
1986 Taiwan 
Commercial heat processed 
bottled peanuts 
A 9 
Contamination of peanuts with 
spores of C. botulinum, 
time and temperature abuse 
Chou et al. (1988) 
1987 Canada 
Home-bottled chantarelle 
mushrooms 
A 11 Inadequate acidification CDC (1987b) 
1987 UK 
Commercial pre-packed kosher in-
flight airline meal 
A 1 Temperature abuse Colebatch et al. (1989) 
1989 UK Commercial hazelnut yoghurt B 27 (1) 
Insufficient  heat process of 
conserved hazelnut  
O'Mahony et al. (1990) 
1989 Canada Home-made bean soup A 1 Unknown Leclair et al. (2013) 
1989 USA Commercial chopped garlic in oil A 3 
Anaerobic garlic storage, 
temperature abuse, no controlling 
factors i.e. acid or salt 
Morse et al. (1990) 
1991 Canada Home-canned asparagus A 3 (1) Unknown Leclair et al. (2013) 
1993 Canada 
Home-made beef and vegetable 
soup 
A 1 Unknown Leclair et al. (2013) 
1993 USA Commercial canned cheese sauce A 8 (1) 
Post-opening contamination, lack 
of adequate refrigeration 
Townes et al. (1996) 
1993 Italy Commercial roasted eggplant in oil B 7 
Insufficient acidification/heat 
treatment 
CDC (1995b) 
1994 USA 
Commercial potato-based and 
eggplant-based dips 
A 30 
Foil-wrapped potatoes kept at 
ambient temperature 
Angulo et al. (1998) 
1994 USA Commercial clam chowder A 2 Temperature abuse Peck (2006) 
1994 USA 
Home-prepared stew containing 
roast beef and potatoes 
A 1 
Product left at ambient 
temperature under a cover  
CDC (1995a) 
1995 Canada Commercial pâté B 2 Temperature abuse Leclair et al. (2013) 
1996 Italy 
Commercial acidified cream 
cheese 
A 8 (1) 
Heat process insufficient to 
destroy spores of C. botulinum, 
break in chill storage 
Aureli et al. (2000) 
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1997 Italy Home-prepared pesto/oil B 3 Inadequate acidification Peck (2009) 
1997 Germany Home-prepared beans A 1 Poor hygiene of meal preparation Peck (2009) 
1997 Iran Commercial traditional cheese A 27 (1) Unsafe process Pourshafie et al. (1998) 
1998 Algeria 
Commercial processed meat 
(“kashir”) 
A 340 (37) Unknown Lund and Peck (2013) 
1998 Thailand Home-canned bamboo shoots A 13 (2) Unsafe process CDC (1999) 
1998 UK 
Home-bottled mushrooms in oil 
brought back from Italy 
B 2 (1) Unknown CDC (1998) 
1998 Argentina 
Commercial meat roll 
(“matambre”) 
A 9 
Unsafe process/storage in heat-
shrinked plastic bags, 
temperature abuse 
Villar et al. (1999) 
1999 France Commercial chilled fish soup A 1 Temperature abuse at home Peck (2009) 
1999 Canada Home-canned tomatoes B 3 
Insufficient acidification, 
temperature abuse 
Loutfy et al. (2003) 
1999 Japan Commercial curry boiled in bag A 1 Temperature abuse Kobayashi et al. (2003) 
2000 France Home-canned asparagus B 9 Unknown Abgueguen et al. (2003) 
2000 Canada 
Home-made sausage used to 
prepare spaghetti sauce 
A 1 Unknown Leclair et al. (2013) 
2001 Canada 
(Outbreak 1) Commercial cooked 
boneless pork/(Outbreak 2) Home-
made fish 
A/B 2 Temperature abuse Leclair et al. (2013) 
2001 USA Commercial frozen chili sauce A 16 
Temperature abuse during 
storage in a shop 
Kalluri et al. (2003) 
2002 
South 
Africa 
Commercial tinned fish in tomato 
sauce 
A 2 (2) 
Corrosion of tin, which allowed 
for contamination of C. botulinum 
spores 
Frean et al. (2004) 
2002 Denmark Commercial garlic in dressing B 1 Unknown Lindström et al. (2006) 
2002 Canada 
Restaurant, baked potato in 
aluminium foil 
A 1 Unknown Bhutani et al. (2005) 
2003 France 
Commercial produced beef and 
poultry sausage (“halal”) 
B 4 Unknown Lindström et al. (2006) 
2003 UK 
Home-prepared meat product 
(“bigos”) brought back from Poland 
B 1 
Possible temperature abuse 
during transport 
McLauchlin et al. (2006) 
2004 UK 
(Outbreak 1) Commercial 
prepared hummus/(Outbreak 2) 
person returning from Georgia 
Unknown/A 2 
Time and temperature abuse 
during storage at home/unknown 
McLauchlin et al. (2006) 
2004 USA Home-made pruno A 5 Unsafe process Vugia et al. (2009) 
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2005 UK 
Home-preserved pork brought 
back from Poland 
B 1 
Unsafe process/time and 
temperature abuse 
McLauchlin et al. (2006) 
2005 Turkey 
Home-made condensed yogurt 
(“süzme”) buried under soil 
A 10 (2) Unsafe process Akdeniz et al. (2007) 
2006 
Canada/ 
USA 
Commercial chill carrot juice A 6 (1) Storage at room temperature CDC (2006a) 
2006 USA Home-prepared fermented tofu A 2 Unsafe process CDC (2007) 
2006 Thailand Home-canned bamboo shoots A 163 Unsafe process CDC (2006b) 
2006 Taiwan 
Home-prepared fermented goat 
meat 
B 5 Unsafe process Tseng et al. (2009) 
2006 Austria Home-slaughtered pork and bacon B 5 
Possible contamination during 
slaughtering and freezing of pork 
in airtight bags 
Meusburger et al. (2006) 
2006 Canada 
(Adult intestinal botulism)  
Commercial peanut butter 
A 1 
Undergone previous bowel 
surgery 
Sheppard et al. (2012) 
 
2007 Canada 
(Adult intestinal botulism) 
(Outbreak 1) Commercial peanut 
butter/(Outbreak 2) 
A/A and B 2 
Undergone previous bowel 
surgery/Unknown 
Sheppard et al. (2012) 
 
2007 USA 
Commercial canned hot dog chili 
sauce 
A 8 Insufficient heat process Juliao et al. (2013) 
2007 Australia Commercial nacho meal A 1 Unknown Peck (2009) 
2007 China Commercial produced sausage A 66 Unknown Lund and Peck (2013) 
2008 USA 
(Outbreak 1) Home-canned green 
bean and carrot blend/(Outbreak 
2) Home-canned green beans 
A 4/3 Insufficient heat process Date et al. (2011) 
2008 France Commercial chicken enchiladas A 2 Temperature abuse at home King (2008) 
2008 Turkey 
Home-packed black olives 
affected Dutch nationals 
B 8 Insufficient acidification Swaan et al. (2010) 
2009 USA Home-canned asparagus A 3 Insufficient heat process Date et al. (2011) 
2010 France 
Home-made canned beans or 
salted roast pork 
A 5 (1) Unknown Oriot et al. (2011) 
2011 Austria Unknown B 4 Unknown Vossen et al. (2012) 
2011 France 
(Outbreak 1)/(Outbreak 2) 
Commercial green olive paste 
A 5/3 
Insufficient sterilisation process 
applied to the product 
Pingeon et al. (2011) 
2011 Finland Commercial conserved olives B 2 
Failure in the processing, 
packaging and transportation of 
product 
Jalava et al. (2011) 
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2011 USA 
Commercially produced potato 
soup 
A 2 Time and temperature abuse CDC (2011b) 
2011 UK 
Commercially produced korma 
sauce 
A 3 Insufficient acidification Browning et al. (2011) 
2012 USA Home-fermented tofu B 2 
Possible contamination of bulk 
tofu with C. botulinum spores 
CDC (2013) 
 
? Iran 
Home-pickled vegetables/Caviar 
fish 
A and B/A 8/1 Unknown 
Barari (2010)/Zadeh et 
al. (2007) 
Non-proteolytic C. botulinum 
1987 USA/Israel 
Commercial uneviscerated, salted, 
air-dried fish (“kapchunka”) 
E 8 (1) Lack of refrigeration CDC (1987a) 
1991 Sweden 
Commercial vacuum-packed 
smoked rainbow trout 
E Unknown Unknown Peck (2009)   
1991 Egypt 
Commercial uneviscerated,  
salted fish (“faseikh”) 
E > 91 
Suspected temperature abuse 
with possible anaerobic 
conditions  
Weber et al. (1993) 
1992 USA 
Commercial uneviscerated, salted 
fish (“moloha”) 
E 4 Insufficient salt CDC (1992) 
1994 Sweden 
Commercial vacuum-packed 
smoked fish 
E Unknown Unknown Peck (2009) 
1995 Canada 
Home-made marinated and 
smoked fish 
E 3 (1) Unknown Leclair et al. (2013) 
1995 Canada 
Home-made fermented walrus 
meat 
E 9 Insufficient heat process Peck (2009) 
1997 Germany 
(Outbreak 1) Commercial hot-
smoked vacuum-packed fish 
(“raucherfisch”) imported from 
Canada/(Outbreak 2) Home-
smoked vacuum-packed fish 
(“lachsforellen”) 
E 6 Suspected temperature abuse 
Korkeala et al. 
(1998)/Peck (2009) 
1997 France Fish E 1 Unknown Boyer et al. (2001) 
1997 Argentina Home-cured ham E 6 Unknown Peck (2009) 
1998 France 
(Outbreak 1) Commercial vacuum-
packed frozen scallops imported 
from China/(Outbreak 2) 
Commercial vacuum-packed 
prawns from in Nigeria 
E 2 
Possible temperature abuse 
during thawing/Unknown 
Boyer et al. (2001) 
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Table 1.2 Examples of foodborne botulism incidents in the last 30 years involving proteolytic C. botulinum and non-proteolytic       
C. botulinum 
1998 Germany 
Commercial smoked vacuum-
packed fish 
E 4 Unknown Peck (2009) 
1999 Finland Home-prepared fish eggs E 1 Unknown Lindström et al. (2004) 
1999 France 
(Outbreak 1) Salmon or fish 
soup/(Outbreak 2) Grey mullet 
E 2 Unknown Boyer et al. (2001) 
2001 Australia Reheated chicken E 1 Temperature abuse Peck (2009) 
2001 USA 
Home-prepared beaver tail and 
paws 
E 3 
Prolonged storage at ambient 
temperature 
CDC (2001) 
2001 Canada Home-made fermented salmon E 4 Insufficient salt Peck (2009) 
2002 USA 
Home-made beluga whale 
(“muktuk”) 
E 8 
Possible contamination of whale 
carcass with C. botulinum spores 
McLaughlin et al. (2004) 
2003 Norway Home-made fish (“rakfisk” ) E 6 Unknown Eriksen et al. (2004) 
2003 Germany Home-prepared air-dried fish E 3 Lack of secondary barrier Eriksen et al. (2004) 
2004 Germany 
Commercial vacuum-packed 
smoked salmon  
E 1 Consumed after “use by date” Peck (2009) 
2005 USA Home-salted fish  E 5 Insufficient salt Sobel et al. (2007) 
2006 Finland 
Commercial vacuum-packed  
smoked whitefish 
E 1 Temperature abuse Peck (2009) 
2006 Iran Home-made soup (“ashmast”) E 11 Unknown Vahdani (2006) 
2009 France 
Commercial vacuum packed hot-
smoked whitefish 
E 3 
Temperature abuse before 
consumption 
King et al. (2009) 
? Taiwan 
Commercial vacuum-packed dried 
bean curd 
E 1 Unknown Lai et al. (2011) 
Toxin type not identified 
2005 Kazakhstan Home-dried fish Unknown 25 (1) Unknown Peck (2006) 
2011 Russia 
Vegetable salad served in a 
canteen 
Unknown 48 Unknown Khamzina (2011) 
2011 Germany Unknown Unknown 2 Unknown Anon. (2011) 
2012 Canada 
Egyptian dish (“fesikh”) prepared 
from grey mullet 
Unknown 3 Unknown CFIA (2012) 
2012 USA Home-canned food Unknown 3 Unknown DHMH (2012) 
2013 Italy Commercial produced pesto Unknown 30 Unknown Powell (2013) 
2013 USA Home-canned elk meat Unknown 1 Insufficient  heat process Chapman (2013) 
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1.2 Chilled food in the UK 
Urban development, growing industrialization and social changes have led to the 
development of products which require no or little preparation time prior to 
consumption. Often these products are minimally heated and stored under 
chilled conditions (at or below 8.0°C (targeting 5.0°C)) and are variously known 
as sous-vide, cook-chill and ready-to-eat foods, ready meals, and refrigerated 
processed foods of extended durability (REPFEDs) (Figure 1.2). 
 
 
 
Figure 1.2 UK Retail Prepared Chilled Food Market 2009 – 2012  
Source: Chilled Food Association (2013) 
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Chilled food products have been available since the 1960s in the form of sliced 
meats and pies. Over the years, the range of products has increased 
enormously, with over 12000 quick and easy to prepare foods such as: 
sandwiches, pizzas, luxury meal kits, leafy salads, dairy desserts, dips, salads 
available in the UK (Figure 1.2). They are based on traditional British cuisine as 
well as a wide range of international meals.  
 
In the last two decades the chilled food market has been the most dynamic food 
sector in the UK, and possibly in the world, with 317% growth in value between 
1999 and 2011. The UK market is dominated by a few multiple retailers with their 
own brands and is estimated to be worth £14.4 billion in 2012 (Figure 1.3) 
 
 
Figure 1.3 UK Retail Chilled Prepared Food Market 2007 – 2012 
Source: Chilled Food Association (2013) 
 
The largest segments of the market are convenience foods, retail sandwiches, 
rolls, baguettes (28.5%), sliced cooked meat (14.9%), chilled ready meals (9.5%) 
and value added poultry (7.5%). The remaining 40% includes fresh pasta, chilled 
leafy salads and prepared fruits, pizza, breads, soups, cakes, seafood and salad 
dressings (Figure 1.2). 
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The characteristic features of chilled products, apart from the short period of time 
needed for their preparation, are their high nutritional value, sensory quality and 
limited amount of preservatives. Their microbiological safety and quality relies on 
a moderate heat treatment (70 – 95°C) with consumer storage at chill 
temperature (below 8.0°C in UK). Often these foods are packed under a low-
oxygen atmosphere and can have a shelf life up to 42 days.  
 
Chilled food conditions may support growth or survival of many foodborne 
pathogens including Escherichia coli, Listeria monocytogenes, Clostridium 
perfringens, Bacillus cereus, Staphylococcus aureus, Salmonellae or                 
C. botulinum, and this has a serious impact on consumer health and safety. 
Vegetative cells of pathogens such as E. coli or L. monocytogenes would not be 
expected to survive the heat treatment delivered, but could present a hazard if 
there was post-process contamination. Bacterial spores would survive many of 
the heat treatments and, in the case of spores of non-proteolytic C. botulinum, 
could lead to growth and neurotoxin formation at chill temperatures (Stringer et 
al., 1997). Non-proteolytic C. botulinum is considered as the major concern in the 
production of chilled foods and has been previously implicated in foodborne 
botulism outbreaks (Table 1.2). Outbreaks have usually been associated with 
time or temperature abuse during storage (Peck et al., 2008). Growth of 
proteolytic C. botulinum will be controlled by effective chilled storage but may be 
an issue in the case of prolonged temperature abuse, with some botulism 
outbreaks reported (Table 1.2). 
 
Considering the severe adverse health effects and the serious commercial 
implications of foodborne botulism (the estimated cost of one foodborne botulism 
case in the USA is $30 million (Peck, 2009)), and the increasing consumer 
demand for chilled foods (Figure 1.3), the control of non-proteolytic C. botulinum 
in minimally heated chilled foods is essential and requires the identification of 
appropriate controls (e.g. effective heating time, product acidity, aw) based on 
sound science as well as a systematic approach to inform the public concerning 
safety. This can be achieved by well-defined and implemented risk assessment, 
risk management and risk communication – the three components of risk 
analysis.  
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1.3 Risk Analysis 
Chilled foods have many benefits such as convenience (easy to prepare and 
easy to take away), extended shelf life, adaptation to consumer’s preferences 
(e.g. small portions for individuals) and the availability of a wide range of ethnic 
meals (e.g. British, Italian, Indian, oriental), but their production faces a number 
of safety issues. One of the most important is that they are a potential vehicle for 
the transmission of hazardous agents (i.e. viruses, bacteria or parasites) that 
may lead to foodborne disease, e.g. E. coli O104:H4 (outbreak associated with 
sprouts) (Buchholz et al., 2011), Yersinia enterocolitica O:9 (associated with 
ready-to-eat salad mix) (MacDonald et al., 2011) and C. botulinum (outbreaks 
associated with vacuum packed fish) (Table 1.2). Illness caused by these 
agents, in the “best scenario” can lead to a variety of mild symptoms and in the 
“worst scenario” to death. 
 
In addition, the complexity of chilled foods, together with a developing global 
transport of raw materials and ingredients (Ercsey-Ravasz et al., 2012) can 
make it difficult to trace the origins of their content. For example the most recent 
scandal in Europe associated with the presence of horsemeat in burgers and 
ready meals, revealed problems with the control and the ability to trace the 
source of food materials, and the complexity of processes involved in the 
production and distribution of many food products (Morley, 2013). 
 
Ensuring public health protection and progressing international trade requires the 
setting of mutually agreed international standards, regulations and process 
requirements. These requirements should be scientifically justified to support fair 
trade. Risk analysis is one of the most recent and structured approaches which 
not only represents relevant scientific information in a transparent way, but also 
manages the policy and exchange of information concerning food safety 
(FAO/WHO, 1995). In addition, the application of risk analysis not only provides 
benefits on an international and national level, but also to industry by ensuring a 
consistent approach to the safety and quality of food, and an effective traceability 
in the food network, which minimizes recalls and protects manufacturer’s 
reputation. 
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1.3.1 Historical aspects of risk analysis 
The desire for safe food has a long history. The earliest method for controlling 
safety and protecting society from illness and deaths associated with 
consumption of particular products was the prohibition of manufacture and 
distribution. One example is a ban on the production of blood sausages by 
Emperor Leo VI of Byzantium in the 10th century, because of poisoning possibly 
caused by C. botulinum (Erbguth, 2004). The accumulation of scientific 
knowledge has replaced prohibition with guidelines, laws and recommendations 
which aim to control and minimize the risk associated with certain products.        
A significant milestone in food safety regulations appeared with the development 
of sterilization processes, which allowed for storage of perishable products for a 
long period in an ambient temperature. Work carried out by Esty and Meyer 
(1922) on the heat resistance of spores of C. botulinum in low-acid, canned 
foods is a classic example of research used to establish process criteria for 
commercially produced foods.  
 
An important development in food science was made in the 1960s by the 
National Aeronautics and Space Administration (NASA) to ensure food safety for 
the first manned space mission. This was the development of the Hazard 
Analysis and Critical Control Point system (HACCP) (Ross-Nazzal, 2008). The 
final version of HACCP with seven principles and guidelines for its application in 
food safety was accepted by the Codex Alimentarius Commission (CAC) in 
1997, and gave the system an international dimension.  
 
The HACCP system is a systematic preventive approach to food safety 
management, which identifies potential hazards associated with each step of 
food manufacturing, establishes critical limits for hazards and systems for their 
control. Nevertheless, due to fact that originally the HACCP system was 
designed to different purpose than food safety, there are drawbacks in its 
application. One of weak points of the HACCP system is a lack of an objective 
and quantitative approach in estimating the risk associated with particular 
hazards. Moreover, HACCP itself is not an effective way to ensure consumer 
health at an international level (it does not allow to control the burden of 
foodborne diseases in the country), and this became a major concern for food 
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safety authorities with developing international trade. In 1995 the World Trade 
Organization (WTO) in order to facilitate the trade between nations introduced 
The Agreement on the Application of Sanitary and Phytosanitary Measures (SPS 
Agreement). The SPS Agreement required associated countries to protect 
human, animal and plant health by food law based on risk analysis (WTO, 1995).  
 
1.3.2 The elements of risk analysis 
Risk analysis is a structured, systematic process composed of three 
interconnected elements: risk assessment (see section 5), risk management and 
risk communication (Figure 1.4).  
 
The process supports food safety authorities in controlling risks to human health 
and safety, and food manufacturers in assessing the process 
parameters/measures that need to be applied during product manufacture to 
control hazards (chemical, physical or biological). Moreover, risk analysis helps 
understanding and managing risks associated with particular hazards and 
improves food safety control systems. 
 
 
Figure 1.4 The three elements of risk analysis 
Source: CAC (1999; 2007) 
 
Risk analysis may vary in details according to the actual risk, the purpose of the 
analysis and available resources, but in all cases, it should be transparent and 
well documented. 
Risk Assessment
(evaluation of 
scientific data on 
severity and adverse 
effects to humans of 
hazard)
Risk Management
(evaluation and assessment 
of risk, identification and 
selection, implementation, 
monitoring and review of 
management options)
Risk 
Communication
(communication regarding 
the hazard between risk 
assessors, risk managers 
and widely – stakeholders, 
media and consumers 
(e.g. via labelling))
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1.4 Purpose of this research 
The primary aims of this research are to:  
(i) generate and collate data on the variation in physiological response 
between strains of non-proteolytic C. botulinum 
(ii) to quantify the effect that strain variability has on the risk of adverse 
effects associated with a model dairy-based minimally heated chilled 
food. 
 
Data on strain variability have been generated through experimental study and 
an extensive literature review. Since spore heat resistance and the ability to grow 
at chill temperatures are important elements of pathogenicity for non-proteolytic 
C. botulinum, these two parameters have been studied in detail. A literature 
survey has been carried out that describes the effect of strain variability on the 
heat resistance of spores of non-proteolytic C. botulinum (Chapter 2), and 
experimental data has been generated to describe the effect of strain variability 
on growth of non-proteolytic C. botulinum at chill temperatures (Chapter 3). 
Additionally, the effect of carbohydrate (the major carbon and energy source for 
non-proteolytic C. botulinum) source on the variation in growth from different 
strains of non-proteolytic C. botulinum has also been examined experimentally 
(Chapter 4). These observations on physiological variability between strains 
have been compared with genetic variability data available in the published 
literature (Chapter 5). Finally Chapter 5 also summarise the background to 
Quantitative Microbial Risk Assessment and places in context the information 
obtained in previous chapters on non-proteolytic C. botulinum strain variability. 
These data are combined in a QMRA model to describe the impact of strain 
variability on the risk presented by non-proteolytic C. botulinum in a minimally 
processed chilled food.  
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2. Heat resistance of spores of non-proteolytic              
C. botulinum: a systematic literature review 
Heat treatment is one of the most important controlling factors used to prevent 
growth and associated neurotoxin formation by non-proteolytic C. botulinum in 
chilled foods. It is generally agreed that a heating process used to deliver a 6D 
reduction in spore concentration is sufficient to control non-proteolytic                
C. botulinum (ACMSF, 1992). The purpose of the present study is to review the 
available data on the heat resistance properties of non-proteolytic C. botulinum 
spores in a systematic manner and to obtain probability distributions for 
parameters describing the heat resistance of spores. Parameters are 
subsequently used in a QMRA model for minimally heated chilled foods. The 
analysis of 880 D and 528 z-values reveals that there is a significant difference in 
spore heat resistance properties when recovered in the presence and absence 
of lysozyme. A total of 505 D and 340 z-values collected at temperatures at and 
below 83°C were used to obtain a probability distribution representing the 
variability in spore heat resistance of strains recovered in media which did not 
contain lysozyme, and 325 D and 160 z-values were obtained at a range of 75°C 
– 95°C to derive a probability distribution for heated spores recovered in media 
that did contain lysozyme. Linear regression for the collected data suggested two 
z-values, z = 7°C and z = 9°C, for spores recovered with and without lysozyme. 
Using the 99% confidence limit of the fit to thermal death data suggested that the 
time required to effect a 6D reduction in the spore concentration when heating at 
90°C was approximately 5 minutes. In addition the data were used to test 
hypotheses regarding the dependency of spore heat resistance on toxin type, 
strain, heating technique, method of D-value determination and testing 
laboratory.  
 
2.1 Background 
Spores of non-proteolytic C. botulinum are considerably less heat resistant than 
those of proteolytic C. botulinum, however, the mild heat treatments applied to 
chilled products may allow the survival of spores of non-proteolytic C. botulinum, 
and combined with the ability to grow and form toxin at chilled temperature, this 
makes non-proteolytic C. botulinum a major concern for the study of modern 
minimally heated chilled foods (Peck, 2006). 
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Currently there are a number of guidelines related to the safety of chilled foods, 
e.g. shelf life, salt concentration, aw, pH, transport and storage temperature. One 
recommendation is that a heat treatment of 90°C for 10 minutes or equivalent, is 
necessary to deliver a 6D reduction for spores of non-proteolytic C. botulinum 
(Table 2.1) (“6D” is reduction of the population density of microorganisms by six 
orders of magnitude). This heat treatment is used for longer shelf life chilled 
products.  
 
Recommendation/guidance 
Recommended parameters of heat 
treatment 
Report on Vacuum Packaging and 
Associated Processes (ACMSF, 
1992) 
90°C/10 minutes or equivalent 
z = 9.2°C 
Code of Hygenic Practise for 
Refrigerated Packaged Foods with 
Extended Shelf Life (CAC, 1999). 
not stated: factors given which need to 
be considered when developing 
scheduled heat 
Guidelines for Good Hygienic Practise 
in the Manufacture of Chilled Foods 
(CFA, 2006). 
90°C/10 minutes or equivalent 
z = 7.0°C below 90°C 
z = 10.0°C above 90°C 
Recommendations for the Production 
of Prepackaged Chilled Food (ECFF, 
2006). 
90°C/10 minutes or equivalent 
z = 7.0°C below 90°C 
z = 10.0°C above 90°C 
Food Standards Agency guidance on 
the safety and shelf life of vacuum 
and modified atmosphere packed 
chilled foods with respect to non-
proteolytic C. botulinum (FSA, 2008). 
90°C/10 minutes or equivalent 
z = 9.2°C below 90°C 
z = 10.0°C above 90°C 
Fish and Fishery Products Hazards 
and Control Guidance (USFDA, 
2011). 
Fish and 
fishery 
products 
 
90°C/10 minutes or 
equivalent 
z = 7.0°C below 90°C 
z = 10.0°C above 90°C 
Blue crabmeat 85°C/31 minutes 
z = 9.0°C 
Dungeness 
crabmeat 
90°C/57 minutes 
z = 8.6°C 
Table 2.1 Examples of currently recommended heat treatments related to safety 
of minimally heated chilled foods 
Source: ACMSF (1992); CAC (1999); FSA (2004); CFA (2006); ECFF (2006); FSA 
(2008); USFDA (2011) 
 
In order to protect consumers from hazards that are associated with non-
proteolytic C. botulinum in minimally heated chilled foods, the Advisory 
Committee on the Microbiological Safety of Food (ACMSF), Food Standards 
Agency (FSA) and Chilled Food Association (CFA) recommended processes that 
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deliver a heat treatment of 90°C for 10 minutes or equivalent lethality when 
combined with storage at chill temperature (Table 2.2). 
 
Heating 
temperature 
(°C) 
Required heating time (t) (min) required and estimated  
D-value (min) according to 
FSA ACMSF CFA/ECFF 
t D-value t D-value t D-value 
70 - 1675 277.8 - 
75 - 464 77.5 - 
80 129 21.5 129 21.5 270 45.0 
85 36 6.0 36 6.0 52 8.7 
90 10 1.7 10 1.7 10 1.7 
95 3.2 0.5 not indicated 3.2 0.5 
100 1.0 0.2 not indicated 1.0 0.2 
z-value < 
90°C 
z = 9.2°C z = 9.2°C z = 7.0°C 
z-value > 
90°C 
z = 10.0°C not indicated z = 10.0°C 
Recommended shelf life: 10 days to 42 days 
Recommended storage temperature:   8°C 
Table 2.2 Equivalent 6D time/temperature combinations for spores of non-
proteolytic C. botulinum 
Source: ACMSF (1992), CFA (2006), ECFF (2006), FSA (2008) 
 
2.1.1 Spore heat resistance 
Heat treatment as a preservation technique 
A number of processing techniques are used to ensure microbiological food 
safety and to prevent food spoilage, allowing for prolonged shelf life by slowing 
or preventing the growth of microorganisms, inactivation of microorganisms or 
restricting the access of microorganisms to the product (Gould, 2000). Methods 
of processing food can be divided into two main categories: physical and 
chemical. 
 
Physical methods of food preservation include the use of heat, refrigeration, 
freezing, frozen storage, dehydration (Peck et al., 1993), new food preservation 
technologies (e.g. high intensity light, high voltage electric discharge, high 
intensity magnetic field pulses, ultrasonication) or a combination of physical and 
chemical methods (e.g. use of salt, benzoic acid, sorbic acid). Despite the wide 
range of available food preservation technologies, the most widely used method 
for inactivation of spoilage and pathogenic microorganisms for many years has 
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been heat treatment (Pflug and Gould, 2000). Heat processes such as 
pasteurization and sterilization allow not only for destruction of vegetative 
bacterial cells but may also inactivate bacterial spores in commercial food 
(Brown, 2000).  
 
In order to determine the heat treatment for a particular food product, which 
would assure consumer safety, two main factors need to be considered: the 
heating characteristics of products and the heat resistance properties of the 
microorganism of concern in that food. In terms of minimally heated chilled 
foods, the spore-forming bacterium non-proteolytic C. botulinum is a pathogen of 
concern, and this chapter summarises data on its spore heat resistance. 
Bacterial endospores 
Since the discovery of bacterial endospores by Cohn and Koch in 1876, their 
resistance and dormancy have been thoroughly investigated, due to the 
problems that spores present to the food industry (Setlow and Johnson, 1997).  
A number of spore-forming bacteria, notably C. botulinum, C. perfringens,         
Bacillus cereus, and occasionally Bacillus subtilis and Bacillus licheniformis 
(Brown, 2000) produce toxins that can cause food spoilage, foodborne illness or 
even death (Del Torre et al., 2004).  
 
Bacterial spores are able to survive unfavourable conditions such as extreme 
temperatures, the presence of preservatives, UV light, desiccation, harsh 
chemicals, irradiation and physical damage. Spore resistance properties and 
their worldwide occurrence in soil samples (Carlin, 2011; Heyndrickx, 2011) 
ensure that foods are potentially contaminated, and an important aim of food 
processing is to reduce the number of spores in food products to a commercially 
acceptable level (Atrih and Foster, 2002).  
 
In a majority of circumstances the presence of dormant spores in food does not 
pose a risk to the consumers. However, spore germination and outgrowth under 
favourable conditions can lead to the formation of vegetative cells and toxin 
production in the case of pathogens, or in other circumstances may lead to food 
spoilage (Ciarciaglini et al., 2000). 
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Endospore structure 
Endospores are produced by Gram-positive bacterial species such as anaerobic 
Clostridium and aerobic Bacillus (with B. subtilis often used as a model spore 
forming organism for facultative anaerobes (Errington, 2003)) and their basic 
structure (Figure 2.1) is similar (Atrih and Foster, 2002).  
 
 
Figure 2.1 Electron micrograph of a cross-section through a non-proteolytic      
C. botulinum spore 
Source: Micrograph courtesy of Dr. M. L. Parker, Institute of Food Research, Norwich, 
UK  
 
The external layer of the spore, the exosporium, is strain specific with differences 
in its presence, structure and thickness between different sporulating species 
(Stevenson and Vaughn, 1972; Henriques and Moran, 2007). When present, the 
exosporium constitutes about 2% of the mass of the spore (Matz et al., 1970) 
and is composed of an inner paracrystalline basal layer and external hair-like 
nap (Henriques and Moran, 2007) formed of proteins, lipids and carbohydrates 
(Matz et al., 1970; Ball et al., 2008). The explicit function of the exosporium is not 
known. However, being the outermost external layer of the spore it provides       
a barrier to large molecules e.g. antibodies, hydrolytic enzymes and 
macrophages (Kang et al., 2005; Ramarao and Lereclus, 2005; Steichen et al., 
2005). It is also thought to play a role in spore adhesion to surfaces and 
resistance to cleaning (Faille et al., 2007; Lequette et al., 2011). The mechanism 
and extent to which the exosporium may have a role in spore germination is not 
fully understood. Two enzymes (alanine racemase and inosine hydrolase) 
located in the exosporium might play a role in spore germination (Todd et al., 
2003; Redmond et al., 2004). 
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Plasma membrane 
Coat layers 
Cortex 
peptidoglycan layer 
Interspace 
Exosporium 
Germ cell wall 
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The exosporium is separated from the electron-dense coat by a region called the 
interspace. In species lacking the exosporium (e.g. Bacillus subtilis), the coat is 
the outermost layer. The coat is mainly composed of proteins from 8 to 65 kD in 
size (50 – 60% of the total protein within spore). There are two morphologically 
distinct, closely packed layers in the spore coat: an inner – lamellar-like layer, 
and electron-dense outer layers (Henriques and Moran, 2007). Together with the 
exosporium (when present), the coat plays an important role in the resistance of 
spores to chemical and enzymatic assault and UV light (Gould et al., 1970; 
Zheng et al., 1988; Riesenman and Nicholson, 2000). Moreover, proteins that 
comprise the spore coat are responsible for spore resiliency (Setlow, 2006). 
Interestingly, it was shown that the coat is the main barrier for the cortex against 
lysozyme, a peptidoglycan-hydrolysing enzyme, whose activity results in spore 
germination (Peck et al., 1993), and might influence resistance to predatory 
microorganisms (e.g. Tetrahymena thermophile) (Zheng et al., 1988). 
 
Under the coat is a thick layer of modified peptidoglycan (PG), structurally similar 
to cell wall peptidoglycan, which plays an important role in spore heat resistance 
by maintaining the dehydrated state of the spore protoplast (Popham and 
Setlow, 1993). The PG layer consists of an inner, germ cell wall layer and the 
cortex. The cortex has a unique structure, highly conserved across species, and 
subtle variations in its structure have a significant effect on spore wet heat 
resistance and core water content (Atrih and Foster, 2001). The cortex is rapidly 
hydrolysed by lytic enzymes during germination, which is crucial for spore core 
expansion and subsequent outgrowth (Dowd et al., 2008).  
 
Between the germ cell wall and the core is the expandable plasma membrane, 
that is not permeable to small hydrophilic compounds (Swerdlow et al., 1981; 
Cowan et al., 2004). The plasma membrane, also called the inner forespore 
membrane, is sensitive to oxidizing agents triggering spore germination 
(Cortezzo et al., 2004), but nevertheless as a strong permeability barrier it plays 
a significant role in spore resistance. 
 
The centre of the spore – core (cytoplasm), contains the genetic material (DNA), 
metabolic components (enzymes, dipicolinic acid (DPA) and divalent cations) 
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and small acid soluble proteins (SASPs) (Atrih and Foster, 2002). The SASPs 
comprise about 20% of total core protein and are essential for spore resistance 
protecting its DNA (Popham et al., 1995; Leyva-Illades et al., 2007; Moeller et al., 
2009). DPA, which comprises 5 – 15% of the dry weight of spores, also plays        
a crucial role in spore resistance (Setlow, 2006). 
Basis of spore heat resistance 
The identity of targets whose damage results in heat killing of bacterial spores is 
crucial in preventing food spoilage, food poisoning and infectious diseases 
caused by spore-forming bacteria. Throughout the years, several hypotheses 
have been put forward to explain the mechanism responsible for spore 
resistance to heating e.g. core dehydration (Nakashio and Gerhardt, 1985), 
peptidoglycan expansion (Atrih et al., 1998), changes in spore core mineral 
content (Beaman and Gerhardt, 1986), denaturation of macromolecular 
components (e.g. proteins, RNA and DNA) (Belliveau et al., 1992; Setlow and 
Setlow, 1998). However, although the mechanism of spore resistance remains 
not fully understood, many factors have been identified, which modulate spore 
heat resistance: inherent thermal resistance (Warth, 1978), sporulation 
temperature and media composition (Ababouch et al., 1995; Sala et al., 1995; 
Palop et al., 1999a), core water content and permeability (Beaman and Gerhardt, 
1986; Popham et al., 1995),  spore mineral content (Bender and Marquis, 1985; 
Beaman and Gerhardt, 1986; Igura et al., 2003) and α/β-Type SASPs properties 
(Fairhead et al., 1993; Popham et al., 1995). 
 
Despite the considerable number of studies on endospore resistance, it is 
apparent that resistance does not solely rely on one factor, but it is a complex 
mechanism. The knowledge of factors responsible for differences in the heat 
resistance of spores of different organisms remains also unclear. However, 
understanding of this mechanism is crucial for food production in order to 
potentially deliver a less severe heat treatment to the product, reduce time and 
costs, while ensuring microbiological stability. 
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2.1.2 Determination of bacterial heat resistance 
There are two main methods of bacterial spore heat resistance determination: 
establishing a survivor curve or conducting thermal death time (TDT) studies. 
Survivor curve 
In this method, a known concentration of spores is heat treated in a test medium 
for a given period of time, and the number of survivors is enumerated with time. 
Enumeration of the heat treated spore suspension can be determined either by  
a Most Probable Number (MPN) method, or by plating of appropriate aliquots 
onto a microbiological growth medium. The logarithm of the number of survivors 
plotted as a function of heating time gives the survivor curve.  
 
From many years, the semilogarithmic survivor curve has been the most 
important tool used to calculate microbial survival parameters. Usually it is          
a straight line, but there are many examples in the literature where it is reported 
to be parabolic, sigmoidal, or linear but with a shoulder or tail (Figure 2.2).  
 
 
Figure 2.2 Shape of semilogarithmic survivor curve of bacterial spores after       
a heat treatment  
a) commonly observed linear curve, b) and c) linear with shoulder (Palop et al., 1999b), 
d) linear with a tail – biphasic (Peck et al., 1992a), e) sigmoid, f) parabolic (Licciardello 
and Nickerson, 1963) 
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The most common explanations for the differences in shape of a survivor curve 
are the presence of a heterogeneous population of spores, showing a different 
response (Pflug, 2001), the occurrence of spore activation, clumping, “heat 
adaptation” (Gould et al., 1983), or errors associated with the experimental 
technique, e.g. uneven dispersion of spores in the tube, therefore occurrence of 
spores being subjected to dry rather than moist heat or using the open tube 
technique (Graikoski and Kempe, 1964). 
 
Despite frequent examples of divergence (in some cases due to poor technique), 
the approach generally taken is to assume a semilogarithmic relationship, where 
at a given temperature and given time interval, the same fraction of the bacterial 
population will be destroyed regardless of the initial population size. Therefore, 
data on the heat resistance of a homogeneous population of spores gathered 
under ideal conditions (e.g. uniform lethal stress, optimal recovery media) can be 
described by first order reaction kinetics given by equation 2.1 (Bigelow and Esty 
(1920)), from which we can calculate the rate of thermal death of a specific 
organism 
 
 
     
  
        2.1 
 
where, N(t) is a number of microorganisms at the time (t) and k is a thermal 
death rate constant (min-1) expressed as 
 
   [
             
 
] 2.2 
 
where No is an initial number of microorganisms. 
A solution of the equation 2.1 is often rewritten as 
 
           
    2.3 
 
Although the survival curve technique is relatively simple, it is very time 
consuming, when a large number of strains are tested at a several temperatures. 
Through the years, several systematic experimental techniques for measuring 
the heat resistance of bacterial spores have been developed. The most common, 
Chapter 2 
48 
that allow for successive sampling and enumeration are: thermoresistometer 
(Stumbo, 1948), capillary tube method (Wilder and Nordan, 1957), screw-capped 
tube method (Kooiman and Geers, 1975), metal tube method (Odlaug and Pflug, 
1977), flask method (Bucknavage et al., 1990), universal bottle method (Gaze 
and Brown, 1990), and vial method (Juneja and Eblen, 1995). 
Thermal Death Time 
A second, common method for determining the heat resistance of bacterial 
spores is conducting Thermal Death Time (TDT) studies. TDT is the length of 
time required to kill a known number of spores in a medium at a specific 
temperature. The TDT is based on a growth/no growth method. Its precision is 
improved by increasing the number of replicates. TDT can be determined by 
exposing a spore suspension to heat for a fixed time. Spore survival is 
determined by either direct incubation or by subculturing and assessment of 
growth/no growth. The TDT is assumed to be between the longest heating time 
when a positive growth result (tmax) was noted and the shortest heating time 
when growth was not observed (tminimum) (Bigelow and Esty, 1920; Alderman et 
al., 1972), and can be expresses as the geometric mean of two times 
 
    √             2.4 
 
Commonly used practical approaches include the TDT tube (Bigelow and Esty, 
1920) and TDT can (Townsend et al., 1938). 
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2.1.3 Treatment of heat resistance data to calculate D-value 
In order to calculate the effect of temperature on the death rate of various 
microorganisms the concept of decimal reduction time (D-value) was introduced. 
The D-value is the time (min), at a particular temperature, required to reduce the 
bacterial viable count by 90% (i.e. to result in a 1-log reduction). The D-value 
depends on temperature, the type of microorganism and the food/medium in 
which the microbe is heated and it can be determined in several ways. 
Survival curve 
The most common method is to plot the log of surviving population against 
heating time. When a straight line is obtained, the D-value can be read directly 
from the slope of survival curve (Figure 2.3). If an initial shoulder is observed, the 
D-value can be obtained from the straight portion of the graph (Figure 2.2). 
 
 
Figure 2.3 Graphical representation of survival curve and concept of D-value 
 
Equally, the D-value can be estimated mathematically following from equation 
2.2, where the D-value is inversely related to the constant k (equation 2.2) 
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Thermal Death Time 
In the case of Thermal Death Time studies, the D-value can be calculated in 
several ways. The most common approaches were introduced by Stumbo 
(1948), Stumbo et al. (1950) and Schmidt (1957) or originate from equation 2.4. 
 
Stumbo (1948) used the formula 
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where a is the total number of heated samples multiplied by the number of 
spores per sample and b is the number of surviving spores (calculated by 
assuming one surviving spore per container when less than the total number of 
containers showed survival) after the heating time (t). 
 
The Stumbo-Murphy-Cochran (1950) method also used the equation 2.6 to 
estimate the number of survivors, except that now a is the total number of heated 
samples multiplied by the number of spores per tube, b is the most probable 
number of spores ( ̅  surviving the treatment per sample (calculated from 
 ̅           
 
 
, where n = total number of replicates, q = number of units 
showing no growth) multiplied by the number of replicates after an exposure time 
(t). 
 
The calculation of Schmidt (1957) is based on two assumptions: 
1) “any sample not showing survivors at a given exposure time, would not 
show survivors at longer time of exposure” 
2) “any sample showing survivors at a given exposure time would show 
survivors at a shorter exposure time”. 
These assumptions allow for calculation of the probability of sterility    
   
     
, 
where n = cumulated samples not surviving each exposure time, obtained by 
adding the negative samples downward from the shortest exposure time to the 
longest and m = cumulated samples surviving each exposure time obtained by 
adding the positive samples upward from the longest exposure time to the 
shortest).  
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Therefore, the D-value can be calculated according to 
 
      
    
         
 2.7 
 
where a is the initial number of spores per tube and LD50 is a point on                 
a probability curve (obtained from plotting the probability of sterility versus time), 
that represents the time, at which 50% of tubes will be sterile. 
 
Alternatively a D-value can be estimated using equation 2.8 
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where TDT is calculated according to equation 2.4 and nD is a reduction of 
orders of magnitude (e.g. if N0 = 10
9 of spores, therefore nD = 9). 
 
The D-values calculated according to above methods, based on an example with 
N0 = 10
9 spores, T = 90°C and 10 replicate cans, are summarised in Table 2.3 
and Table 2.4. 
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Heating 
time (t) 
No. of containers Stumbo (1948) Stumbo et al. (1950) Schmidt (1957) 
minutes Tested +ve -ve loga b logb 
D-
value q n/q log(n/q)  ̅ b logb 
D-
value loga m n m+n P 
D-
value 
2.0 10 9 1 10 9 0.95 0.22 1 10.00 1.00 2.30 23.03 1.36 0.23 9 19 1 20 0.09  
2.5 10 7 3 10 7 0.85 0.27 3 3.33 0.52 1.20 12.04 1.08 0.28 9 10 4 14 0.31  
3.0 10 2 8 10 2 0.30 0.30 9 1.11 0.05 0.11 2.23 0.02 0.30 9 3 13 16 0.78  
3.5 10 1 9 10 1 0.00 0.36 8 1.25 0.10 0.22 1.05 0.35 0.36 9 2 21 23 0.88  
4.0 10 0 10 10           9 0 31 31 0.97  
Mean D-value     0.29       0.29      0.28 
Table 2.3 Calculations of D-value according to the procedures of Stumbo (1948), Stumbo et al. (1950) and Schmidt (1957) 
 
 
Table 2.4 Calculation of D-value according to equation 2.4 
+ve – number of positive containers after heating time (t) 
-ve – number of sterile containers after heating time (t) 
Heating time (t) No. of containers Replicates 
minutes Tested +ve -ve 1 2 3 4 5 6 7 8 9 10 
2.0 10 9 1 - + + + + + + + + + 
2.5 10 7 3 - - - + + + + + + + 
3.0 10 2 8 - - - - - - - - + + 
3.5 10 1 9 - - - - - - - - - + 
4.0 10 0 10 - - - - - - - - - - 
9D 
   
0.00 2.24 2.24 2.74 2.74 2.74 2.74 2.74 3.24 3.74 
D-value 
   
0.00 0.25 0.25 0.30 0.30 0.30 0.30 0.30 0.40 0.42 
Mean D-value 
  
0.31 
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2.1.4 Calculation of z-value 
A D-value refers to a specific temperature. In order to calculate equivalent 
thermal processes and indicate the relative impact of heating at different 
temperatures on a microorganism, the concept of z-value was introduced. It is    
a measure of the change in death rate with a change in temperature. The z-value 
is a change of temperature (°C), for which the D-value is reduced/increased by   
a factor of 10, and may be expressed as follows 
 
   
     
                 
 2.9 
 
in which logD(T1) and logD(T2) are logD values corresponding to T1 and T2. 
Smaller z-values indicate greater sensitivity to increasing heating treatment. The 
z-value can also be determine by plotting (at least two) logD values versus 
temperature (Figure 2.4). 
 
 
Figure 2.4 Graphical representation of the concept of z-value 
 
D and z-values are the most common parameters use in the food industry for 
describing the impact of heat treatment (and other technologies) on the reduction 
of a microbial population. Together these are used for the development of food 
preservation processes to ensure the safety of food for consumers. 
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2.1.5 Alternatives and limitations of D-values 
F-value 
In order to determine the effect of a heat process for a particular food, the F-
value may be used (Pflug, 1987). The F-value (min) is often a sterilization 
process, which aims to inactivate bacterial spores and is generally used at 
temperatures greater than 100°C. It can be converted to other temperatures 
(using a specific z-value) and is a characteristic value for each type of food, due 
the influence of food properties on the destruction of spores. The F-value is        
a central concept in the canning industry, where it is referred to as F0, the 
“reference unit of lethality”. Heating at 121°C for 3 min is known as Fo = 3 (with z-
value = 10°C), which aims to provide 1012 reduction of population density of 
proteolytic C. botulinum spores in low acid canned foods (Hoxey et al., 2006). 
The F-value can be calculated from the equation (Pflug and Gould, 2000) 
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where, N(F) is the endpoint of preservation process, the number of surviving 
microorganisms per unit. 
Alternatives to D-values 
As mentioned above, many deviations from the straight line of semilogarithmic 
survivor curves have been reported. Therefore, in order to model the microbial 
survival curves, alternative approaches to first order reaction kinetics have been 
proposed by Linton et al. (1996), Anderson et al. (1996), Xiong et al. (1999) and 
Stone et al. (2009). These and other authors have used alternative models to 
describe thermal death data and to calculate death rate parameters. 
 
A substitute for D-value has been suggested by Mossel (1977); as MPEDn-
values (most probable effective heat dissipation to achieve n overall decimal 
reduction of CFU under certain conditions), which solved the problem of 
shoulders and tailing. Also Valdramidis, Bernaerts, Van Impe and Geeraerd 
(2005) defined an alternative parameter denoted as txD (time required for x log 
reductions in the microbial population (or xD)). 
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Limitations of D-value 
Despite the utility of D and z-values in designing the heat process to ensure the 
microbial safety and quality of food, there are certain limitations that should be 
considered. First of all, the D-value is a specific parameter for a particular 
microorganism, therefore care should be taken when it is used for identification 
and comparison of heat resistance of different microorganisms. Limitations of   
D-value are also associated with the experimental procedure itself. Many factors 
such as age of culture, estimate of initial number of spores, pH of suspension, 
dimensions of test tubes, thickness of glass in tubes and experience of the 
experimenter have a large impact on the value of heat resistance parameters. 
Pflug (2001) indicated that using the initial number of organisms as 106 in 
calculations instead of a true value of 0.5 x 106 causes underestimation of         
D-value by 5%. Therefore it is important to determine the N0 precisely.                
A challenge also arises from temperature control and temperature changes 
during the heat treatment. Also care should be taken when comparing the data 
generated by different laboratories. Pflug (2005) has shown that there is             
a variability in D-values measured by various laboratories, even using the same 
testing system. 
 
In spite of evidence of deviations from the first order kinetics model, with 
consequent doubts in the accuracy of D and z-values, there is no universally 
accepted alternative approach, therefore these parameters still have wide use for 
determining the heat process for novel formulation of food products. 
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2.1.6 Rationale for this review 
An extensive literature survey has been carried out in order to provide                 
a comprehensive description of the thermal death of spores of non-proteolytic   
C. botulinum, and to identify and characterise strain variability. Very often the 
presence of lysozyme in the recovery medium and other recovery conditions are 
responsible for variability of D and z-values between strains of non-proteolytic   
C. botulinum. However, previously such data have not been collected in              
a systematic and extensive manner. Therefore the outputs of this review can 
provide information for updating microbiological risk assessment and helping to 
ensure the microbiological safety of new minimally heated chilled food products. 
Previous reviews 
Five other reviews of the heat resistance of spores of non-proteolytic                 
C. botulinum have been carried out (Lund and Notermans, 1993; ICMSF, 1996; 
Lindström et al., 2006; Membrè and McClure, 2006; Stringer and Peck, 2008). 
Lund and Notermans (1993) reported 12 sources, ICMSF (1996) collected D and 
z-values from 9 sources, Lindström et al. (2006) summarised data from 18 
studies, Membré and McClure (2006) described 24 sources, and Stringer and 
Peck (2008) collected data from 20 studies. 
Some conclusions from these reviews are: 
i. heat resistance of spores depends on many factors (type of strain tested, 
composition of heating menstruum and recovery conditions), 
ii. spores of non-proteolytic C. botulinum type B strains are more resistant 
than those of type E and F, 
iii. in most of these studies thermal inactivation appeared to follow the first-
order reaction kinetics, from which D-values were calculated,  
iv. presence of lytic enzymes, e.g. lysozyme, in recovery medium increase 
the recovery of viable, sublethally damaged spores 
The above reviews provide valuable information about the range of D and          
z-values of non-proteolytic C. botulinum in different heating mentruum at different 
temperatures. Nevertheless, they do not (except Membré and McClure (2006)) 
analyse/model these data to determine the most appropriate target heat process 
and z-value to allow the setting of equivalent process for the manufacture of 
microbiologically safe minimally heated chilled foods. 
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Objectives 
The purpose of this study was to collect and summarize literature data on the 
thermal inactivation of spores of non-proteolytic C. botulinum, in a systematic 
manner, and to use this information to derive probabilistic distributions for 
parameters of thermal inactivation models for inclusion in QMRA. Additionally, 
the validity of current recommendations for food processing and the effect of 
toxin type on spore heat resistance is considered. 
The contribution of this review 
According to the most recent QMRA guidelines (USDA/FSIS and EPA, 2012) risk 
assessments should be established on systematically developed scientific 
evidence, presented in a clear, transparent way, which would be easily 
communicated to interested bodies. In this thesis, a systematic review of 
literature data has been carried out in a transparent and reproducible manner, 
following a standard set of stages, to ensure that relevant and reliable data are 
available for a QMRA model. Hence, this provides a comprehensive description 
of knowledge on the heat resistance of non-proteolytic C. botulinum spores in 
foods.  
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2.2 Methods of literature search and data analysis 
2.2.1 Search methods for identification of studies 
A systematic review on the heat resistance of non-proteolytic C. botulinum 
spores has been performed. Resources included online databases (Web of 
Science, SCOPUS, PubMed and Google Scholar), published reviews, personal 
literature collections, unpublished Institute of Food Research data and 
references cited in eligible articles.  
 
Electronic searches 
The search was performed on the following electronic databases: 
 Web of Science (1977 to February 2011) (Figure 2.5) 
Advanced search (ts-subject) 
1. ts = botulinum (#1) 
2. ts = spores (#2) 
3. ts = heat (#3), ts = temperature (#4), ts = inactivation (#5), ts = thermal (#6) 
4. #3 OR #4 OR #5 OR #6 (#7) 
5. #1 AND #2 AND #7 
 SCOPUS (1973 – 2011) 
Advanced search 
1. ALL (“botulinum”) (#1) 
2. ALL (“spores”) (#2) 
3. ALL (“heat treatment”) OR (“temperature”) OR (“inactivation”) OR 
(“thermal”) (#3) 
4. #1 AND #2 AND #3 (#4) 
5. ALL(“type B”) OR (“type E”) OR (“type F”) (#5) 
6. #4 AND #5 
 PubMEd 
1. All fields (“botulinum”) 
2. All fields (“spores”) 
3. All fields (“heat or inactivation or thermal or survival”) 
4. #1 AND #2 AND #3 
 Google Scholar (1920 – 2011) 
Advanced Scholar Search 
1. articles with the exact phrase “botulinum spores” 
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2. with at least one of the words “treatment” OR “heat” OR “thermal” OR 
“inactivation” 
3. words occur: anywhere in the article 
4. articles only in: Biology, Life Science, Environmental Science, Medicine, 
Pharmacology, Veterinary Science 
 
 
Figure 2.5 Number of references identified from example key words from 
electronic searches in Web of Science 
 
Searching other resources 
Manual searching 
Private databases of Dr Terry A. Roberts, Dr Barbara M. Lund and Prof Michael 
W. Peck and the Institute of Food Research lab books were searched manually.  
 
Personal contacts 
The review includes data originating from private organizations e.g. Unilever. 
One academic dissertation was obtained throughout personal contact with Dr 
Miia Lindström. Personal contact with Dr Sandra C. Stringer, Dr Barbara M. 
Lund, Prof Michael W. Peck and Dr Gary C. Barker ensured that important 
articles have not been missed. 
botulinum
n = 15,258
spores
n = 35,759
heat OR temperature 
OR inactivation OR
thermal n = 2,813,840
Web of Science 
database
1977 - 2011
Included in all 3
n = 385
Eligible
n = 16
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Searches were not restricted by country or language. The references of the 
eligible articles were also searched, a process that was conducted until no new 
references were identified. Previous reviews were also searched for possible 
references. Non-peer reviewed articles were also included.  
Criteria and quality assessment of studies 
Studies, which were considered as eligible, were assessed against quality 
criteria in order to minimize the risk of bias. There is no standard agreement on 
assessing the quality of research. According to the guidance of CRD (2009) for 
conducting systematic reviews, so far two tools have been developed for 
assessing quality, such us: checklists of quality items and scales with summary 
scores. Since, a checklist is more flexible and can be specifically designed for 
particular studies; it was used in this review. 
Each study was assessed against methodological quality criteria according to 
whether: 
a) the aim of the study was measuring the heat resistance of C. botulinum 
spores  
b) non-proteolytic C. botulinum strains were tested 
c) thermal treatment was performed by wet thermal process, but does not 
include high pressure processing, pulse electric field process or 
microwave energy 
d) spore suspensions were used in studies 
e) tests were performed in the range 50 – 95˚C  
f) thermal death point clearly present heat treatment (e.g. come up time) 
g) the strain name or toxin type was defined 
h) there was an adequate description of heating menstruum used 
i) there was an adequate description of heating method 
j) there was an adequate description of recovery method  
k) there was an adequate description of recovery media  
l) there was an adequate description of recovery conditions 
m) D and z-values were given by the author 
n) there was an adequate description of D and z-value method calculation 
o) D-value measures more than 1 log reduction of initial spore concentration 
p) there are no inhibitory factors in heating menstruum or during recovering 
(e.g. low pH) 
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q) if D and z-values were not given, it was possible to calculate them from 
surviving data by plotting and fitting the best straight line by linear 
regression. In case of TDT method, where at least two points were given 
(the last positive and the first negative) the D-value of non-proteolytic      
C. botulinum was calculated using equation 2.4 
Data with lysozyme (+LYS) in a recovery medium: 
r) kinetic data with LYS clearly separates heat sensitive and heat resistant 
fraction and shows an example curve 
 
Studies did not have to meet all 16 or 17 (in the case of publications with 
lysozyme in recovery media) criteria to be included in the analysis. The 
mandatory criteria are those from ‘a’ to ‘e’ and ‘m or q’ (points ‘m’ and ‘q’ are 
treated as interchangeable). The remaining points take account of the precision 
and methodological reliability of the study. Studies that met fewer than 8 of the 
above criteria and did not meet the mandatory criteria were considered as ‘low’ 
quality, those meeting 8 – 12 (13 for data with lysozyme) criteria were of 
‘medium’ quality, and those meeting 13 – 16 (17 for data with lysozyme) criteria 
were of ‘high’ quality. Only studies of medium and high quality were included in 
the final analysis.  
 
When the TDT method was used in studies with lysozyme, the document was 
only assessed against criteria but no quality rank was given. These data were 
analysed separately, since it was impossible to distinguish heat sensitive and 
heat resistant fractions. This rule was applied to the following publications: 
Notermans et al. (1990), Peterson et al. (1997), Scott and Bernard (1985), 
Juneja and Eblen (1995), Juneja et al. (1995a and 1995b). Although in the last 
three studies the heat resistance of spores was determined using the survivor 
curve, there was no graphical representation of an example curve and the 
authors calculated only one D-value. 
 
Collecting the data from the included studies 
Extracted data were labelled by strain and type of toxin produced, heating 
menstruum, temperature of heat treatment, D (min) and z-values (˚C) and its 
method of calculation, heating method, recovery medium, and conditions. Where 
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possible pH, aw and addition of various nutrients to heating mentruum were also 
recorded. All data were included in an Microsoft Excel spreadsheet (Microsoft 
Excel, 2010). If the D-value was not reported, but the source provided                 
a temperature at which the heat treatment was performed, starting inoculum and 
surviving spores, the D-value was determined from given tables or figures by 
fitting the best straight line using linear regression. When the heat treatment was 
conducted using the TDT method, the D-value was calculated according to 
equation 2.4. Some z-values were determined from reported or calculated        
D-values. In some publications the original authors questioned the quality of 
either the methodology or the way the experiment was conducted. In these 
cases such data were not included. In many cases the eligibility of articles 
retrieved by the electronic and manual searches was discussed with a senior 
scientist at IFR. Endnote X6 (2012) software was used for managing the 
bibliographic records.  
An overview of the statistical and mathematical approach 
Thermal properties of non-proteolytic C. botulinum spores are represented by     
a complex set of D and z-values, often labelled by categorical variables that 
included: strain name, toxin type, heating menstruum, heating technique and 
method of D-value calculation. The aim of the mathematical approach is to 
present the probability distribution for parameters D and z. In order to obtain       
a distribution for D, that describes the whole collected dataset, known D-values 
measured at various temperatures are transformed to one particular temperature 
using a known z-value. Additionally, a statistical analysis is used to evaluate the 
full database and to identify factors that influence the magnitude of the 
parameters above. Differences between groups of D-values are examined by     
a standard t-test. In the case of two or more groups the difference between mean 
D-values is tested using one-way analysis of variance (ANOVA), by SPSS 
Statistics software (IBM (version 21), 2012). The assumption of homogeneity of 
population variance is tested by Levene’s test.  When the homogeneity is 
assumed, the Tukey test was used in post-hoc analysis. If the assumption 
regarding the equal variance was violated, an adjusted F- statistic by Welch 
statistic was used with Games-Howell (which allows for comparison of groups 
with unequal variance and sample size) as the post-hoc test. The differences 
were tested at a 5% significance level. 
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2.2.2 Statistical and mathematical analysis 
A number of authors e.g. Scott and Bernard (1985), Peck et al. (1993) observed 
that the presence of lytic enzymes during recovery had a large effect on the 
measured decimal reduction time for spores of non-proteolytic C. botulinum. 
Therefore the collected data from 48 eligible sources was divided into two major 
subsets. Firstly, -LYS (recovery of spores in the absence of lysozyme) and 
secondly +LYS (recovery of spores in the presence of lysozyme). The lysozyme 
was either deliberately added to medium in which spores were recovered, or the 
heat treatment and recovery was conducted in a food substrate, where the 
activity of lytic enzymes has previously been observed. 
 
Due to the occurrence of biphasic survival curves for recovery in the presence of 
lysozyme, D-values were determined for each part of the curve: i.e. for the 
fraction of spores not permeable to lysozyme (heat sensitive (+LYS HS)) and for 
the fraction of spores permeable to lysozyme (heat resistant (+LYS HR)). When 
the heat resistance of spores was determined by the TDT method (+LYS TDT), 
the data were treated separately (this subset also contains the publications of 
Juneja et al. as mentioned above). 
 
The number of reports for both parameters D and z were plotted against 
temperature to illustrate the minimum, maximum and dominant temperatures at 
which experiments were performed for all strains and for particular toxin types.  
 
The average value of logD(T), at every fixed temperature, T, was plotted (for 
both subsets of data (-LYS) and (+LYS)) against the temperature to illustrate    
D-values and to fit a thermal destruction line using the method of least squares. 
 
Throughout the analysis the following expressions were used: all strains –        
D-values for all strains (irrespectively on toxin type), type B toxin strains, type E 
toxin strains, type F toxin strains and mixed strains – i.e. a “cocktail” of strains, 
which corresponds to a mixture of more than one toxin type.  
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2.2.2.1 Probability distribution of D(T) 
Under particular conditions D-values are fixed but uncertain. A distribution used 
to represent uncertain D-values should correspond with all non-negative values. 
Moreover, although D-values are finite in general extreme (high) values cannot 
be ignored and this should be considered when developing the uncertainty 
distributions.  
 
As lognormal distribution meets these requirements, and is a well-known 
distribution for microbiologists and this was used to express the uncertainty 
concerning the measured D-value at fixed temperature (T)  
 
         (
 
√       
)  
              
    2.11 
 
where µ and σ are the mean and standard deviation of the natural logarithm of D. 
Collected D-values vary over a wide range; therefore the lognormal distribution is 
consistent with the collected data. 
 
The statistical descriptors of the data, <D> and σD, are related to the lognormal 
parameters according to 
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and 
   √     
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The transformation of parameters from ln<D> to log<D> involves a simple 
change of base: log<D> = ln<D>/ln(10). 
 
2.2.2.2 Probability distribution of z-value 
Similarly to D-values, under particular conditions, the z-value is fixed but 
uncertain. It is normal to assume that z-value is bounded by minimal and 
maximal values. In this case distribution for the uncertainty associated with        
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z-value is limited to distributions which cover real values e.g. beta, triangular or 
uniform. In this work the uncertainty associated with z-value was represented by 
a beta distribution. The distribution of z-values was fitted to a beta distribution 
with four parameters (a, c, α1 and α2) 
 
       
                  
                    
 2.14 
 
where a and c are the minimum and maximum values of the range, α1 and α2 are 
continuous shape parameters and β  is the Beta Function 
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The mean, <z>, of the beta distribution is given by 
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The cumulative beta probability density function, CDF, can be used in the add-in 
package Solver® for Microsoft Excel (2010) to establish the fitted parameters. 
The fit was achieved by minimizing the sum of squared deviations, SS, of the 
differences between the actual data and the fit (least squares fitting) 
 
    ∑[       ]
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where, yi is the data point, and yfit is the value of the fitted distribution. The initial 
estimates of distribution parameters (a, c, α1 and α2) were changed several times 
and the fit recalculated in order to obtain the smallest SS value. When the same 
z-value was recorded on more than one occasion, only one point is used in the 
cumulative distribution fitting process. Therefore, the model gives a conservative 
bias to predicted values. Fitted parameters were subjected to some constraints 
such as e.g. α > 0. 
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The upper and lower confidence interval, UCL and LCL, for the parameter, and 
the assessment of goodness of fit were calculated according to method 
described by Brown (2001). The confidence interval of  ̂ were calculated 
according to the formula 
 
     ̂             2.18 
 
where  ̂ represents one of four parameters, n is the number of observations, p is 
the number of parameters, tα,n - p is the 100(1 - α/2) percentile of the t-distribution 
with n - p degrees of freedom, α is confidence level and S.E. is an estimate of 
parameter’s standard error (which expresses the variability arising from the 
sampling process). 
 
2.2.2.3 Probability distribution of D'(Tref) 
The data concerning D-values reflect measurements at several temperatures. 
Nevertheless, when using a z-value it is possible to convert the information about 
D(T) to one reference temperature, Tref. In this case 80°C was used as Tref, since 
it is a dominant temperature at which the measurement of D-values were 
conducted. Moreover, it is a commonly applied temperature in production of 
minimally heated chilled foods. The transformation of D(T) into D'(Tref) can be 
made following the definition of z (equation 2.9) 
 
   (    )        
            2.19 
 
All D(T) are converted to equivalent D'(80) using two approaches: when z-value 
is dependent on and independent of temperature. In the first case, the z-value 
used in calculations corresponds to the actual temperature range at which the 
heat resistance was conducted. When a z-value is not given for the particular 
experiment for -LYS data, the corresponding mean value for a toxin type is used 
(for type B, E, F and mixed strains <z> = 6.9°C, 6.9°C, 6.5°C and 6.7°C 
respectively). If the information about the z-value was missing for +LYS data, the 
mean value of z = 7.5°C, 9.6°C and 11.4°C for HS, HR and TDT respectively 
were used.  
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When the independence of z-value on T is assumed, the beta distribution of      
z-value as described above is used. The transformation of probability distribution 
can be written symbolically as 
 
  (     (    ))   (       )  
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where logD(T) is the logarithm of the D-value at fixed T. The computation of 
uncertainty regarding the z-value in equation 2.20 can be performed using          
a Monte Carlo simulation process (described in details in section 5.1.4) with 
@RISK – risk analysis add-in for Microsoft Excel software (2010). 
 
The parameters of p(logD'(80)) are obtained for ten subsets of D'(80) 
corresponding to T in different temperature ranges: 50 – 79°C, 50 – 80°C,        
50 – 81°C, 50 – 82°C, 50 – 83°C, 50 – 85°C, 50 – 88°C, 50 – 90°C, 50 – 92°C 
and 50 – 93°C. To build the final distribution, in each case the distribution of 
p(logD'(80)) is weighted according to the number of experiments conducted at 
each temperature. For a graphical presentation of logD'(80), a box plot was 
used, with minimum, maximum – whiskers, mean – vertical line inside the box 
and 95th and 5th percentiles – top and bottom of box. 
 
2.2.2.4 Anderson-Darling test 
To test if logD(T) values transformed to logD'(80) to build the distribution of 
p(logD'(80)) are consistent across the temperature range the Anderson-Darling 
test is used. The test compares the distribution of empirical data with                  
a theoretical normal distribution, and its parameter is defined as 
 
         2.21 
 
where n is the sample size and S is calculated according to 
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where the F(Yi) is a cumulative distribution function of the particular p(logD'(80)). 
The Anderson-Darling statistic tests whether data is normally distributed. The 
hypothesis regarding the distributional form is rejected at a significance level, if 
the calculated value, A2, is greater than the critical value, given in Table 2.5. 
 
Distribution α = 0.15 α = 0.10 α = 0.05 α = 0.025 α = 0.01 
Critical value 1.610 1.933 2.492 3.070 3.857 
Table 2.5 The critical values for Anderson-Darling test for normal distribution 
Source: Stephens (1974) 
 
In order to conduct the Anderson-Darling test, each D(T) collected from the 
literature is converted to logD'(80) with assumed dependency of z on T (as 
described above). Ten subsets of logD'(80) have been created corresponding to 
different temperature ranges. For each subset <logD'(80)> and σlogD'(80) have 
been calculated and an Anderson-Darling test conducted. The analysis has two 
purposes: to test if the normal distribution is a good representation of the data for 
logD'(80), and to assess if the form of the D-value distribution changes as 
successively higher temperatures are included in the range: e.g. if D-value 
measured at higher T transformed to logD'(80) belongs to the same population. 
 
2.2.2.5 Testing the significance of T and z-value dependence 
An independent sample t-test with unequal variance was conducted to compare 
the differences in logD'(80) based on two assumptions: a z-value dependent on 
and independent of T (a significance level 5% was used). 
 
2.2.2.6 Testing the validity of temperature transformation 
In order to verify the validity of the D'(80) transformation, a one-way ANOVA was 
conducted. The ANOVA compares the means of logD'(80) evaluated from data in 
temperature ranges from 50 to 83°C and logD'(80) evaluated from one particular 
temperature. The test was conducted for data at four dominant temperatures:     
T = 70°C, 75°C, 77°C, 82°C. Additionally the mean of logD'(80) was compared 
with logD values measured at a fixed temperature of 80°C (D(80)). In total six 
pairwise comparisons were made. The logD'(80) with assumed dependence of  
z-value on T was used in the analysis. 
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2.2.2.7 Testing the dependence of spore heat resistance on toxin type 
The hypothesis stating that there is no significant difference in spore heat 
resistance for spores with different toxin type was tested at four temperatures. 
For D(75) an independent sample t-test was performed for type B and E toxin 
type strains. A one-way ANOVA was conducted for pairwise comparison of 
D(80), D(82) and D'(80) converted from temperatures at 50 – 83°C for type B, E, 
F and mixed strains. 
 
2.2.2.8 Testing the dependence of spore heat resistance on heating 
menstruum 
The complete set of logD(T) values was plotted against T, and linear regression 
computed  
 
              2.23 
 
where parameters α is intercept and β is the slope of the linear regression which 
is equivalent to inverse of the z-value, β = 1/z. With logD(T) as the response 
variable and T as the factor, a linear regression procedure using MS Excel was 
performed to estimate α and β. Estimated parameters are used to calculate the 
z-value and corresponding D'(80) for culture media and food matrices. The 95th 
and 99th UCL of predicted response and 95th UCL and LCL of the fit are 
estimated. Based on equation 2.23 the 99th UCL of the model was used to 
calculate the heating time at 80°C needed for a 6D reduction of spore 
concentration as a function of T in order to review current process 
recommendations. 
 
In order to determine whether there is a difference in heat resistance of spores 
measured in culture media and food matrices a standard t-test and a 5% 
significance level was used. 
 
2.2.2.9 Testing the dependence of spore heat resistance on heating 
technique 
To examine whether spore heat resistance is dependent on the heating 
technique used, a one-way ANOVA was conducted. The analysis was carried 
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out for logD'(80) measured using nine different heating techniques reported in 48 
eligible studies.  
 
2.2.2.10 Testing the dependence of spore heat resistance on method of    
D-value calculation 
A one-way ANOVA was used to compare the mean of logD'(80) derived from 
data according to four methods of D-value calculation.  
 
2.2.2.11 Testing the dependence of spore heat resistance on strain of non-
proteolytic C. botulinum 
An unsupervised hierarchical clustering algorithm, with dissimilarity metric based 
on Euclidean distance, was used to indicate a strain classification pattern based 
on their heat resistance. Clustering was conducted using SPSS Statistics 
software. The hypothesis that there is a significant difference in spore heat 
resistance between different strains of non-proteolytic C. botulinum was tested 
for seven strains for which there were at least 20 D-values in the database. The 
analysis was conducted based on logDˈ(80) values using a one-way ANOVA. 
 
2.2.2.12 Testing the dependence of spore heat resistance on testing 
laboratory 
In order to test whether D-values are significantly different in relation to 
laboratory (or authors) in which they were generated, the one-way ANOVA was 
use. The analysis was conducted for six laboratories, from which the largest 
number of D-values was recorded. 
 
2.2.2.13 Testing the similarity of +LYS HS and +LYS HR fractions 
The significant difference in heat resistance of spores permeable and not 
permeable to lysozyme was tested using a standard t-test with assumed unequal 
variance. The analysis was performed for +LYS HS and HR fractions of D-values 
measured at T = 75°C, 78°C and 80°C and D'(80). For HS fraction a D'(80) 
transformed from the temperature range 75 – 83°C, and for HR fraction D'(80) in 
a temperature range between 75 – 95°C, was used. A similar procedure was 
applied in order to compare the D-value of the +LYS HS fraction with -LYS data 
at T = 78°C, 80°C and D'(80). A significance level of 5% was used. 
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Other 
Unpublished data, 
personal contacts, 
references of eligible 
articles 
Eligible n = 10b) 
Total n = 48 sources 
Searching: Databases, manual searching, unpublished data, personal 
contacts, references of eligible articles 
 Total reports identified: n = 15,037 
 
Manual search 
Dr Terry A. Roberts,  
Dr Barbara M. Lund and 
Prof Michael W. Peck 
private databases 
Total reports screened 
n= 13,648 
Total “botulinum” 
identified 
n = 66,220 
Total “spores” 
identified 
n = 164,534 
Total 
“heat/thermal/inactivation
/temperature/heat 
treatment/survival” 
n = 5,421,672 
Electronic Searches 
Google Scholar (n = 157) 
Web of Science (n = 385) 
SCOPUS (n = 566) 
PubMed (n = 181) 
 
Reports meeting all 
three criteria 
 n = 1,289 
Eligible n = 22a) Eligible n = 16 
Total reports screened 
n = 100 
2.3 Results 
2.3.1 Description of studies on spore heat resistance 
2.3.1.1 Output of literature search 
The searches identified a total of 15,037 records. Figure 2.6 describes the flow of 
these records through the map.  
 
A manual search of private databases yielded 16 eligible publications (Figure 
2.6). 
Figure 2.6 Flow literature search, for non-proteolytic C. botulinum spores heat 
resistance, through the map  
a) 22 eligible articles not found in previous manual search 
b) 10 eligible articles not found in previous searches 
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Keywords for electronic searches of public databases varied according to 
database. A search of article’s title in Google Scholar for “botulinum” (with of all 
the words), “spores” (with the exact phrase), 
“heat”/”thermal”/”inactivation”/”temperature”/”heat treatment”/”survival” (with at 
least one of the words), yielded 157 records. A search of the 1977 – 2011 Web 
of Science for “botulinum” (ts = topic) yielded 15,258 citations, search for 
“spores” (ts) yielded 35,759 citations, for 
“heat”/“temperature”/“inactivation”/“thermal” (ts) yielded 2,813,840 citations. 
There were 385 citations that were included in all three searches (Figure 2.6).    
A search of the 1973 – 2011 SCOPUS for “botulinum” (all fields) yielded 37,071 
citations, for “spores” 99,377, for “heat treatment”/“temperature”/“inactivation”/ 
“thermal” 1,194,345 references. Combining all three citations yielded 955 
sources. Due to the large number of citations further search (type B strain/type 
E/type F) yielded 4,358,280 citations. The combination of four searches 
generated 566 references. Advanced search for “botulinum” in PubMed yielded 
13,891 citations, for “spores” 29,398 and 
“heat”/“temperature”/“inactivation”/“thermal”/“survival” 1413,487 citations. There 
were 181 sources that were included in all three searches. In total from 
electronic searches twenty-two publications were judged eligible. 
 
Other sources yielded a further ten eligible articles, to give a total of 48 eligible 
articles (Figure 2.6).  
 
2.3.1.2 Analysis of electronic search (Web of Science and SCOPUS 
example) 
Further analysis has been carried out of results from searches of Web of Science 
and SCOPUS. A search of the Web of Science database yielded 385 citations 
that include all three searches (botulinum AND spores AND (heat OR 
temperature OR inactivation OR thermal)). The most common sources were the 
Journal of Food Protection (83 records), Applied and Environmental Microbiology 
(37 records) and International Journal of Food Microbiology (32 records). Similar 
results were obtained in searching of SCOPUS, with Journal of Food Protection 
showing 76 records, International Journal of Food Microbiology 66 records, and 
Applied and Environmental Microbiology 37 records (Table 2.6). 
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Table 2.6 Number of records for non-proteolytic C. botulinum spore heat 
resistance, rank by source in Web of Science and SCOPUS search 
 
The most common records appearing in both databases that met all searching 
criteria included M. W. Peck as an author, with 41 in Web of Science and 46 
records in SCOPUS (Figure 2.7). The second most common author was V. M. 
Balasubramaniam with 20 in Web of Science and 16 records in SCOPUS 
database. Records of V. K. Juneja, T. J. Montville and S. C. Stringer appeared 
12 times each in Web of Science search, and 13, 5 and 13 respectively in 
SCOPUS (Figure 2.7). 
 
 
Figure 2.7 Summary of the eleven authors, who have published most articles on 
non-proteolytic C. botulinum spore heat resistance (by number of articles found 
in SCOPUS and Web of Science databases) 
SCOPUS database (orange bars), Web of Science (green bars) 
0 10 20 30 40 50
Peck, M.W.
Balasubramania…
Juneja, V.K.
Montville, T.J.
Stringer, S.C.
Korkeala, H.
Lindström, M.
Solomon, H.M.
Schaffner, D.W.
Smith, J.P.
Carlin, F.
Number of documents
Source 
Web of Science SCOPUS 
Record 
count 
% of 
385 
Record 
count 
% of 
566 
Journal of Food Protection 83 22 76 13 
Applied and Environmental Micro. 37 10 37 7 
International Journal Food Micro. 32 8 66 12 
Journal of Food Science 25 6 24 4 
Food Microbiology 19 5 24 4 
Letters in Applied Microbiology 17 4 12 2 
Journal of Applied Microbiology 16 4 30 5 
Journal of Food Safety 12 3 12 2 
Food Control 6 2 9 2 
Journal of Food Engineering 6 2 11 2 
Critical Reviews in Food Science 2 0 12 2 
Other sources 130 34 313 45 
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Approximately 41% (Web of Science) and 32% (SCOPUS) of records were from 
authors based in USA, 18% (Web of Science) and 17% (SCOPUS) from UK-
based authors, and 5% (Web of Science and SCOPUS) were from authors 
located in Canada (Table 2.7). A majority of the documents were published in the 
period between 2000 and 2011. The number of published recorded in SCOPUS 
database increased from only six before 1995, to on average of 31 documents 
per year between 1997 and 2009, and 65 records in 2010 (Figure 2.8). 
 
Table 2.7 Number of records for non-proteolytic C. botulinum spore heat 
resistance by country of laboratory in Web of Science and SCOPUS search 
 
 
Figure 2.8 Number of records for non-proteolytic C. botulinum spore heat 
resistance search, published annually in SCOPUS and Web of Science between 
1990 and 2011 
SCOPUS database (orange line), Web of Science (green line) 
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Year
Source 
Web of Science SCOPUS 
Record 
count 
% of 385 
Record 
count 
% of 566 
USA 159 41 183 32 
UK 71 18 94 17 
Canada 20 5 27 5 
France 18 5 44 8 
Australia 17 4 24 4 
Netherlands 16 4 29 5 
Spain 16 4 41 7 
Finland 13 3 18 3 
New Zealand 11 3 19 3 
Germany 10 3 19 3 
Other sources 34 9 68 12 
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2.3.1.3 Eligible records 
The most common reason for exclusion of studies was testing of proteolytic      
C. botulinum strains. Further reports were excluded as tests were performed on 
vegetative cells or heat resistance of toxins was tested. Many publications 
described inactivation of non-proteolytic C. botulinum by high pressure 
processing, radiation or chemical treatment; therefore they were also excluded 
from the analysis. As of September 2011, 48 eligible studies were identified. 
Appendix 1 provides a summary of included studies. 
 
Although differences in the physiological properties of certain toxin types of         
C. botulinum were observed in the early decades of 20th century (Gunnison and 
Meyer, 1929), the first study on the heat resistance of non-proteolytic                
C. botulinum spores was reported in 1950’s. Nine reports were published before 
1969, ten between 1970 – 1979 and six between 1980 – 1989. The majority had 
publication dates between 1990 and 1999, with only three reports dated between 
2000 and 2011 (Figure 2.9). 
 
 
Figure 2.9 Eligible records of non-proteolytic C. botulinum spore heat resistance 
studies by publication date (n = 48) 
Pre – 1959 (dark blue), 1960 – 1969 (red), 1970 – 1979 (green), 1980 – 1989 (violet), 
1990 – 1999 (light blue), 2000 – 2011 (orange) 
2%
19%
21%
13%
40%
6%
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The largest numbers of eligible studies were published in the Journal of Food 
Protection (9), Journal of Food Science (6), Applied and Environmental 
Microbiology (4), Letters in Applied Microbiology (4), Journal of Applied 
Microbiology (2), Journal of Food Safety (2) and Journal of General Microbiology 
(2). Other journals, e.g. Journal of Milk and Food Technology, Marine Fisheries 
Review, Food Science (TAIPEI) and Australian Journal of Biological Science 
published one study each. Nine studies were published in Conference 
Proceedings (3), Academic dissertations (3) and Reports (3). Two studies were 
reported in Technical Memoranda, and single studies were published in a book 
and an abstract of annual meeting and a research bulletin. The database also 
contains unpublished data from the Institute of Food Research (Figure 2.10). 
 
 
Figure 2.10 Eligible records of non-proteolytic C. botulinum spore heat 
resistance studies by published source (n = 48) 
Conference Proceedings (dark blue), Academic dissertations (red), Reports (dark 
green), Technical Memorandum (violet), Book chapter (turquoise), Abstract of annual 
meeting (orange), Research bulletin (light blue), Unpublished data (pink), Scientific 
Journals (light green) 
 
Altogether a total of 880 D-values were collected, with the greatest number (205) 
originating from the Institute of Food Research (23.2%). Approximately 6.0% of 
data points were derived from Bohrer et al. (1973), 5.9% from Chai and Liang 
(1992) and 10.2% from two publications by Juneja and colleagues (Juneja et al., 
6%
6%
6%
4%
2%
2%
2%
2%
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Reports
Technical
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Book section
Abstract of annual
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1995a; Juneja et al., 1995b). Between 10 and 38 D-values were from each of      
a further 19 documents (which together constituted 45% of collected data) and 
less than 9 D-values were from each of 24 sources (which constituted 
approximately 10%) out of 880 D-values (Figure 2.11). 
 
Approximately 30% of z-values were derived from studies by Bohrer et al. 
(1973), Chai and Liang (1992) and the Institute of Food Research. In the case of 
16 eligible articles the z-value was not given by authors and was impossible to 
calculate it from the presented data. 
 
2.3.1.4 Results of quality assessment 
In total, 48 eligible studies were included, from which relevant information 
detailed in section 2.2.1 was extracted. Details of included data are summarised 
in Appendix 2. 
 
The included studies were assessed against the quality criteria specified in 
section 2.2.1. The purpose of the quality rating was to provide a descriptive 
overview of the methodological robustness of the included studies. Details of 
quality ranking are summarised in Table 2.8. Thirty-five sources were ranked as 
“high” quality, 7 as “medium” and 6 documents were not given the quality rank. 
The data without a quality rank were related to experiments in which the TDT 
method was used to determine the heat resistance of spores in the presence of 
lysozyme in a recovery medium, or studies, where a survival curve was not 
presented. These data were treated separately, since it was believed that there 
were heat resistant and heat sensitive fractions, but only a single D-value was 
reported by the authors. Data considered as “low” quality were not included. 
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Figure 2.11 Number of D and z-values collected for non-proteolytic C. botulinum spore heat resistance from eligible studies (n = 48) 
D-values (dark bars), z-values (green bars) 
0
20
40
60
80
100
A
ld
er
m
an
 e
t a
l.,
 1
97
2
A
ld
er
to
n 
et
 a
l.,
 1
97
4
A
ng
el
ot
ti,
 1
97
0
A
pp
le
ya
rd
 a
nd
 G
az
e,
 1
99
3
B
oh
re
r 
et
 a
l.,
 1
97
3
B
uc
kn
av
ag
e 
et
 a
l.,
19
90
C
ha
i a
nd
 L
ia
ng
, 1
99
2
C
ris
le
y,
 e
t a
l.,
 1
96
8
D
eP
an
to
ja
, 1
98
6
D
uh
 a
nd
 R
en
, 1
99
5
E
kl
un
d 
et
 a
l.,
19
67
F
er
na
nd
ez
 a
nd
 P
ec
k,
 1
99
7
G
az
e 
an
d 
B
ro
w
n,
 1
99
0
G
ra
ik
os
ki
 a
nd
 K
em
pe
, 1
96
4
G
re
cz
 a
nd
 T
an
g,
 1
97
0
IF
R
 u
np
ub
lis
he
d 
da
ta
Ito
 e
t a
l.,
 1
96
7
Ito
 e
t a
l.,
 1
97
0
Ju
ne
ja
 a
nd
 E
bl
en
, 1
99
5
Ju
ne
ja
 e
t a
l.,
 1
99
5
Ju
ne
ja
 e
t a
l.,
 1
99
5a
K
ra
lo
vi
c,
 1
97
3
Li
cc
ia
rd
el
lo
, 1
98
3
Li
nd
st
rö
m
 e
t a
l.,
 2
00
3
Ly
nt
 e
t a
l.,
 1
97
7
Ly
nt
 e
t a
l.,
 1
97
9
Ly
nt
 e
t a
l.,
 1
98
3
M
an
n,
 1
96
6
M
em
br
e 
an
d 
M
cC
lu
re
, 2
00
6
M
ur
re
ll 
an
d 
S
co
tt,
 1
96
5
N
C
A
, 1
96
6
N
ot
er
m
an
s 
et
 a
l.,
 1
99
0
O
hy
e 
an
d 
S
co
tt,
 1
95
7
P
ec
k 
et
 a
l.,
 1
99
2a
P
ec
k 
et
 a
l.,
 1
99
2b
P
ec
k 
et
 a
l.,
 1
99
3
P
et
er
so
n 
et
 a
l.,
 1
99
7
R
ho
de
ha
m
el
 e
t a
l, 
19
91
R
ob
er
ts
 a
nd
 In
gr
am
, 1
96
5
S
ch
m
id
t, 
19
64
S
co
tt 
an
d 
B
er
na
rd
, 1
98
2
S
co
tt 
an
d 
B
er
na
rd
, 1
98
5
S
m
el
t, 
19
80
S
ol
om
on
 e
t a
l.,
 1
97
7
S
tr
in
ge
r 
an
d 
P
ec
k 
19
97
S
tr
in
ge
r 
an
d 
P
ec
k,
 1
99
6
S
tr
in
ge
r 
et
 a
l.,
 1
99
7
S
tr
in
ge
r 
et
 a
l.,
 1
99
9
N
u
m
b
er
 o
f 
d
at
a 
p
o
in
ts
Source
Chapter 2 
79 
 
Table 2.8 Quality rank of eligible studies on the heat resistance of spores of non-proteolytic C. botulinum (n = 48)  
V quality criteria was met; - the information was missing, not given or not clear from the text; x the information does not apply; X source did not 
undergo the quality ranking; *source describe both -LYS and +LYS data, H – high quality, M – medium quality  
(see Appendix 1 for more information) 
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2.3.2 Statistical and mathematical analysis 
2.3.2.1 Summary of collected data 
Thermal destruction of non-proteolytic C. botulinum spores has been studied in 
foods, buffer and media under different recovery conditions at a temperature 
range of 50 – 95°C. In the case of -LYS data, a temperature of 80°C was most 
frequently tested (151 D-values). Other dominant temperatures at which           
D-values were determined were 70°C, 75°C, 77°C, 79°C and 82°C, with 61, 66, 
50, 37 and 57 data points at these temperatures, respectively. When lysozyme 
was added to a recovery medium, the temperature at which the heat resistance 
of spores was determined was generally higher, with 105 D-values reported at 
90°C, 52 at 80°C and 67 at 85°C (Figure 2.12). 
 
 
Figure 2.12 Summary of temperatures at which D-values for spores of non-
proteolytic C. botulinum were measured  
-LYS data (blue bars), +LYS data (red bars) 
 
Reported number of D and z-values for all strains, for particular toxin types and 
for mixed strains are summarised in Table 2.9. In total 880 D-values and 528     
z-values were generated from the 48 eligible sources, with 308 D-values for type 
B strains, 386 for type E strains, 67 for type F strains and 119 for mixed strains 
(i.e. strains of more than one toxin type). The database was separated into two 
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major subsets with 551 D- and 368 z-values from -LYS studies, and 325 D- and 
160 z-values from +LYS studies. 
 
Table 2.9 Summary of published D and z-values for spores of non-proteolytic   
C. botulinum from 48 eligible sources 
 
Approximately 70% of collected z-values were generated from -LYS 
experiments. In general, smaller z-values could be observed for -LYS, with     
<z> = 6.7°C (for all strains) and higher z-values were reported for +LYS, with  
<z> = 10.3°C (Figure 2.13).  
 
 
Figure 2.13 Summary of published z-values for spores of non-proteolytic          
C. botulinum from 48 eligible sources 
-LYS data (blue bars), +LYS HS fraction (green bars), +LYS HR fraction (red bars), 
+LYS TDT data (yellow bars) 
 
The highest reported z-value was 22.6°C for mixed spores (type B and E toxin) 
(Juneja et al., 1995a) and the lowest reported value was 4.1°C for strain 8E 
heated in water and enumerated on RCM (Roberts et al., 1965). 
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Parameter D-value z-value 
Strains Total % -LYS +LYS Total % -LYS +LYS 
All strains 880 100 551 329 528 100 368 160 
Type B strains 308 35 103 205 139 26 48 91 
Type E strains 386 44 330 59 297 56 258 39 
Type F strains 67 8 63 4 59 11 59 0 
Mixed strains 119 13 55 61 33 7 3 30 
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2.3.2.2 Heat resistance of spores of non-proteolytic C. botulinum with 
recovery in the absence of lysozyme (-LYS) 
Summary of D-values 
The average D-value at each heating temperature was plotted against 
temperature and two lines were fitted by linear regression (Figure 2.14). For one 
line all data were used, for the other, only data corresponding to temperatures at 
and below 83°C were used (see section 2.2.2.4 for explanation). 
 
 
Figure 2.14 Mean and standard deviation of D-values (min) for spores of non-
proteolytic C. botulinum at fixed heating temperatures (-LYS) 
All strains (black square), type B strains (blue circle), type E strains (red circle), type F 
strains (yellow circles), mixed strains (violet circles), ACMSF recommended heat 
treatment of chilled food at 90°C/10 minutes (pink square) 
 
Figure 2.14 is a visualisation of 551 data points. The error bars represent one 
standard deviation of the mean and reveal the uncertainty in reported D-values 
at each temperature. The mean D-values at 75°C, 79°C, 80°C and 82°C have 
the widest error bar, which is an effect of combining the large number of            
D-values that were measured at these temperatures (Figure 2.12). The size of 
error bars in Figure 2.14 reflects variability in data obtained from different 
laboratories in many different experiments. The value of logD(T) calculated for 
lower temperatures (50 – 65°C), which present very small error bars, involve only 
a few data points, determined in one laboratory by Bucknavage et al. (1990). 
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Probability distribution of D(T) 
In order to obtain the parameters of uncertainty distributions for D(T),                  
a logarithmic transformation is used. The parameters for a normal distribution for 
logD(T) and the corresponding parameters for a lognormal distribution of D(T) at 
each heating temperature are summarised in Table 2.10. The fitting procedure is 
described in section 2.2.2.1. 
 
T (°C) 
Normal distribution of logD(T) Lognormal distribution of D(T) 
<logD(T)> (min) σlogD(T) (min) <D(T)> (min) σD(T) (min) 
50 3.99 0.26 11690 7675 
55 3.05 0.04 1126 104 
60 2.89 0.05 781 90 
65 2.21 0.55 361 720 
66 2.53 0.46 593 854 
70 1.36 0.28 28.20 20.25 
71 1.54 0.30 44.02 34.42 
72 2.36 0.20 254 123 
73 1.07 0.14 12.38 4.10 
74 0.90 0.21 8.93 4.58 
75 0.71 0.49 9.69 15.54 
77 0.50 0.42 5.05 6.28 
78 0.22 0.30 2.11 1.65 
79 0.01 0.39 1.53 1.71 
80 0.16 0.41 2.26 2.71 
81 0.40 0.32 3.30 2.80 
82 -0.21 0.55 1.37 2.74 
83 0.54 0.45 5.93 8.23 
85 0.04 0.60 2.85 6.82 
88 0.16 0.10 1.48 0.35 
90 -0.27 0.43 0.88          1.13 
92 -0.50 0.33 0.42 0.37 
93 -0.16 -0.01 0.69 0.02 
Table 2.10 Parameters for normal distribution of logD(T) (min) and 
corresponding lognormal distribution of D(T) for heat resistance of non-
proteolytic C. botulinum spores (-LYS) 
 
The highest average value <logD(T)> was recorded for experiments performed 
at 50°C, whereas the lowest at 92°C. According to equation 2.1 the D-value is    
a representation of the time-temperature relationship: the higher the heating 
temperature, the shorter time needed to reduce the concentration of spores. In 
general this relationship is reflected in the recorded data, but occasionally 
fluctuations can be observed and attributed to natural experimental variability. 
This can be observed for example for D-values measured at 72°C and 81°C 
(Table 2.10). 
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Probability distribution of z-values 
Beta distributions for z-value were obtained by fitting to the observed data (which 
are summarised in Table 2.11 – see section 2.2.2.2 for more details). The fit was 
not obtained for mixed strains, because only two z-values were recorded for this 
subset. 
 
Subset of data 
No. of collected  
z-values  
No. of z-values used 
to build p(z)*  
All strains 368 340 
Type B strains 48 42 
Type E strains 258 245 
Type F strains 59 51 
Mixed strains 3 2 
Table 2.11 Number of collected z-values from eligible studies and number of     
z-values (°C) used to build distribution of p(z) for heat resistance of non-
proteolytic C. botulinum spores (-LYS) 
*see section 2.2.2.4 for explanation on why all z-values were not included 
 
Based on empirical z-values, parameters of a beta distribution were fitted using 
MS Excel Solver® (see section 2.2.2.2). An example fit obtained for all strains is 
illustrated in Figure 2.15. 
 
 
Figure 2.15 Cumulative beta probability density function fit of z-values (°C) for 
spores of non-proteolytic C. botulinum (all strains) 
Experimental data points (filled circles), fit based on the initial parameter estimates (thick 
line), 95% confidence interval around the fit (dashed lines) 
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The best fit was obtained for all strains with one constraint (c   16.5). A fit was 
obtained for remaining subsets of z-values, but data were subjected to further 
constraints. The fitted lines represented the data and often they extend to high  
z-values; therefore the estimated parameters are more difficult to interpret. The 
UCL and LCL calculated for each of the fitted parameters are based on an 
estimate of the standard error (S.E.). In some cases the negative values for LCL 
are non-physical and represent the difficulty of the fitting procedure. When the fit 
was considered poor, due to a small number of data points, the estimated 
parameter values for type B, E and F strains are less reliable. 
 
Parameters presented in Table 2.12 describe beta distributions for z-value. The 
mean z-value was calculated according to equation 2.16. Distributions of           
z-values for all strains, type B strains, type E strains and type F strains, based on 
parameters in Table 2.12, are illustrated in Figure 2.16. The calculated mean     
z-value for all strains is 6.7°C with 95% confidence interval [4.4, 10.0]. 
 
Toxin 
type 
Parameter Estimate S.E. UCL LCL Constraint 
A
ll
 
s
tr
a
in
s
 a 3.7 0.4 4.5 2.9 
 c 16.5 5.2 27.0 6.0 c   16.5 
α1 2.9 1.0 5.0 0.8 
 α2 9.6 7.2 24.0 -4.8 
 <z> 6.7    
T
y
p
e
 B
 
s
tr
a
in
s
 a 4.0 1.1 6.1 1.3 a = 4.0 
c 30.0 162 382 -322 c   30.0 
α1 1.1 1.5 4.3 -2.2 α1   1.0 
α2 10.0 71 165 -146 
 <z> 6.4    
T
y
p
e
 E
 
s
tr
a
in
s
 a 3.5 0.8 5.1 2.0 a   3.5 
c 11.2 1.6 14.5 8.0 
 α1 3.4 1.7 6.9 -0.1 
 α2 4.6 2.9 10.5 -1.3 
 <z> 6.8    
T
y
p
e
 F
 
s
tr
a
in
s
 
a 4.0 11.8 34.3 -26.3 a = 4.0 
c 30.0 1414 3665 -3605 c   30.0 
α1 3.9 61.8 162 -155 α1  1.2 
α2 49.5 3385 8751 -8652 
 <z> 5.9     
Table 2.12 Parameters of beta distribution for z-values (°C) for non-proteolytic  
C. botulinum spores obtained from MS Excel Solver® fit with specified 
constraints, and calculated UCL and LCL (-LYS) 
a is minimum and c maximum of fitted z-value, α1 and α2 are continuous shape 
parameters and <z> is mean z-value 
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Figure 2.16 Beliefs concerning z-value (°C) for non-proteolytic C. botulinum 
spores (-LYS) 
All strains (black line), type B strains (blue line), type E strains (red line), type F strains 
(yellow line) 
 
Probability distribution of D'(80) 
The conversion of logD(T) into equivalent logD'(80) was developed in two ways: 
with an assumed dependency and independency of z-value on T (see section 
2.2.2.3 for details). The parameters of the lognormal distributions for logD(T) and 
the corresponding normal distributions for D(T) are summarised in Table 2.13. It 
is apparent from Figure 2.14, that logD(T) values measured at higher T (above 
~80°C) have a different behaviour pattern compared with logD(T) values 
measured at lower T. The same pattern was observed, when a conversion of 
logD(T) into logD'(80) included the logD(T) values in the higher T range (Table 
2.13). When D-values measured at higher temperatures (above ~80°C) were 
included in the calculation of D'(80), the uncertainty associated with D'(80) was 
greater. 
 
When a transformation of logD(T) into logD'(80) was conducted in two different 
ways, σlogD'(80) was slightly greater when z-value was assumed to be independent 
of T. This is associated with the fact that the transformation includes greater 
variability associated with the distribution of p(z) and probability distribution of 
logD(T). Similar observations apply to parameters of the normal distribution.  
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D'(80) (min) assumed z dependent on T 
T range (°C) 50-79 50-80 50-81 50-82 50-83 50-85 50-88 50-90 50-92 50-93 
n 288 439 444 501 505 532 534 542 550 551 
<D'(80)> 1.36 1.67 1.71 1.79 1.87 2.16 2.27 2.32 2.43 2.56 
σD'(80) 1.57 2.08 2.13 2.31 2.51 3.22 3.50 3.59 3.90 4.25 
<logD'(80)> -0.05 0.02 0.03 0.04 0.05 0.08 0.09 0.10 0.11 0.12 
σlogD'(80) 0.40 0.42 0.42 0.43 0.44 0.47 0.48 0.48 0.49 0.50 
D'(80) (min) assumed z independent on T 
<D'(80)> 1.61 1.97 1.97 2.12 2.23 2.82 2.82 3.15 3.52 3.52 
σD'(80) 3.09 3.64 3.64 4.07 4.44 6.52 6.52 7.84 9.45 9.45 
<logD'(80)> -0.13 -0.03 -0.03 -0.01 0.00 0.05 0.05 0.07 0.09 0.09 
σlogD'(80) 0.54 0.53 0.53 0.54 0.55 0.59 0.59 0.61 0.63 0.63 
Table 2.13 The parameters for the normal distribution of logDˈ(80) (min) for 
spores of non-proteolytic C. botulinum at different temperature ranges (-LYS) 
 
A simple visualisation (Figure 2.17) shows that although the mean values for 
logD'(80) are very close, there is a small shift to higher values, and the range of 
the box and the whiskers are wider, suggesting increasing uncertainty in 
p(log(D'(80)) as D-values recorded at higher heating T are included. 
 
 
Figure 2.17 A box plot for p(log(D'(80)) for spores of non-proteolytic C. botulinum 
converted from log(D(T)) at different heating temperature ranges (z-value 
assumed to be dependent on T) (-LYS) 
The upper and lower border of the box is the value of the 95th and 5th percentiles. The 
vertical ‘whiskers’ represent the min and max values. The mean estimate for each 
temperature range is represented by the horizontal line within the box 
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Anderson-Darling test 
The Anderson-Darling test was conducted with logD'(80) for data collected for 
ten different temperature ranges (see section 2.2.2.4). The Anderson-Darling 
parameter, A2, was calculated for the different ranges of temperatures specified 
in Table 2.13. The values of A2 were used to indicate which D-values could be 
considered part of the same population, and if the transformed data were 
normally distributed. 
 
The calculated A2 value for each of the different subsets of data ranged from 
1.79 to 5.94 (Table 2.14). The variability of calculated A2 for the subsets of 
temperature range indicates that a change in the distribution of D-value is 
detected when data from experiments conducted at higher temperatures were 
included. 
 
A2 
Temperature range (°C) 
50-79 50-80 50-81 50-82 50-83 50-85 50-88 50-90 50-92 50-93 
1.79 1.44 1.41 1.98 2.18 4.06 4.28 4.91 5.39 5.94 
Table 2.14 Calculated values of Anderson-Darling for p(logD'(80)) for spores of 
non-proteolytic C. botulinum at different temperature ranges (-LYS) 
 
The critical value of 2.492 for a 5% level of significance, as given in Table 2.5, is 
less than calculated values (4.06, 4.28, 4.91, 5.39 and 5.94) for logD'(80) 
converted from data including temperatures above 83°C. Therefore, the 
Anderson-Darling test rejects the hypothesis that the D-values converted from    
T > 83°C follow the normal distribution. 
 
Since the critical value is greater than A2 = 2.18, for logD'(80) in the range of 50 – 
83°C, the Anderson-Darling test supports the hypothesis that D-values are 
sampled from a normal distribution. Therefore, it is accepted that data (n = 505) 
with estimated parameters <logD'(80)> = 0.05 min and σlogD'(80) = 0.44 min (see 
Table 2.13) corresponding to D-values in the range of 50 – 83°C are normally 
distributed.  
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Testing the significance of temperature and z-value dependence 
The two-sample t-test showed that there was no significant difference between 
the normal distribution for logD'(80) with parameters <logD'(80)> = 0.05 min and 
σlogD'(80) = 0.44 min, and logD'(80) distributed normally with parameters 
<logD'(80)> = 0.00 min and σlogD'(80) = 0.55 min (t-statistic = -1.56, degree of 
freedom: 957, p = 0.12) (Figure 2.18). This shows that using either a single        
z-value corresponding to actual measurement of D-value at the heating T, or         
a distribution of z-values does not have a significant effect on the parameters of 
p(logD'(80)). This result confirms the validity of using the p(z) in risk assessment.  
 
 
Figure 2.18 Belief concerning logD'(80) (min) value for spores of non-proteolytic        
C. botulinum obtained using two approaches: z-value is dependent on and 
independent of temperature 
Assuming independency z-value of T (the distribution of p(z) was used in transformation 
of logD(T) into logDˈ(80)) (black line), assuming dependency z-value of T (z-values or 
mean of reported z-values were used in transformation of logD(T) into logDˈ(80) (red 
line) 
 
The uncertainty distribution for logD'(80) converted with the p(z) has a greater 
standard deviation than logDˈD(80) converted using reported z-value (or mean of 
z-values) (Figure 2.18). Clearly, including uncertainty in the z-value represents   
a conservative factor in the evaluation of the heat treatment of spores. Therefore, 
the normal distribution for logD'(80) with parameters <logD'(80)> = 0.00 min and 
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σlogD'(80) = 0.55 min and corresponding parameters for a lognormal distribution 
equal to <D'(80)> = 2.23 and σD'(80) = 4.44 min will be used in a model to 
represent the uncertainty in D-value in QMRA (Chapter 5). 
 
Testing the validity of temperature transformation 
A one-way ANOVA was used to determine whether the conversion of logD-
values to logDˈ(80) is consistent across all heating temperatures. This analysis 
revealed that the logD'(80) transformation is not consistent across all tested 
temperatures (F-statistic = 3.48, between groups degree of freedom: 5 and within 
groups: 884, p < 0.01). The Tukey test indicated that only D'(80) measured at 
70°C and 75°C are not consistent. 
 
D'(80)  
converted from T 
n 
logDˈ(80) (min) 
Min Max <Dˈ(80)> σDˈ(80) 
D'(80) (70°C) 61 -0.79 0.70 -0.04 0.33 
D'(80) (75°C) 66 -0.95 1.59 -0.05 0.51 
D'(80) (77°C) 50 -0.89 1.25 -0.01 0.45 
D(80) 151 -0.70 1.41 0.16 0.41 
D'(80) (82°C) 57 -0.74 1.74 0.12 0.52 
D'(80) (50-83°C) 505 -1.05 1.74 0.05 0.44 
Table 2.15 Summary of transformed D-values (min) for spores of non-proteolytic 
C. botulinum measured at different heating temperatures 
 
Most importantly there is no significant difference (Tukey test) in D-values 
originating from experiments measuring spore heat resistance at 80°C 
(<logD(80)> = 0.16 min, σlogD(80) = 0.41 min) and D-values transformed from 
temperatures in a range of 50°C and 83°C (<logD'(80)> = 0.05 min, σlogD'(80) = 
0.44 min). Also no significant difference was observed in the distribution of D'(80) 
transformed from T in a range of 50 – 83°C and D'(80) converted from 70°C 
(<logD'(80)> = -0.04, σlogD'(80) = 0.33), 75°C (<logD'(80)> = -0.05, σlogD'(80) = 0.51), 
77°C (<logD'(80)> = -0.01, σlogD'(80) = 0.45) and 82°C (<logD'(80)> = 0.12, σlogD'(80) 
= 0.52) (Table 2.15). However, the mean for D(80) is significantly higher than 
that for D'(80) converted from 70°C and for D'(80) converted from 75°C. 
 
As shown above, with the exception of heating at 70°C and 75°C, the 
temperature transformation of D-values appears to be consistent, thus it can 
concluded that the normal distribution of logD'(80) with parameters (<logD'(80)> 
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= 0.05, σlogD'(80) = 0.44) and the corresponding lognormal distribution with 
parameters (<D'(80)> = 1.87, σD'(80) = 2.51) is a good representation of the data.  
 
Consequently, as indicated in the previous section, both distributions 
(<logD'(80)> = 0.00, σlogD'(80) = 0.55 and <logD'(80)> = 0.05, σlogD'(80) = 0.44) and 
its corresponding lognormal distribution (<D'(80)> = 1.87, σD'(80) = 2.51 and 
<D'(80)> = 2.23, σD'(80) = 4.44) can be used to present the uncertainty associated 
with D-values of non-proteolytic C. botulinum spores, for example in risk 
assessment. Figure 2.19 is a visual representation of all tested distributions with 
parameters given in Table 2.15. 
 
 
Figure 2.19 Belief concerning the distribution of logD'(80) converted from 
different heating temperatures for spores of non-proteolytic C. botulinum  
p(D'(80)) (70°C) (violet line), p(D'(80)) (75°C) (pink line), p(D'(80)) (77°C) (green line), 
p(D(80)) (black line), p(D'(80)) (82°C) (yellow line) and p(D'(80)) (50 – 83°C) (blue line) 
 
Testing the dependence of spore heat resistance on toxin type 
Ever since the publication of data by Scott and Bernard (1982), which indicated 
higher spore heat resistance of type B strains than type E strains, there has been         
a debate whether the heat resistance properties of C. botulinum spores are 
associated with the type of toxin formed by the organism. Statistical analysis of 
the data collected in this thesis shows that there is no significant difference in 
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heat resistance of type B, E and F strains based on D-values measured at three 
different heating temperatures (75°C, 80°C, 82°C), and D'(80) converted from all 
data collected at 50 – 83°C. Only in one case did a one-way ANOVA of D-values 
reveal a significant difference in heat resistance for different toxin types            
(F-statistic = 5.64, between groups degree of freedom: 3 and within groups: 147, 
p < 0.01), where the mean D-value measured at 80°C for mixed strains appeared 
to be significantly lower than the mean D-value for type B strains (Table 2.16). 
Figure 2.20 is a visualisation of normal distributions for logD for different toxin 
types, with parameters given in Table 2.16 for three heating temperatures and 
logDˈ(80) transformed from 50 – 83°C. 
 
Toxin type B E F Mixed 
T (°C)/min <logD> σlogD <logD> σlogD <logD> σlogD <logD> σlogD 
75 0.71 0.50 0.68 0.58     
80 0.32 0.34 0.18 0.38 0.21 0.45 -0.03 0.45 
82 0.20 0.85 -0.28 0.51 -0.27 0.29   
50 – 83 0.15 0.50 0.17 0.43 0.08 0.30 0.00 0.50 
Table 2.16 Summary of D-values (min) for type B, E, F and mixed strains of non-
proteolytic C. botulinum spores at different temperatures 
An empty cell indicate that there were no reported data 
 
 
Figure 2.20 Belief concerning the logD value (min) for different toxin types of 
non-proteolytic C. botulinum spores measured at 75°C, 80°C, 82°C, and 
logDˈ(80) measured at 50 – 83°C  
Toxin type B (blue line), toxin type E (red line), toxin type F (yellow line), mixed strains 
(violet line), all strains (black dashed line) 
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Testing the dependence of spore heat resistance on heating menstruum 
In total 505 data points, from 48 eligible studies corresponding to 39 different 
heating menstruum were collected, with 261 D-values determined in culture 
media or buffer and 244 D-values in food matrices. 
 
The output of the linear regression analysis for all D-values (Table 2.17) 
indicates that the model is a good fit to data (p < 0.01), i.e. there is a strong 
correlation between heating temperature and measured D-value. 
 
 Source of variation df Sum of squares F p 
Model 1 235 1279 <<10-10 
Residual error 503 92 
  Total error 504 327 
  Variable Coefficients Standard error t p 
α 10.51 0.28 37.67 <<10-10 
β = 1/z 0.13 0.00 -35.77 <<10-10 
Table 2.17 Analysis of variance and parameter estimates for linear regression of 
D-values (min) for non-proteolytic C. botulinum spores (n = 505) fitted to 
equation 2.23 
df – degree of freedom, F – ratio of the between groups variance and the within variance 
p – probability that the result observed in a study could have occurred by a chance 
 
The validity of the model was checked by a graphical observation of the residual 
error distribution (data not presented). The normality of residual error can be 
assumed. The data and line of best fit with its 95% UCL and LCL, and predicted 
values (with its 95% and 99% upper limits) are plotted on Figure 2.21. 
 
The best correlation between heating temperature and measured D-value was 
observed for food matrices, with an R2 (% of variation of the data explained by 
the fitted line) of 0.76. Good correlation was also observed for all menstrua (R2 = 
0.72), whereas the lowest correlation for media/buffer (R2 = 0.61) (Table 2.18).  
 
Menstruum 
Parameters of lines of best fit (50 – 83°C) Mean z-value from 
published data Equation for fitted line R
2
 z-value D(80) 
All menstrua LogD=10.506-0.1299T 0.72 7.7 1.29 6.7 (S.D.=1.54, n = 340) 
Media/buffer LogD=10.680-0.1323T 0.61 7.6 1.24 6.9 (S.D.=1.77, n = 144) 
Food matrices LogD=10.407-0.1285T 0.76 7.8 1.35 6.6 (S.D.=1.32, n =196) 
Table 2.18 Summary of published data on the effect of different heating 
menstrua on the heat resistance of non-proteolytic C. botulinum spores 
S.D. – standard deviation 
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Figure 2.21 Summary of published heat resistance data for non-proteolytic       
C. botulinum spores heated in all menstrua 
Food matrices (green circles), media/buffer (blue squares), line of best fit (black solid 
line) (see Table 2.17 for parameters of this line), 95% UCL and LCL of the mean (black 
dashed line), 95% UCL of predicted response (red dashed line), 99% UCL (red dashed 
line) and current recommendation of heat treatment for chilled food (ACMSF, 
90°C/10min, z = 9.2°C) (green solid line) 
 
From the line of best fit for all menstrua D(80) is 1.29 min (16.60 min when using 
99% upper limit of the model), which is in agreement with reported D-values from 
the literature review measured at 80°C (0.20 – 25.84 min). 
 
The mean reported z-value for all menstrua was 6.7°C, with a standard deviation 
of 1.54°C (Table 2.18), and it is very close to the mean z-value reported for 
media/buffer (z = 6.9°C) and food matrices (z = 6.6°C). Slightly higher z-values 
were obtained from estimated parameter of the line of best fit, with a z-value of 
7.7°C for all menstrua. 
 
Current recommendation of the FSA, ACMSF and CFA/ECFF for the heat 
treatment of minimally heated chilled foods includes heating for 10 min at 90°C 
or equivalent (Table 2.2). This treatment is considered to provide a 6D reduction 
of non-proteolytic C. botulinum spores concentration. The line derived from the 
current ACMSF recommendation (90°C/10 min, z = 9.2°C) plotted on Figure 2.21 
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gives higher logD values than the 99% upper limit given by the thermal death 
model. However, the ACMSF recommendation was based on relatively little data 
(Gaze and Brown, 1990).  
 
From Figure 2.21 it is apparent that almost all of the reported D-values lie below 
the 99% UCL prediction line. There are six D-values from five different studies 
that are higher than those predicted by the thermal death model and the current 
recommendation. Two D-values are from Scott and Bernard (1982) who reported 
D(82) of 32.30 min and D(83) = 16.70 min. Other points that fall above this line 
corresponds to tuna (in oil) with D(72) = 226.50 min (Bohrer et al., 1973) and 
D(83) = 14.16 min for raw egg white calculated from data given by Alderman et 
al. (1972). Although the latter authors (Alderman et al., 1972) reported 
coagulation of the egg white, the carryover of trace amount of active hen egg 
white lysozyme to the recovery medium (TPGY broth) cannot be excluded. 
Further D-values that fall above the line are: D(80) = 25.84 min calculated from 
data given by Murrell and Scott (1966) (the heating menstruum and incubation 
time were not given) and D(75) = 274.76 min calculated from studies of 
Fernandez and Peck (1997).  
 
Four out of six of the above D-values were obtained when incubation of heated 
test tubes was carried out for prolonged time e.g. Scott and Bernard (1982) – 
30°C/168 days, Bohrer et al. (1973) – 29°C/168 – 336 days, Fernandez and 
Peck (1997) – 25°C/90 days. It was observed by many authors e.g. by Lynt et al. 
(1983) that an extended period of incubation permits germination of damaged 
spores, thereby increasing measured spore heat resistance. 
 
From the analysis of collected data the highest average D-value was noted for 
raw egg white with D = 32.61 min (n = 1) and the lowest for 0.05M phosphate 
buffer, 0.34 min (n = 2). Bohrer et al. (1973) reported that the heat resistance of 
spores depends on heating menstrum. The D-values reported by authors for 
spores of type E strains were greater for foods high in fat and protein content 
than for phosphate buffer. However, a t-test analysis of data summarized in this 
thesis (n = 505) for 39 different heating menstrua (Table 2.19) has shown that 
there is no significant difference in the heat resistance of spores measured in 
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media/buffer (n = 13) (<logD'(80) = 0.05, σlogD'(80) = 0.40) and food matrices (n = 
27) (<logD'(80) = 0.05, σlogD'(80) = 0.48); (t-statistic = -0.02, degree of freedom: 
472, p = 0.98).  
 
Heating menstruum n 
logD'(80) (min) 
Min Max <D'(80)> σD'80 
0.017M phosphate buffer 13 -0.03 0.18 0.05 0.08 
0.03M phosphate buffer 4 -0.55 -0.14 -0.32 0.17 
0.05M phosphate buffer 2 -0.50 -0.45 -0.47 0.04 
0.067M phosphate buffer 133 -1.05 1.74 0.05 0.38 
0.1M phosphate buffer 12 -0.41 0.59 0.14 0.38 
autoclaved chub fish 2 0.76 0.91 0.83 0.10 
béchamel sauce 1 0.86 0.86 0.86 
 blue crabmeat 27 -0.09 0.80 0.10 0.17 
bolognaise sauce 1 0.97 0.97 0.97 
 broccoli puree 10 -0.47 0.16 -0.19 0.24 
carrot homogenates 5 0.50 0.78 0.66 0.11 
clam liquor 9 -0.27 1.25 0.14 0.60 
cod 4 1.15 1.26 1.19 0.05 
corn brine 4 0.41 0.56 0.49 0.06 
crabmeat 25 -0.23 0.64 0.23 0.27 
distilled water 2 -0.31 0.07 -0.12 0.27 
fine carrot 2 0.20 0.26 0.23 0.04 
haddock slurry 4 -0.30 -0.10 -0.20 0.11 
meat medium 2 0.63 1.59 1.11 0.68 
menhaden Surimi 4 0.21 0.32 0.28 0.05 
milk (evaporated) 4 0.22 0.33 0.27 0.05 
oyster homogenates 72 -0.74 0.70 -0.26 0.38 
peas 2 0.52 0.59 0.55 0.05 
physiological saline 4 0.58 0.60 0.59 0.02 
potato puree 9 -0.53 0.09 -0.24 0.21 
pre-coagulated egg white 1 0.43 0.43 0.43 
 PY broth 40 -0.95 0.78 0.21 0.45 
raw egg white  1 1.51 1.51 1.51 
 salmon 1 0.46 0.46 0.46 
 sardines (in tomato sauce) 4 0.65 0.82 0.75 0.08 
shrimp 1 0.28 0.28 0.28 
 tomato homogenates 37 -0.79 0.19 -0.21 0.20 
TPB broth 1 0.26 0.26 0.26 
 TPG or TYD 38 -0.70 0.71 -0.16 0.32 
TPGY broth 1 0.49 0.49 0.49 
 tuna 1 0.01 0.01 0.01 
 tuna (in oil) 6 1.02 1.18 1.08 0.06 
water 9 -0.48 0.10 -0.13 0.16 
whitefish chubs 5 0.20 0.63 0.32 0.18 
not given 2 0.18 1.41 0.80 0.87 
Table 2.19 Summary of D-values (min) for spores of non-proteolytic C. botulinum 
measured in different heating menstrua 
 
Testing the dependence of spore heat resistance on heating technique 
For decades researchers have debated whether heating technique influences 
measured spore heat resistance. In order to test if heating technique has an 
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impact on magnitude of measured D-value a one-way ANOVA with logD'(80) as 
the dependent variable and heating techniques as the independent variable was 
conducted. 
 
Heating technique n 
logD'(80) (min) 
Min Max <D'(80)> σD'80 
bottles in water bath 46 -0.79 1.26 0.01 0.49 
flasks in water bath 20 -0.26 0.70 0.17 0.32 
sealed ampules in water bath 4 0.58 0.60 0.59 0.02 
sealed capillaries in oil bath 16 -1.05 1.25 -0.15 0.61 
sealed capillaries in water bath 7 -0.22 0.10 -0.07 0.10 
TDT cans in water bath 25 0.22 1.18 0.65 0.30 
TDT tubes in water bath 231 -0.74 1.74 0.00 0.38 
unsealed TDT tubes in water bath 3 -0.35 0.43 -0.06 0.43 
screw-cap vials in water bath 12 -0.41 0.59 0.14 0.38 
screw-cap tube in water bath 98 -0.95 1.59 0.09 0.48 
method not given by author 43 -0.70 0.71 -0.15 0.30 
Table 2.20 Summary of D-values (min) for spores of non-proteolytic C. botulinum 
measured using different heating techniques 
 
Levene’s F-test revealed that the homogeneity of variance assumption was not 
met (p < 0.01), in this case Welch’s F-test was used. The analysis shows that     
D-values differ depending on heating technique applied (F-statistic = 105.64, 
between groups degree of freedom: 10 and within groups: 494, p < 0.01). From 
the Games-Howell test and from Table 2.20 it is apparent that D-values, where 
sealed ampules and TDT cans in water bath were used as heating techniques 
have mean values of logD'(80) greater than remaining heating techniques.  
 
Testing the dependence of spore heat resistance on method of D-value 
determination 
Several authors have suggested that the method of D-value determination and 
calculation is an important factor influencing measured spore heat resistance. 
For example Chai and Liang (1992) have suggested that the D-value measured 
according to the TDT method can be higher than that measured using survival 
curves. Within 48 eligible studies, five main methods were employed in the 
measurement of the D-value (see section 2.1.2). The majority of D-values were 
determined or calculated according to the survivor curve method, and for 23 
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reported data points information about the method of D-value determination was 
not given (Table 2.21). 
 
Method of D-value measurement n 
logD'(80) (min) 
Min Max <D'(80)> σD'(80) 
Survivor curve 251 -1.05 1.59 0.01 0.45 
TDT 23 -0.03 1.51 0.51 0.41 
TDT/Stumbo(1948) 53 -0.06 1.18 0.36 0.35 
TDT/Stumbo(1950) 13 -0.55 1.74 0.28 0.71 
TDT/Schmidt(1957) 142 -0.74 0.54 -0.11 0.33 
Method not given by author 23 -0.10 0.29 0.13 0.09 
Table 2.21 Summary of D-values (min) for spores of non-proteolytic C. botulinum 
according to method of measurement 
 
A one-way ANOVA was used to test the differences in D-value determined or 
calculated according to different methods. Since Levene’s statistic shows that 
the equal variance assumption was violated (p < 0.01) Welch’s F-test was 
applied, which indicated that the mean D-values differed significantly across all 
measurement methods (F-statistic = 18.14, between groups degree of freedom: 
5 and within groups: 499, p < 0.01). 
 
The Games-Howell statistic indicated that the D-values calculated by TDT and 
TDT/Stumbo(1948) are not significantly different, p = 0.82, the same result was 
observed for TDT/Stumbo(1950) and TDT/Schmidt(1957). Similarly D-values 
obtained from survivor curves are in agreement with D-values calculated 
according to TDT/Stumbo(1950). The mean value of logD'(80) calculated 
according to TDT and TDT/Stumbo (1948) is significantly greater than the mean 
of logD'(80) obtained from survivor curves. But the logD'(80) calculated 
according to TDT/Schmidt(1957) is significantly smaller than the one obtained 
from survivor curves.  
 
Although the method of D-value measurement has a significant effect on its 
magnitude, this is not substantial from a risk assessment point of view. The 
distribution parameters for D'(80) allows for inclusion of uncertainty associated 
with experimental procedures.  
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Testing the dependence of spore heat resistance on strain of non-proteolytic     
C. botulinum 
Spore heat resistance of non-proteolytic C. botulinum was measured for 35 
strains of different toxin types. Table 2.22 summarizes strains for which the       
D-value was measured at least three times. The most common strains tested 
were Eklund 17B (n = 70) and Beluga (n = 52). The highest average D'(80) was 
noted for strain Nanaimo (3.10 min), whereas the lowest was for strain Crab 
25V-2 (0.26 min).  
 
Strains* 
Toxin logD'(80) (min) logD(80) (min) 
type n Min Max <D'(80)> σD'(80) n <D(80)> σD(80) 
CBW25 B 4 -0.24 0.44 0.12 0.30 2 0.13 0.21 
Eklund 17B B 70 -0.95 1.56 0.18 0.49 33 0.35 0.36 
Kap B2 B 10 -0.53 0.41 -0.21 0.29 3 0.04 0.37 
Kap B5 B 3 0.18 0.42 0.32 0.12 3 0.32 0.12 
1304E E 13 -0.34 0.27 0.09 0.20 3 0.22 0.05 
8E E 14 -1.05 0.26 -0.31 0.39 2 0.08 0.25 
Alaska E 39 -0.72 1.51 0.01 0.45 7 0.28 0.30 
ATCC 17786 E 37 -0.79 0.19 -0.21 0.20 
   ATCC 9564 E 11 -0.77 1.41 0.40 0.73 5 0.60 0.76 
Beluga E 52 -0.51 0.70 0.10 0.25 12 -0.04 0.19 
Crab 25 V-1 E 11 -0.45 0.11 -0.27 0.16 
   Crab 25 V-2 E 11 -0.74 0.01 -0.64 0.22 
   Crab G21-5 E 27 -0.72 0.80 -0.20 0.37 
   Detroit  E 6 -0.27 1.25 0.34 0.70 
   Iwanai E 3 -0.35 0.20 -0.05 0.28 2 0.10 0.14 
Minneapolis E 5 -0.28 0.36 0.01 0.29 3 0.19 0.22 
Minnesota E 12 -0.14 0.76 0.02 0.24 
   Mixed strains E E 4 0.21 0.32 0.28 0.05 
   Nanaimo E 3 0.47 0.52 0.49 0.03 1 0.52 
 Saratoga E 47 -0.23 1.18 0.42 0.35 15 0.40 0.28 
Vancouver Herring E 4 -0.40 0.23 -0.18 0.29 1 -0.40 
 Whitefish E 3 -0.41 -0.08 -0.30 0.19 2 -0.41 0.00 
190 F 14 -0.39 -0.07 -0.19 0.11 
   Craig 610 F 11 -0.58 0.42 0.16 0.28 1 -0.12 
 Eklund 202F F 28 -0.23 0.60 0.15 0.27 2 0.19 0.59 
Mixed strains   45 -0.70 1.59 0.00 0.50 44 -0.03 0.45 
Not specified  3 0.01 0.18 0.09 0.09 1 0.18 
 Table 2.22 Summary of D-values (min) for spores of different strains of non-
proteolytic C. botulinum measured at heating temperature of 80°C and 
transformed to Dˈ(80) from 50 – 83°C 
*table presents only strains for which D-values were noted at least three times, the 
remaining 11 strains (for which D-value was measured once or twice) were not 
presented 
 
For strains for which D-values were determined at least 20 times (Eklund 17B, 
Alaska, ATCC 17786, Beluga, Crab G21-5, Saratoga and Eklund 202F) a one-
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way ANOVA was conducted to test for evidence of a significant difference in 
spore heat resistance of D-value between strains. The homogeneity of variance 
assumption was violated (p < 0.01 in Levene’s test), therefore the Welch test 
was used to assess the difference. The analysis revealed that the D-values 
significantly differed between strains (F-statistic = 14.02, between groups degree 
of freedom: 6 and within groups: 293, p < 0.01). Significantly more heat resistant 
compared to other strains appeared to be strain Saratoga (p < 0.01). The          
D-values for strains ATCC 17786 and Crab G21-5 are significantly smaller 
compared to D-values recorded for strains Eklund 17B, Beluga, Saratoga and 
Eklund 202F (p < 0.01). No significant difference in D-values was observed for 
strains Eklund 17B, Alaska and Beluga. The D-value for strain Alaska is not 
significantly different to that of all strains (except Saratoga). Interestingly 
according to statistical analysis the heat resistance of spores of Eklund 17B and 
Eklund 202F are exactly the same (p < 1.0). 
 
The clustering analysis revealed (results not presented) that there is no observed 
pattern based on heat resistance properties of tested strains, and it is subjected 
to many variable factors e.g. recovery media, recovery conditions, heating 
method and heating conditions. 
 
Evaluating the dependence of spore heat resistance on testing laboratory 
All the collected data points (n = 505) were obtained from experiments carried 
out in 23 different laboratories (Table 2.23). In order to compare the heat 
resistance of spores tested by different laboratories/authors a one-way ANOVA 
was performed. Data collected from six laboratories with the largest number of 
reported D-values: Campden BRI (n = 46), Chai & Liang (n = 52), Food and Drug 
Administration (FDA) (n = 92), Institute of Food Reseach (IFR) (n = 92), National 
Canners Association (NCA) (n = 78), Unilever (n = 38) were used in an analysis 
with logD'(80) as the dependent variable and laboratory/author as the 
independent variable (Table 2.23). 
 
The data failed Levene’s F-test for homogeneity of variance (p < 0.01), therefore 
Welch’s F-test with a significance level of 1% was used. The results of a one-
way ANOVA revealed statistical significance, which indicates that not all           
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D-values collected by different laboratories/authors are similar (F-statistic = 
44.62, between groups degree of freedom: 5 and within groups: 392, p < 0.01). 
 
Laboratory/author n 
logD'(80) (min) 
Min  Max <D'(80)> σD'(80) 
Alderman et al. 4 0.43 1.51 0.90 0.45 
Alderton et al. 2 -0.31 0.03 -0.14 0.24 
Angelotti 4 0.04 0.16 0.10 0.06 
Bucknavage et al. 20 -0.26 0.70 0.17 0.32 
Campden BRI 46 -0.79 1.26 0.01 0.49 
Chai & Liang 52 -0.74 0.03 -0.43 0.25 
Crisley et al. 6 -0.10 0.63 0.25 0.24 
Duh & Ren 2 0.20 0.26 0.23 0.04 
Eklund et al. 4 0.58 0.60 0.59 0.02 
FDA 92 -0.39 0.80 0.08 0.22 
Graikoski & Kempe 4 -0.35 0.43 -0.12 0.36 
Grecz&Tang 1 0.23 0.23 0.23 
 IFR 92 -0.95 1.59 0.09 0.49 
Kralovic 1 0.18 0.18 0.18 
 Licciardello 16 -1.05 1.25 -0.15 0.61 
Mann 2 0.01 0.07 0.04 0.04 
NCA 78 -0.55 1.18 0.26 0.34 
NFPA 12 -0.50 1.74 0.45 0.77 
Ohye & Scott 6 -0.40 0.52 0.09 0.45 
Roberts & Ingram 9 -0.48 0.10 -0.13 0.16 
Schmidt 2 0.26 0.36 0.31 0.08 
Unilever 38 -0.70 0.71 -0.16 0.32 
USDA 12 -0.41 0.59 0.14 0.38 
Table 2.23 Summary of D-values (min) for spores of non-proteolytic C. botulinum 
measured in different laboratories 
 
From a post-hoc Games-Howell comparison test, the values of D'(80) converted 
from D-values reported by Chai & Liang (1992) are significantly lower than D'(80) 
from other laboratories/authors. The D'(80) converted from data obtained in IFR 
are not significantly different from data reported by Campden, FDA and NCA and 
Unilever. A significant difference was also not observed between data collected 
by Campden, FDA, NCA, and Unilever. A significant difference in D'(80) was 
observed between data reported by FDA and NCA (p = 0.01) and Unilever (p = 
0.01). The D'(80) originating from D-values reported by NCA are significantly 
different from those reported by Unilever (p < 0.01).  
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Final comments 
Spore heat resistance does not solely depend on a single factor. There are 
several sources of variability determining heat resistance properties. The 
clustering technique have failed to demonstrate a clear pattern of resistance of 
spores in respect of strain or type of neurotoxin formed. The most likely 
explanation for the failure to demonstrate such a pattern is the considerable 
variation in experimental approaches used by different authors. The effect of      
a number of these factors has been shown to be significant. The generation of   
a high quality dataset on the heat resistance of individual strains of non-
proteolytic C. botulinum requires the use of a consistent and rigorous 
experimental approach and the testing of a number of strains (data for 35 strains 
are reported in this review) in triplicate. This is a substantial undertaking, 
requiring the preparation and testing of a substantial number of spore crops. 
Considering the time required this is unlikely to be carried out. 
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2.3.2.3 Heat resistance of spores of non-proteolytic C. botulinum with 
recovery in the presence of lysozyme (+LYS) 
Summary of D-values 
Data on spore heat resistance with recovery in the presence of lysozyme or data 
originating from experiments where recovery was conducted in seafood (see 
section 2.2.2), was divided into three subsets: heat sensitive fraction (+LYS HS 
fraction), heat resistant fraction (+LYS HR fraction) and data where the D-value 
was measured using the TDT method (+LYS TDT) (this also contain studies by 
Juneja et al.). Due to the relatively small number of +LYS D-values in the dataset 
(compared with -LYS dataset), an analysis was not conducted separately for 
different toxin type.  
 
Heat resistance of spores was measured in different heating menstrua and in the 
temperature range of 70 – 95°C, with 80°C, 85°C and 90°C being the most 
frequently tested temperatures. For the +LYS HS subset there were 27 D-values, 
for the +LYS HR subset there were 105 D-values, and for +LYS TDT subset 
there were 125 D-values reported, with 16, 46 and 60 z-values, respectively. 
Figure 2.22 is a visualisation of average D-values for each subset of data. 
 
 
Figure 2.22 Mean and standard deviation of D-values (min) for spores of non-
proteolytic C. botulinum at fixed heating temperatures (+LYS) 
+LYS HS (blue circles), +LYS HR (red circles), +LYS TDT (yellow circles) 
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It is apparent from the Figure 2.22 that D-values corresponding with the +LYS 
HR fraction are much higher than those obtained for the +LYS HS fraction. The 
heat resistance determined by TDT method gives D-values which are between 
those for the HS and HR fractions. The small error bars for the +LYS TDT 
subsets at 70°C, 89°C, 92°C and 94°C correspond with only a few data points 
determined in one laboratory. The largest error bars are observed for +LYS HS 
at 85°C and represent data obtained by four different authors. 
 
Probability distribution of D(T) 
For the three subsets of data (HS, HR and TDT) the parameters of the normal 
distribution for logD(T) and corresponding lognormal distribution (see section 
2.2.2.1) at each heating temperature are included in Table 2.24. The D-values 
recorded for the HR fraction are substantially higher (<D> = 186 min at T = 75°C) 
than those for the HS fraction (<D> = 16.73 min at T = 75°C). The lowest 
average D-value for the HS fraction corresponded to <D> = 0.43 min at T = 82°C 
and for the HR fraction to <D> = 3.45 min at 85°C. The lowest average D-value 
for the TDT subset of data was calculated when spores were heated at 94°C with 
<D> = 3.18 min and the highest when heated at 70°C, with <D> = 40.69 min. 
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70 
    
    
1.59 0.13 40.69 12.46 
75 1.12 0.30 16.73 13.09 2.18 0.28 186 133 1.41 0.20 28.58 13.89 
78 0.41 0.14 2.71 0.90 1.65 0.21 50 25.77 
    80 0.16 0.26 1.73 1.14 1.37 0.64 69 194 0.87 0.43 12.10 15.62 
81 0.28 0.19 2.10 0.96 1.74 0.22 62 33.79 
    82 -0.37 0.08 0.43 0.08 1.34 0.13 22.88 7.01 
    
83 -0.28 0.19 0.58 0.27 1.37 0.22 26.65 14.42 
    
85 -0.35 0.57 1.06 2.27 1.50 0.39 3.45 0.90 0.74 0.61 14.74 36.37 
88 -0.22 0.53 1.27 2.35 0.95 0.37 12.81 13.23 
    89 
        
1.08 0.05 12.10 1.40 
90 -0.03 0.21 1.05 0.54 1.29 0.20 21.68 10.54 0.22 0.57 3.93 8.42 
91 
    
0.91 0.31 10.49 8.55 0.88 0.04 7.62 0.70 
92 
        
0.75 0.04 5.65 0.52 
93 -0.40 0.20 0.44 0.22 0.60 0.03 3.99 0.28 0.62 0.04 4.19 0.39 
94 
    
    
0.50 0.05 3.18 0.37 
95 
    
0.54 0.13 3.63 1.11 
    
Table 2.24 Parameters for normal distribution of logD(T) (min) and 
corresponding lognormal distribution of D(T) for non-proteolytic C. botulinum 
spores for the HS, HR and TDT subsets (+LYS) 
empty cells indicate that there were no data collected at particular temperature 
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Probability distribution of z-values 
As described in section 2.2.2.2, distributions of z-values, p(z), were obtained for 
HR and TDT subsets of data. There were too few data for the HS fraction and it 
was not possible to obtain reliable parameters for the distribution of p(z). There 
were 46 z-values obtained for the HR fraction and 90 z-values for TDT subset 
(Table 2.25). 
 
Subset of data 
No. of collected 
z-values 
No. of z-values taken 
to build p(z)* 
HS fraction 21 - 
HR fraction 46 46 
TDT data 90 90 
Table 2.25 Number of collected z-values (°C) from eligible studies and number 
of z-values used to build distribution of p(z) for non-proteolytic C. botulinum 
spores (+LYS) 
*see section 2.2.2.4 for explanation on why all z-values were not included 
 
Table 2.26 summarises the estimated parameters with the standard error, UCL 
and LCL that are used to build the beta distribution. The parameters for TDT 
subset have large S.E., therefore care should be taken when the distribution of 
p(z) is used. The mean value, <z>, was calculated according to equation 2.16. 
 
Subset Parameter Estimate S.E. UCL LCL Constraint 
H
R
 
a 4.0 5.2 16.4 -8.4 a = 4.0 
c 19.6 24.4 77 -38.2 c   13.0 
α1 3.1 7.4 20.6 -14.4 α2  6.0 
α2 6.0 25.6 59 -47.3 
 <z> 9.3    
T
D
T
 
a 7.5 4.6 17.1 -2.1 a   7.5 
c 25.0 375 814 -764 22   c   25 
α1 2.9 19.0 42.8 -36.97 α1  1.0 
α2 20.2 582 1243 -1202 
 <z> 9.7    
Table 2.26 Parameters of beta distribution for z-values (°C) for non-proteolytic  
C. botulinum spores obtained from MS Excel Solver® fit with specified 
constraints, and calculated UCL and UCL (+LYS) 
(a is minimum and c maximum of fitted z-value, α1 and α2 are continuous shape 
parameters and <z> is mean z-value) 
 
Distributions of z-values for TDT dataset and the HR fraction of the dataset, 
based on the parameters in Table 2.26 are illustrated in Figure 2.23. The 
calculated value of <z> for the HR fraction is 9.3°C with a 95% confidence 
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interval [5.4, 14.3] and for TDT dataset is 9.7°C with a 95% confidence interval 
[7.9, 12.4]. 
 
 
Figure 2.23 Beliefs concerning z-value (°C) for spores of non-proteolytic           
C. botulinum (+LYS) 
TDT subset of data (black line), HR fraction (red line) 
 
Probability distribution of D'(80) 
The conversion of logD(T) into equivalent logD'(80) was developed in the two 
ways as used previously for the -LYS data (see section 2.2.2.3). Parameters for 
log normal and corresponding normal distributions of logD'(80) of HS and HR 
fractions corresponding to D-values measured at different heating temperature 
ranges are summarised in Table 2.27.  
 
When the transformation of the D-value into D'(80) for the HS fraction contains 
the D-values measured at higher heating temperatures there is an increase 
uncertainty for p(D'(80)) and the mean value of D is higher. For the HR fraction 
added D-values originating from higher heating temperatures increase the 
uncertainty for p(D'(80)), but the mean value of D does not increase by the same 
magnitude. 
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Since the +LYS TDT subset does not distinguish the HS and HR spore fraction it 
was not used in further analysis. For the +LYS TDT subset, the distribution of 
p(D'(80)) was built only for one subset of temperatures, corresponding to all 
collected D-values in the range of 70 – 94°C (n = 125). The normal distribution of 
logD'(80) is parameterized with <logD'(80)> = 1.28 min and σlogD'(80) = 0.78 min. 
The corresponding parameters of lognormal distribution are equal to <D'(80)> = 
96 min and σD'(80) = 470 min. 
 
HS fraction 
D'(80) (min) assumed z dependent on T 
T range (°C) 75-80 75-81 75-82 75-83 75-85 75-88 75-90 75-93 
n 22 23 26 27 45 48 88 89 
<D'(80)> 1.40 1.48 1.42 1.42 2.22 2.42 14.51 14.84 
σD'(80) 0.68 0.76 0.65 0.65 2.38 2.80 44.44 41.39 
<logD'(80)> 0.10 0.12 0.11 0.11 0.18 0.20 0.69 0.70 
σlogD'(80) 0.20 0.21 0.19 0.19 0.38 0.40 0.64 0.64 
D'(80) (min) assumed z independent of T 
<D'(80)> 1.20 1.33 1.29 1.32 6.43 8.94 387.36 396 
σD'(80) 0.86 1.04 0.98 0.95 16.01 26.93 8048 8236 
<logD'(80)> -0.01 0.02 0.02 0.03 0.38 0.45 1.27 1.28 
σlogD'(80) 0.28 0.30 0.28 0.28 0.61 0.66 1.07 1.07 
 
HR fraction 
D'(80) (min) assumed z dependent on T 
 T range (°C) 75-80 75-81 75-82 75-83 75-85 75-88 75-90 75-91 75-93 75-95   
n 23 24 27 28 50 53 97 99 101 105 
<D'(80)> 47.08 48.18 47.16 46.15 106 101 199 203 214 213 
σD'(80) 60 62 56 53 177 162 330 338 368 354 
<logD'(80)> 1.46 1.47 1.48 1.48 1.74 1.73 2.01 2.02 2.03 2.04 
σlogD'(80) 0.43 0.43 0.41 0.40 0.50 0.49 0.50 0.50 0.51 0.50 
D'(80) (min) assumed z independent of T 
<D'(80)> 36.88 37.74 38.04 38.04 101 101 246 246 240 245 
σD'(80) 27.65 28.29 27.31 27.31 135 135 440 440 413 423 
<logD'(80)> 1.47 1.48 1.49 1.49 1.78 1.78 2.08 2.08 2.08 2.09 
σlogD'(80) 0.29 0.29 0.28 0.28 0.44 0.44 0.52 0.52 0.51 0.51 
Table 2.27 The parameters for normal distribution of logDˈ(80) (min) for spores 
of non-proteolytic C. botulinum at different temperature ranges (+LYS) 
 
Anderson-Darling test 
As in the case of -LYS data the Anderson-Darling test was used to determine if 
all collected D-values represent a single population. The Anderson-Darling test 
was conducted for the HS and HR fractions of spores, according to the method 
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described in section 2.2.2.4. The only difference lies in the range of 
temperatures, and therefore the number of subsets and calculated A2 values. 
Eight A2 values were calculated for the HS fraction and ten for the HR fraction. 
The values were calculated based on parameters <logD'(80)> and σlogD'(80) with 
assumed dependency of z-value on T (Table 2.28). 
 
A2 
Fraction 
Temperature range (°C) 
75-80 75-81 75-82 75-83 75-85 75-88 75-90 75-91 75-93 75-95 
HS 1.22 1.17 1.32 1.44 3.27 3.24 4.43  4.52  
HR 1.33 1.29 1.46 1.53 1.04 1.15 2.24 1.95 1.72 1.87 
Table 2.28 Calculated values of Anderson-Darling for p(logD'(80)) for spores of 
non-proteolytic C. botulinum at different temperature ranges (+LYS) 
empty cells indicate there were no data in this range 
 
For the HS subset the lowest A2 was calculated at the temperature range 75 – 
81°C (A2 = 1.17), whereas the highest for logD'(80) at 75 – 93°C (A2 = 4.52). 
Across the tested subsets the most significant change in A2 value was observed 
between logD'(80) converted from 75 – 83°C and logD'(80) converted from 75 – 
85°C. The critical value of 2.492 for the 5% level of significance, as given in 
Table 2.5, is less than the calculated values of 3.27, 3.24, 4.43 or 4.52 for 
logD'(80) converted from data at above 83°C. Therefore the results of the 
Anderson-Darling test indicate that inclusion of the transformation into logD'(80) 
D-values measured at temperatures above 83°C will cause a deviation. 
Therefore, we can assume that data (n = 27) with estimated parameters 
<logD'(80)> = 0.11 min and σlogD'(80) = 0.19 min represent the same population of 
data. The corresponding lognormal distribution parameters are <D'(80)> = 1.42 
min and σD'(80) = 0.65 min (Figure 2.24).  
 
The “cut off” point above 83°C for the HS fraction is in agreement with results of 
the Anderson-Darling analysis for -LYS data. Since the +LYS HS fraction 
represents spores not affected by the presence of lysozyme, it is not unexpected 
that they show the same property as the -LYS spores. 
 
The calculated A2 (Table 2.28) for the HR fraction reveals homogeneous data 
across all heating temperature ranges, with the lowest for logD'(80) in the range 
of 75 – 85°C (A2 = 1.04). The highest A2 was calculated for logD'(80) for heating 
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temperatures in the range of 75 – 90°C (A2 = 2.24). Since the calculated A2 value 
of 1.87 for logD'(80) transformed from temperatures in the range 75 – 95°C is 
smaller than the critical value of 2.492, there is no reason to reject the null 
hypothesis. It is accepted that all logD values measured at each of heating 
temperature for the HR fraction represent a single population. The belief 
concerning the heat resistance of the HR fraction of spores has normal 
parameterisation with <logD'(80)> = 2.09 min and σlogD'(80) = 0.51 min, and 
corresponding lognormal <D'(80)> = 245 min and σD'(80) = 423 min (Figure 2.24).  
 
 
Figure 2.24 Belief concerning logD'(80) value for spores of non-proteolytic        
C. botulinum for HS and HR fractions and TDT data (+LYS) 
HS fraction (blue line), TDT data (yellow line), HR fraction (red line) 
 
Testing the similarity of +LYS HS and +LYS HR fractions 
Collected D-values for +LYS data has shown that addition of lysozyme during 
recovery following a heat treatment affects their measured heat resistance. 
Based on 34 separate tests it was estimated that the HR fraction constitutes 
approximately 0.02 to 3.12% of the initial spore population. Thus, the HS fraction 
predominates.  
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Figure 2.25 illustrates probability distributions of the D-values for the HS and HR 
fractions obtained at three temperatures and converted to logD'(80). It is noted 
from the graphs that the distribution for the HR fraction is significantly shifted to 
higher values. 
 
 
Figure 2.25 Beliefs concerning the distribution of D-values at different 
temperatures for spores of non-proteolytic C. botulinum (+LYS) 
Heat sensitive (+LYS HS) fraction (blue line), heat resistant (+LYS HR) fraction (red line) 
 
The Anderson-Darling analysis and the distribution parameters for logD'(80) 
indicates that there is a difference in D-values for these two fractions. This 
hypothesis is confirmed by a standard t-test analysis. The spore heat resistance 
of the HR fraction at four temperatures is significantly greater than that of the HS 
fraction (Table 2.29).  
 
D-value measured at T t df p 
D(75) 1.90 7 < 0.01 
D(78) 1.75 16 < 0.01 
D(80) 1.80 11 < 0.01 
D'(80) 1.66 112 < 0.01 
Table 2.29 Results of t-test analysis for heat sensitive (+LYS HS) and heat 
resistant (+LYS HR) fractions for spores of non-proteolytic C. botulinum 
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Heat resistance of spores recovered in absence (-LYS) or presence (+LYS) of 
lysozyme 
A t-test analysis of the +LYS HS fraction and the -LYS data revealed that there is 
no statistical significant difference in logD values for these two subsets of data at 
78°C, 80°C and logD'(80) transformed from temperatures in a range 50 – 83°C 
for -LYS and 75 – 83°C for +LYS HS fraction (Figure 2.26).  
 
 
Figure 2.26 Comparison of heat resistance of spores of non-proteolytic             
C. botulinum recovered in presence and absence of lysozyme  
-LYS data (blue full line and dark blue squares), +LYS HS fraction (blue dashed line and 
light blue squares), +LYS HR fraction (red squares) 
 
Since the distribution of logD'(80) for -LYS is built from much more data, then the 
+LYS HS data are not considered further. The analysis of the dependence of 
spore heat resistance on heating menstruum (+LYS HR fraction) revealed similar 
results to the -LYS subset, i.e. there is no significant difference in D-values 
measured in media/buffer and food matrices (data not shown). 
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Practical application of heat treatment parameters 
Table 2.30 and Table 2.31 summarise D and z-values calculated using different 
methods. For the -LYS subset, the calculated z-values ranged from 6.8 – 9.8°C. 
A z-value of 6.8°C (Figure 2.13) is the mean of all reported values in eligible 
studies and a value of 9.8°C is obtained from the plot in Figure 2.14. Both          
z-values include data from experiments performed at temperatures above 83°C. 
As shown from the Anderson-Darling analysis (see section 2.3.2.2), these data 
should not be included; therefore these z-values are of limited value. By taking 
account of data generated at 83°C and below, z-values of 8.1°C and 7.7°C are 
obtained from the slope of the line of best fit (Figure 2.14 and Figure 2.21). The 
former z-value was fitted to the average logD values (single point) at each 
heating temperature whereas the latter, was fitted to all logD values (multiple 
points) reported at each heating temperature. The beta distribution of z-value 
with parameters a = 3.7, c = 16.5, α1 = 2.9 and α2 = 9.6 (with <z> = 6.7°C) (Table 
2.12) includes the range of all above values. 
 
Data for the +LYS HR subset were collected in the range of 75 – 95°C, with the 
majority of D-values generated at 85°C or 90°C. The z-values were higher than 
reported for the -LYS data with a mean of 9.6°C (Figure 2.13). From the slope of 
the line of best fit (fitted to the average of logD values) (Figure 2.22) a z-value of 
14.3°C was obtained. The highest recorded z-value in the literature for the +LYS 
HR fraction was 13.0°C (Figure 2.13), therefore 14.3°C  could be an artefact due 
to the limited number of data available for fitting procedure. For logD the R2 value 
of the fitted line is very small (R2 = 0.3), therefore the z-value calculated from the 
slope is likely to be imprecise (Figure 2.22).  
 
Based on this analysis, a z-value for -LYS data should be in the range of 6.7 – 
8.1°C, and for +LYS HR data a z-value should be in the range of 9.3 – 9.6°C.     
A single integer temperature is generally used for the z-value, thus z-values of 
7°C and 9°C may be appropriate for these two datasets. 
 
As shown in Table 2.31 for -LYS data, exclusion of D-values generated above 
83°C had an important effect on D'(80), which decreased from 2.76 to 1.87 
minutes (Table 2.13). The mean value of D(80) = 2.26 min (Table 2.10) is in 
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agreement with the mean value for the fitted distribution of D'(80) (<D> = 2.23 
min) (Table 2.13). The lowest D-value at 80°C (1.29 min) was calculated from 
the thermal death model (Table 2.18). Using the 95th and 99th UCL of the thermal 
death model, calculated values of D are respectively 9.02 and 16.60 minutes 
(Figure 2.21).  
 
Data  Calculation method Source 
(Table/ Figure) 
Mean 
(SD*/R
2
)
a) T (°C) n 
-L
Y
S
 
Raw data Figure 2.13 6.8 (1.6*) 50-93 368 
Fitted line (average logD value) Figure 2.14 9.8 (0.9) 50-93 -- 
Fitted line (average logD value) Figure 2.14 8.1 (0.9) 50-83 -- 
Fitted line (logD values) Figure 2.21 7.7 (0.7) 50-83 -- 
Fitted distribution Table 2.12 6.7 (1.5*) 50-83 340 
+
L
Y
S
 H
R
 Raw data Figure 2.13 9.6 (2.1*) 75-95 46 
Fitted line (average logD value) Figure 2.22 14.3 (0.8) 75-95 -- 
Fitted line (logD values) not shown 21.3 (0.3) 75-95 -- 
Fitted distribution Table 2.26 9.3 (2.3*) 75-95 46 
+
L
Y
S
 
T
D
T
 
Raw data  Figure 2.13 11.4 (4.3*) 70-94 90 
Fitted line (average logD values) Figure 2.22 24.5 (0.8) 70-94 -- 
Fitted line (logD values) not shown 17.2 (0.5) 70-94 -- 
Fitted distribution (all z-values) Table 2.26 9.3 (8.5*) 70-94 90 
Table 2.30 Summary of z-values (°C) for spores of non-proteolytic C. botulinum 
calculated by different methods 
a) number in brackets present R2, which assess the “goodness” of fitted line, and 
standard deviation calculated from data (as indicated with asterisk) 
 
Higher values were calculated for the +LYS HR fraction, with a mean value of 
Dˈ(80) = 213 min (calculated from raw data), and a mean value distribution of   
D-value <D'(80)> = 245 min (Table 2.27). A smaller value was noted for             
D measured at 80°C (D(T) = 69 min) (Table 2.24), but this is calculated from only 
nine data points (compare with 105 for D'(80)). Also the D-value of 45.71 min 
calculated from the thermal death model (data not shown) is small compared to 
other recorded D-values. The small R2 = 0.3 for +LYS HS (fitted line – logD 
values) indicates that the fitted trendline does not provide a very good 
approximation for the data (Table 2.30). 
 
 
 
 
 
Chapter 2 
114 
Data Calculation method 
Source 
(Table/ 
Figure) 
logD 
value 
(min) 
<D> ± (σD)* 
(min) 
T 
(°C) 
n 
-L
Y
S
 
Raw data D'(80) Table 2.13 0.13 (0.5) 2.76 ± (4.9) 50-93 551 
Raw data D'(80) Table 2.13 0.05 (0.4) 1.87 ± (2.5) 50-83 505 
Raw data D(80) Table 2.10 0.16 (0.4) 2.26 ± (2.7) 80 151 
Fitted line (thermal death model) Table 2.18 0.11 1.29 80 -- 
Fitted distribution D'(80) Table 2.13 0.00 (0.5) 2.23 ± (4.4) 50-83 505 
+
L
Y
S
 
H
R
 Raw data D'(80) Table 2.27 2.04 (0.5) 213 ± (354) 75-95 105 
Raw data D(80) Table 2.24 1.37 (0.6) 69 ± (194) 80 9 
Fitted line (thermal death model) not shown 1.66 45.71 80 -- 
Fitted distribution D'(80) Table 2.27 2.09 (0.5) 245 ± (423) 75-95 105 
+
L
Y
S
 
T
D
T
 Raw data D'(80) not shown 1.08 (0.5) 23.33 ± (38.8) 70-94 129 
Raw data D(80) Table 2.24 0.87 (0.4) 12.10 ± (15.62) 80 30 
Fitted line (thermal death model) not shown 1.00 9.94 80 -- 
Fitted distribution D'(80) sec. 2.3.2.3 1.28 (0.8) 96 ± (470) 70-94 129 
Table 2.31 Summary of calculated D-values (min) at 80°C and D'(80) for spores 
of non-proteolytic C. botulinum for different subsets of data  
*data are given as mean ± standard deviations 
 
Based on the 95% and 99% UCL of the thermal death model (-LYS data) (see 
section 2.3.2.2 – testing the dependence of spore heat resistance on heating 
menstruum), time to a 1D and 6D reduction in the non-proteolytic C. botulinum 
spore population, at different temperatures can be calculated (Table 2.32). 
According to the model predictions heating for 54 and 100 minutes at 80°C and 
2.68 and 4.91 minutes at 90°C would be required to achieve a 6D reduction 
using 95% and 99% UCL, respectively (Table 2.32). Due to low R2 value heating 
time required to provide the 1D and 6D reduction for +LYS HR fraction was not 
calculated. 
 
Table 2.32 Equivalent heat treatments for 1D and 6D reduction of non-proteolytic 
C. botulinum spores based on the fitting of thermal inactivation data published in 
the literature (n = 505) using 95% and 99% upper confidence limits (-LYS) 
T 
(°C) 
Time (min) 
1D 6D 
Expected 
value 
95% UL 99% UL 
Expected 
value 
95% UCL 99% LCL 
70 25.88 182 337 155 1092 2020 
75 5.80 40.50 75 34.81 243 449 
80 1.29 9.02 16.60 7.80 55 100 
85 0.29 2.01 3.69 1.75 12.04 22.11 
90 0.07 0.45 0.82 0.39 2.68 4.91 
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2.4 Discussion 
As indicated in section 2.1.6 five other reviews of the heat resistance for spores 
of non-proteolytic C. botulinum have been carried out previously. The output of 
this review not only provides information about the range of reported D and       
z-values, but also confirms existing hypothesis regarding the heat resistance of 
non-proteolytic C. botulinum spores and puts forward new ones. 
 
This review found several key results. First of all, -LYS D-values measured at 
above 83°C do not change significantly with heating temperature. The statistical 
analysis indicates that data for T > 83°C are not consistent with the data 
obtained from measurement at lower heating temperatures. In the studies of De 
Pantoja (1986) the decimal reduction time of spores measured at 85°C was 
slightly higher than the D-value observed at 80°C. Similarly, in a report published 
by Membrè and McClure (2006) D-values measured at above 90°C were not 
included in a model and were analysed separately. There are two possible 
explanations: firstly – a change in spore heat resistance might be associated with 
experimental factors (uneven dispersion of spores in the test tube, evaporation of 
water – exposure to dry heat rather than moist heat). Moreover, D-values at 
higher temperatures (~90°C) take values in a range of 0.01 – 1 min. Physical 
measurement of values of this magnitude present many problems. Secondly – 
changes in heat resistance might be associated with change in physical 
properties of spores (late activation of heat resistant spores present in the 
population). 
 
A second key finding is that this review of the current literature did not 
demonstrate that heat resistance of spores is associated with toxin type, which 
was believed to be the case by many researchers. For example, in the studies of 
Scott and Bernard (1982) the heat resistance of spores of type B strains 
appeared to be greater than that of spores of type E strains. Nevertheless, these 
authors acknowledged that results for the tested strains were not consistent with 
reports by other researchers. The authors explained that this could possibly be 
caused by different batches of recovery media and the age of spores. Other 
studies which tested strains of two different toxin types in the same heating 
system were published by Lynt et al. (1977; 1979; 1983). These authors 
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evaluated the spore heat resistance of five strains of type E and three strains of 
type F in crabmeat. The study revealed that the heat resistance of spores of type 
F strains was similar to type E strains. The only difference lay in the slope of line 
obtained from plotting D-value against temperature. Consequently, spores of 
type F strains had lower z-values. This finding agreed with the results of this 
review, where the z-value for type E spores is 6.8°C, and for spores of type F 
strains the mean z-value = 5.6°C. Similarly, a study of spore heat resistance for 
type B and E strains in cod and carrot homogenates at 70 – 92°C, revealed that 
there was no difference in spore heat resistance for strains of different toxin type 
within the same heating menstruum (Gaze and Brown, 1990). The results were 
in agreement with Juneja et al. (1995a), who reported on the heat resistance of 
type B and E strains tested in two different recovery media. According to the 
studies of Peck et al. (1993) spores of strain Eklund 17B (type B) recovered in 
+LYS medium were more heat resistant than spores of strain Beluga (type E). 
Nevertheless, further testing of ten strains (four type B, four type E and two type 
F) at 85°C, revealed no association between toxin type and apparent spore 
resistance. 
 
In this review, only in one case, following heating at 80°C, the mean of D-value 
for mixed strains appeared to be lower than the D-value of type B and E strains. 
The data at this temperature for mixed strains originates from a report by 
Membrè and McClure (2006) for which some information was missing because 
the heat treatment experiment was not conducted by the authors. There was no 
information about the strains used, except general information e.g. “type B (6), 
type E (15) and type F (3) were used”. Since there was no possibility to retrieve 
the original data, strains were treated as mixed strains. This could lead to bias in 
the analysis. As the difference was observed only for one heating temperature 
and only for mixed strains, this finding is not significant for an overall analysis. 
Thus, the overall evidence from the literature is that spore heat resistance is not 
associated with the type of neurotoxin formed. However, the possibility still arises 
for subtle differences, but that are not evident from the literature data. This could 
only be revealed by testing of a large number of strains in a well-controlled study. 
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The test carried out in this study failed to demonstrate a relationship between the 
heat resistance of spores and the heating menstruum. Data published in a report 
by Bohrer et al. (1973) show that the measured D-value was higher in food than 
phosphate buffer. Moreover, a correlation was observed between spore heat 
resistance and the amount of proteins and fat. Strain Saratoga exhibited             
a greater heat resistance in foods high in fat and protein such as tuna in oil and 
sardines in tomato sauce, with D(77) = 40.9 min and 20.0 min respectively, 
whereas D-value measured in 0.067M phosphate buffer was 4.1 min. There was 
no correlation observed between thermal heat resistance of spores and 
carbohydrate content in food, with D(77) = 11.2 min measured for corn in brine. 
Similar results were reported by Lynt et al. (1979), where the heat resistance of 
the strain Eklund 202F was greater in crabmeat (D(77) = 9.5 min, D(79) = 3.5 
min, D(82) = 1.2 min) than in 0.067M phosphate buffer (D(77) = 4.3 min, D(79) = 
3.5 min, D(82) = 0.3 min). The D-values calculated for strain Crab G 21-5 by 
Solomon et al. (1977) appeared to be lower in TPGY broth as a heating 
menstruum (with D(82) = 1.5 min) compared with crabmeat (D(82) = 3.0 min). 
These are the only studies which were directly designed to test the dependence 
of the heat resistance parameters on heating menstruum, i.e. where at least two 
different menstrua were used in one experiment. Nevertheless, considering the 
large number of collected data in this review (n = 505 D-values) the heat 
resistance of spores measured in different food matrices (n = 27) does not 
appear to be significantly different from that measured in media\buffer (n = 13). 
This finding agreed with the analysis of 269 collected D-values by Membrè and 
McClure (2006). However, the average D-value appears to be slightly higher, 
when determined in meat products or seafoods (Table 2.19). Since only a few 
data points correspond with these heating menstrua it is very difficult to draw 
significant conclusions. Thus, while individual studies have shown that measured 
spore heat resistance can appear greater in foods than in media\buffer, the 
overall dataset does not reveal a relationship. It might be that the great variety of 
techniques used by researchers in different laboratories has obscured this 
relationship.  
 
In the studies of Alderman et al. (1972), it was shown that not only the heating 
menstruum itself but the physical state (i.e. the water activity (aw)) of the 
Chapter 2 
118 
menstruum is important in the heat resistance of spores. Spores heated in raw 
fish had a greater D-value than those heated in autoclaved fish. Similar results 
were observed for raw egg white (D(83) = 14.2 min) and pre-coagulated egg 
white (D(83) = 1.2 min). Addition of sodium chloride to the heating menstruum 
sometimes lead to an increase of D-value (Bucknavage et al., 1990). When the 
heat resistance of spores was tested by Murrell and Scott (1966) in menstruum 
with aw = 0.90 a value of D(80) = 25.8 min was obtained, whereas at aw = 1.0 the 
D(80) = 0.3 min. Appleyard and Gaze (1993) suggested that a prior sublethal 
heat treatment increases the measured D-value. They also concluded that the 
time after which the D-value was determined following the heat treatment is        
a significant factor. These authors reported that the greatest D-value was 
determined immediately after heat shocking at 50°C for 60 min (D(70) = 43.8 
min). Holding samples after the heat treatment for 4 hours at room temperature 
decreases the D-value (D(70) = 32.8 min) and storage of samples for 24 hours at 
6°C lowered the D-value further (D(70) = 22.4 min). Therefore it can be 
concluded that not only the heating menstruum itself, but its physical state (lower 
aw), and the time for which the medium is kept before determining the D-value 
have an impact on the decimal reduction time. 
 
This review confirms that spore heat resistance depends on heating technique. 
Although there are not many publications which directly compare the impact of at 
least two different heating techniques on D-value for the same non-proteolytic   
C. botulinum strain. An attempt was made by Graikoski and Kempe (1964) but 
the results were not very reliable, as in many cases the reduction in spore 
concentration was small. Of the nine heating techniques considered, TDT cans 
and sealed ampoules in a water bath appeared to give the highest mean value 
for logD'(80) with <logD'(80)> = 0.65 min and 0.59 min, respectively. The          
D-values obtained in experiments with sealed ampoules were from a study by 
Eklund et al. (1967a) and as this method appears to be very tedious this is an 
isolated report. The TDT can technique is more commonly employed in studies 
of heat resistance for spores at high temperatures (> 100°C). Moreover, the 
mean value of logD'(80) determined using TDT cans technique was mainly 
calculated from D-values reported by Bohrer et al. (1973), with products high in 
fat and proteins as heating medium.  
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According to De Pantoja (1986), the method of calculation can affect the           
D-value. This is in agreement with findings from this review. Analysis of 505      
D-values revealed that D-values calculated according to methods of TDT and 
TDT/Stumbo(1948) are significantly higher than those calculated according to 
the survivor curve and TDT/Schmidt(1957) method. Similar results were obtained 
in a hypothetical example presented in Table 2.3 and Table 2.4. In the results of 
De Pantoja (1986), a comparison of decimal reduction times obtained by three 
different methods of calculation, the TDT/Stumbo(1948) method appeared to 
give the highest D-values. The inconsistency arising from differences in D-values 
calculated from survivor curve and TDT methods causes a variation in z-value. 
This was reported by Lynt et al. (1977; 1979), Licciardello (1983) and Chai and 
Liang (1992). In all studies z-values calculated from TDT curves were lower than 
z-values calculated from survivor curve data. 
 
This review indicates that strain ATCC 9564, with <D'(80)> = 10.3 min (n = 11) 
and strain Detroit (<D'(80)> = 8.0 min (n = 6)) are the most heat resistant. Strains 
Crab 25 V-2 (n = 11) and Whitefish (n = 3) had lowest mean value of D'(80) (0.3 
and 0.5 min) (all were type E strains). Nevertheless, this information should be 
interpreted with caution. In spite of such a large database it is difficult to 
distinguish the most and least heat resistant strains since they seem to vary with 
heating temperature as indicated for example by Bohrer et al. (1973) and Ito et 
al. (1970). Additionally, difficulty to determine the most heat resistant strain can 
arise from variability in spore crop (Blocher and Busta, 1983) and number of 
factors (as shown above) determining spore heat resistance. Thus it is not easy 
to compare strains from studies that have used different methods (e.g. heating 
menstruum, heating technique). The results from testing a number of strains in   
a very reproducible way would be of great interest.  
 
It is apparent from this review that recovery media, especially addition of 
lysozyme, has a large effect on measured D-value, resulting in biphasic survivor 
curves, which represents a mix of two fractions of spores with different heat 
resistance properties. The first part of the survival curve describes heat sensitive 
spores (HS) and the second heat resistant spores (HR). It was estimated that the 
heat resistant fraction can constitute approximately 0.02 – 3.1% of the 
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population. Lindström et al. (2003) estimated the heat resistant fraction as ~0.1% 
of spores, and Peck et al. (1993) estimated the fraction as ~0.2 – 1.4%, with the 
fraction dependent on the strain. The biphasic survivor curve, and consequently 
the increased number of surviving spores, was observed when as little as 0.1µg 
lysozyme ml-1 was added to the recovery medium. In studies by Peck et al. 
(1992a) the maximum spore recovery was achieved at concentrations ~5 – 10 µg 
lysozyme ml-1. Furthemore, addition of vegetable juices to the plating medium or 
recovery of heated spores in a medium containing crabmeat can also result in    
a biphasic curve (Stringer and Peck, 1996; Peterson et al., 1997). An explanation 
of the biphasic curve is included in section 2.1.2.  
 
The main purpose of this systematic literature review was to collect data 
describing the heat resistance parameters of spores of non-proteolytic               
C. botulinum. As a result the lognormal distribution of D'(80) with parameters 
<D'(80)> = 2.23 min and σD'(80) = 4.44 min was obtained in order to represent 
belief concerning the heat resistance of non-proteolytic C. botulinum spores       
(-LYS). When the activity of lysozyme is included the parameters for a lognormal 
distribution of HR fraction are <D'(80)> = 245 min and σD'(80) = 423 min. The beta 
distribution for z-values (-LYS data) has parameters a = 3.7, c = 16.5, α1 = 2.9, α2 
= 9.6 with <z> = 6.7°C.  
 
Thermal inactivation parameters for non-proteolytic C. boutlinum spores were 
also determined by Van Asselt and Zwietering (2006), with <logD(120)> = -1.47 
min, σlogD(120) = 0.71 min and z = 18.6°C. The parameters were estimated from 
the relationship of log transformed D-values and temperature. Parameters 
transformed to 80°C are <logD(80)> = 0.68 min and σlogD(80) = 0.71 min and 
corresponding parameters for a lognormal distribution are <D(80)> = 18.21 min 
and σD(80) = 66.86 min. The parameters are significantly higher than the ones 
obtained in this review. The main reason is that data used by Van Asselt and 
Zwietering (2006) included D-values from experiments when recovery of spores 
was conducted in media which contained lysozyme. The estimate of parameters 
was based on 175 data points. Probability distributions for D'(80) from this 
review, from the ACMSF recommendation (1992) and from Van Asselt and 
Zwietering (2006) are illustrated in Figure 2.27. 
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Figure 2.27 Belief concerning the distribution of D'(80) for spores of non-
proteolytic C. botulinum according to different authors 
This review (-LYS) (blue line), this review (+LYS) (red line), Van Asselt and Zwietering 
(2006) (blue dotted line), ACMSF “90/10” rule, converted to D'(80) using beta distribution 
obtained in present study for z-value (2.9, 9.6, 3.7, 16.5) (black line) 
 
Collected data from this review was also used to review the current 
recommendations that a heat treatment of 10 min at 90°C is needed to reduce 
the concentration of non-proteolytic C. botulinum spores by six orders of 
magnitude in respect of minimally heated chilled foods products (ACMSF, 1992). 
The model (-LYS) presented in this thesis predicted that heating at 90°C for ~5 
min is needed (based on 99% upper limit of prediction) for a 6D inactivation of 
spores. Thus, the current ACMSF recommendation provides a good level of 
safety. There are six studies (Murrell and Scott, 1966; Alderman et al., 1972; 
Bohrer et al., 1973; Scott and Bernard, 1982; Scott and Bernard, 1985; 
Fernandez and Peck, 1997) in which D-values are reported that are higher than 
those predicted by the model presented in this thesis. Four of these studies used 
the TDT method and the inactivation kinetics were not reported. Moreover, in 
these particular studies the heated spores were transferred to nutrient-rich 
medium and incubated for prolonged time. This procedure is known to result in 
larger D-values as a combination of prolonged storage and subculturing of 
spores into new nutrient medium, favours their germination and outgrowth. The 
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two remaining D-values (D(80) = 25.8 min and D(75) = 274 min from the studies 
of Murrell and Scott (1966) and Fernandez and Peck (1997) have been 
calculated from data given in the publication. However, despite these points, 
there is no reason to reject this model.  
 
Using the 99% UCL for the time required for a 6D reduction of non-proteolyic       
C. botulinum spores heated at 80°C gives longer heating time than that 
calculated by Membrè and McClure (2006), but it is shorter than the time 
recommended by ACMSF and CFA (Table 2.33). The equivalent heating time at 
90°C for the 99% UCL, using the z-value of 7°C is ~5 min which is in agreement 
with results of Notermans (1990) where heating at 90°C for 4 min is sufficient to 
provide a 5D safety factor. However, since the model from this review did not 
include data above 83°C, there is not enough evidence to question the validity of 
the ACMSF recommendation. 
 
Table 2.33 Heating time required at 70 – 90°C to provide a 6D safety factor 
respect to spores of non-proteolytic C. botulinum according to ACMSF (1992), 
CFA (2006), Membrè and McClure (2006) and the model obtained in this thesis 
from a review of current literature (-LYS)  
* time calculated from 99th upper confidence limits of prediction 
 
From the data summarised in this study two z-values are recommended; z = 7°C 
for data where there is no evidence for lysozyme activity, otherwise z = 9°C. So 
far, current recommendations do not consider the influence of lysozyme present 
in heated products. In the summary by Membrè and McClure (2006) any data 
from studies with lysozyme present in the recovery medium were excluded from 
the data set. Significantly higher D-values, and z-values in heating system with 
lysozyme means that manufacturers need to ensure that the food product is free 
of lytic enzyme activity before setting the thermal processing. Two z-values 
T 
(°C) 
Time (min) 
ACMSF 
(1992) 
“90/10” 
(z = 9.2°C) 
CFA 
(2006) 
“90/10” 
(z = 7°C) 
Membrè and 
McClure (2006) 
 “90/7” 
(z = 9.2°C)*
 
Model for current literature 
review 
Expected 
value 
95% 
UCL 
99% 
UCL 
70 1675 -- -- 155 1092 2019 
75 464 -- 283 34.81 243 448 
80 129 270 81 7.80 54 100 
85 36 52 23.5 1.75 12.04 22.11 
90 10 10 6.9 0.39 2.68 4.91 
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recommended by the CFA, ECFF and USFDA (Table 2.1) related to the safety of 
minimally heated chilled foods are made with respect to heating temperature with 
a lower z-value (7.0°C or 9.2°C) below 90°C and a higher z-value (10.0°C or 
10.2°C) above 90°C. A similar approach should be taken in the presence of 
lysozyme. 
 
From the analysis presented in this chapter it can be concluded that the heat 
inactivation parameters for spores of non-proteolytic C. botulinum depend on 
many factors, e.g. variation of strains, experimental conditions, heating method 
and recovery conditions. There are a large number of reported D and z-values. 
The range of reported D(80) values was 0.20 to 25.84 min (-LYS data) and 0.69 
to 111 min (+LYS) and z-values ranged from 4.1°C to 22.4°C. The choice of 
appropriate single parameters when estimating the effect of heat inactivation for 
a particular product is considerable. A poor choice may result in either over 
processing (which affects the sensory and nutritional value of the food) or, in the 
worst case scenario, under processing affecting consumer safety.  
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2.5 Conclusions 
From an extensive literature survey, a total of 880 D-values and 528 z-values 
determined at 27 different temperatures were obtained. An in-depth analysis 
allowed the following conclusions: 
i. Established data provide a strong quantitative support for modelling of the 
thermal properties of the spores of non-proteolytic C. botulinum as they 
allow for including uncertainty and variability into QMRA 
ii. Recovery media, especially the addition of lysozyme has a large impact 
on measured thermal properties of spores, resulting in biphasic curves, 
with significantly different D-values observed for the +LYS HS and +LYS 
HR fractions. Therefore these data need to be treated separately 
iii. The distribution of D-values for the -LYS data was not significantly 
different to that for the +LYS HS 
iv. D-values for the -LYS and +LYS HS obtained at high temperatures          
(> 83˚C) include uncertainty arising from experimental method and these 
data should not be included in the analysis 
v. Examination of data for B, E and F strains indicates that there are no 
significant differences between probability distributions of the D-values, 
demonstrating that the heat resistance of spores is not associated with 
their toxin type 
vi. Indication of the strains that form the most and least heat resistant spores 
is difficult to assess due to the large number of factors that influence the 
D-value variability 
vii. Spore heat resistance does not depend strongly on heating menstruum, 
nevertheless slightly higher D-values were observed in meat products 
viii. Spore heat resistance depends on heating technique, with higher           
D-values obtained when TDT cans and sealed ampoules were used  
ix. The D-value depends on the method of calculation, with the calculated 
decimal reduction time according to TDT and TDT/Stumbo(1948) being 
higher than from survivor curves 
x. A lognormal distribution of D'(80) with parameters <D'(80)> = 2.23 min 
and σD'(80) = 4.44 min represents belief concerning the heat resistance of 
non-proteolytic C. botulinum spores (-LYS). When the activity of lysozyme 
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is confirmed the parameters for a lognormal distribution are <D'(80)> = 
245 min and σD'(80) = 423 min  
xi. The beta distributions of z-values for -LYS data were described with 
parameters a = 3.7, c = 16.5, α1 = 2.9, α2 = 9.6 and <z> = 6.7°C. For +LYS 
HR a = 4.0, c = 19.6, α1 = 3.1, α2 = 6.0 and <z> = 9.3°C  
xii. The time needed for a six order of magnitude reduction in concentration of 
non-proteolytic C. botulinum spores in the absence of lysozyme at 90°C is 
~5 min (based on 99% UCL) 
xiii. A suitable z-value for spores of non-proteolytic C. botulinum might be 7°C 
(based on the -LYS data). While for the +LYS HR fraction, a suitable       
z-value is 9°C 
 
Heat treatment is one of major factors used to control the C. botulinum hazard in 
food; therefore this process should be optimized in order to deliver sufficient 
microbial inactivation. The use of probability distribution of appropriate 
parameters in designing the heat treatment allows for the inclusion of variability 
(physiological property of spores) and uncertainty (associated with technical 
errors of conducted tests) into calculations. Therefore, the distribution 
parameters for p(z) and p(logD'(80)) obtained in this chapter not only support the 
decision-making process regarding the choice of optimal heat treatment but also 
allow for a calculation of the level of confidence in QMRA. 
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3. Variability in growth of non-proteolytic C. botulinum 
strains at chill temperatures 
The variability in growth of non-proteolytic C. botulinum type B, E and F strains 
has been examined at chill temperatures (3.0°C – 10.0°C). The results 
demonstrate that the growth response from spores varies with inoculum 
concentration and incubation temperature, and is strain specific. A classification 
analysis reduced the variability of growth response by assigning strains to 
homogeneous groups according to their physiological response. These clusters 
are used to establish distributions of growth times – crucial information in 
quantifying the risk with respect to C. botulinum. Interestingly clusters of strains 
of non-proteolytic C. botulinum are associated with the type of toxin produced.  
 
3.1 Background 
Non-proteolytic C. botulinum spores can survive the moderate heat treatment 
that is applied to chilled foods, and thus remain viable, subsequently germinate, 
outgrow and produce neurotoxin (type B, E or F) during storage. Neurotoxin 
formation by non-proteolytic C. botulinum has been reported at a temperature as 
low as 3.0°C (Peck et al., 2006). Protecting chilled foods from growth or toxin 
production by pathogenic microorganisms frequently relies on two steps in          
a HACCP system: heat treatment and storage at refrigeration temperature. 
Complying with EU Regulation No 852/2004 (2004) the chilled foods 
manufacturers shall implement the principles of HACCP system and following 
the Food Hygiene (England) Regulations (2006) producers must ensure that 
these foods are kept at or below 8°C throughout the whole supply chain. 
Although it should be possible to maintain these temperatures in commercial 
storage, there is a chance of temperature abuse during purchasing, transport, or 
storage in domestic conditions. 
 
According to a study of UK domestic storage practices by George et al. (2010), 
approximately 87.5% of consumers stored chilled ready meals in a fridge, 0.3% 
at ambient temperature and 9.8% in a freezer (the remaining interviewees 
declared that they do not purchase chilled food). The same study showed that 
3% of people expected to store chilled ready to eat meals for more than seven 
days prior to consumption and 4% did not know the product shelf life. 
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The above report also indicated that 7.0°C was the dominant mean operating 
temperature of domestic fridges; however 29% of tested fridges operated with     
a mean temperature at or above 9.0°C (Figure 3.1). It should be noted that the 
average air temperature varied in different parts of a fridge, being 9.6°C in the 
bottom compartment, 5.9°C at the top and 4.7°C on the central shelf (George et 
al., 2010). Other factors, such as cleaning, loading, seals and fridge age also 
affected the refrigerator temperature. 
 
 
Figure 3.1 Frequency distribution of mean domestic fridge temperatures in the 
UK 
Source: George et al. (2010) 
 
The storage temperature is one of the crucial elements in quantitative risk 
assessment when evaluating the safety of chilled foods (see Chapter 5), as it is 
generally a significant source of uncertainty and sensitivity. Given the fact that 
only 15% of UK families use a thermometer to monitor the fridge temperature 
(Laguerre et al., 2002), food manufacturers need to consider consumer 
behaviour when assessing product shelf life as it can influence the potential for 
growth of foodborne pathogens. All bacteria have a particular temperature 
growth range, and this range with its growth rate, is a crucial factor in food 
safety. In order to ensure the safety of chilled foods, it is vital to understand the 
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impact of chill temperatures on bacterial growth, and there is immense benefit in 
understanding its relationship with strain variability. 
 
It is well-known that not all bacterial strains respond in the same way to 
environmental conditions. It is a natural property of bacteria that for two strains of 
the same species, one will have more rapid and another slower growth even in 
identical circumstances. Previously published studies for several foodborne 
pathogens including E. coli O157:H7 (Nauta and Dufrenne, 1999), Salmonella 
enterica (Lianou and Koutsoumanis, 2011), Bacillus cereus (Carlin et al., 2013) 
demonstrated intra-species variability in growth properties under different 
environmental conditions. Although, predictive microbiology models, have been 
applied successfully in prediction of bacterial growth and consequently in 
production of safe food, they only provide one deterministic prediction of growth, 
rather than the probability distribution for population growth at a given time. 
These models do not account the variability within each species (Nauta and 
Dufrenne, 1999). Thus, in order to understand the variability of growth for non-
proteolytic C. botulinum a probabilistic model for the time to growth is used, 
which allows it implementation in a QMRA (Nauta, 2002). 
 
The growth of non-proteolytic C. botulinum at chill temperatures has been 
examined previously, published studies were mainly focused on determination of 
growth rate (Graham and Lund, 1993), the probability of growth from a single 
spore (Jensen et al., 1987), and the effect of pH and NaCl on growth (Graham et 
al., 1997). None of the published studies assessed strain-dependent growth 
properties at chill temperatures. Inclusion of the variable growth response of 
different strains of non-proteolytic C. botulinum at chill temperatures in the form 
of probability distribution will allow for better quantification of hazard 
characterisation and improved risk assessment. Moreover, generated data will 
be used in an estimation of the time preceding observation of growth of non-
proteolytic C. botulinum – a dominant component of risk presented to chilled 
foods (see section 5.2.4.4).  
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3.2 Material and methods 
Assessment of the variability in growth response of non-proteolytic C. botulinum 
strains during incubation at chill temperatures is based on two independent 
experiments. Experiment one (“Minimal growth temperature of non-proteolytic   
C. botulinum strains”) was carried out previously by Stringer and Webb at IFR 
(unpublished data), whereas experiment two was carried out as part of these 
studies. The methodologies in both experiments are similar. In experiment one, 
the growth of 40 strains at ten incubation temperatures (in the range of 3.0°C – 
10.0°C) for one spore concentration, s, (s = 106 spores tube-1) was tested. 
Whereas in experiment two, the growth of 24 non-proteolytic C. botulinum strains 
from seven different inoculum concentrations was examined at a single 
temperature of 6.0°C. Clustering analysis was used to assess strain variability. 
Tested strains were assigned to particular clusters based on the parameter         
  calculated from growth tests. The parameter describes the time needed for half 
of inoculated tubes to show growth. In order to express uncertainty in the           
 -value, a normal cumulative distribution function was fitted for each identified 
cluster of non-proteolytic C. botulinum strains. The effect of non-proteolytic       
C. botulinum strain variability on growth at chill temperature was assessed based 
on data generated in both experiments. Additionally data from experiment two 
were analysed in terms of probability of growth of non-proteolytic C. botulinum at 
6.0°C. 
 
3.2.1 Strains 
The strains used are listed in Table 3.1. In total the growth at chill temperature 
was tested for forty-two strains of non-proteolytic C. botulinum. Experiment one 
was performed using forty strains (13 type B, 22 type E and 5 type F). In 
experiment two, twenty-four strains were tested (11 type B, 9 type E and 4 type 
F). Chosen strains were isolated in different laboratories from various locations. 
These strains were also used in the tests described in Chapter 4. 
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IFR 
no. 
Chill 
temperature 
incubation test 
Carbohydrate 
utilization test Strain name 
Isolation details Receive
d from** 
Exp. 1* Exp. 2 Exp. 1 Exp. 2 Source Location Date 
Type B strains 
81-23 v v v v Hobbs FT50 Herring UK 1960s? UR 
81-30 v v v v Eklund 17B  Pacific sediments USA 1965 NCIMB 
83-01 v v v v Eklund 2B Pacific sediments USA 1965 UR 
86-17 v v v v Colworth BL15 Haddock Norway 1960s? UR 
87-02 v v v v CDC 3875 Human stool from botulism case Iceland 1981 CDC 
87-04 nt v nt v CDC 4672 U-1 Whey – botulism case Iceland 1983 CDC 
90-04 v nt nt v 2129B Unknown France 1950s? NFPA 
93-06 v v nt v CDC 5900 Human stool from botulism case Italy 1986 CDC 
93-10 v nt nt v Kapchunka B2 Dried salted whole whitefish [Kapchunka] USA 1981 NFPA 
93-11 v v nt v Kapchunka B5 Dried salted whole whitefish [Kapchunka] USA 1981 NFPA 
02-51 v v nt v ATCC 17844 Unknown   Unknown Unknown UH 
05-20 v v nt v IFR 05/020 Scallops Canada 2005 IFR 
05-25 v v v v IFR 05/025 Dried egg pasta (“Fettucine”) UK 2005 IFR 
05-29 v nt nt v IFR 05/029 Dried egg pasta (“Trucioli”) UK 2005 IFR 
Type E strains 
81-26 v nt v v Beluga Fermented Beluga whale [Muktuk] USA 1950 UR 
81-27 nt nt nt v Foster B96 Smoked fish USA 1981 UR 
81-31 v v v v Hazen 36208 Labrador smoked salmon USA 1934 NCIMB 
86-21 v v v v Prevot P34 Pond-reared freshwater perch  France  1951 UR 
87-01 v v nt v Dolman VH  Pickled herring Canada 1949 CDC 
93-07 v nt v v CDC 7854 Dried salted whole mullet (“Faseikh”) Egypt 1991 CDC 
93-08 v nt nt v CDC 8073 Human stool from botulism case USA 1991 CDC 
02-06 v nt nt nt CB-K-3E Rainbow trout surface Finland 1995 UH 
02-07 nt v nt v CB-K-9E Rainbow trout intestines Finland 1995 UH 
02-09 v v nt nt CB-K-18E Lake trout intestines Finland 1995 UH 
02-10 nt nt nt v CB-K-19E Whitefish roe Finland 1996 UH 
02-13 v nt nt nt CB-K-22E Burbot skin Finland 1996 UH 
02-14 v nt nt nt CB-K-23E Burbot intestines Finland 1996 UH 
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02-15 v v nt v CB-K-24E Burbot surface Finland 1996 UH 
02-21 v nt nt nt CB-K-31E Vendace Finland 1996 UH 
02-22 v nt nt v CB-K-32E Vendace Finland 1996 UH 
02-24 v nt nt nt CB-K-34E Frozen whitefish roe Finland 1996 UH 
02-25 v v v nt CB-K-36E Vacuum-packed cold smoked rainbow trout Finland 1996 UH 
02-26 v v nt nt CB-K-37E Vacuum-packed hot smoked whitefish Finland 1996 UH 
02-29 v v nt nt CB-K-40E Vacuum-packed cold smoked rainbow trout Finland 1996 UH 
02-32 v nt nt nt CB-K-44E Trout intestine Finland 1998 UH 
02-33 v nt nt nt CB-K-45E Trout skin Finland 1996 UH 
02-35 v nt nt nt CB-S-3E Sediment mud Finland 1995 UH 
02-43 nt nt nt v CB-S-20E Fishfarm sediment Finland 1997 UH 
02-47 v nt nt nt CB-S-27E Fishfarm sediment Finland 1997 UH 
02-50 v nt nt nt CB-R-24 Unknown Finland Unknown UH 
08-02 nt nt v nt NCTC 8266 Local home canned salmon (Nanaimo) Canada 1944 HPA 
Type F strains 
86-32 v v v v Eklund 202F Pacific sediments USA 1965 UR 
86-33 v v v v Hobbs FT10 Atlantic Herring UK 1970s UR 
86-34 v v nt v Craig 610 Salmon from Columbia River USA 1965 UR 
06-01 v nt v nt IFR 06/001 Scallops Canada 2006 IFR 
06-05 v v nt v IFR 06/005 Scallops Canada 2006 IFR 
Table 3.1 Details of non-proteolytic C. botulinum strains used in chill temperature incubation studies (Chapter 3) and carbohydrate 
assessment studies (Chapter 4) 
*(Chill temperature incubation test) Exp. 1: Minimal growth temperature of non-proteolytic C. botulinum strains (Stringer and Webb, unpublished 
data), Exp. 2: Variability in growth of strains of non-proteolytic C. botulinum at refrigeration temperatures; (Carbohydrate utilization test) Exp. 1: 
Initial experiment – Effect of carbohydrate source on growth and neurotoxin formation by non-proteolytic C. botulinum (API® strips), Exp. 2: 
Main test – Effect of carbohydrate source on growth and neurotoxin formation by non-proteolytic C. botulinum (tests conducted in bottles) 
**Originally from: CDC = C. Hatheway, Centers for Disease Control, USA; HPA = K. Grant, Health Protection Agency, UK, IFR = isolated at IFR; 
NCIMB = National Collection of Industrial Food and Marine Bacteria, UK; NFPA = V. Scott, National Food Processors Association, USA; UH = 
M. Lindström, University of Helsinki, Finland; UR = J. Crowther, Unilever Research, UK, v – strains tested, nt – strains not tested
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3.2.2 Culture medium 
In both experiments, cultures of non-proteolytic C. botulinum strains were 
maintained in double-strength Robertson’s Cooked Meat Medium (CMM) with 
added glucose (Southern Group Laboratory, Corby, UK). Growth of strains at 
chill temperatures was determined in PYGS broth (Lund et al., 1990). Viande-
levure (VL) layered blood agar, Reinforced Clostridial Medium containing 5% 
(w/v) skim milk (RCM) (Lund et al., 1985), and Tryptic Soya Agar (TSA) (Difco) 
plates were used to test cultures for purity. 
 
3.2.3 Spore preparation 
For spore-forming pathogens, the bacteria are commonly present in the 
environment in the spore form, and spores are the most common source of food 
contamination (Carlin, 2011). Thus it was appropriate to use spores as the 
inoculum in these experiments. In order to minimise additional variables, spores 
were not heat shocked before inoculation. 
 
Different crops of spores of each strain were prepared for use in experiment one 
and experiment two. Spores were produced in 20 ml of CMM. The medium was 
inoculated with 100 µl of an actively growing culture in PYGS broth using strict 
anaerobic technique. After incubation for 8 days at 20°C, the spore-containing 
medium was filtered through a sterile 50 ml disposable vacuum filtration system 
with 20 µm nylon net filter (Steriflip-NY20, Millipore) and the spores harvested 
from the filtrate by centrifugation (10 000 x g, 4.0°C, 20 min). The spores were 
then washed five-times in 10 ml sterile ice-cold 0.85% (w/v) NaCl using the same 
centrifugation conditions, and resuspended in 1 ml of ice-cold 0.85% NaCl and 
stored at 4.0°C until required.  
 
Purity and the absence of significant proteolytic activity were checked on VL agar 
plates and RCM + milk plates. To verify that the spore preparations were not 
contaminated with aerobic bacteria, spores were plated on TSA plates and 
incubated at ambient temperature for 2 days. The viable count was determined 
on PYGS agar incubated for 2 days at 30°C. All plates (except TSA) were 
incubated anaerobically under headspace of H2/CO2 (90:10, v/v). Before use, 
spores were diluted to the desired concentration using a 10-fold dilution series. 
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3.2.4 Experimental design 
In experiment one, Stringer and Webb (unpublished data) measured the growth 
of 40 non-proteolytic C. botulinum strains at 10 different incubation temperatures 
(3.0°C, 4.0°C, 5.0°C, 5.5°C, 6.0°C, 6.5°C, 7.0°C, 8.0°C, 9.0°C and 10.0°C) using 
one spore concentration (s = 106 spores tube-1). Three replicate tubes each 
containing 20 ml PYGS medium were used at each temperature. Inoculated 
tubes were examined at regular intervals for turbidity and gas production for 90 
days. 
 
In experiment two, growth of 24 strains at different inoculum concentrations (s = 
106, 105, 104, 103, 102, 101 and 100 spores tube-1) was measured. Based on the 
results from Stringer and Webb, it was decided to conduct these tests at             
a temperature of 6.0°C. Five replicate tubes each containing 20 ml of PYGS 
medium were inoculated and examined for turbidity and gas production 
periodically for up to 60 days. In order to test the sterile handling and for visual 
comparison, uninoculated tubes were incubated in both experiments. 
 
3.2.5 Experimental procedure 
In experiment one, spores were diluted to one concentration, s = 107 ml-1, 
whereas in experiment two, there was a series of seven concentrations, from      
s = 107 ml-1 to a final concentration of s = 101 ml-1. Dilution series were prepared 
in an anaerobic cabinet (Don Whitley Scientific, Shipley, UK). Growth tests were 
conducted in 20 ml of anaerobic PYGS medium in glass tubes (18 x 150 mm, 
BellCo Glass, USA) sealed with a butyl rubber stopper crimped closed with an 
aluminium cap. Each of the tubes contained a Durham tube (10 x 75 mm) 
(Laboratory Sales, UK) to capture gas formed thereby permitting observation of 
growth. An aliquot of 100 µl of appropriate spore suspension was injected into 
three or five replicates of PYGS broth, using a sterile 1 ml Terumo syringe with 
sterile 27Gx½ inch needle (Figure 3.2). 
 
To ensure anaerobic conditions before injection, the syringes were flushed with 
N2/H2 (90:10, v/v) using the Hungate technique. Two dilutions, s = 10
3 ml-1 and   
s = 102 ml-1 were also spread plated, in duplicate, onto PYGS agar and 
incubated anaerobically at 30°C for 2 days in an atmosphere of H2/CO2 (90:10, 
v/v) to confirm the inoculated spore concentration. Spore suspensions, diluent 
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and culture medium were maintained on ice during these procedures. The above 
technique was used in both experiment one and experiment two. 
 
 
Figure 3.2 Inoculation of test tubes with non-proteolytic C. botulinum spore 
suspension 
 
3.2.6 Temperature monitoring 
In both experiments inoculated tubes were incubated in racks in a water-bath in 
low-temperature incubators (Figure 3.3). In experiment two, one standard probe 
(Type I) connected to a wireless transmitter (MD5031, Don Whitley Scientific, 
Shipley, UK) was placed in each rack in a tube containing 20 ml of test media. 
The temperature was recorded at intervals of 20 min using a Labguard2 
Monitoring System (Don Whitley Scientific, Shipley, UK). Temperature probes 
were calibrated against a reference mercury thermometer certified by the 
National Physical Laboratory. At the end of the 60-day incubation period, the 
data were analysed, and the mean temperature and variation in temperature 
were determined. 
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Figure 3.3 Incubation of inoculated tubes in water-bath, with inserted probes  
 
3.2.7 Probability of growth for non-proteolytic C. botulinum strains at 
chill temperatures 
For both experiments the probability of growth, P(s,t), at time, t, at a particular 
inoculum level, s, was estimated based on the observed fraction of growth  
 
   
  
  
 3.1 
 
where Np is the number of tubes showing growth and Nt is the total number of 
tubes.  
 
The probability of growth as a function of storage time was fitted to                      
a monotonically increasing function (Whiting and Oriente, 1997) using the MS 
Excel SOLVER® add-in 
 
         
    
           
 3.2 
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where Pmax is the maximum probability of growth after 90 days (experiment one) 
or 60 days (experiment two) (0        1), k is a rate at which tubes show 
growth (days-1), t is the incubation time (days), and τ is the time (days) 
corresponding with the midpoint of the above function, i.e. time to probability of 
growth equal to 0.5 (0     60 or 90 days). The UCL and LCL for parameter     
τ were calculated according to equation 2.18.  
 
Data points, where the number of positive tubes did not increase from a previous 
observation were not used in the fitting procedure model which makes the 
estimated τ-value slightly smaller than if all observations are used. Therefore, the 
model predicts growth sooner and provides a conservative bias to the prediction. 
 
The parameter   is the calculated value that takes account of the time when first 
visible growth was observed, t1, and can be used to estimate the time that 
precedes the observation of growth, tmin (G. C. Barker, personal communication) 
 
                 3.3 
 
where    
  
 
 is a fraction of the  -value which corresponds with the first 
observation of growth at time, t1. A minimal fraction,        = 0.58 obtained from 
many observations of t1, is used with the obtained value of   to establish tmin for 
each case. The minimal fraction corresponds with a value from G.C. Barker and 
M.W. Peck (personal communication) which is estimated for relatively small 
spore inoculum and so represents a conservative approach at high spore 
concentrations (which is crucial in calculating the risk associated with non-
proteolytic C. botulinum spores in relation to chilled foods). The tmin is an 
important parameter that will be used in calculation of risk presented to minimally 
heated chilled foods by non-proteolytic C. botulinum (see section 5.2.4.4). 
  
Additionally, for each strain the time, tp, at which the probability of growth 
reached a particular value P(α), can be calculated as 
 
 
              
(
    
    
)   
 
   3.4 
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where  , k, Pmax are the estimated parameters. 
 
The above procedure for calculation of the probability of growth for non-
proteolytic C. botulinum strains at chill temperatures was only applied to results 
for experiment two. 
 
Based on MPN counts (Most Probable Number) the probability, P1, for one spore 
to initiate growth at 6.0°C at each observation time was calculated from (Lund et 
al., 1990) 
 
    
                                          
                                                     
 3.5 
 
Calculation of the probability of growth from a single spore was based only on 
data from experiment two, as only the experimental design applied in this study 
included different inocula concentrations. 
 
3.2.8 Variability in growth of strains of non-proteolytic C. botulinum 
at chill temperatures 
Assessment of non-proteolytic C. botulinum strain variability is based on a single 
parameter, τ, that characterizes growth from different inocula at different 
incubation temperatures. The τ-value was calculated for data from experiment 
one and experiment two according to equation 3.2. 
 
The τ-value is a consistent way to represent the dynamics of growth in particular 
conditions (depending on for example: inoculum concentration, salt 
concentration, pH, temperature) and is a fitted parameter that describes the 
probability of observing growth with time (measured in days). The τ-value is an 
estimate of the time when half of the replicates show growth.  
 
An unsupervised hierarchical clustering algorithm, with a dissimilarity metric 
based on Euclidean distance, was used to show strain classification patterns 
based on the τ parameter. Clustering was conducted using the heatmap.2 
function in the gplot package of the R Statistics Environment (Team, 2012). The 
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clustering was conducted for the τ-value calculated from results of both 
experiments. In the heat map, colours are assigned to represent the τ-value for 
each strain at the particular incubation temperature (experiment one) or spore 
inoculum concentration (experiment two). 
 
The clustering procedure for data originating from experiment one was based on 
the parameter τ calculated for temperatures of 6.0°C, 6.5°C, 7.0°C, 8.0°C, 9.0°C 
and 10.0°C for one inoculum concentration (s = 106 spores tube-1). Since not all 
strains grew at the lower incubation temperatures (3.0°C, 4.0°C, 5.0°C and 5.5 
°C) these data were not included in the analysis.  
 
In the second experiment, the parameter τ was calculated for all spore 
concentrations, however only τ-values calculated for higher inoculum 
concentrations were used in the clustering analysis. Whiting and Oriente (1997) 
indicated that parameter values obtained for lower spore concentration were not 
always reliable (i.e. sometimes negative values for Pmax and k or UCL of              
τ greater than incubation time), therefore the clustering technique was conducted 
on τ-values corresponding with s = 106, 105 and 104 spores tube-1. Strains 81-23, 
02-51 and 81-31 showed poor growth at chill temperatures and were excluded 
from the analysis. In order to allow comparisons between experiment one and 
experiment two, clustering of strains based on the τ-value from experiment one 
was conducted only for strains used in experiment two. 
 
Based on the results of experiment two, the mean (    and the standard 
deviation      of τ-value for cluster members corresponding to an inoculum of  s 
= 106, 105, 104 spores tube-1 were calculated and a normal cumulative 
distribution function, CDF, was used to represent the strain variability 
 
      
 
 
[      
    
  √ 
 ] 3.6 
 
where erf is the “error function”. 
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3.2.9 Statistical analysis 
In order to assess whether the τ-values differ significantly between variables of 
the cluster, the MANOVA was used. The multiple comparison of clusters 
centroids (means of the cluster scores for the τ-value) was conducted using the 
Games – Howell test. The significant difference was tested based on variables 
from experiment two (s = 106, 105 and 104 spores tube-1). The statistical analysis 
was performed by SPSS Statistics software (IBM). The differences were tested 
at a 5% significance level. 
 
In addition, the MANOVA test was used to assess whether the cluster 
membership of non-proteolytic C. botulinum strains is associated with isolation 
source. The analysis was performed on τ-values calculated for type E strains 
from experiment one, for three temperatures (5.5°C, 6.0°C and 6.5°C). 
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3.3 Results  
3.3.1 Temperature variation during incubation 
The actual temperatures at which strains were incubated in experiment two are 
summarised in Table 3.2. Temperature monitoring data for experiment one are 
not available. There were slight variations in mean incubation temperature 
between strains stored in the four different incubators. The mean incubation 
temperatures over the 60 day period ranged from 5.8°C to 6.2°C, with a typical 
standard deviation of 0.2°C (Table 3.2).  
 
Temperature (°C) 
Toxin 
type 
Strain Min Max Mean S.D. 
Toxin 
type 
Strain Min Max Mean S.D. 
T
y
p
e
 B
 
81-30 
4.9 6.4 5.8 0.2 
T
y
p
e
 B
 81-23 
4.8 6.8 5.9 0.2 
83-01 87-02 
86-17 87-04 
05-20 93-06 
93-11 
5.4 6.8 6.1 0.1 
T
y
p
e
 E
 86-21 
5.2 6.8 6.1 0.2 
02-51 87-01 
05-25 02-07 
T
y
p
e
 E
 
81-31 02-09 
02-15 
4.2 6.6 6.0 0.2 
T
y
p
e
 F
 86-32 
5.0 6.8 6.2 0.2 
02-25 86-33 
02-26 86-34 
02-29 06-05 
Table 3.2 Temperature variation for each strain of non-proteolytic C. botulinum 
during observations of growth at 6.0°C for 60 days in experiment two 
 
3.3.2 Growth at chill temperatures 
Full details of incubation temperatures, different inoculum concentrations and 
growth responses from spores in PYGS broth measured in experiments one and 
two are given in Appendix 3 and Appendix 4. 
 
3.3.2.1 Experiment one 
The number of days prior to the first observation of growth, at each refrigeration 
temperature, was recorded for each tested strain (Table 3.3). All strains showed 
growth at 8.0°C, 9.0°C and 10.0°C. Only one strain (81-31) did not grow at 
temperatures below 8.0°C (Table 3.3). The same strain also showed weak or no 
growth when tested in experiment two (only one tube showing growth after 40 
days of incubation at the concentration of s = 106 spores tube-1, no additional 
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growth observed after 60 days). Weak growth at chill temperature was also 
observed for strain 81-23 (Table 3.3). 
 
Toxin 
type 
Strain 
Time to first observation of growth (days) at specified 
incubation temperature (°C) 
4.0 5.0 5.5 6.0 6.5 7.0 8.0 9.0 10.0 
T
y
p
e
 B
 
81-23 > 90 > 90 > 90 > 90 39 25 14 7 5 
81-30 > 90 77 39 25 18 14 8 7 5 
83-01 > 90 42 32 18 14 11 8 6 5 
86-17 > 90 > 90 28 18 14 11 8 6 4 
87-02 > 90 > 90 35 21 14 11 7 6 5 
90-04 > 90 > 90 > 90 28 18 14 11 7 5 
93-06 > 90 32 25 18 11 8 5 5 4 
93-10 > 90 39 25 14 11 11 6 6 5 
93-11 > 90 39 25 14 11 11 7 5 4 
02-51 > 90 > 90 56 25 14 11 11 6 5 
05-20 > 90 35 25 18 14 11 8 6 5 
05-25 > 90 46 70 21 14 11 7 5 5 
05-29 > 90 > 90 35 25 14 11 7 6 5 
T
y
p
e
 E
 
81-26 > 90 67 32 18 18 11 8 6 5 
81-31 > 90 > 90 > 90 > 90 > 90 > 90 25 14 11 
86-21 > 90 25 18 11 11 11 6 5 4 
87-01 > 90 > 90 35 18 14 14 8 6 5 
93-07 > 90 > 90 > 90 21 18 11 7 5 4 
93-08 > 90 28 14 11 8 8 6 5 4 
02-06 > 90 > 90 25 14 11 11 8 5 5 
02-09 > 90 56 21 14 11 11 7 5 5 
02-13 > 90 32 14 11 8 8 7 5 4 
02-14 > 90 > 90 > 90 49 18 11 7 6 4 
02-15 67 21 14 11 11 8 6 5 4 
02-21 > 90 39 28 11 11 8 6 5 4 
02-22 > 90 > 90 > 90 35 14 11 6 5 4 
02-24 > 90 > 90 46 25 14 11 6 5 4 
02-25 > 90 > 90 32 14 11 8 7 5 4 
02-26 > 90 81 39 21 14 11 8 5 5 
02-29 > 90 25 21 11 11 11 6 5 4 
02-32 > 90 32 21 14 11 11 7 5 4 
02-33 > 90 32 21 14 11 11 7 5 5 
02-35 > 90 39 21 14 11 8 7 5 4 
02-47 > 90 > 90 > 90 18 11 11 6 5 4 
02-50 > 90 42 21 18 11 11 7 5 4 
T
y
p
e
 F
 86-32 > 90 42 35 21 18 11 7 5 5 
86-33 > 90 53 28 18 14 11 6 5 4 
86-34 > 90 > 90 35 21 18 11 6 5 4 
06-01 > 90 > 90 39 25 18 14 7 6 5 
06-05 > 90 > 90 42 25 18 14 8 6 5 
Table 3.3 Time to first visible growth (days) (t1) of non-proteolytic C. botulinum 
strains in PYGS at different incubation temperatures from 106 spores tube-1 
during 90 days of incubation (experiment one) [data of Stringer and Webb] 
Tests were also carried out at 3.0°C, but growth was not observed in 90 days 
 
At an incubation temperature of 3.0°C growth was not observed after 90 days, 
and at 4.0°C only one strain (02-15) showed visible growth on day 67. At 5.0°C 
and 5.5°C, some strains did not show visible growth within 90 days of incubation, 
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while others formed gas after 21 days of incubation (e.g. strain 02-15 at 5.0°C). 
At 6.0°C, all strains (with the exception of 81-23 and 81-31) grew, with the first 
tubes being turbid at day 11 (strains 86-21, 93-08, 02-13, 02-15, 02-21 and     
02-29). The longest period prior to visible growth was noted on day 56 for strain 
02-14. One tube inoculated with spores of this strain did not show growth for the 
remaining incubation period. A temperature of 6.0°C was used in experiment two 
with different spore inoculum concentrations. 
 
At a lower incubation temperatures the time to visible growth was greater (Table 
3.3). Growth was first observed after 4, 5, 5, 8, 8, 11, 14, 21 and 67 days at 
10.0°C, 9.0°C, 8.0°C, 7.0°C, 6.5°C, 6.0°C, 5.5°C, 5.0°C and 4.0°C, respectively. 
 
Within each set of incubation conditions, tubes showed growth in narrow bands. 
For example, at 7.0°C, 93% of tubes in which growth occurred were first positive 
between days 8 and 14, whereas at 10.0°C, 97% of positive tubes showed 
growth between days 4 and 6 (Table 3.4). 
 
Although most growth was initiated within a short time period, occasionally 
growth was delayed by several days. At 4.0°C only one strain showed growth at 
day 67. None of the remaining strains tested showed visible growth within 90 
days of incubation. At 5.0°C and 5.5°C only one out of three tubes showed 
growth for some strains e.g. 81-30, 02-26 and 86-32. 
 
3.3.2.2 Experiment two 
The number of days prior to the first observation of growth (turbidity and for gas 
production) for each spore inoculum concentration is presented in Table 3.5. 
 
For experimental convenience, a smaller number of strains were tested in 
experiment two compared to experiment one. All 24 strains used in experiment 
two grew at 6.0°C, from s = 106 spores tube-1. Exceptionally, for strains 81-23 
and 81-31 only two and one tube (out of five) were positive for growth, with the 
first growth observed on day 37 and 40, respectively. When tubes were 
inoculated with approximately one spore, growth was observed in more than half 
of the tested strains, with strains 02-09 and 02-25 growing in all five tubes. 
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Table 3.4 Total number of tubes and percentage of tubes showing visible growth from 106 spores tube-1 of non-proteolytic              
C. botulinum when incubated at chill temperatures for 90 days (experiment one) 
+ve – number of tubes showing visible growth, % – percentage of tubes showing visible growth 
Day of incubation 
Temperature (°C) 
4.0 5.0 5.5 6.0 6.5 7.0 8.0 9.0 10.0 
+ve % +ve % +ve % +ve % +ve % +ve % +ve % +ve % +ve % 
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 59 49 
5 0 0 0 0 0 0 0 0 0 0 0 0 1 1 57 48 55 46 
6 0 0 0 0 0 0 0 0 0 0 0 0 25 21 50 42 3 3 
7 0 0 0 0 0 0 0 0 0 0 0 0 46 38 8 7 0 0 
8 0 0 0 0 0 0 0 0 3 3 18 14 34 28 2 2 0 0 
11 0 0 0 0 0 0 8 7 45 37 72 60 8 7 0 0 2 2 
14 0 0 0 0 3 3 30 24 31 26 21 18 3 3 3 3 1 1 
18 0 0 0 0 9 8 26 22 29 24 3 3 0 0 0 0 0 0 
21 0 0 3 3 15 13 12 9 5 4 0 0 0 0 0 0 0 0 
25 0 0 4 3 14 11 22 18 0 0 3 3 1 1 0 0 0 0 
28 0 0 3 3 8 7 3 3 1 1 0 0 2 2 0 0 0 0 
32 0 0 11 9 7 6 4 3 0 0 0 0 0 0 0 0 0 0 
35 0 0 2 2 7 6 3 3 0 0 0 0 0 0 0 0 0 0 
39 0 0 5 4 11 9 1 1 1 1 0 0 0 0 0 0 0 0 
42 0 0 7 6 2 1 1 1 1 1 0 0 0 0 0 0 0 0 
46 0 0 2 1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 
49 0 0 1 1 4 3 1 1 1 1 0 0 0 0 0 0 0 0 
53 0 0 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 
56 0 0 1 1 3 3 1 1 0 0 0 0 0 0 0 0 0 0 
60 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
63 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
67 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
70 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 
74 0 0 5 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
77 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
81 0 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
90 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Total (out of 120 tubes) 2 2 52 43 87 73 112 93 117 98 117 98 120 100 120 100 120 100 
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Toxin 
type 
Strain 
Time to first observation of growth (days) at specified spore 
inoculum concentration (spores tube-1) 
106 105 104 103 102 101 100 
T
y
p
e
 B
 
81-23 37 > 60 > 60 > 60 > 60 > 60 > 60 
81-30 16 17 20 25 25 31 > 60 
83-01 12 14 17 20 23 24 37 
86-17 12 14 17 23 30 37 34 
87-02 12 16 21 28 26 28 28 
87-04 16 20 24 30 34 > 60 > 60 
93-06 12 16 18 18 23 24 > 60 
93-11 11 12 14 16 17 19 > 60 
02-51 20 59 60 > 60 > 60 > 60 > 60 
05-20 11 12 16 20 23 25 32 
05-25 17 18 20 23 25 > 60 > 60 
T
y
p
e
 E
 
81-31 40 59 40 > 60 > 60 > 60 > 60 
86-21 11 11 12 13 16 18 18 
87-01 11 12 13 16 17 19 20 
02-07 11 11 12 14 16 17 21 
02-09 11 11 12 13 16 18 20 
02-15 11 11 12 14 16 18 19 
02-25 11 11 12 13 16 17 18 
02-26 11 11 14 16 21 26 54 
02-29 11 11 11 14 16 18 20 
T
y
p
e
 F
 86-32 12 14 19 20 27 23 26 
86-33 16 17 19 20 23 25 37 
86-34 13 17 19 23 25 32 > 60 
06-05 17 20 23 26 > 60 > 60 > 60 
Table 3.5 Time to first visible growth (days) (t1) of non-proteolytic C. botulinum 
strains in PYGS at different inoculum concentrations at 6.0°C during 60 days of 
incubation (experiment two) 
 
At higher spore inoculum concentration the time at which growth was first 
observed (at 6.0°C) was shorter. The first positive tubes were observed at 11 
day when inoculated with s = 106, 105 and 104 spores tube-1 and 13, 16, 17 and 
18 days when inoculated with s = 103, 102, 101 and 100 spores tube-1, 
respectively. As tubes were observed at discrete times, it is possible that the 
same time observed for the three largest inoculum concentrations is associated 
with the experimental procedure. Growth may have been first visible between 
days when growth was examined. 
 
In a similar manner to experiment one, tubes showed growth in narrow bands. 
With s = 106 spores tube-1, 77% of positive tubes at day 16, showed growth 
between day 11 and 16 (Table 3.6). Moreover for the following strains: 93-11, 
05-20, 86-21, 87-01, 02-07, 02-09, 02-15, 02-25, 02-26, 02-29 all five tubes first 
showed growth on day 11. 
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Table 3.6 Total number of tubes and percentage of tubes showing visible growth from different inoculum concentrations of non-
proteolytic C. botulinum spores during incubation at 6.0°C for 60 days (experiment two) 
+ve – number of tubes showing visible growth, % – percentage of tubes showing visible growth 
Day of incubation 
Inoculum concentration (spores tube-1) 
106 105 104 103 102 101 100 
+ve % +ve % +ve % +ve % +ve % +ve % +ve % 
11 50 41 34 26 5 4 0 0 0 0 0 0 0 0 
12 9 7 8 7 25 21 0 0 0 0 0 0 0 0 
13 8 7 7 6 1 1 7 6 0 0 0 0 0 0 
14 9 7 9 8 9 8 22 18 0 0 0 0 0 0 
16 15 13 6 5 7 6 9 8 29 23 0 0 0 0 
17 8 7 5 4 4 3 4 3 3 2 3 2 0 0 
18 4 3 14 11 6 5 5 4 5 4 12 11 2 2 
19 1 1 6 5 9 8 1 1 2 2 13 11 4 3 
20 3 2 8 7 7 6 11 9 2 2 7 6 8 7 
21 1 1 2 2 3 2 3 2 1 1 0 0 8 7 
23 1 1 2 2 9 8 8 7 10 7 5 4 2 2 
24 1 1 2 2 4 3 2 2 1 1 3 2 1 1 
25 0 0 0 0 4 3 9 8 8 7 3 2 0 0 
26 0 0 0 0 1 1 3 2 2 2 2 2 1 1 
27 0 0 0 0 0 0 2 2 3 2 1 1 0 0 
28 0 0 0 0 0 0 3 2 2 2 4 3 1 1 
30 0 0 1 1 2 2 3 2 8 7 6 5 0 0 
31 0 0 0 0 1 1 0 0 5 4 1 1 0 0 
32 0 0 0 0 2 2 1 1 2 2 1 1 1 1 
34 0 0 0 0 3 2 1 1 2 2 1 1 1 1 
37 1 1 0 0 0 0 1 1 5 4 3 2 2 2 
40 1 1 0 0 1 1 0 0 2 2 3 2 1 1 
42 0 0 0 0 0 0 0 0 0 0 2 2 1 1 
44 0 0 0 0 0 0 2 2 1 1 0 0 0 0 
48 0 0 0 0 1 1 1 1 1 1 2 2 2 2 
51 0 0 0 0 0 0 0 0 0 0 1 1 0 0 
54 0 0 0 0 0 0 1 1 1 1 2 2 1 1 
59 1 1 2 2 0 0 0 0 0 0 0 0 1 1 
60 0 0 0 0 1 1 0 0 0 0 0 0 0 0 
Total (out of 120 tubes) 113 95 106 89 105 87 99 82 95 79 75 63 37 34 
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3.3.3 Probability of growth for non-proteolytic C. botulinum strains at 
chill temperatures 
The procedure for calculation of growth for non-proteolytic C. botulinum strains is 
described in section 3.2.7. An example visualisation for strain 83-01 as a function 
of seven different inocula concentrations is presented in Figure 3.4. In this case 
Pmax is unity for 10
1 to 106 spores tube-1, and is 0.4 for s = 100 spores tube-1. 
 
 
Figure 3.4 Increasing probability of growth with time for strain 83-01 during 60 
days of incubation at 6.0°C 
Symbols represent data (with following spore concentrations, s: ● 106, ■ 105, ♦ 104,        
x 103, ▲ 102, □ 101, ○ 100 spores tube-1), lines represent the fit of data to continuous 
function. Pmax is a maximum probability of growth, τ – estimate of time when half of the 
replicates show growth and k is the rate at which tubes show growth. 
 
The parameter values of the fitted model (see section 3.2.7) for the highest three 
spore inoculum concentrations for 24 strains (tested at 6.0°C in the second 
experiment) are given in Table 3.7. When there is no growth after 60 days of 
incubation the cells in Table 3.7 are empty. Pmax for a majority of strains at all 
three inoculum concentrations (s = 106, 105 and 104 spores tube-1) was equal to 
one after 60 days of incubation. The only exceptions were noted for strains: 81-
23 for which Pmax = 0.4 at s = 10
6 spores tube-1; 86-17, with Pmax = 0.8 at s = 10
5 
spores tube-1; 02-51 with Pmax = 0.2 at s = 10
5 spores tube-1; and 81-31 with Pmax 
= 0.2 for all three inocula concentrations. These strains gave limited growth in 
experiment two.  
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Table 3.7 Estimated values for k, τ with its upper and lower 95% confidence limits, t1, fτ and t0.1 calculated for growth of non-
proteolytic C. botulinum strains when incubated at 6.0°C for 60 days with different spore concentrations (experiment two) 
* Strains ordered according to toxin type produced, a) t1 – time when the first growth was observed (see Table 3.3 and Table 3.5); 
b) tmin – time 
preceding observation of growth; c) k – rate of the increase of positive tubes (days-1); d) τ – time when growth in half of the tubes is observed; e) fτ 
– fraction of τ-value that gives minimum time for observed growth; f)LCLτ and UCLτ are lower and upper 95% confidence intervals; g) time at 
which the probability of growth reached 0.1 
Strain* 
Inoculum concentration (spores tube-1) 
106  105  104  
t1
a)
 tmin
b) 
k
 c)
 τd) fτ 
e) 
LCLτ UCLτ
 f)
 t0.1
g) 
t1 tmin k τ fτ LCLτ UCLτ t0.1 t1 tmin k τ fτ LCLτ UCLτ t0.1 
81-23                         
81-30 16 9 6.6 15.9 100 15.9 15.9 15.6 17 10 1.8 17.8 96 17.0 18.5 16.6 20 12 0.3 21.4 94 20.1 22.7 15.0 
83-01 12 8 17.9 13.0 92 13.0 13.0 12.9 14 8 8.8 13.8 100 13.8 13.8 13.6 17 10 1.4 17.4 98 17.4 17.5 15.8 
86-17 12 7 8.9 12.0 100 12.0 12.0 11.8 14 8 0.5 13.2 100 12.7 13.6 8.7 17 10 9.6 17.0 100 17.0 17.0 16.8 
87-02 12 8 2.3 13.1 92 13.0 13.1 12.1 16 10 1.1 16.5 97 16.2 16.9 14.5 21 14 0.7 23.5 89 23.1 23.9 20.5 
87-04 16 9 18.1 15.0 100 15.0 15.0 14.9 20 12 2.1 20.3 99 20.2 20.3 19.2 24 14 1.9 24.8 97 24.4 25.1 23.6 
93-06 12 7 18.4 12.0 100 12.0 12.0 11.9 16 10 1.4 17.2 93 17.1 17.2 15.6 18 11 1.6 18.9 95 18.8 18.9 17.4 
93-11 11 6 18.5 10.5 100 10.5 10.5 10.4 12 7 8.8 12.2 99 12.2 12.2 11.9 14 8 8.1 14.1 100 14.0 14.1 13.8 
02-51 20 12 1.1 20.7 97 20.6 20.8 18.6                 
05-20 11 6 20.7 10.5 100 10.5 10.5 10.4 12 7 2.2 12.3 98 12.2 12.3 11.2 16 9 1.2 15.9 101 15.8 16.0 14.1 
05-25 17 10 8.0 16.9 100 16.9 16.9 16.7 18 10 8.7 18.0 100 18.0 18.0 17.8 20 12 1.1 21.5 93 21.4 21.6 19.5 
81-31                         
86-21 11 6 21.0 10.5 100 10.5 10.5 10.4 11 6 21.0 10.5 100 10.5 10.5 10.4 12 7 18.0 11.5 104 11.5 11.5 11.4 
87-01 11 6 18.5 10.5 100 10.5 10.5 10.4 12 7 9.2 11.8 100 11.8 11.8 11.6 13 8 1.3 13.9 93 13.6 14.3 12.2 
02-07 11 6 18.5 10.5 100 10.5 10.5 10.4 11 6 18.5 10.5 100 10.5 10.5 10.4 12 7 18.0 11.5 104 11.5 11.5 11.4 
02-09 11 6 18.5 10.5 100 10.5 10.5 10.4 11 6 18.6 10.9 100 10.9 10.9 10.8 12 7 17.6 11.5 104 11.5 11.5 11.4 
02-15 11 6 18.5 10.5 100 10.5 10.5 10.4 11 6 18.0 10.5 100 10.5 10.5 10.4 12 7 17.6 11.5 104 11.5 11.5 11.4 
02-25 11 6 18.5 10.5 100 10.5 10.5 10.4 11 6 18.0 10.5 100 10.5 10.5 10.4 12 7 17.6 11.5 104 11.5 11.5 11.4 
02-26 11 8 18.5 13.0 84 10.5 10.5 12.9 11 6 18.0 10.5 100 10.5 10.5 10.4 14 8 17.5 13.5 104 13.5 13.5 13.4 
02-29 11 6 18.5 10.5 100 10.5 10.5 10.4 11 6 18.0 10.5 100 10.5 10.5 10.4 11 6 20.7 10.5 105 10.5 10.5 10.4 
86-32 12 7 7.4 12.1 100 11.7 12.4 11.8 14 9 0.9 16.3 86 16.2 16.4 13.8 19 11 1.4 19.6 97 19.3 19.9 18.0 
86-33 16 9 7.0 15.9 100 15.9 15.9 15.6 17 10 2.8 17.5 97 17.5 17.5 16.7 19 13 0.6 22.3 85 22.2 22.4 18.3 
86-34 13 8 2.8 13.5 96 13.4 13.6 12.7 17 10 2.8 17.5 97 17.4 17.6 16.7 19 11 2.2 19.7 96 19.7 19.8 18.7 
06-05 17 10 1.6 17.8 95 17.8 17.9 16.5 20 12 7.7 19.9 100 19.7 20.2 19.7 23 16 1.3 24.0 83 27.5 28.0 19.5 
Chapter 3 
148 
The parameter k is highly variable with some dependence on spore inoculum 
concentration. Greater values were observed at s = 106 spores tube-1 (ranging 
from 1.1 to 21.0 days-1) compared with an inocula of s = 104 spores tube-1 (from 
0.3 to 20.7 days-1). Nevertheless, Whiting and Oriente (1997) considered, the 
estimated value for k as difficult to interpret and not the most important 
parameter in the model. Also for the purpose of this study, the emphasis was on 
parameter τ and not the rate at which tubes showed growth. 
 
From the risk assessment point of view the parameter τ is of crucial importance. 
It is a parameter obtained from fitting a mathematical function to a set of 
observed data, i.e. time leading to bacterial growth. The parameter τ increased 
with decreasing inoculum concentration, ranging from 10.5 to 20.7 (mean value 
    13.0) days for an inoculum of s = 10
6 spores tube-1, from 10.5 to 20.3 (mean 
value     14.2) days for s = 10
5 spores tube-1 and from 10.5 to 27.8 (mean 
value     17.1) days for an inoculum of s = 10
4 spores tube-1. Moreover, a lower 
concentration of spores (when s = 104, s = 105 or s = 106 spores tube-1) generally 
increased the confidence interval about the τ-value with the highest interval 
observed for strain 81-30 [20.1; 22.7] when s = 104 spores tube-1.  
 
From the time when the first growth was observed, t1, (Table 3.5) the fraction of 
τ, giving the minimal time for observed growth,   , can be calculated. For the 
main experiment, the smallest    was 84%, 86% and 83% for s = 10
6, 105 and 
104 spores tube-1 respectively, and individual values varied for different strain, 
different inoculum concentration and temperature (Table 3.7).  
 
Both the τ-value and t1 are parameters which inform about the time prior to the 
observation of bacterial growth (as indicated by turbidity or gas production). 
Previous experience in our laboratory had indicated that turbidity or gas 
production can be detected when the concentration of cells is typically ~106 ml-1 
(M. W. Peck, personal communication). One requirement of risk assessment is to 
assess the time, before bacterial growth can be initiated. Due to a complex 
combination of several variables (e.g. strain, incubation conditions, spore load) it 
is not possible to indicate the absolutely safe time. Nevertheless, the concept of 
tmin (time preceding observation of growth) estimates the shortest time when any 
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growth can be expected (G. C. Barker, personal communication). Time, tmin is     
a safety boundary; a time before the product safety is highly probable (Figure 
3.5).  
 
Calculation of the minimal time for expected growth, tmin, follows from equation 
3.3. A value of min(  ) = 58% (G. C. Barker and M. W. Peck, personal 
communication) was used to calculate values for tmin based on data from the 
second experiment (Table 3.7). For different strains the smallest tmin for s = 10
6 
and 105 spores tube-1 was calculated to be 6 days and the highest 12 days 
(mean value        8). For s = 10
4 spores tube-1 these times were 6 and 16 
days respectively (mean value        11).  
 
 
Figure 3.5 Observed time of growth, t1; time preceding observation of growth, 
tmin and time when half of tubes show growth, τ, for non-proteolytic C. botulinum 
strain 06-05 (from s = 106, 105 and 104 spores tube-1 incubated at 6.0°C for 60 
days) 
Symbols represent data (with following spore concentrations, s: ● 106, ■ 105, ♦ 104 
spores tube-1) lines represent the fit of data to continuous function, tmin (●), t1 (●) 
 
The estimated parameters of k, τ and Pmax were also used to calculate the time, 
t0.1 (Table 3.7), at which the probability of growth is 0.1. Due to the small range of 
time when all replicates become positive, t0.1 is often only 0.1 – 2.1 days smaller 
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than the estimated value of τ. The difference was much greater with decreasing 
spore concentration.  
 
Strain variability is also expressed in the relationship between the probability of 
growth from a single spore, P1, and the incubation time at 6.0°C (Table 3.8).     
P1 for growth at 6.0°C of twenty-two strains ranged from 3.5 x 10
-7 to 5.1 x 10-1 
when incubated for 20 days, 1.9 x 10-7 to 1.0 when incubated for 30 days and  
3.8 x 10-7 to 1.0 after 60 days of incubation. In relation to toxin type, the 
probability of growth after 60 days of incubation was: from 3.8 x 10-7 (strain 02-
51) to 5.2 x 10-2 (strain 05-20) for ten type B strains, from 1.2 x 10-4 (strain 87-01) 
to 1.0 (strains 86-21 and 02-09) for eight type E strains, and 1.6 x 10-4 (strain 06-
05) to 1.3 x 10-2 (strain 86-32) for four type F strains. For two strains (81-23 and 
81-31) the probability of growth from a single spore was less than 2.0 x 10-7. 
Although in many cases the calculated P1 is very small, there is still a possibility 
of growth that cannot be ignored.  
 
 -log10 P1
a
 of growth 
T
y
p
e
 B
 
Strain Incubation day 20 Incubation day 30 Incubation day 60 
81-23 > 6.70 > 6.70 6.70 
81-30 4.33 3.22 1.13 
83-01 3.48 1.56 0.48 
86-17 5.27 4.94 4.63 
87-02 5.28 3.58 2.22 
87-04 5.46 4.11 3.81 
93-06 3.45 1.17 1.17 
93-11 1.31 0.64 0.64 
02-51 6.42 5.71 5.42 
05-20 3.29 1.95 0.29 
05-25 4.84 3.01 1.99 
T
y
p
e
 E
 
81-31 > 6.70 > 6.70 6.70 
86-21 0.29 0.00 0.00 
87-01 3.02 2.92 2.92 
02-07 1.79 1.68 1.68 
02-09 0.39 0.00 0.00 
02-15 0.73 0.58 0.58 
02-25 0.70 0.51 0.51 
02-26 4.47 2.05 1.26 
02-29 1.43 1.08 1.08 
T
y
p
e
 F
 86-32 3.91 1.74 0.88 
86-33 4.33 3.23 2.42 
86-34 4.12 2.32 1.97 
06-05 5.57 4.30 3.80 
Table 3.8 The effect of incubation time on the probability (P1) of growth from       
a single spore of 24 strains of non-proteolytic C. botulinum in PYGS during 60 
days of incubation at 6.0°C 
a
 P1 was calculated as the proportion of spores that resulted in growth (as indicated by MPN) at 
6.0°C compared to number of inoculated spores (measured by plate count) 
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3.3.4 Variability in growth of strains of non-proteolytic C. botulinum 
at chill temperatures 
The time when half of the tubes become positive (τ-value) is shorter at higher 
incubation temperatures (Figure 3.6), and with higher spore inoculum 
concentrations (Figure 3.7). Interestingly, the estimated τ-values for type E 
strains is generally lower than for those of type B and F strains when tested at 
6.0°C (Figure 3.7). A similar but weaker pattern was observed when τ-values 
were measured at one spore concentration (s = 106 spores tube-1) and different 
incubation temperatures (Figure 3.6). Thus under these chill temperature test 
conditions non-proteolytic C. botulinum type E strains generally grew faster than 
type B or F strains.  
 
Moreover, it is apparent from both Figure 3.6 and Figure 3.7 that the uncertainty 
associated with τ-value decreased with higher incubation temperature and with 
higher inoculum concentration. 
 
 
Figure 3.6 Estimates of τ-value for non-proteolytic C. botulinum strains 
incubated at chill temperatures with 106 spores tube-1 for 90 days (data from 
experiment one) 
Type B strains (blue line), type E strains (red line), type F strains (yellow line) 
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Figure 3.7 Estimates of τ-value for non-proteolytic C. botulinum strains 
incubated at 6.0°C for 60 days with various spore inoculum concentrations (data 
from experiment two) 
Type B strains (blue line), type E strains (red line), type F strains (yellow line) 
 
The clustering of non-proteolytic C. botulinum strains using heat maps (Figure 
3.8 and Figure 3.9) was based on τ-values (days) calculated in experiments one 
and two (see section 3.2.8). The columns are spore concentrations (spores  
tube-1) or temperatures (°C), and the rows represent 19 strains (experiment one) 
or 21 strains (experiment two). The τ-values are summarised in Table 3.9. 
 
In the heat maps, colours at a particular point are assigned to represent the       
τ-value for the strain at the particular inoculum concentration or incubation 
temperature, with red corresponding to a small number (< 9 in experiment one 
and < 15 in experiment two) of days needed for half of tested tubes to show 
growth, green corresponds to a high number (> 20 in experiment one and > 25 in 
experiment two) of days, and black corresponds to an intermediate number of 
days (Figure 3.8 and Figure 3.9). 
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Toxin 
type 
Strain 
 Temperature (°C) Inoculum concentration (spores tube
-1
) 
6.0 6.5 7.0 8.0 9.0 10.0 10
6
 10
5
 10
4
 10
3
 10
2
 10
1
 10
0
 
T
y
p
e
 B
 
81-30 22.2 17.9 13.9 7.5 6.5 4.6 15.9 17.8 21.4 24.7 28.5 35.5 
 
83-01 22.6 14.1 11.1 7.5 5.5 4.6 13.0 13.8 17.4 21.3 25.2 26.3  
86-17 16.2 13.9 9.5 7.5 5.5 3.5 12.0 13.2 17.0 23.6 30.5 41.4 
 
87-02 21.0 14.1 9.5 7.1 5.5 4.6 13.1 16.5 23.5 29.3 36.0 27.9 
 
87-04       15.0 20.3 24.8 36.2    
93-06 15.2 9.5 7.5 5.1 4.6 3.5 12.0 17.2 18.9 22.8 22.8 27.5 
 
93-11 13.9 9.5 9.5 6.5 4.6 3.5 10.5 12.2 14.1 16.4 18.4 20.3 
 
05-20 16.2 12.5 9.5 8.1 5.5 4.6 10.5 12.3 15.9 19.9 26.1 38.3 
 
05-25 21.0 12.5 9.5 6.5 5.1 4.6 16.9 18.0 21.5 24.3 32.4 
  
T
y
p
e
 E
 
86-21 11.1 9.5 9.5 5.5 4.6 3.5 10.5 10.5 11.5 13.0 15.8 17.9 19.0 
87-01 18.1 12.5 12.5 7.5 6.0 4.6 10.5 11.8 13.9 15.8 17.1 18.9 
 
02-07 
      
10.5 10.5 11.5 13.5 15.0 18.5 
 
02-09 12.5 9.5 9.5 6.5 4.6 4.6 10.5 10.9 11.5 13.0 15.0 17.8 20.3 
02-15 11.1 9.5 7.5 5.5 4.6 3.5 10.5 10.5 11.5 13.8 15.0 18.7 19.9 
02-25 13.9 9.5 8.1 6.5 4.6 3.5 10.5 10.5 11.5 12.8 15.0 17.3 18.5 
02-26 21.1 12.5 9.5 7.5 4.6 4.9 13.0 10.5 13.5 15.5 19.0 29.3 
 
02-29 11.1 9.5 9.5 6.0 4.6 3.5 10.5 10.5 10.5 13.5 15.0 18.7 
 
T
y
p
e
 F
 86-32 21.1 15.1 10.7 6.5 4.9 4.6 12.1 16.3 19.6 21.9 29.0 22.7  
86-33 16.2 12.5 9.5 5.5 4.6 3.5 15.9 17.5 22.3 20.8 24.0 
  
86-34 19.5 15.1 9.5 5.5 4.6 3.5 13.5 17.5 19.7 23.5 29.4 
  
06-05 27.9 17.7 14.1 7.5 5.5 4.6 17.8 19.9 24.0 
    
Table 3.9 Tau (τ) value calculated for non-proteolytic C. botulinum strains 
incubated at chill temperatures with 106 spores tube-1 for 90 days (experiment 
one) and incubated at 6.0°C for 60 days with different spore inoculum 
concentrations (experiment two) 
An empty cell indicates that growth was not observed at the tested conditions (except 
strains 87-04 and 02-07, which were not tested in experiment one) 
 
In general the estimated τ-value for all strains at 8.0°C, 9.0°C and 10.0°C are 
very close (Figure 3.8). The variability of 19 tested strains primarily arises from 
growth at lower temperatures (6.0°C, 6.5°C and 7.0°C), which are more typical 
refrigeration temperatures. Four clusters have been identified. The cluster 3 is 
predominant and mainly composed of type E strains (five out of seven strains are 
of type E). It contains the fastest growing strains with a small τ-value at higher 
temperatures and a not significantly higher τ-value at lower temperatures. 
Clusters 1 and 2 contain the next fastest growing strains, and are closely linked  
(Figure 3.8). Cluster 1 is characterized by strains with low τ-value at higher 
temperatures, moderate at 6.5°C and 7.0°C, and higher τ-values at 6.0°C. This 
cluster is composed of 2 type F strains, 3 type B strains and one type E strain. 
The τ-values in the cluster 2 are of moderate magnitude at 6.0°C and lower at 
6.5°C and 7.0°C, and the cluster is composed of two type B strains, one type F 
and one type E strain. Finally, two slowly growing strains, 81-30 (type B) and   
06- 05 (type F), with a lower τ-value at 8.0°C, 9.0°C and 10.0°C, higher at 6.0°C 
and moderate at 6.5°C and 7.0°C are in the cluster 4.  
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Figure 3.8 Hierarchical clustering of τ-values calculated for non-proteolytic        
C. botulinum strains incubated at chill temperatures for 90 days with 106 spores 
tube-1 (experiment one) 
Different strain number colour corresponds to toxin type: type B strains (blue colour), 
type E strains (red colour), type F strains (yellow colour). Tested strains were classified 
into four clusters: cluster 1 (n = 6), cluster 2 (n = 4), cluster 3 (n = 7) and cluster 4 (n = 2) 
 
Figure 3.9 summarises the effect of spore inoculum concentration on the τ-value. 
Strain variability is lower at a higher inoculum concentration. The τ-value 
calculated for 21 strains was grouped into four clusters. Cluster 4 contains the 
fastest growing strains, and is the most homogeneous cluster characterised by 
type E strains with low τ-value across three inoculum concentrations (Figure 
3.9). Cluster 3 contains the next fastest growing strains and is composed of four 
type B and two type E strains with low (at s = 106 spores tube -1) and moderate 
(at s = 105 and 106 spores tube-1) τ-values. Clusters 1 and 2 contain the slowest 
growing strains. Cluster 1 is predominant and composed of type B and F strains 
with a moderate τ-value at s = 105 spores tube-1 and a high τ-value at s = 104 
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spores tube-1. Two strains 06-05 and 87-04 form cluster 2 which is characterised 
by a high τ-value calculated for s = 104 spores tube-1. 
 
 
Figure 3.9 Hierarchical clustering of τ-value calculated for non-proteolytic         
C. botulinum strains incubated at 6.0°C for 60 days with 106, 105 and 104 spores 
tube-1 (experiment two) 
Different strain number colour corresponds to toxin type: type B strains (blue colour), 
type E strains (red colour), type F strains (yellow colour). Tested strains were classified 
into four clusters: cluster 1 (n = 7), cluster 2 (n = 2), cluster 3 (n = 6) and cluster 4 (n = 6) 
* Assigned cluster membership based on analysis of data in experiment one 
 
One very important feature of the output of the clustering analysis is the 
agreement of cluster membership determined in the two independent datasets. 
In particular, strains in cluster 3 in experiment one and cluster 4 in experiment 
two are characterised by the most rapid growth (smallest τ-values). These two 
clusters contain similar (primarily type E) strains. Strains of cluster 4 (experiment 
one) and cluster 2 (experiment two) are those with the slowest growth (highest  
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τ-values). Strains in cluster 1 (both experiments), cluster 2 (experiment one) and 
cluster 3 (experiment two) (with τ-value greater in cluster 1) are those with 
moderate growth (Table 3.10), with strains assigned to cluster one showing 
faster growth.  
 
P
a
ra
-
m
e
te
r 
C
lu
s
te
r Experiment one 
C
lu
s
te
r Experiment two 
Temperature (°C) 
Inoculum concentration (spores 
tube
-1
) 
6.0 6.5 7.0 8.0 9.0 10.0 106 105 104 
Min 
C
lu
s
te
r 
1
 
(n
 =
 6
) 19.5 12.5 9.5 5.5 4.6 3.5 
C
lu
s
te
r 
1
 
(n
 =
 7
) 12.0 16.3 18.9 
Max 22.6 15.1 11.1 7.5 5.5 4.9 17.0 18.1 23.5 
   21.1 13.9 10.0 6.8 5.0 4.5 14.2 17.3 21.0 
   1.0 1.2 0.7 0.8 0.4 0.5 2.0 0.6 1.7 
Min 
C
lu
s
te
r 
4
 
(n
 =
 2
) 22.2 17.7 13.9 7.5 5.5 4.6 
C
lu
s
te
r 
2
 
 (
n
 =
 2
) 15.0 20.0 24.8 
Max 27.9 17.9 14.1 7.5 6.5 4.6 17.9 20.3 27.8 
   25.1 17.8 14.0 7.5 6.0 4.6 16.4 20.1 26.3 
   4.0 0.1 0.1 0.0 0.7 0.0 2.0 0.2 2.1 
Min 
C
lu
s
te
r 
2
 
(n
 =
 4
) 
16.2 12.5 9.5 5.5 4.6 3.5 
C
lu
s
te
r 
3
  
(n
 =
 6
) 
10.5 10.5 13.5 
Max 18.1 13.9 12.5 8.1 6.0 4.6 13.0 13.8 17.4 
   16.7 12.9 10.3 7.2 5.4 4.1 11.6 12.3 15.3 
   1.0 0.7 1.5 1.1 0.6 0.6 1.3 1.2 1.7 
Min 
C
lu
s
te
r 
3
 
(n
 =
 7
) 11.1 9.5 7.5 5.1 4.6 3.5 
C
lu
s
te
r 
4
 
 (
n
 =
 6
) 10.5 10.5 10.5 
Max 15.2 9.5 9.5 6.5 4.6 4.6 10.5 10.9 11.5 
   12.7 9.5 8.7 5.9 4.6 3.7 10.5 10.3 11.3 
   1.7 0.0 1.0 0.6 0.0 0.4 2.1 0.2 0.4 
Significant differences between clusters (p < 0.05) 
1 > 3, 2 > 
3, 1 > 4, 
2 > 4 
2 > 1, 2 > 
3, 2 > 4, 1 
> 3, 1 > 4, 
3 > 4 
2 > 1, 2 > 
3, 2 > 4, 1 
> 3, 1 > 4, 
3 > 4 
Table 3.10 Comparisons of τ-values calculated for clusters of non-proteolytic C. 
botulinum strains from 106 spores tube-1 incubated at chill temperatures for 90 
days (experiment one) and from three inoculum concentration incubated at 6.0°C 
for 60 days (experiment two) 
 
A MANOVA analysis indicated a significant difference between clusters            
(F-statistic = 14.3, p < 0.01) based on Wilk’s Lambda. The differences among 
clusters were observed in the mean τ-value of three spore concentrations with    
s = 106 spores tube-1 having the smallest impact in assigning strains into clusters 
(Table 3.10). 
 
Although the heat map procedure was conducted for a single parameter (τ-
value), its actual determination is based on two different and independent 
factors: incubation temperature and inoculum concentration. The consistency in 
the strain classification pattern shows a natural biological relationship between 
these strains (based on the ability to growth at chill temperatures). 
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Interestingly, in general, the strain clustering pattern is closely associated with 
toxin type. In both experiment one and experiment two, strains that belong to the 
slowest growing (cluster 2 for experiment two) are of type B and F, whereas 
those strains showing fastest growth are in cluster 4 and are of type E (cluster 4 
for experiment two – Figure 3.8). There were a few inconsistences in this pattern 
e.g. strains 87-01 and 02-26 (type E) clustered with type B strains (experiment 
two). This could be associated with strain property (e.g. variability in spore 
germination) or experimental error (e.g. unequal number of inoculated spores). 
Cluster membership (including its association with toxin type) was also obtained 
when cluster analysis was conducted on raw data i.e. all tubes showing growth 
as a function of incubation time (data not shown). A closer analysis of the results 
of the clustering procedure showed that most of the type E strains that showed 
the fastest growth originated from one geographical location. Therefore, to test 
whether rapid growth at chill temperature was a general property of type E 
strains or restricted to strains from Finland, the MANOVA test was used. The 
analysis was conducted on results for type E strains from experiment one, as 
strains used in this experiment represent a wider range of isolation source 
compared with strains used in experiment two. For type B and F strains sources 
were too diverse (13 type B strains isolated from nine different locations and five 
type F – three locations), therefore these strains were not analysed. The τ-value 
calculated for type E strains listed in Table 3.3 (except strain 81-31) and only for 
temperatures: 5.5°C, 6.0°C and 6.5°C were used in analysis (since these gave 
most variation in strain response). The statistical analysis (based on Wilks’ 
Lambda) revealed that there is no significant difference in τ-value calculated for 
strains isolated from different countries (Table 3.11). Therefore it can be 
concluded that the more rapid growth of non-proteolytic C. botulinum type E 
strains at chill temperature is not associated with their source of isolation. 
 
Toxin type Isolated in Number p-value F-value 
Type E 
Canada 1 
0.31 1.61 
Finland 15 
France 1 
USA 2 
Egypt 1 
Table 3.11 Results of MANOVA analysis for τ-value for type E strains of non-
proteolytic C. botulinum isolated from different geographical localisations. 
p – probability that the result observed in a study could have occurred by a chance 
F– ratio of the between groups variance and the within variance 
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In addition to the aforementioned time to growth differences between toxin types, 
there is also a relationship between cluster membership and the probability of 
growth from a single spore (Table 3.12).  
 
Cluster number Toxin type Strain -log10P1 
Cluster 1 
F 86-33 2.42 
B 81-30 1.13 
B 05-25 1.99 
B 87-02 2.22 
B 93-06 1.17 
F 86-32 0.88 
F 86-34 1.97 
Cluster 2 
F 06-05 3.80 
B 87-04 3.81 
Cluster 3 
B 93-11 0.64 
E 87-01 2.92 
B 05-20 0.29 
E 02-26 1.26 
B 83-01 0.48 
B 86-17 4.63 
Cluster 4 
E 02-25 0.51 
E 02-15 0.58 
E 02-07 1.68 
E 86-21 0.00 
E 02-09 0.00 
E 02-29 1.08 
Table 3.12 The probability of growth from a single spore of non-proteolytic        
C. botulinum at 6.0°C for 60 days in relationship to cluster membership and toxin 
type (Clusters from experiment two – Figure 3.9) 
 
The strains belonging to cluster 2 are those with the lowest probability of growth 
from a single spore (P1 = 1.58 x 10
-4). Cluster 1 consists of strains for which      
P1 ranges from 3.8 x 10
-3 to 1.3 x 10-1. For the majority of strains in cluster 3, P1 
ranges from 5.5 x 10-2 to 5.1 x 10-1. Nevertheless the probability of growth from   
a single spore of two strains (87-01 and 86-17) is much lower, 1.2 x 10-3 and 2.3 
x 10-5 respectively. The highest value of P1 is observed for strains belonging to 
cluster 4 and it ranges from 8.3 x 10-2 to 1.0, with the exception of strain 02-07 
for which the P1 = 2.1 x 10
-2. The above relationship with the clusters is not         
a great surprise, as the probability of spore growth is also calculated from the 
dataset generated in experiment two. The observed deviation (e.g. for strains 86-
32, 87-01, 86-17 and 02-07) could be due to fact that the calculation of P1 was 
based on the exact number of inoculated spores as measured by plate count. 
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However the overall close relationship between the two clustering variables 
strongly indicates that any deviation in number of added spores did not have                    
a measurable effect on growth at chill temperature. 
 
Based on the strain clustering pattern in experiment two, the mean and standard 
deviation of the τ-value for the three inoculum concentrations were calculated 
within each (experiment two) cluster (Table 3.10), and a cumulative distribution 
function, CDF, of a normal distribution was used to represent the variability. 
 
The influence of spore concentration on the distribution of the τ-value within each 
cluster is shown in Figure 3.10. As expected, the time needed for observed 
growth is higher with lower spore inoculum concentration. This is due to the fact 
that within a larger population there is a greater probability that at least one 
spore will initiate growth and that fewer multiplications are necessary for visible 
growth. In addition for each inoculum concentration the variability associated with 
each cluster is smaller than the variability that would be associated with the 
whole population of non-proteolytic C. botulinum strains (Figure 3.10). Similarly, 
at the lower inoculum concentrations, there is greater strain variability in 
response to incubation conditions. With a high concentration of spores (s = 106 
spores tube-1) turbidity is expected within 10.5 – 16.4 days, whereas with a lower 
inoculum (s = 104 spores tube-1) it is expected within 11.3 – 26.3 days (Table 
3.10). Interestingly, the inoculum concentration has a relatively small effect on 
strains of cluster 1 as the distribution of τ-value for s = 104 and 105 spores tube-1 
does not differ significantly. The biggest changes are observed for strains 
belonging to the slowest growing strains in cluster 2, where the distribution of    
τ-value is affected by spore inoculum concentration. 
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Figure 3.10 The cumulative probability, CDF, of the τ-value based on incubation 
of non-proteolytic C. botulinum strains assigned to four clusters at 6.0°C for 60 
days with different concentrations of spores  
Cluster 4 (black line), cluster 3 (violet line), cluster 1 (pink line), cluster 2 (green line) 
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3.4 Discussion 
Since the discovery of the ability of non-proteolytic C. botulinum to produce 
different types of toxin, it has been suggested that the toxin type may be aligned 
with other phenotypic properties of strains. Nevertheless, few studies have 
tested this hypothesis. 
 
This chapter describes the observation of time to initiate growth at chill 
temperature for 40 strains (experiment one) and 24 strains (experiment two) as  
a function of incubation temperature and spore inoculum concentration. Cluster 
analysis based on growth properties indicated that there is a classification 
pattern which can contribute to organisation of risk assessment for groups of 
strains. Moreover the clustering analysis revealed that the cluster membership 
aligns with toxin type.  
 
The analysis of two independent datasets indicated that, in general terms type E 
strains showed more rapid grow at chill temperatures forming one cluster. Three 
other clusters were principally composed of type B and type F strains with less 
rapid growth in the same conditions.  
 
There are no previous studies for direct comparison of the clustering patterns 
presented in this chapter. Derman et al. (2011) previously investigated the 
genetic diversity of non-proteolytic C. botulinum strains using AFLP analysis, but 
found no association of growth properties with assigned AFLP cluster. The 
discrepancy with current studies could be due to the different clustering variable 
used, different strains examined, or experimental design. Interestingly, a t-test 
analysis of growth rates given in the Derman study, revealed that there is no 
significant difference in growth rates of strains of different toxin type at 10.0°C, 
although at 37.0°C, type E strains had significantly higher growth rates than type 
B and F strains.  
  
Graham et al. (1997) previously reported that type F strains grow faster than type 
B or E strains. In the same study, growth of non-proteolytic C. botulinum was 
observed in 5 – 6 weeks at 3.0°C, but not at 2.1°C. Also growth at 4.0°C, 5.0°C, 
8.0°C and 10.0°C was observed after 3, 2, 1 and 1 weeks of incubation. Such 
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differences in observations of time to growth in comparison with the results of 
this chapter are perhaps unexpected, and may reflect a low but variable 
likelihood of growth at chill temperatures. 
 
The observations of time to growth presented here are comparable with 
previously published studies in Table 3.13. In general, the results obtained in 
experiment one agreed with previously published data. The greatest discrepancy 
is at 3.0°C and 4.0°C. A number of previous authors have reported growth at 
4.0°C and below, while in experiment one only one strain (02-15) grew at 4.0°C 
and no strains grew at 3.0°C. For example Schmidt et al. (1961) reported growth 
of strains VH (87-01), Iwanai, Beluga (81-26) and 8E after 45, 31, 31 and 45 
days of incubation at 3.3°C. It should be noted that, the precise concentration of 
spores used for each strain was not given (giving the range of concentrations) 
and that growth was tested in food substrate (beef stew). Furthermore Eklund et 
al. (1967a) observed growth at 3.3°C from strains 86-32 and 288F after 39 and 
53 days of incubation, respectively (from s = 106 spores tube-1). Different results 
obtained from these experiments could be associated with the different culture 
media used. For example Carlin et al. (2000) showed that the ability of spores to 
lead to growth was affected by medium composition. When s = 107 spores tube-1 
were inoculated into PYGS broth, potato purée or broccoli purée the first visible 
growth was observed after 8, > 56 and 56 days when incubated at 6.0°C, 
respectively. 
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Strain 
Observation from previous studies Observation from present study 
s 
(spores tube
-1
) 
Medium 
Temp 
(°C) 
Time to 
growth 
(days)
a) 
Reference 
s 
(spores 
tube
-1
) 
Temp (°C) 
Time to 
growth 
(days)
b) 
87-01 4 x 106  – 1 x 107 beef stew  3.3 45 Schmidt et al. (1961) 106 3.0 > 90 
Iwanai 4 x 106  – 1 x 107 beef stew  3.3 31 Schmidt et al. (1961) nt nt nt 
81-26 4 x 106  – 1 x 107 beef stew 3.3 31 Schmidt et al. (1961) 106 3.0 > 90 
8E 4 x 106  – 1 x 107 beef stew 3.3 45 Schmidt et al. (1961) nt nt nt 
86-32 2 x 106 CMM 3.3 39 Eklund et al. (1967a) 106 3.0 > 90 
86-32 2 x 105 CMM 3.3 39 Eklund et al. (1967a) 106 3.0 > 90 
288 F 2 x 106 CMM 3.3 53 Eklund et al. (1967a) nt nt nt 
288 F 2 x 105 CMM 3.3 68 Eklund et al. (1967a) nt nt nt 
81-30 2 x 106 CMM 3.3 > 85 Eklund et al. (1967b) 106 3.0 > 90 
81-30 2 x 105 CMM 3.3 > 109 Eklund et al. (1967b) 106 3.0 > 90 
mixed B strains  105 PYGS 4.0 91 Graham et al. (1997) nt nt nt 
G 21-5 2 x 105 TPGY 4.0 52 Solomon et al. (1977) nt nt nt 
mixed E strains  105 PYGS 4.0 70 Graham et al. (1997) nt nt nt 
mixed F strains  105 PYGS 4.0 > 91 Graham et al. (1997) nt nt nt 
86-32 2 x 106 CMM 4.4 18 Eklund et al. (1967a) 106 4.0 > 90 
86-32 2 x 105 CMM 4.4 22 Eklund et al. (1967a) 106 4.0 > 90 
288 F 2 x 106 CMM 4.4 23 Eklund et al. (1967a) nt nt nt 
288 F 2 x 105 CMM 4.4 25 Eklund et al. (1967a) nt nt nt 
81-30 2 x 106 CMM 4.4 24 Eklund et al. (1967b) 106 4.0 > 90 
81-30 2 x 105 CMM 4.4 33 Eklund et al. (1967b) 106 4.0 > 90 
mixed strains 3 x 108 PYGS 5.0 28 Stringer et al. (1997) 106 5.0 21 
mixed B strains  105 PYGS 5.0 28 Graham et al. (1997) 106 5.0 32 
mixed E strains  105 PYGS 5.0 12 Graham et al. (1997) 106 5.0 21 
mixed F strains  105 PYGS 5.0 12 Graham et al. (1997) 106 5.0 42 
mixed strains 3 x 108 PYGS 5.0 28 Stringer et al. (1997) 106 5.0 21 
86-32 2 x 106 CMM 5.6 14 Eklund et al. (1967a) 106 6.0 21/12 
86-32 2 x 105 CMM 5.6 17 Eklund et al. (1967a) 105 6.0 14 
288 F 2 x 106 CMM 5.6 15 Eklund et al. (1967a) nt nt nt 
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288 F 2 x 105 CMM 5.6 19 Eklund et al. (1967a) nt nt nt 
81-30 2 x 106 CMM 5.6 17 Eklund et al. (1967b) 106 5.5 39 
81-30 2 x 105 CMM 5.6 21 Eklund et al. (1967b) 106 5.5 39 
mixed strains 106 meat 
medium 
6.0 8 Peck et al. (1995) 106 6.0 11 
mixed strains 106 meat 
medium 
6.0 7 Peck et al. (1995) 106 6.0 11 
mixed strains 106 meat 
medium 
8.0 5 Peck et al. (1995) 106 6.0 6 
mixed strains 106 meat 
medium 
8.0 4 Peck et al. (1995) 106 6.0 6 
G 21-5 2 x 104 
TPGY 
broth 
8.0 14 Solomon et al. (1977) nt nt nt 
Minneapolis 2 x 106 TPG  8.0 7 Segner et al. (1966) nt nt nt 
mixed strains 106 meat 
medium 
10.0 4 Peck et al. (1995) 106 10.0 4 
Minneapolis 2 x 106 TPG 10.0 4 Segner et al. (1966) nt nt nt 
mixed strains 106 meat 
medium 
10.0 5 Peck et al. (1995) 106 10.0 4 
mixed strains 3 x 108 PYGS 10.0 7 Stringer et al. (1997) 106 10.0 4 
Table 3.13 Comparisons of results from previous studies on growth of non-proteolytic C. boutlinum at chill temperatures with results 
obtained in this thesis 
a) noted as t1 – time when the first growth was observed, 
b) time presented as (experiment one/experiment two), results noted for “mixed strains” 
in present study corresponds to shortest time when visible growth was observed at given temperature, CMM – cooked meat medium, TPGY – 
tryptone-peptone-glucose-yeast extract, TPG – trypticase-peptone-glucose medium, nt – strain was not tested 
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The first signs of growth for non-proteolytic C. botulinum type B, E and F strains 
at 6.0°C were observed on day 11, 11 and 18, respectively (results of experiment 
one). Similar results were obtained in experiment two, with the only difference 
that for type F strains the first observation of growth was recorded on day 12. 
Peck et al. (1995) first observed growth from the same inoculum concentration of 
mixed strains in a meat medium after 4 and 7 days at 10.0°C and 6.0°C, 
respectively. This is close to results of Stringer et al. (1997), where growth from 
the same spore inoculum at 10.0°C and 5.0°C was first observed after 7 and 28 
days of incubation. Visible growth and toxin production at 8.0°C were detected 
from spores of type E strains (Solomon et al., 1977) after 14 days of incubation. 
Growth of non-proteolytic C. botulinum type E was detected in the current study 
at 8.0°C on day 7. The discrepancy in the results is very likely associated with 
the lower inoculum concentration used by Solomon et al. (1977). Nevertheless, 
the results of experiment one in the present study were in agreement with those 
reported by Segner et al. (1966) where turbidity of type E strains at 8.0°C was 
reported on day 7 and at 10.0°C on day 4.  
 
The cluster analysis based on τ-values was reflected in the probability of growth 
from a single spore as a function of time. The P1 for a single type B spore at 
6.0°C ranged from 3.8 x 10-7 to 5.2 x 10-2, from 1.2 x 10-4 to 1.0 for type E and of 
1.6 x 10-4 to 1.3 x 10-2 for type F (data from experiment two). Lower P1 values for 
a single type E spore were noted by Jensen et al. (1987) with a range from      
5.8 x 10-7 to 5.8 x 10-2, and Ikawa et al. (1986), with a range of 4.6 x 10-8 to 2.2 x 
10-7 for type B, but in both these previous studies growth was tested at the lower 
temperature of 4°C. Stringer et al. (1997) showed, in culture media, that the 
probability of growth from a single spore for mixture of six different strains within 
23 weeks was 8.2 x 10-4, 3.3 x 10-1 and 1, when incubated at 5.0°C, 10.0°C and 
30.0°C respectively. Lund et al. (1990) reported a higher probability of growth 
from a single spore (type B strain), between 0.01 and 1, after 20 days incubation 
at 6.0°C. The studies of Lund et al. (1990) and Jensen et al. (1987) also reported 
that the probability of growth from a single cell is much higher than the probability 
of growth from a single spore. 
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Since the discovery that strains of non-proteolytic C. botulinum form one of three 
different botulinum neurotoxins, there has been speculation as to whether the 
type of neurotoxin formed is associated with physiological properties such as 
growth at chilled temperatures. Previous studies have failed to prove/disprove 
the hypothesis that growth at chill temperature is associated with the type of 
toxin formed. Combining data on growth of different strains at chill temperature 
from multiple studies has also failed to resolve this issue, as it is difficult to obtain 
reproducible results using different experimental systems. For example there 
might be differences in spore crop properties (which could be attributed to slight 
variations in conditions during sporulation, harvesting and washing of spores, 
and length and conditions of storage) or growth test conditions (such as 
pretreatment of spores, growth medium, test system, degree of anaerobiosis).  
 
In the present study, two high quality datasets has been considered and 
demonstrated that type of neurotoxin formed is associated with growth at chill 
temperature. Strains that form type E neurotoxin show faster growth at chilled 
temperatures than strains that form type B or type F neurotoxin. 
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3.5 Conclusions 
There is no doubt that growth of non-proteolytic C. botulinum at chill 
temperatures in foods presents a significant hazard. Therefore incubation 
temperature is a vital factor in the control and minimization of risk associated 
with non-proteolytic C. botulinum.  
 
From the results in this chapter the following conclusions can be drawn: 
i. Strain variability of non-proteolytic C. botulinum increased as the test 
conditions became more difficult (i.e. lower inoculum concentration, lower 
incubation temperature)  
ii. The finding of this study can be used in strain selection for exploitation in 
food safety challenge studies considering growth through identification of 
strains which show high growth capability (e.g. 86-21, 02-09 and 02-15) 
iii. The probability of growth from a single spore of non-proteolytic                
C. botulinum at 6.0°C after 60 days of incubation ranged from 3.5 x 10-7 to 
1 depending on tested strain 
iv. The τ-value is a convenient parameter that is used to assess strain 
variability based on observed growth at a) different temperatures from      
a high spore inoculum and b) different spore inoculum concentrations at 
6.0°C 
v. Variability of the growth kinetic behaviour among non-proteolytic             
C. botulinum strains is affected by the incubation temperature and spore 
inoculum concentration 
vi. The clustering of non-proteolytic C. botulinum strains based on τ-value 
determined in two independent experimental datasets groups the tested 
strains into four clusters; clusters 1, 2 and 3 are generally associated with 
toxin type B and F and cluster 4 is generally associated with toxin type E, 
with strains in cluster 4 showing the most rapid growth, meaning that 
growth of type E strains occurs faster than for type B and F strains 
vii. A combination of information from the probability of growth from a single 
spore and clustering pattern provides a strong support for the 
homogeneous cluster of strains 
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viii. The statistical analysis for type E strains revealed that the cluster 
membership was not affected by country from which the isolate was 
sourced 
 
Cluster analysis is a very powerful method, which identifies behaviour patterns 
within the tested strains. Treating strains in terms of groups rather than 
individually reduces the number of risk assessments that are required when 
considering the large number of naturally occurring strains. In this study the 
classification of non-proteolytic C. botulinum strains was performed as a function 
of many variables: type of toxin formed, concentration of inoculum, temperature 
and time of incubation leading to growth in the model system. The four clusters 
obtained can be utilized when assessing the risk of non-proteolytic C. botulinum 
in a minimally heated dairy-based dessert (see section 5). It should be noted that 
this study has focused on testing unheated spores. A future study could consider 
whether heated spores that are incubated at chill temperature show a similar 
clustering pattern. In addition, analysis was based only on limited number of 
strains used in both experiments. 
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4. Effect of carbohydrate source on variability in growth 
and neurotoxin formation by strains of non-
proteolytic C. botulinum 
The variability in carbohydrate utilization by non-proteolytic C. botulinum type B, 
E and F strains has been examined. The results show distinct patterns in 
fermentation of carbohydrates. Analysis of this variability leads to the clustering 
of non-proteolytic C. botulinum strains according to their metabolic capability and 
may reveal important information about corresponding hazards. The data are 
used to establish a classification model to indicate the significance for risk 
assessment. 
 
4.1 Background 
Microorganisms are frequently exposed to a changing physical and chemical 
environment, and need to respond to these changes. This response might 
involve the formation of new enzymes to reflect a change in the available carbon 
source. A greater understanding of the metabolic capacity of microbes may 
suggest mechanisms that could be used to control or inhibit bacterial growth, and 
give an opportunity to extend the shelf life of food products. 
 
The metabolism of microorganisms is dependent on their growth environment 
and genome-encoded enzymes. The minimum requirement for microbial growth 
is a source of nitrogen, carbon, energy (Dawes, 1964), various minerals 
(Southam, 2012), water and oxygen (in the case of aerobic bacteria). Bacteria 
frequently obtain carbon from organic compounds (such as proteins, lipids, or 
carbohydrates). Strains of non-proteolytic C. botulinum, are defined as 
chemoorganotrophic, deriving both energy and carbon from organic compounds 
such as glucose, xylose, sucrose, maltose (Holt and Sneath, 1985). Strains of 
non-proteolytic C. botulinum are highly saccharolytic, and possess the ability to 
degrade a range of carbohydrates (Lund and Peck, 2000). 
 
One of the most fundamental biochemical processes in many living organisms is 
carbohydrate metabolism. Carbohydrates or carbohydrate derivatives (e.g. sugar 
alcohols, sugar amines, sugar acids, deoxy sugars, glycolsylamines, sugar 
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phosphates) serve as structural elements in living cells and as a source of 
energy for the growth of many microorganisms. Carbohydrates are organic 
compounds that consist of carbon, hydrogen and oxygen (with 2:1 ratio of 
hydrogen to oxygen). Chemically they are divided into simple (monosaccharides 
and disaccharides) and complex (polysaccharides, oligosaccharides). 
 
One starting point for carbohydrate catabolism is the oxidation of glucose 
(C6H12O6) to pyruvic acid. This metabolic pathway, known as glycolysis is 
common to both prokaryotic and eukaryotic organisms, with glucose used by 
many cell types. The chemical steps involved in glucose breakdown are always 
the same; differences lie in the involved enzymes. In glycolysis, also known as 
the Embden-Meyerhof-Parnas pathway, glucose is split into two pyruvate 
molecules with the generation of adenosine-5'-triphosphate (ATP) and reduced 
nicotinamide adenine dinucleotide (NADH). Glycolysis is a 10-step pathway 
divided into two stages (Figure 4.1). In the first stage, reactions 1-5, α-D-glucose 
is phosphorylated to glyceraldehyde-3-phosphate with the consumption of two 
ATP molecules. In the second stage, reactions 6 to 10, glyceraldehyde-3-
phosphate is converted into pyruvate. Moreover, at this stage per molecule of 
glucose, four ATP and two NADH molecules are produced (Figure 4.1). 
 
In the presence of oxygen, aerobic microorganisms catabolise glucose, in           
a process called aerobic respiration, where pyruvate is oxidized to CO2 and H2O. 
Anaerobic organisms convert pyruvate to products such as ethanol, acetic acid 
or lactic acid, depending on the species. In the case of strains of non-proteolytic 
C. botulinum, the end-products of metabolism are typically acetate and butyrate 
(Lund and Peck, 2000).  
 
Given that carbohydrates are some of the most widely distributed organic 
compounds, being important constituents of plants and animals, and that non-
proteolytic C. botulinum grows and persists in a wide variety of environments rich 
in decaying plant and animal material, sediments and soil (the main source of 
food contamination) (Carlin, 2011), it is vital from a food safety point of view to 
identify carbohydrates that can be a source of energy and carbon. 
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Figure 4.1 The glycolysis pathway 
Source: Adopted from Stanier et al. (1977) 
 
Since the ability of bacteria to utilize carbohydrate is an important part of their 
metabolism, certain carbohydrates have long been used for the cultural 
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differentiation and classification of microorganisms. Although the phenotypic 
properties of non-proteolytic C. botulinum strains have been described previously  
(Hobbs et al., 1965; Moore et al., 1966; Eklund et al., 1967a; Holdeman and 
Brooks, 1970; Holdeman et al., 1977; Holt and Sneath, 1985) tests were 
previously conducted on a limited number of strains, which does not allow for 
assessing strain variability. 
 
This chapter describes the classification of non-proteolytic C. botulinum strains 
based on the ability to ferment different carbohydrates and considers the 
importance of this information for quantitative risk assessment. 
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4.2 Materials and methods 
The variation in carbohydrate utilization by non-proteolytic C. botulinum strains 
has been determined in a two-part study. In the initial experiment, a greater 
number of carbohydrates and small number of strains were tested. Whereas in 
the main experiment, the utilization pattern of fewer carbohydrates by a greater 
number of strains was determined. In order to verify whether the ability of a strain 
to utilise a particular carbohydrate is coupled with toxin production, an amplified 
enzyme-linked immunosorbent assay (ELISA) test was conducted. 
 
Strain classification using a clustering procedure was based on the formation of 
acid (measured as a fall in pH) and/or gas when strains were incubated with 
different carbohydrate. Results are used to establish a classification model to 
indicate the significance for risk assessment in relation to non-proteolytic           
C. botulinum in food products. 
 
4.2.1 Strains 
Experiments were performed using 33 strains of non-proteolytic C. botulinum 
type B, E and F selected from the Institute of Food Research culture collection, 
and summarised in Table 3.1 (section 3.2.1). The purity of cultures was tested 
using the procedures given in section 3.2.2. 
 
4.2.2 Culture medium 
Anaerobic peptone-yeast extract-glucose-starch (PYGS) broth, as described 
previously (Lund et al., 1990) was used as the subculture medium. For 
carbohydrate utilization tests, an anaerobic Carbohydrate Medium Base (CMB) 
was prepared using strict anaerobic technique and contained the following: 
Oxoid Peptone Bacteriological (LP 0037), 10.0 gL-1; Oxoid Yeast Extract 
(LP0021) 5.0 gL-1; Sodium chloride, 5.0 gL-1; Cysteine HCl, 0.5 gL-1; Hemin 
solution (0.05%) 10.0 mlL-1; Vitamin K1 solution (0.0001%) 0.2 mlL
-1; Resazurin 
solution (0.02%) 5.0 mlL-1; and glass-distilled water to 1 kg. The unadjusted pH 
of the medium was between 5.8 and 6.0. The hemin and vitamin K1 solutions 
were prepared according to Holdeman et al. (1977) and were added to boiled, 
oxygen-free medium. Before sterilization by autoclaving, the pH of the medium 
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was adjusted under anaerobic conditions by the addition of an appropriate 
volume of 5 M KOH, to pH 6.8 – 7.0.  
 
4.2.3 Carbohydrates used 
To test the variability in carbohydrate utilization, in the initial experiment, the 
API® 50CH standardized system (bioMérieux, Basingstoke, UK) was used 
(Figure 4.2). This test kit is more generally used in conjunction with the API® 50 
CHL Medium for the identification of Lactobacillus, or with API® 50 CHB/E 
Medium for the identification of Bacillus, Enterobacteriaceae and Vibrionaceae.  
The API® strip (Figure 4.2) consists of plastic strips of 10 individual, miniaturized 
tests tubes (cupules) used to test the fermentation of 49 carbohydrates and their 
derivatives (Table 4.1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 The API® 50 CH standardized 
system used in initial carbohydrate 
experiment  
 
 
In the main experiment, a greater number of strains were tested with a smaller 
number of carbohydrates: myo-Inositol (Fluka 57570), D-(+)-Melezitose 
monohydrate (Fluka 63620), Amylopectin from maize (Sigma 10120), Amylose, 
from potato (Fluca A0512), Glycogen from bovine liver – Type IX (Fluca G0885), 
Xylitol, ≥ 99% (Fluca X3375), Levan from Erwinia herbicola (Sigma L8647), 
Pullulan from Aureobasidium pullulans (Sigma P4516) and Chitosan (Aldrich 
448877). These tests were conducted in bottles. 
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Cupule Carbohydrate QTY (mg tube-1) 
0 Control - 
1 Glycerol 1.64 
2 Erythritol 1.44 
3 D-arabinose 1.40 
4 L-arabinose 1.40 
5 D-ribose 1.40 
6 D-xylose 1.40 
7 L-xylose 1.40 
8 D-adonitol 1.36 
9 Methyl-βD-Xylopyranoside 1.28 
10 D-galactose 1.40 
11 D-glucose 1.56 
12 D-fructose 1.40 
13 D-mannose 1.40 
14 L-sorbose 1.40 
15 L-rhamnose 1.36 
16 Dulcitol 1.36 
17 Inositol 1.40 
18 D-mannitol 1.36 
19 D-sorbitol 1.36 
20 Methyl-αD-Mannopyranoside 1.28 
21 Methyl-αD-Glucopyranoside 1.28 
22 N-acetylglucosamine 1.28 
23 Amygdalin 1.08 
24 Arbutin 1.08 
25 Esculin 
ferric citrate 
1.16 
0.152 
26 Salicin 1.04 
27 D-cellobiose 1.32 
28 D-maltose 1.40 
29 D-lactose (bovine origin) 1.40 
30 D-melibiose 1.32 
31 D-saccharose (sucrose) 1.32 
32 D-trehalose 1.32 
33 Inulin 1.28 
34 D-melezitose 1.32 
35 D-raffinose 1.56 
36 Amidon (starch) 1.28 
37 Glycogen 1.28 
38 Xylitol 1.40 
39 Gentiobiose 0.50 
40 D-turanose 1.32 
41 D-lyxose 1.40 
42 D-tagatose 1.40 
43 D-fucose 1.28 
44 L-fucose 1.28 
45 D-arabitol 1.40 
46 L-arabitol 1.40 
47 Potassium Gluconate 1.84 
48 Potassium 2-Ketogluconate 2.12 
49 Potassium 5-Ketogluconate 1.80 
Table 4.1 The carbohydrates included in the API® 50 CH strip  
Source: bioMérieux (2002) 
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4.2.4 ELISA for botulinum neurotoxin type B 
An ELISA assay was conducted to test whether the growth of non-proteolytic      
C. botulinum strains in the presence of tested carbohydrates was confirmed by 
neurotoxin formation. The test was conducted only for type B strains. 
 
4.2.4.1 Neurotoxin and antibody biotinylation 
Purified botulinal neurotoxin type B, derived from the Okra strain, with                 
a measured potency of 2 x 107 MLD50 mg
-1 was obtained from Metabiologics 
(Madison, Wisconsin, USA). The potency of botulinum neurotoxin was 
determined by Metabiologics using a mouse test.  
 
A polyclonal antibody against botulinum neurotoxin type B was obtained from 
Metabiologics. Antibodies were biotinylated using the EZ-Link Micro Sulfo-NHS-
LC-Biotin kit (21935) according to the manufacturer’s instructions. Antibody was 
dissolved in phosphate-buffered-saline (PBS) to a final concentration of 200 
μgml-l (0.18 mM) and sulfo-NHS-LC-biotin solution (9 mM) was added to give     
a molar ratio of 50:1 (biotin:antibody). The reaction was incubated on ice for one 
hour and then desalted using a column. Purified protein sample, was collected 
into the column and stored at -20°C.  
 
4.2.4.2 Buffers and diluents 
Carbonate-bicarbonate buffer, at pH = 9.6, contained: Na2CO3, 1.59 gL
-1 and 
NaHCO3, 2.93 gL
-1 of glass-distilled water. Tris-buffered saline-Tween 20 
(TBST), pH = 7.5, contained: one sachet of TBS (Sigma, T6664) with 0.05 ml of 
Tween 20 (Sigma) L-1 of glass-distilled water; the pH was adjusted with 
concentrated HCl. Casein assay buffer, pH = 7.8 contained: 1% (w/v) vitamin-
free casein (Sigma), 25mM Na2HPO4 and 150 mM NaCl in glass-distilled water. 
The buffer was filtered through a 0.45 µm membrane to reduce the background 
signal. PBS/BSA buffer (2% in glass-distilled water) contained 1 tablet of PBS 
(Sigma) and 10 gL-1 of Bovine serum albumin (BSA). 
 
4.2.4.3 Measurement of neurotoxin formation 
A Nunc Maxisorb microtitre plate (Thermo Fisher, Loughborough, UK) was 
coated with 100 µl well-1 of anti-B toxin capture antibody at a concentration of     
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1 µg ml-1 in carbonate-bicarbonate buffer (pH = 9.6) and incubated at 4.0°C over 
night. Unreacted sites were blocked by adding 200 µl of filtered casein assay 
buffer to each well and incubating at 37°C for 90 minutes. Coated plates were 
prepared in advance and stored at -18°C until required.  
 
Botulinum neurotoxin complex standard was diluted in PBS/BSA to three 
concentrations (0.25 – 5 ngnl-1). Samples were diluted in 1:2 PBS/BSA and 100 
µl of standard neurotoxin solution or test sample was added to duplicate wells of 
prepared plates. The negative control received 100 µl of PBS/BSA. Plates were 
incubated at 37°C for 2 hours then washed five times with Tris-buffered saline 
with 0.05% Tween 20 (TBST), pH = 7.5 (300 µl). Next, 100 µl of a 1:200 dilution 
of 1 µlml-1 biotinylated detector antibody in PBS/BSA was added to each well. 
Plates were incubated for 60 min at 37°C and washed. 
 
Streptavidin-horseradish peroxidase enzyme conjugate (Prozyme, Europa 
Bioproducts, Ely, UK) was diluted 1:5000 in PBS/BSA and 100 µl pipetted into 
each well. Plates were incubated at 37°C for 60 minutes. Following further 
washing, 100 µl of 3,3’,5’5’-Tetramethylbenzidine (TMB, Europa Bioproducts, 
Ely, UK) was added into each well. After a defined period of time (dependent on 
colour development), 50 µl well-1 of stop solution (0.3 M H2SO4) was added. The 
absorbance within the wells was measured at 450 nm. The detection limit was 
calculated from the mean plus three standard deviations of the absorbance value 
of the negative control. All the tests were carried out in duplicate.  
 
4.2.5 Experimental design 
Carbohydrate utilization by non-proteolytic C. botulinum strains was tested in two 
experiments. Initially, the API® 50CH system was evaluated for the identification 
of the biochemical profile of 15 strains. Based on the obtained results, further 
experiments examined the utilization of nine carbohydrates by 30 strains. In 
order to confirm observations of growth, for chosen strains, neurotoxin formation 
was measured using an ELISA assay for type B toxin. Due to a discrepancy 
between pH measurement and ELISA test results, additional investigations were 
undertaken using an INFORS Multifors fermenter (Reigate, UK). 
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4.2.6 Experimental procedure – carbohydrate utilization by strains of 
non-proteolytic C. botulinum 
Stock cultures of each strain were prepared by transferring 100 µl of culture into 
new anaerobic CMM with glucose and incubated at 30°C over night, then 
maintained at +4°C until required. For testing the ability to utilize carbohydrate an 
aliquot of stock cultures (100 µl) of each strain were transferred into 10 ml of 
PYGS broth and incubated at 30°C over night or at 15°C over a weekend. 
 
In the initial experiment (Figure 4.3), actively growing populations were cultured 
on PYGS agar and incubated at 30°C in an anaerobic cabinet under H2/CO2 
(90:10, v/v). Simultaneously the purity of the strains was checked (see section 
3.2.2). An inoculum was prepared by picking a colony from the plate using          
a sterile loop and suspended in 10 ml of CMB medium. The turbidity of the 
prepared suspension was equivalent to 2 McFarland Standard units (opacity 
standard allowing estimation of the density of a bacterial suspension). Using       
a sterile pastette the bacterial suspension was distributed into API® strips, 
containing 49 carbohydrate substrates (plus a control). After incubation in 
humidity chamber in an anaerobic cabinet for 30°C/48h the pH was measured 
(pH meter 3-star Thermo Scientific Orion, Waltham, USA, equipped with Eutech 
Instruments, Wallerstraat, Netherlands, pH electrode). 
 
In the main experiment, 100 µl of actively growing culture was transferred into 80 
ml of double strength anaerobic CMB. An aliquot of 5 ml of inoculated CMB was 
transferred into bottles containing 5 ml of sterile anaerobic water with 0.1 g of     
a particular carbohydrate. A Durham tube (10 x 75 mm) was placed in the bottom 
of the medium to observe gas production. After incubation at 30°C for 48 hours 
in an anaerobic cabinet, the bottles were observed for gas production and the pH 
and toxin concentration were measured (toxin for type B strains only). Each 
strain was tested in duplicate (Figure 4.4).  
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Figure 4.3 The work flow of the initial experiment of carbohydrate utilization by 
strains of non-proteolytic C. botulinum (using API® strips) 
 
 
Figure 4.4 The work flow of the main experiment of carbohydrate utilization by 
strains of non-proteolytic C. botulinum (using bottles) 
100 µl
30 C/over night
PYGS
PYGS
30 C/over night
30 C/48 h
pH measurement
CMB
CMM
30 C/overnight
PYGS 0.1 g of carbohydrate + 
5 ml of anaerobic water
Incubation 30 C/48 h
CMM
100 µl 100 µl
80 ml of 2 X CMB
pH measurement
5 ml
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4.2.7 Experimental procedure – growth and neurotoxin formation by 
strains of non-proteolytic C. botulinum type B within                  
a fermenter system 
A detailed study of growth and toxin formation by non-proteolytic C. botulinum in 
the presence of glucose was tested using a fermenter system. The test was 
conducted using strains 86-17 and 93-06. Strains were selected based on the 
substantial amount of toxin produced as indicated by ELISA assay. 
 
The tested strains were grown at 30°C over night in PYGS. Aliquots of 50 µl of 
actively growing cultures were transferred into 50 ml of CMB and incubated at 
30°C over night in an anaerobic cabinet.  
 
The fermenter system used consisted of paired 1L vessels, each containing 800 
ml of CMB (control) or CMB with 10 gL-1 of glucose. After autoclaving at 121°C 
for 20 min the fermenters were constantly sparged with N2/H2 (90:10, v/v) (0.5 L 
min-1) to maintain anaerobic conditions within the medium. Fermenters were 
equipped with pH (PHS-EFP-K8-225, Finesse, Switzerland) and redox (Pt805-
DPAS-SC-K8S/200, Mettler-Toledo, Switzerland) electrodes, and IRIS NT5 
software (Version 5, Infors) was used to monitor and control fermenter 
parameters: temperature (°C), pH, stirrer speed (rpm) and redox potential (mV). 
Fermenters were stired at 100 rpm. The temperature during the fermenter 
experiments was maintained at 30°C. Before inoculation, the fermenter pH was 
adjusted to 7.1 by addition of 1.5 M NaOH. Experiments were initiated by 
inoculating the fermenters with 50 ml of cultures of strain 86-17 or strain 93-06. 
Fermenters were sampled after inoculation and at 30 minutes intervals, until 
stationary phase was reached. A small quantity (5 ml) of culture was removed 
from each fermenter to determine growth by measurement of optical density at 
600 nm, and for toxin production measured by ELISA. Figure 4.5 illustrates the 
fermenter system. 
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Figure 4.5 Fermenter system used for testing the growth and neurotoxin 
formation by non-proteolytic C. botulinum strains in the absence and presence of 
glucose (Multifors, INFORS, Reigate, UK) 
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4.2.8 Analysis of data on the effect of non-proteolytic C. botulinum 
strain variability on carbohydrate utilization pattern 
The ability of strains to utilise a carbohydrate was determined by pH 
measurement. The two-step experimental design allowed for testing of a large 
number of carbohydrates, and also of a large number of strains. 
 
4.2.8.1 Initial experiment 
In the initial experiment the fermentation of 49 carbohydrates by 15 non-
proteolytic C. botulinum strains (6 type B, 6 type E and 3 type F strains) was 
determined by pH measurement. A carbohydrate was considered to be 
fermented if a pH drop in relation to the control treatment (CMB without 
carbohydrate) was observed. A drop more than 1.0 pH unit below the control 
was considered as strong fermentation, whereas a drop of between 0.5 and 1.0 
pH units was weak fermentation. 
 
The pH data were subject to cluster analysis to classify isolates. A graphical 
visualisation of the main carbohydrate experiment results is presented as           
a heatmap (unsupervised hierarchical clustering algorithm, with a dissimilarity 
metric based on Euclidean distance). The distance between members of 
different clusters was calculated based on the pH measurements. The most 
physiologically homogeneous strains are placed at the lowest hierarchical level. 
Strain heterogeneity increases with higher hierarchical level within a given 
cluster. The procedure was conducted using the “heatmap.2” function in the 
gplot package of the R Statistics Environment (Team, 2012). 
 
4.2.8.2 Main experiment 
In the main experiment, the fermentation of nine carbohydrates by a larger 
number of strains (30) was examined. Substrates were classified as to whether 
or not they produce acid, gas, toxins or all three. Carbohydrate fermentation was 
demonstrated by a change in the pH as indicated in section 4.2.8.1. The criteria 
for gas production were based on the amount of gas produced in a Durham tube: 
-, no gas production; +, minimal gas production (tube 20 – 50% full), ++, high gas 
production (tube 50 – 80% full); -/+, one sample negative, one sample with 
minimal gas production, +/++, one sample with minimal gas production, one 
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sample with moderate gas production. The data (pH/gas) for each carbohydrate 
are expressed as the average of duplicate tubes. 
 
Cluster analysis was performed using measured pH in the presence of 
carbohydrates following the procedure applied in initial experiment (section 
4.2.8.1). 
 
The pH profiles for thirty strains incubated in the presence of nine carbohydrates 
were also analysed by principal component analysis (PCA) and displayed as      
a biplot diagram to visualize strains location in the classified clusters. The PCA 
was conducted on a dataset representing the difference in pH of control (basal 
medium without carbohydrate) and medium with a particular carbohydrate. The 
PCA compressed the information from the measured pH profile to a small 
number of dimensions, and they were plotted as points in a two-dimensional 
display, of which the x and y axes represent the first and second principal 
components, respectively, and the original variables (carbohydrates) were 
indicated by arrows. The direction and length of the arrows indicate how each 
carbohydrate contributed to the first two components in the biplot.  PCA was 
performed using the “princomp” function in the stats package of the R Statistics 
Environment (Team, 2012). 
 
4.2.9 Statistical analysis 
To test whether the measured pH of the medium containing carbohydrates 
(dependent variable) varied across clusters (independent variable), multivariate 
analysis of variance (MANOVA) with Games – Howell test for multiple 
comparison was used. The statistical analysis was performed using the SPSS 
Statistics software. The differences were tested at a 5% significance level. 
Chapter 4 
184 
4.3 Results 
The results of pH measurement from both experiments allowed first of all, for 
clustering of carbohydrate in terms of their use by non-proteolytic C. botulinum 
strains, and secondly to distinguish homogeneous groups of strains in terms of 
their carbohydrate metabolism. 
 
4.3.1 Initial experiment 
Based on the API® 50 CH profiles of 15 non-proteolytic C. botulinum strains the 
phenotypic diversity of the tested isolates is summarised in Table 4.2. Thirty-two 
carbohydrates were not fermented by any strain (except strain 86-21, which 
fermented D-mannitol). A majority of cultures fermented glycerol, D-ribose,       
D-glucose, D-fructose, D-mannose, D-sorbitol, N-acetylglucosamine, D-maltose, 
D-saccharose, D-trehalose and D-turanose. Interestingly the fermentation of six 
carbohydrates; inositol, D-melezitose, amidon (starch), glycogen, xylitol and      
D-adonitol varied with the tested strain (Table 4.2). All type E strains fermented 
D-melezitose (except strain 86-21, but see main experiment) and showed weak 
ability to ferment D-adonitol, but did not ferment amidon (except strain 08-02), 
glycogen and xylitol. Type F strains fermented amidon, glycogen and D-adonitol, 
but not D-melezitose and xylitol. Type B strains fermented amidon and glycogen. 
The fermentation of xylitol and D-adonitol by type B strains was strain 
dependent.  
 
In general the pH of a medium with a utilized carbohydrate was in the region of 
pH = 5.20. In some cases the pH was below 5.00, e.g. strains 81-30 (D-glucose), 
86-21 (D-glucose, D-fructose, D-mannose, D-sorbitol) and 81-31 (D-ribose,         
D-fructose). The lowest recorded pH value was 4.81, for strain 81-31 when 
growth was in the presence of D-fructose. Some carbohydrates e.g. potassium 
2-ketogluconate, potassium 5-ketogluconate appeared to increase the pH of the 
basal media (in a relation to the pH of the control) in the presence of non-
proteolytic C. botulinum strains. Detailed results of the pH measurements are 
summarised in Appendix 5. 
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Toxin type B E F 
Carbohydrate 81-23 81-30 83-01 86-17* 87-02 05-25* 81-26 81-31* 86-21 93-07 02-25* 08-02 86-32 86-33 06-01* 
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Control - - - - - - - - - - - - - - - 
Erythritol - - - - - - - - - - - - - - - 
D-arabinose - - - - - - - - - - - - - - - 
L-arabinose - - - - - - - - - - - - - - - 
D-xylose - - - - - - - - - - - - - - - 
L-xylose - - - - - - - - - - - - - - - 
Methyl-βD-
xylopyranoside 
- - - - - - - - - - - - - - - 
D-galactose - - - - - - - - - - - - - - - 
L-sorbose - - - - - - - - - - - - - - - 
L-rhamnose - - - - - - - - - - - - - - - 
Dulcitol - - - - - - - - - - - - - - - 
D-mannitol - - - - - - - - ++ - - - - - - 
Methyl-αD-
mannopyranoside 
- - - - - - - - - - - - - - - 
Methyl-αD-
glucopyranoside 
- - - - - - - - - - - - - - - 
Amygdalin - - - - - - - - - - - - - - - 
Arbutin - - - - - - - - - - - - - - - 
Esculin ferric 
citrate 
- - - - - - - - - - - - - - - 
Salicin - - - - - - - - - - - - - - - 
D-cellobiose - - - - - - - - - - - - - - - 
D-lactose (bovine 
origin) 
- - - - - - - - - - - - - - - 
D-melibiose - - - - - - - - - - - - - - - 
Inullin - - - - - - - - - - - - - - - 
D-raffinose - - - - - - - - - - - - - - - 
Gentiobiose - - - - - - - - - - - - - - - 
D-lyxose - - - - - - - - - - - - - - - 
D-tagatose - - - - - - - - - - - - - - - 
D-fucose - - - - - - - - - - - - - - - 
L-fucose - - - - - - - - - - - - - - - 
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D-arabitol - - - - - - - - - - - - - - - 
L-arabitol - - - - - - - - - - - - - - - 
Potassium 
gluconate 
- - - - - - - - - - - - - - - 
Potassium 2-
ketogluconate 
- - - - - - - - - - - - - - - 
Potassium 5-
ketogluconate 
- - - - - - - - - - - - - - - 
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Glycerol ++ ++ + + + + + + - + + - + ++ + 
D-ribose ++ ++ ++ ++ ++ + + ++ ++ ++ ++ ++ ++ ++ ++ 
D-glucose ++ ++ ++ ++ ++ + ++ ++ ++ ++ ++ ++ ++ ++ ++ 
D-fructose ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
D-mannose ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ 
D-sorbitol ++ ++ ++ ++ ++ + + ++ ++ + ++ ++ ++ ++ ++ 
N-
acetylglucosamine 
++ ++ + ++ ++ + + ++ ++ + ++ ++ ++ + ++ 
D-maltose - ++ ++ + ++ + + ++ ++ ++ ++ ++ ++ ++ ++ 
D-saccharose ++ ++ ++ ++ + - ++ ++ ++ + ++ ++ ++ ++ ++ 
D-Trehalose ++ ++ ++ ++ + + + ++ ++ ++ ++ ++ ++ ++ ++ 
D-Turanose ++ ++ ++ ++ + + + ++ ++ ++ ++ ++ ++ ++ ++ 
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Inositol + - ++ + - + + - ++ + ++ ++ ++ + - 
D-melezitose - - - - - - + ++ - ++ ++ ++ - - - 
Amidon (starch) ++ ++ ++ ++ + + - - - - - ++ ++ + ++ 
Glycogen ++ ++ ++ ++ ++ + - - - - - - ++ ++ ++ 
Xylitol - ++ ++ ++ - - - - - + - - - - - 
D-adonitol - + - ++ - - - - + + + + ++ + + 
Table 4.2 Carbohydrate utilization by strains of non-proteolytic C. botulinum type B, E, F (as indicated by fall in pH), the results of 
the initial experiment 
- no pH drop observed 
+ weak fermentation (pH reduction of 0.5 – 1.0 unit) 
++ strong fermentation (pH reduction of > 1.0 unit) 
* results present the average of two independent growth tests 
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Figure 4.6 The heatmap of pH measurement results obtained from the 
incubation of non-proteolytic C. botulinum strains in the presence of different 
carbohydrates (initial experiment) 
Different strain number colour corresponds to toxin type: type B strains (blue colour), 
type E strains (red colour), type F strains (yellow colour). Tested carbohydrates were 
classified into two clusters: cluster 1 (n = 35) and cluster 2 (n = 14) and strains into three 
clusters: cluster 1 (n = 6), cluster 2 (n = 3), and cluster 3 (n = 6) 
 
Graphical visualisation of the measured pH is illustrated using a heatmap. 
Unsupervised hierarchical clustering, as shown in Figure 4.6, segregated the 49 
carbohydrates into two distinguishable clusters. The first cluster includes 
carbohydrates for which (apart from a few exceptions) the pH value did not 
change substantially in relation to the control when inoculated with non-
proteolytic C. botulinum strains. The second cluster consists of carbohydrates for 
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which the pH drops at least 0.5 units below the control (except for a few 
carbohydrates). Carbohydrates that were variably utilised by different strains 
were present in both clusters. Interestingly those carbohydrates presenting 
different fermentation properties, correlated with the strain toxin type. For 
example, xylitol appears to be utilised by some type B strains (but not by type E 
and F) and D-melezitose is utilised by type E strains (but not by B and F strains). 
Inositol, amidon and glycogen show a similar response. 
 
Most interestingly, the classification of strains in relation to the ability to utilize 
different carbohydrates distinguishes strains that form type E toxin from those 
that form B and F toxin (Figure 4.6). 
 
4.3.2 Main experiment 
In the main experiment, the ability of thirty strains of non-proteolytic C. botulinum 
to utilise a smaller number of carbohydrates was tested. This was based on pH 
measurement, gas formation and also by toxin production. Additionally, to 
investigate the influence of carbohydrate on the behaviour of two strains             
a fermenter system was used. 
 
4.3.2.1 Carbohydrate utilization 
Selected carbohydrates (inositol, D-melezitose, glycogen, xylitol and two 
components of starch (amylopectin and amylose)), which in the initial experiment 
appeared to be fermented only by certain strains of non-proteolytic C. botulinum, 
were tested in the main experiment with greater number of strains. Additionally 
three new carbohydrates (levan, pullulan and chitosan) were also tested, as 
according to a genomic study of Stringer et al. (2013) may be fermented by 
some, but not all, strains. 
 
Results from the main experiment supported observations made in the initial 
experiment regarding the phenotypic diversity of non-proteolytic C. botulinum 
strains (Table 4.3). 
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Toxin type 
Carb. Control  Inositol D-Melezitose Amylopectin Amylose Glycogen Xylitol Levan Pullulan Chitosan 
Strain pH Gas  pH Gas  pH Gas  pH Gas  pH Gas  pH Gas  pH Gas  pH Gas  pH Gas  pH Gas  
T
y
p
e
 B
 
Control  6.58 - 6.57 - 6.60 - 6.61 - 6.65 - 6.53 - 6.59 - 7.48 - 6.59 - 7.07 - 
81-23 5.99 + 5.57 + 5.87 +/++ 5.06 +/++ 5.12 +/++ 5.04 +/++ 5.90 + 6.75 + 5.64 + 6.63 + 
81-30 5.85 + 5.85 + 5.69 + 4.74 +/++ 5.02 +/++ 4.76 +/++ 5.03 +/++ 6.78 + 5.88 + 6.67 + 
83-01 5.95 + 5.44 + 5.43 +/++ 4.81 + 4.98 +/++ 4.87 ++ 5.00 ++ 6.72 + 5.42 +/++ 6.55 + 
86-17 6.14 + 5.84 + 5.91 + 4.79 +/++ 4.88 ++ 4.79 ++ 4.99 ++ 6.74 + 5.56 + 6.10 + 
87-02 6.10 + 5.68 + 5.94 + 5.05 + 5.25 ++ 5.03 + 5.93 + 6.86 + 5.98 + 6.66 + 
87-04 5.97 + 5.51 + 5.88 +/++ 5.22 +/++ 5.27 ++ 5.17 ++ 5.87 + 6.77 + 5.95 + 6.55 -/+ 
90-04 5.96 + 5.11 +/++ 5.93 +/++ 5.30 ++ 5.50 + 5.40 ++ 5.97 + 6.84 + 6.00 + 6.95 + 
93-06 6.08 + 5.54 + 5.95 +/++ 5.44 -/++ 5.36 + 5.46 ++ 6.00 + 6.81 + 6.01 + 6.69 + 
93-10 5.86 + 5.54 + 5.72 + 5.84 + 5.87 + 5.83 +/++ 5.78 + 6.30 + 5.88 + 6.68 + 
93-11 6.13 + 5.59 ++ 5.93 ++ 6.02 + 6.10 + 6.05 + 5.99 + 6.82 + 5.90 + 6.53 + 
02-51 5.90 + 5.53 +/++ 5.79 + 5.17 ++ 5.26 ++ 5.20 ++ 5.77 + 6.35 + 5.87 + 6.70 -/+ 
05-20 6.00 + 5.95 + 5.86 + 4.69 +/++ 4.86 ++ 4.80 ++ 5.02 ++ 6.88 + 6.01 + 6.77 + 
05-25 5.86 + 5.75 +/++ 5.78 +/++ 5.25 +/++ 5.43 + 5.15 +/++ 5.84 + 6.69 + 5.85 + 6.82 + 
05-29 5.87 + 5.60 + 5.74 + 5.28 +/++ 5.47 +/++ 5.29 ++ 5.81 + 6.74 + 5.83 + 6.84 + 
T
y
p
e
 E
 
81-26 6.12 + 5.03 +/++ 4.83 +/++ 6.08 + 6.11 + 6.13 + 6.05 + 6.87 + 6.09 + 6.66 + 
81-27 5.99 + 4.73 +/++ 4.81 +/++ 6.01 + 6.05 -/+ 6.03 + 6.00 + 6.89 + 6.10 + 6.64 -/+ 
81-31 5.88 + 4.97 ++ 4.75 +/++ 5.83 + 5.88 + 5.82 + 5.76 + 6.72 + 5.85 + 6.52 -/+ 
86-21 6.07 + 4.94 ++ 4.67 ++ 6.06 -/+ 6.11 + 6.07 + 6.25 + 6.83 + 6.08 + 6.70 + 
87-01 5.95 + 5.46 +/++ 4.80 ++ 5.90 + 5.92 + 5.88 + 5.80 + 6.68 + 5.91 + 6.56 + 
93-07 6.24 + 4.71 ++ 4.94 ++ 6.16 + 6.25 + 6.20 + 4.96 ++ 6.85 + 6.20 + 6.66 + 
93-08 5.99 + 4.71 ++ 4.74 ++ 5.97 + 6.00 + 5.98 + 5.90 + 6.84 + 6.01 + 6.60 + 
02-07 6.16 + 4.74 +/++ 4.80 ++ 6.16 + 6.17 + 6.09 + 6.05 + 6.81 + 6.16 + 6.68 + 
02-10 5.99 + 4.76 ++ 4.83 ++ 6.00 + 6.03 + 5.97 + 4.84 ++ 6.77 + 5.99 + 6.55 + 
02-15 6.10 + 5.07 + 4.84 ++ 6.05 +/++ 6.04 + 6.02 + 5.97 + 6.76 +/++ 6.00 + 6.58 + 
02-22 5.92 + 4.97 ++ 4.63 ++ 5.87 + 5.92 + 5.89 + 5.80 + 6.75 + 5.92 + 6.62 + 
02-43 6.07 + 4.89 +/++ 4.70 ++ 6.05 + 6.14 + 6.13 + 6.09 + 6.82 + 6.14 + 6.64 + 
T
y
p
e
 F
 86-32 5.92 + 5.24 + 5.79 + 4.93 ++ 5.15 ++ 4.90 ++ 5.83 + 6.81 + 5.91 + 6.60 + 
86-33 5.97 + 5.43 + 5.80 +/++ 5.14 ++ 5.14 +/++ 5.10 ++ 5.80 + 6.77 + 5.85 + 6.56 -/+ 
86-34 6.01 + 5.44 + 5.89 + 5.00 ++ 4.99 ++ 5.04 ++ 5.86 + 6.71 + 6.03 + 6.63 + 
06-05 5.99 + 5.70 + 5.86 + 4.98 ++ 5.11 ++ 4.97 ++ 5.83 + 6.75 + 5.98 + 6.62 + 
Table 4.3 Carbohydrate utilization by strains of non-proteolytic C. botulinum type B, E, F (as indicated by a fall in pH) (results of the 
main experiment) 
The data (pH/gas) for each carbohydrate are expressed as the average of duplicate bottles at the end of the incubation period; weak fermentation: pH drop 
between 0.5 – 1.0 units (light brown shaded boxes), strong fermentation: pH drop > 1.0 unit (dark brown shaded boxes), - no gas production, + minimal gas 
production (tube 20 – 50% full), ++ high gas production (tube 50 – 80% full), -/+ one sample negative, one sample with minimal gas production, +/++ one 
sample with minimal gas production, one sample with moderate gas production 
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The pH profiles of the tested strains (Table 4.3) were compared in a dendrogram 
generated by hierarchical cluster analysis (Figure 4.7). The strains were divided 
into three groups (cluster 1, 2, and 3) which contained 12, 4 and 14 strains, 
respectively. Striking differences in the ability to utilize carbohydrates by strains 
were observed between the three clusters. 
 
 
Figure 4.7 The heatmap of pH measurement results obtained from the 
incubation of non-proteolytic C. botulinum strains in the presence of different 
carbohydrates (main experiment) 
Different strain number colour corresponds to toxin type: type B strains (blue colour), 
type E strains (red colour), type F strains (yellow colour). Tested strains were classified 
into three clusters: cluster 1 (n = 12), cluster 2 (n = 4), and cluster 3 (n = 14) 
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Cluster 1 is composed of strains which show an ability to utilize amylopectin, 
amylose and glycogen. Only a few strains produced acid from inositol and the pH 
was reduced only by 0.5 units. Cluster 2 consists of strains which produce 
substantial quantities of acid from amylopectin, amylose, glycogen and xylitol. 
Exceptionally strain 83-01 appears to produce small amounts of acid from 
inositol, D-melezitose and pullulan. Cluster 3 includes strains which utilize 
inositol and D-melezitose (except strains 93-10 and 93-11). These strains do not 
produce acid from amylopectin, amylose, glycogen, levan, pullulan, chitosan and 
from xylitol (except strains 93-07 and 02-10). There were two sub-clusters in 
cluster 3. The first sub-cluster comprised all type E strains, and the second sub-
cluster contained two type E strains (93-07 and 02-10) and two type B strains 
(93-10 and 93-11). These four strains were divergent from other type B and type 
E strains (Figure 4.7). 
 
The characteristics of each cluster in terms of the pH measurement obtained 
from the incubation of strains in the presence of nine carbohydrates are shown in 
Table 4.4. In general cluster membership was associated with the type of toxin 
produced. Cluster 3 is composed of type E strains (except strains 93-10 and 93-
11, which are of type B), cluster 2 of type B strains, and cluster 1 of type B and F 
strains (Figure 4.7). In most of the cases a pH drop was associated with gas 
production with the largest quantity of gas produced in the presence of inositol 
and D-melezitose (type E strains), amylopectin, amylose and glycogen (type B 
and F strains) (Table 4.3). 
 
A MANOVA analysis indicated significant differences between the clusters (F-
statistic = 19.3, p = 0.01), based on Wilk’s Lambda. The differences between 
clusters were observed in the mean pH in the presence of D-melezitose, 
amylopectin, amylose, glycogen, xylitol and pullulan and these carbohydrates 
appear to have the greatest impact when assigning strains into clusters.  
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Carbohydrate 
Cluster 1 
(n = 12) 
Cluster 2 
(n = 4) 
Cluster 3 
(n = 14) 
Significant 
differences 
between clusters 
(p < 0.05) 
Control  5.97 ± (0.07)* 5.99 ± (0.12) 6.03 ± (0.11) NS 
Inositol 5.51 ± (0.19) 5.77 ± (0.22) 5.01 ± (0.31) 1 > 3, 2 > 3, 2 > 1 
D-Melezitose 5.85 ± (0.07) 5.72 ± (0.22) 4.93 ± (0.39) 1 > 3, 2 > 3 
Amylopectin 5.15 ± (0.15) 4.76 ± (0.06) 6.00 ± (0.11) 3 > 2, 3 > 1, 3 > 2 
Amylose 5.25 ± (0.16) 4.94 ± (0.08) 6.04 ± (0.11) 3 > 2, 3 > 1, 1 > 2 
Glycogen 5.14 ± (0.17) 4.81 ± (0.05) 6.00 ± (0.12) 3 > 2, 3 > 1, 1 > 2 
Xylitol 5.87 ± (0.07) 5.01 ± (0.02) 5.80 ± (0.41) 3 > 2, 1 > 2 
Levan 6.74 ± (0.13) 6.78 ± (0.07) 6.76 ± (0.15) NS 
Pullulan 5.91 ± (0.11) 5.72 ± (0.27) 6.02 ± (0.11) 3 > 2, 3 > 1, 3 > 2 
Chitosan 6.69 ± (0.12) 6.52 ± (0.30) 6.62 ± (0.06) NS 
Table 4.4 Comparisons of pH measurement obtained from three clusters of non-
proteolytic C. botulinum strains in the presence of nine carbohydrates (main 
experiment) 
* data are given as mean pH ± standard deviation, NS indicates lack of significant 
difference between variables among clusters. Weak fermentation: pH drop between 0.5 
– 1.0 units (light brown shaded boxes), strong fermentation: pH drop > 1.0 unit (dark 
brown shaded boxes) 
 
To visualize the differences in the pH profiles among the three clusters, they 
were analysed by PCA and represented as points with three colours on a PCA 
biplot diagram of the first two principal components (PC1 and PC2). These two 
components explain 74.4% of the total variance. 
 
Cluster 3 is localized on the left, cluster 1 on the right, and cluster 2 in upper and 
lower-right areas of the diagram. Of the nine carbohydrates, amylopectin, 
amylose and glycogen had large loadings in the direction in which clusters 2 and 
1 were positioned (Figure 4.8). Cluster 3 was localized in the negative direction, 
corresponding with large negative loadings for D-melezitose and inositol (Table 
4.5). The other four carbohydrates (levan, chitosan, xylitol, pullulan) had a much 
less effect on strain clustering, as indicated by arrow’s length (Figure 4.8). 
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Figure 4.8 Principal component analysis (PCA) biplot diagram showing the 
relationship between variables (each carbohydrate; arrows) and 30 strains of 
non-proteolytic C. botulinum classified into three clusters by hierarchical cluster 
analysis 
Different points colours correspond to cluster member: cluster 3 – red (type E strains), 
cluster 2 – blue (type B strains), cluster 1 – yellow (type B and F strains) 
 
Carbohydrate 
Loading of PC % of contribution of variable 
to each PC 
PC 1 PC 2 
PC 1 PC 2 
Inositol -0.34 -0.20 15.0  
D-Melezitose -0.40 -0.21 15.4  
Amylopectin 0.45  17.6  
Amylose 0.45  17.4  
Glycogen 0.45  17.6  
Xylitol 0.15 -0.43  18.6 
Levan  -0.35  14.9 
Pullulan 0.24 -0.47  20.2 
Chitosan  -0.62  26.8 
Table 4.5 Comparison of loadings and contribution of variables to first two 
components in PCA in each cluster of non-proteolytic C. botulinum strains 
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4.3.2.2 Neurotoxin formation by strains of non-proteolytic C. botulinum in 
the presence of tested carbohydrates 
In order to confirm observations of growth, neurotoxin formation was measured 
using an ELISA for the type B strains. The effect of nine carbohydrates on the 
toxicity of non-proteolytic C. botulinum cultures is shown in Table 4.6. 
Unexpectedly, the ability of strains to form acid from the carbohydrates is not 
consistent with the production of toxin (Table 4.6). Strains fermenting a specific 
carbohydrate (e.g. amylopectin, glycogen) did not seem to produce more toxin in 
comparison to growth in basal CMB medium. From these tests, it would appear 
as if growth and neurotoxin formation had been uncoupled. Furthermore, 
carbohydrates that had led to more growth, as measured by a greater fall in pH, 
had not led to more toxin being formed. The tests are useful, however, in 
identifying high and low toxin forming strains. The amount of toxin produced 
ranged from 0.0 – 33.1 ngml-1 depending on tested strain and carbohydrate. The 
weakest toxin producers appeared to be strains 81-23 and 87-04. These two 
strains did not produce a significant amount of toxin in the presence of any 
carbohydrate. The greatest quantity of toxin was produced by strains 87-02 and 
93-06 with amylose being the most favourable carbohydrate for toxin production. 
 
Due to the discrepancy between the measurement of pH and neurotoxin 
formation it was decided not to measure neurotoxin formation by type E and F 
strains. Instead further tests were undertaken to investigate the relationship 
between growth and neurotoxin formation by two type B strains (86-17 and 93-
06) using a fermenter system. 
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Strain 
Carbohydrate 
Control Inositol D-Melezitose Amylopectin Amylose Glycogen Xylitol Levan Pullulan Chitosan 
pH toxin* pH toxin pH toxin pH toxin pH toxin pH toxin pH toxin pH toxin pH toxin pH toxin 
Control 6.58 0.0 6.57 0.0 6.60 0.0 6.61 0.0 6.65 0.0 6.53 0.0 6.59 0.0 7.48 0.0 6.59 nt 7.07 0.0 
81-23 5.99 0.5 5.57 0.5 5.87 0.4 5.06 0.0 5.12 0.0 5.04 0.0 5.90 0.0 6.75 0.0 5.64 0.1 6.63 0.0 
81-30 5.85 1.3 5.85 1.2 5.69 1.6 4.74 0.6 5.02 0.4 4.76 13.4 5.03 3.5 6.78 1.6 5.88 0.3 6.67 0.0 
83-01 5.95 4.8 5.44 5.5 5.43 2.2 4.81 7.1 4.98 6.6 4.87 12.0 5.00 10.6 6.72 1.2 5.42 4.1 6.55 0.4 
86-17 6.14 8.0 5.84 11.6 5.91 5.3 4.79 1.4 4.88 10.8 4.79 13.9 4.99 2.0 6.74 7.4 5.56 5.7 6.10 8.7 
87-02 6.10 9.8 5.68 13.9 5.94 11.3 5.05 6.1 5.25 22.5 5.03 9.1 5.93 12.2 6.86 8.0 5.98 9.7 6.66 10.0 
87-04 5.97 0.0 5.51 0.4 5.88 nt 5.22 0.0 5.27 0.0 5.17 0.0 5.87 0.0 6.77 0.0 5.95 0.3 6.55 3.3 
90-04 5.96 8.8 5.11 4.1 5.93 7.4 5.30 6.5 5.50 20.3 5.40 6.6 5.97 8.2 6.84 nt 6.00 6.2 6.95 9.4 
93-06 6.08 13.3 5.54 5.6 5.95 5.6 5.44 17.5 5.36 33.1 5.46 17.2 6.00 12.4 6.81 nt 6.01 nt 6.69 nt 
93-10 5.86 5.8 5.54 1.9 5.72 nt 5.84 3.5 5.87 4.1 5.83 13.5 5.78 2.1 6.30 nt 5.88 nt 6.68 nt 
93-11 6.13 9.3 5.59 2.8 5.93 nt 6.02 3.1 6.10 2.9 6.05 5.5 5.99 5.2 6.82 nt 5.90 nt 6.53 nt 
02-51 5.90 3.3 5.53 1.0 5.79 nt 5.17 6.3 5.26 14.6 5.20 5.9 5.77 3.1 6.35 nt 5.87 nt 6.70 nt 
05-20 6.00 1.2 5.95 1.1 5.86 2.8 4.69 0.8 4.86 2.2 4.80 12.5 5.02 2.5 6.88 1.9 6.01 2.2 6.77 7.8 
05-25 5.86 6.8 5.75 4.2 5.78 nt 5.25 2.9 5.43 5.9 5.15 7.6 5.84 9.5 6.69 nt 5.85 nt 6.82 nt 
05-29 5.87 7.9 5.60 3.7 5.74 nt 5.28 4.1 5.47 10.2 5.29 3.5 5.81 9.4 6.74 nt 5.83 nt 6.84 nt 
Table 4.6 Type B neurotoxin formation by non-proteolytic C. botulinum strains in the presence of tested carbohydrates (results of 
main experiment) 
* expressed as ngml-1, nt – not tested 
The data (pH/toxin) for each carbohydrate are expressed as the average of duplicate tubes; weak fermentation: pH drop between 0.5 – 1.0 
units (light brown shaded boxes), strong fermentation: pH drop > 1.0 unit (dark brown shaded boxes) 
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4.3.2.3 Growth and neurotoxin formation by strains of non-proteolytic      
C. botulinum within a fermenter system 
Growth and formation of neurotoxin was determined in the presence and 
absence of glucose (for strain 86-17), and only in the presence of glucose (for 
strain 93-06). 
 
The addition of carbohydrate to CMB appears to have a substantial effect on 
growth and toxin production by non-proteolytic C. botulinum strains (Figure 4.9 
and Figure 4.10). Strain 86-17 appeared to growth better in CMB with added 
glucose, as indicated by the OD measurement. 
 
 
Figure 4.9 Growth, changes in pH and toxin production by non-proteolytic         
C. botulinum strain 86-17 in CMB and CMB containing glucose 
pH of CMB without carbohydrate (black solid line), pH of CMB containing glucose (black 
dashed line), OD of CMB without carbohydrate (orange solid line), OD of CMB 
containing glucose (orange dashed line), toxin produced (ngml-1) in CMB without 
carbohydrate (red solid line), toxin produced (ngml-1) in CMB containing glucose (red 
dashed line) 
 
For strain 86-17 in control medium (without glucose), stationary phase was 
reached when the OD600 was ~0.4 after five hours of incubation. A greater OD600, 
~1.0 was noted in the presence of glucose after seven hours of incubation, and 
in both cases it was constant during the remaining incubation time. Whereas in 
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the case of strain 93-06, growth in the presence of glucose the OD600 reached 
~0.8 after ~10 hours, but the OD600 then fell to 0.1 (growth was not observed in 
the CMB in the absence of glucose due to sample lost). 
 
Both strains lowered the pH of CMB containing glucose from 6.95 to 4.69 (strain 
86-17) and 5.05 (strain 93-06). In contrast the pH of control did not fall below 
6.00 for strain 86-17 (Figure 4.9 and Figure 4.10). 
 
 
Figure 4.10 Growth, changes in pH and toxin production by non-proteolytic       
C. botulinum strain 93-06 in CMB containing glucose 
[test also done in absence of glucose but the test failed – results not shown] 
pH of CMB containing glucose (black dashed line), OD of CMB containing glucose 
(orange dashed line), toxin produced (ngml-1) in CMB containing glucose (red dashed 
line) 
 
Interestingly, addition of glucose to CMB also affected toxin production. In the 
control medium the maximum concentration produced by strain 86-17 was 1.19 
ngml-1 and the final concentration was ~1 ngml-1 throughout stationary phase. 
The presence of carbohydrate in medium appears to not only stop the production 
of toxin but was also associated with its degradation. For example the maximal 
concentration of toxin produced by strain 86-17 was 2.39 ngml-1, and was 
reduced to 0 ngml-1, whereas for strain 93-06 the maximal was 9.58 ngml-1 and 
dropped to 0.5 ngml-1.  
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In conclusion, in the presence of glucose strains 86-17 appeared to degrade 
toxin that it have formed, and therefore growth and toxin formation had become 
uncoupled. Although, for strain 93-06 growth was not measured in CMB without 
glucose, it is suspect to show a similar behaviour to strain 86-17. Thus, in the 
carbohydrate fermentation tests, a drop in pH and visual observation of gas 
formation, rather than toxin formation, was taken as evidence of ability to ferment 
the test carbohydrate. Further studies could be dedicated to investigating this 
observation in detail. It may be an unusual feature of this medium since toxin 
survives in PYGS medium (M. W. Peck, personal communication), meat slurry 
(Peck et al., 1995) and many different foods to cause foodborne botulism.  
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4.4 Discussion 
The ability of microorganisms to ferment carbohydrates have been widely used 
for their identification and classification for decades. Previous studies (e.g. 
Eklund et al., 1967a; Holdeman and Brooks, 1970), described the use of 
carbohydrate utilisation patterns to differentiate between proteolytic (Group I)    
C. botulinum and non-proteolytic (Group II) C. botulinum. Nevertheless, this 
property has not been used so far to distinguish strains within these Groups.  
 
The work presented in this chapter, conducted on 33 strains (14 type B, 14 type 
E and 5 type F strains) and 54 different carbohydrates, was used to describe the 
variability of non-proteolytic C. botulinum strains. The results of this analysis 
indicate that the tested strains can be classified according to carbohydrate 
utilisation. 
 
In general terms, the carbohydrates can be separated into a) those that are 
utilised by most/all tested strains, b) those that are not utilised by most/all tested 
strains, and c) those carbohydrates (e.g. xylitol, D-melezitose, inositol, starch, 
amylopectin, amylose, glycogen) for which the fermentation pattern varied 
between strains, with the pattern of utilisation associated with toxin type.  
 
Biochemical properties such as the fermentation of monosaccharides, 
polysaccharides and carbohydrate derivatives by non-proteolytic C. botulinum 
have been summarised previously (Hobbs et al., 1965; Moore et al., 1966; 
Eklund et al., 1967a; Holdeman and Brooks, 1970; Holdeman et al., 1977; Holt 
and Sneath, 1985). The results (Table 4.7) generated in this study (as indicated 
by pH measurement and gas production) are in general agreement with previous 
published data. 
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Fermentation of carbohydrate 
Carbohydrate 
Toxin type 
B B B E E E E F F F F B, E, F B, E, F 
Glucose + + + + + + + + + + + + † 
Maltose V + + + + + + + + + + + + 
Sucrose + + + + + + + + + + + + + 
Fructose + † + + + † + + + † + + + 
Sorbitol + † + V V † + + + † + V V 
Glycerol – – V V – + V + – V + V † 
Lactose – – – – – – – – – – – – – 
Mannose + † + V + † + † + † + + + 
Mannitol – – – – – – – – – – + V – 
Starch V † + – V † – † + † – V V 
Xylose – † – – – † – † – † – – – 
Rhamnose – † – – – † – † – † – – – 
Raffinose – † – – – † – – – † – – – 
Arabinose – † – – – † – † – † – V – 
Cellulose † † † – † † † † † † † † † 
Glycogen + † + – – † – † – † + V V 
Salicin – – – – – – – – – – – – – 
Dulcitol – † – – – † – † – † – – † 
Inulin – † – – – † – † – † – – V 
Galactose V † – † – † – + – † – – V 
Dextrin V † † † – † † + V † † † † 
Trehalose + † + † V † + + + † + + + 
Melibiose – † – † – † – – – † – V – 
Inositol – † V † – † V – + † + V V 
Ribose V † + † + † + + + † + + V 
Amygdalin – † – † – † – † V † – V V 
Cellobiose – † – † – † – † – † – – – 
Esculin V † – † – † – † V † – – – 
D-Melezitose – † – † + † + † – † – V V 
Pectin V † † † V † † † V † † † † 
Adonitol – † V † – † – † V † + V † 
Erythritol – † – † – † – † – † – – † 
Sorbose – † – † – † – † – † – – † 
N-acetylglucosamine † † + † † † + † † † + † † 
D-turanose † † + † † † + † † † + † † 
Xylitol † † V † † † – † † † – † † 
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Table 4.7 Comparison of carbohydrate utilization by strains of non-proteolytic   
C. botulinum type B, E and F with previously published studies and results 
presented in this thesis 
+ positive for all strains; – negative for all strains; V – variable or weak response; † – not 
tested 
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The current study also found that in some circumstances non-proteolytic           
C. botulinum strains lowered the pH of the growth medium below the generally 
accepted minimum growth pH for this bacterium (pH = 5.0; Lund and Peck, 
2000). The lowest recorded pH was 4.81. This observation raises the question 
as to whether non-proteolytic C. botlinum can growth at pH 4.81 – 5.0, or 
whether the low pH might be associated with release of acids on cell lysis or 
another feature of experimental system. A number of published reports (for 
example; Segner et al., 1966; Baird-Parker and Freame, 1967; Graham et al., 
1996; Graham et al., 1997), considered that non-proteolytic C. botulinum strains 
do not grow and produce toxin in foods at pH = 5.0 or below. Some authors have 
previously speculated that the ability of bacteria to grow at low pH could be 
associated with a high concentration of proteins in the studied medium, the 
presence of moulds or bacilli that increase the pH, media acidified with citric or 
acetic acid and the acid moving into the oil phase, high inoculum concentration, 
or incubation temperature (Segner et al., 1966; Baird-Parker and Freame, 1967; 
Smelt et al., 1982; McClure et al., 1994). The observed findings of possible 
growth of non-proteolytic C. botulinum at 4.81 – 5.0, has not been reported 
elsewhere and may reflect that tests at this pH range have not been widely done.  
 
The main experiment with nine carbohydrates provided evidence that the 
additional growth (as indicated by pH drop/gas formation) associated with the 
addition of a carbohydrate was not always associated with increased toxin 
formation by type B strains. Further tests with a fermenter system demonstrated 
that although a larger concentration of toxin was initially formed in the presence 
of glucose, this subsequently disappeared from the culture medium, and may 
have been degraded by the bacterium. Although some inconsistencies in growth 
and toxin production by non-proteolytic C. botulinum have been occasionally 
previously reported (Graham et al., 1997), the observed results in the present 
work were unexpected. The observations made in this study have not been 
previously described in relation to non-proteolytic C. botulinum, and may be        
a novel finding for toxin forming microorganisms.  
 
One possible explanation for toxin degradation is that this protein is being used 
by non-proteolytic C. botulinum as a source of essential nutrients possibly 
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nitrogen and/or carbon. Since this has not been reported previously, it may be 
that the medium is nitrogen-limited, and is an unusual situation for non-
proteolytic C. botulinum to find itself. Alternatively since growth in the presence 
of glucose lowers the pH, toxin degradation could be a consequence of 
acidification of the medium. Although, if this is the explanation it is surprising that 
it had not been reported previously. When Siegel and Metzger (1980) studied the 
effect of various fermentation conditions on the appearance and quantity of toxin 
production by proteolytic C. botulinum in a fermenter system (with different 
medium composition), they did not report any disappearance of toxin. With 
glucose concentrations of 1.5, 1.0, 0.5, and 0.25%, the authors observed a better 
growth of C. botulinum, with the greatest amount of toxin produced in the 
presence of 1.5 and 0.5% of glucose. Potentially, this finding has a massive 
implication, but further investigation of factors influencing toxin degradation by 
non-proteolytic C. botulinum is an area for future research. 
 
The clustering analysis based on pH measurement of 30 strains (main 
experiment) divides the non-proteolytic C. botulinum strains into three groups 
with specific, significantly different substrate utilization profiles (p < 0.05) (Table 
4.8). The first group consisted of strains 86-32, 86-34, 87-02, 06-05, 81-23, 87-
04, 86-33, 90-04, 93-06, 02-51, 05-25, and 05-29. These strains utilise 
amylopectin, amylose and glycogen. The second group consisted of strains 81-
30, 05-20, 83-01, and 86-17, utilising amylopectin, amylose, glycogen and xylitol. 
The third was composed of strains 81-27, 93-08, 81-26, 02-15, 02-07, 86-21, 02-
43, 87-01, 81-31, 02-22, 93-07, 02-10, 93-10, and 93-11. Those strains produced 
acid from inositol and D-melezitose. There was a relationship between the 
classification and toxin produced by strains assigned to each cluster. The 
majority of strains in cluster 3 are of type E toxin type strains, in cluster 2 of type 
B strains, whereas cluster 1 of type B and F strains. This clustering pattern aligns 
with genomic content (Stringer et al., 2013).  
 
Only one previous publication appears to have applied cluster analysis to 
carbohydrate utilization profiles of an organism (Draganova et al., 2011). The 
analysis was conducted on fungal isolates, which divided Beauveria bassiana 
into two groupings that were associated with the source of isolation. In the case 
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of non-proteolytic C. botulinum strains there was no correlation between strain 
cluster membership and geographic source of strain. 
 
Carbohydrate Cluster 1 Cluster 2 Cluster 3 
Inositol - - + 
D-Melezitose - - + 
Amylopectin + + - 
Amylose + + - 
Glycogen + + - 
Xylitol - + - 
Levan - - - 
Pullulan - - - 
Chitosan - - - 
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Table 4.8 Classification of non-proteolytic C. botulinum strains based on the 
ability to acid production in the presence of carbohydrates 
+ strains produce acid in the presence of given carbohydrate, - strains do not produce 
acid in the presence of given carbohydrate 
 
The carbohydrate utilization study was used to characterise phenotypic 
properties of non-proteolytic C. botulinum strains. The results demonstrate 
diversity between their metabolism, showing that non-proteolytic C. botulinum 
form three groups according to carbohydrates utilisation. Interestingly group 
membership is associated with type of toxin produced.  
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4.5 Conclusions 
In this chapter it was demonstrated, for the first time, that strains of non-
proteolytic C. botulinum can be separated into three groups according to their 
pattern of carbohydrate utilisation, and that the groups are associated with type 
of toxin produced. Such information is important for strain identification and also 
has a crucial importance in risk assessment for minimally heated chilled foods. 
 
From the results in this chapter the following conclusions can be drawn: 
i. A total 54 carbohydrates were tested. Most were either degraded by all 
strains or not degraded at all. A small number of carbohydrates were 
variably utilized by non-proteolytic C. botulinum strains 
ii. The ability to utilize carbohydrates led to strain classification into three 
groups: Cluster 1 (composed of type B and F strains), which utilize 
amylopectin, amylose and glycogen; Cluster 2 (composed of type B 
strains), which ferment amylopectin, amylose, glycogen and xylitol; 
Cluster 3 (mainly composed of type E strains), which produce substantial 
amount of acid from inositol and D-melezitose  
iii. The ability of a strain to utilize a given carbohydrate was indicated by a pH 
fall and gas formation, but the production of toxin could not be used to 
show which carbohydrates had been degraded as growth in a presence of 
carbohydrates was uncoupled from production of toxin 
iv. In the presence of glucose toxin formed by non-proteolytic C. botulinum 
86-17 strain was subsequently degraded 
The presented results not only show the clear relationship between strains and 
carbohydrate utilisation but also identify new research questions, including:  
 What mechanisms (i.e. enzymes, genes) determine the ability of a strain 
to utilize a certain carbohydrate? 
 What are the carbohydrate utilization pathways in non-proteolytic            
C. botulinum strains, and is there any variability? 
 What are the mechanisms responsible for toxin degradation in the 
presence of glucose and other carbohydrates?  
This information can lead to better control of hazard associated with non-
proteolytic C. botulinum in food. 
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5. Adding strain variability information to a QMRA model 
for non-proteolytic C. botulinum in minimally heated 
chilled food 
Although non-proteolytic C. botulinum is a pathogenic microorganism of public 
health importance and many risk assessments have previously been published, 
none of them takes into account strain variability and its impact on risk presented 
to minimally heated chilled foods. The common “default” assumption in food 
safety research follows “worst case scenario” which represents all strains of        
a given species that can possibly be found in food. Incorporating the information 
on strain variability in the form of probability distributions may lead to more 
precise analysis and greater flexibility. This chapter describes a modular process 
risk model for a relatively simple model dairy-based minimally heated chilled 
dessert and the hazards arising from non-proteolytic C. botulinum. The estimate 
of risk is based on data describing spore loads in raw materials, spore 
inactivation during thermal processing, distribution of spores in retail units and 
variability in growth of non-proteolytic C. botulinum strains during multi-stage 
storage prior to consumption. The model was used to estimate the probability of 
toxicity of an individual retail unit of dairy-based dessert at point of preparation. 
The probabilistic analysis was built using a Monte Carlo simulation technique. 
The strengths of the approach as well as data gaps and further research have 
been identified. 
 
5.1 Background 
The first step in risk analysis (see section 1.3) is risk assessment. Originally 
systematic risk assessment was first introduced in 1986 to evaluate human 
cancer risks (NRC, 2009), but the methodology has been refined for use in other 
fields e.g. microbial and chemical contamination of food (Fabiansson, 2001). In 
terms of food safety a “hazard” is defined by the CAC (2001) as an “agent or 
condition of food with the potential to cause an adverse health effect”, whereas  
a “risk” is defined as “a function of the probability of an adverse health effect and 
the severity of that effect, consequential to a hazard(s)”. Risk assessment is 
usually carried out by independent experts, and it commonly involves collecting, 
analysing and modelling of information (e.g. from the published literature, 
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challenge tests, assumptions or experts’ knowledge) related to a hazard. Risk 
assessment identifies the hazards and estimates the potential adverse health 
effects for consumers but also is a decision support tool for risk managers. The 
assessment of risk can be conducted qualitatively, semi-quantitatively, 
quantitatively or as     a combination of these. 
 
In qualitative risk assessment the likelihood of an adverse event is identified and 
ranked according to its effect on human health by semantic “scores” (e.g. “very 
low” – very rare but cannot be excluded, “high” – occurs very often). Although 
qualitative risk assessment is relatively quick and easy to conduct there is 
potential for ambiguity. A step forward is a semi-quantitative risk assessment, 
which assigns indicative values to the scales from qualitative risk assessment, 
and is generally conducted when limited data are available. A quantitative risk 
assessment is often more complex, requires a multidisciplinary team and also 
specific technical knowledge (e.g. statistics, biology, mathematics). 
 
5.1.1 Quantitative Microbial Risk Assessment (QMRA) 
QMRA assesses human health risks associated with exposure to hazards for 
pathogenic microorganisms or their toxins, and generally consists of four steps: 
hazard identification, exposure assessment, hazard characterisation and risk 
characterisation (Figure 5.1) (CAC, 1999). A QMRA based on scientific 
evaluation or evidence, estimates the severity and likelihood of illness or 
detriment resulting from exposure to a specific hazard in food. QMRA is a tool, 
which can be used to support a HACCP management system and can assist in 
facilitating international trade (by setting up a sound scientifically supported food 
safety policy) (Nauta et al., 2007). 
 
5.1.2 QMRA and the HACCP system 
The QMRA and HACCP system can be used together to control microbiological 
hazards in food, and a crucial step in their implementation is hazard 
identification. The HACCP system is a management tool which is used to 
achieve control of particular hazard but which does not provide additional 
quantitative information about the nature of this hazard under different conditions 
(e.g. temperature and time heating/storage, addition of preservatives) during 
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manufacturing. Therefore QMRA integrated with HACCP can be used as a tool: 
first of all, in setting up the HACCP scheme; secondly, in establishing the 
effective critical limits in a HACCP plan; third, in the identification of points, which 
require greater control and in the optimisation of production parameters. 
Moreover, QMRA models that use a probabilistic approach can estimate 
confidence associated with control and can allow for the inclusion of variability 
and uncertainty arising from properties of a microbial population and from 
imprecise measurements. Most importantly, sensitivity analysis can be included 
in a probabilistic risk assessment to identify the steps or production parameters 
that are of most importance for product safety and what additional measurement 
provides the most valuable information. 
 
5.1.3 Deterministic vs. probabilistic risk assessment 
Calculation of the risk associated with a hazard can be conducted in different 
ways. The most commonly used methods of risk assessment are deterministic 
and probabilistic approaches. The deterministic approach uses a single-point, 
e.g. minimal, maximal, modal or average values for each model parameter, to 
establish the “worst-case”, “best-case” or “most likely” scenarios based on an 
equal weight for all scenarios. Parameters are usually developed by linear 
regression or non-linear curve fitting procedures. The impact of the input 
parameters on the overall model output can be assessed by sensitivity analysis. 
The drawback of this approach is that the model can be over simplified by 
ignoring the variability and uncertainty associated with parameters (see section 
5.1.5).  
 
The second approach in quantitative risk assessment is a probabilistic approach. 
In a probabilistic risk assessment, each model variable is defined as a probability 
distribution rather than as a single value. A crucial advantage of this approach, in 
comparison with a deterministic risk assessment, is the consideration of 
variability and/or uncertainty (section 5.1.5) in risk estimates (Vose, 2008). These 
help in the identification of extreme events. In addition, probabilistic risk 
assessments provide estimates for the confidence limits associated with risks, 
which is an important factor in risk or policy decision making. In many ways 
probability is a consistent way to express and combine beliefs. 
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Figure 5.1 Organisation of risk assessment for hazard arising from foodborne pathogens (CAC, 1999) 
Hazard Characterisation
Information needed:
Frequency (and level) of 
contamination of foods by the 
pathogenic agent, pattern of 
consumption of food of concern, 
the method of product’s 
processing, packaging, storage 
and distribution, predictive 
modeling
Hazard Identification
• Identifies microorganisms 
or microbial toxins of 
concern and disease it 
causes (e.g. symptoms, 
severity)
• Identifies the associated 
food vehicle
Data from:
Scientific literature, food 
industry, government agencies
and international organizations 
databases, experts opinions
Exposure Assessment
• Describes the pathways (and 
the number) in which the 
pathogen reach consumers
• Estimates the number of 
people exposed
• Estimates the level and the 
likelihood of pathogen 
occurrence in food of 
concern at the time of 
consumption
• Provides qualitative or 
quantitative description of 
the effects associated with 
ingestion of pathogen in food
• Ideally it should based on 
the dose-response 
relationship: the relationship 
between number of 
microorganism received and 
resulting health effect
Information needed
In relation to microorganism: e.g. 
ability to replicate, interaction with 
host and environment, transfer of 
genetic material between 
microorganisms. In relation to host: 
e.g. individual host susceptibility, 
previous exposure history, 
persistence of microorganisms in 
the population
Risk Characterisation
• Integrate all three steps into 
a single mathematical model 
to calculate risk for a given 
population
• Include uncertainty 
associated with estimate of 
risk
Expressed as
the probability of infection, 
illness/death
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5.1.4 Monte Carlo simulation in QMRA 
The most common technique applied to construct probability distributions used in 
QMRA is a Monte Carlo simulation. The technique builds the QMRA model by 
generating (e.g. 1000 or 10000 times) a random sample for values of the model 
parameters; the sample is identified with a probability distribution of possible 
outcomes. Therefore it is possible to calculate not only what values a parameter 
can take, but how likely they will occur. An increased number of interations 
(number of samplings) can increase the precision of a calculated probability.      
A Monte Carlo simulation generates samples from the probability distribution and 
combines them according to the dependency of the variables. Other advantages 
of Monte Carlo simulation are: graphical representation of simulation’s outputs 
(an important factor when communicating the risk to risk managers and other 
interested bodies); the relatively simple mathematics and the number of 
commercially available softwares with user-friendly interfaces which makes it      
a widely recognised and used technique (Vose, 2008). The essential factor in     
a Monte Carlo simulation is that it combines probability distributions 
systematically and consistently to give a new distributions. 
 
Monte Carlo methods require random numbers to choose elements of the 
sample (without bias). There are many alternatives to generate random 
numbers, including: Latin Hypercube sampling (LHS), Mid-point LHS or 
importance sampling (Vose, 2008). 
 
5.1.5 Variability and uncertainty in QMRA 
Variability and uncertainty are two important properties of probabilistic variables 
that have an impact on a model (Hartnett et al., 2001) and can be included in     
a calculation of risk by using probability distributions. These two concepts are 
very different, and therefore should be clearly separated in risk assessment 
(when possible) (Nauta, 2000). In terms of QMRA, variability relates to the 
natural variation of a particular property within a (statistical) population (e.g. 
variability of heat resistance in a population of strains, variability in growth from 
single spore (Figure 5.2), variability in processing conditions and product 
composition and variable consumer behaviour (e.g. purchasing pattern)). The 
variability cannot be reduced through further measurements. 
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Figure 5.2 Variable growth of non-proteolytic C. botulinum Eklund 17B initiated 
from a single spore following a heat treatment of 1 min at 80°C (a 3D 
reduction)(observed for 338h) 
Source: Reprinted from “Lag time variability in individual spores of Clostridium 
botulinum” by Stringer et al. (2011) Food Microbiology, 28, p.229. Copyright 2013 by 
Elsevier B.V. Adapted with permission. 
 
Uncertainty arises from lack of sufficient data and an inability to be precise about 
the value of a given parameter. The important difference in dealing with 
variability and uncertainty, is that uncertainty can be reduced e.g. by additional 
tests, study or expert consultations. For example, the final comments in section 
2.3.2.2 were that the uncertainty associated with the D-value of non-proteolytic 
C. botulinum strains could be reduced by testing of at least 35 strains (in 
triplicate). 
 
5.1.6 Variability of non-proteolytic C. botulinum strains 
As introduced in the above sections, an important component of a well-defined 
risk assessment is the identification of variables that have an impact on the 
calculated probability of an adverse event e.g. probability of toxic pack at point of 
consumption. A more sophisticated approach in QMRA it to take account of the 
variability of model parameters, e.g. strain variability.  
 
Strain variability can be a function of several factors, e.g. growth conditions (e.g. 
pH, NaCl concentration, temperature), type of media used and presence of 
competing microorganisms, and generally it increases as the conditions become 
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less favourable (Derman et al., 2011; Lianou and Koutsoumanis, 2012). Although 
a variable response of strains to environmental conditions is frequently reported, 
many risk assessment models for foodborne pathogens omit this property by 
assuming their homogeneous behaviour, which may lead to miscalculation of the 
risk (Nauta, 2000). The failure to include strain variability in a microbial risk 
assessment often results from a lack of available data on strain variation, or 
resulting from time and work required in its acquisition.  
 
Different characteristics of strains of C. botulinum types A, B, E and F led to the 
separation of strains into two distinct groups (proteolytic C. botulinum and non-
proteolytic C. botulinum) decades ago (Lynt et al., 1982). Although the variability 
between strains of these two groups is very clear e.g. different spore heat 
resistance, different temperature growth range, different salt and pH tolerance 
(Table 1.1) and different foods implicated in foodborne botulism (Table 1.2), 
limited information is available regarding the variability of strains within these two 
groups. Considering the fact, that the distinction between strains of proteolytic  
C. botulinum and non-proteolytic C. botulinum has contributed substantially to 
control of the risk presented by C. botulinum, further investigation of the 
physiological and phylogenetic groupings of non-proteolytic C. botulinum strains 
can provide important information for a risk assessment, for pathogen control 
and also in the investigation of foodborne botulism outbreaks. 
 
The present study has quantified the variable physiological response, (heat 
resistance of spores, growth at chill temperatures and effect of carbohydrate 
source on growth) of almost fifty strains of non-proteolytic C. botulinum, and 
described significant variability between strains of different toxin types (Table 
5.1).  
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Toxin formed 
Characteristic Type B Type E Type F Source  
Geographical distributiona) North America, Europe, 
Australia 
Northern Canada, Alaska, 
Nordic countries 
North America Dodds (1993b) 
Genome size (bp) 3 781 509  
(strain Eklund 17B) 
3 659 644  
(strain Alaska E43) 
 Stringer et al. 
(2013) 
Ferment D-glucoseb) + + + Chapter 4 
Ferment D-fructose + + + 
Ferment D-maltose + + + 
Ferment D-saccharose + + + 
Ferment D-melezitose - + - 
Ferment starch + - + 
Ferment glycogen + - + 
Ferment xylitol V - - 
Ferment D-adonitol V V + 
Ferment amylopectin + - + 
Ferment amylose + - + 
Time to growth at chill 
temperatures (days)c) 
4.0°C > 90 67 > 90 Chapter 3 
5.0°C 32 21 42 
5.5°C 25 14 28 
6.0°C 14 11 18 
Maximum growth temperaturesd) 36.6 ± (1.9°C) 39.0 ± (0.8°C) 37.8 ± (0.6°C) Derman et al. 
(2011) 
Spore heat resistancee) (minutes) -LYS Dˈ(80) = 2.74 ± (4.56) Dˈ(80) = 2.41 ± (3.12) Dˈ(80) = 1.53 ± (1.19) Chapter 2 
+LYS Dˈ(80) = 225 ± (401) Dˈ(80) = 194 ± (323)  
Table 5.1 Physiological properties of different toxin types of non-proteolytic C. botulinum 
a) based on percentage of type identified; b) + positive for all strains; - negative for all strains; V variable or weak response; c) Time to growth at chill 
temperatures determined in PYGS broth; d) Maximum growth temperature determined in TPGY broth; e) D-value without/with lysozyme in                
a recovery media (data given as mean ± standard deviation of D-values measured at temperatures in a range 50°C – 83°C (for -LYS) and in          
a range 75°C – 95°C (for +LYS) converted to reference temperature T = 80°C); empty cell indicates that data were not reported 
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Tests conducted on growth properties of non-proteolytic C. botulinum at chill 
temperatures (Chapter 3) distinguished four clusters of strains. Although a small 
amount of variation was observed, these clusters were consistent across two 
independent datasets, generated using different experimental designs. Strain 
clustering correlated with type of neurotoxin formed and revealed groups of 
strong growing and weak growing strains at chill temperatures, with type E 
strains showing the most rapid growth compared to type B and F strains (Table 
5.1). Moreover, the variation between strains of different toxin types was greater 
when test conditions were more demanding e.g. low incubation temperature or 
small inoculum concentration of spores.  
 
Interestingly, the clustering of strains based on growth properties at chill 
temperatures agreed with clusters derived from growth tests in the presence of 
different carbohydrates (Chapter 4). Variability between strains of non-proteolytic 
C. botulinum for both of these growth measures correlates with type of 
neurotoxin formed. Clustering analysis of carbohydrate utilisation was conducted 
on 33 strains in two independent experiments and distinguished three groups of 
non-proteolytic C. botulinum. 
 
The assessment of strain variability based on a literature review of heat 
resistance of non-proteolytic C. botulinum spores (Chapter 2) failed to distinguish 
homogeneous groups of strains in terms of their heat resistance properties (see 
section 2.3.2.2 – testing the dependence of spore heat resistance on strain of 
non-proteolytic C. botulinum). The analysis of collected D-values also revealed 
that there is no significant different between strains of different toxin type (see 
section 2.3.2.2 – testing the dependence of the spore heat resistance on toxin 
type). Nevertheless, summarised data on inactivation kinetic parameters (D and          
z-values) provided valuable information on variability and uncertainty associated 
with those parameters including well-defined probability distributions that are 
suitable for incorporation into inactivation models applied in QMRA, such as       
a model for minimally heated model dairy-based chilled dessert (see section 
5.2.4.2). 
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Several authors have used a range of molecular methods to investigate the 
phylogenetic relationship of C. botulinum strains. Sequencing of the 16s rRNA 
gene by Hutson et al. (1993a; 1993b) supported the physiological grouping 
(Table 1.1) and confirmed that non-proteolytic C. botulinum strains are 
phylogenetically distant from those of proteolytic C. botulinum. Similar results 
were obtained by Hielm et al. (1999), Keto-Timonen et al. (2005), Kirkwood et al. 
(2006), Keto-Timonen et al. (2006), Hill et al. (2007) using ribotyping, pulse field 
gel electrophoresis (PFGE) and amplified fragment length polymorphism (AFLP) 
analysis. 
 
Investigations on the genetic variability between non-proteolytic C. botulinum 
strains has been performed by various authors using a range of methods e.g. 
PFGE (Hielm et al., 1998a; Hielm et al., 1998b; Leclair et al., 2006; Kirkwood et 
al., 2006), randomly amplified polymorphic DNA (RAPD) (Leclair et al., 2006), 
AFLP (Keto-Timonen et al., 2005; Keto-Timonen et al., 2006; Derman et al., 
2011; MacDonald et al., 2011), multilocus sequence typing (MLST), variable-
number tandem-repeat (VNTR) analysis (MacDonald et al., 2011) and DNA 
microarray (Stringer et al., 2013). The results of these test revealed large 
variability and details of the relationships between strains of non-proteolytic       
C. botulinum, which seemed to be associated with toxin serotype. The analysis 
of 17 strains (3 type B, 14 type E and 2 type F) using the ribotyping by Hielm et 
al. (1999) roughly indicated two clusters within non-proteolytic C. botulinum. One 
cluster consists of type E isolates, and the second cluster contains type B and 
type F strains. A very clear separation of type E strains from those of type B and 
F was also observed using AFLP with 15 strains tested (4 type B, 8 type E and 3 
type F) (Keto-Timonen et al., 2006), 24 strains tested (3 type B, 16 type E and 5 
type F) (Derman et al., 2011) and with 37 strains (7 type B, 26 type E and 4 type 
F) (Keto-Timonen et al., 2005). The same strain classification pattern was 
obtained using PFGE with 34 strains (4 type B, 24 type E and 6 type F) 
(Kirkwood et al., 2006) and 39 strains (6 type B, 27 type E and 6 type F) (Leclair 
et al., 2006). The classification pattern obtained by Leclair et al. (2006) using 
PFGE was also confirmed with RAPD. One feature of all these studies is            
a tendency to test large number of type E strains, but few type B or type F 
strains. 
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The most recent study by Stringer et al. (2013) examined the relationship 
between 43 strains of non-proteolytic C. botulinum (14 type B, 24 type E and 5 
type F) using a DNA microarray. The results from this study not only confirmed 
previous observations, but also indicated a genetic biodiversity between type B 
and type F strains (Figure 5.3), where four type B strains (Eklund 17B (81-30), 
Colworth BL151 (86-17), IFR 05/020 (05-20) and Eklund 2B (83-01)) formed       
a separate clade from other type B and F strains. Interestingly the ability to grow 
on different carbohydrates revealed a similar pattern (Chapter 4). Stringer et al. 
(2013) describes the only study where a substantial number of type B strains 
have been tested, therefore a direct comparison with findings of other authors is 
not possible. The DNA microarray used for this comparative genomic indexing 
study was composed of probes based on the genome of the Eklund 17B (type B) 
strain and did not reveal details of the genetic variability between type E strains 
that had been described previously (Hielm et al., 1998b; MacDonald et al., 
2011). 
 
 
Figure 5.3 Genomic indexing of 43 strains of non-proteolytic C. botulinum 
Source: Reprinted from “Genomic and physiological variability within Group II (non-
proteolytic) Clostridium botulinum” by Stringer et al. (2013) BMC Genomics 2013, 14, 
p.333. Copyright 2013 by BioMed Central. Adapted with permission. 
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In conclusion, genomic analysis based on published data, shows a large 
diversity within non-proteolytic C. botulinum strains which is associated with the 
type of neurotoxin formed. Type B and F strains cluster together and are distinct 
from type E strains. The work presented in Chapters 3 and 4 reveals that strains 
from these different phylogenetic groups exhibit different growth properties at 
chill temperatures and also a different ability to utilise various carbohydrates. The 
strong correlation between the genomic groupings and the physiological 
groupings is likely to reflect the real relationship between strains of non-
proteolytic C. botulinum and provides a basis for testing the effect of strain 
variability on a risk assessment for minimally processed chilled foods. 
 
5.1.7 QMRA model  
A QMRA model describes the path of a food product (from farm to fork) or          
a particular part (e.g. steps involved solely in manufacturing) in terms of 
mathematics. In this way QMRA evaluates the effects of different process 
components on the risks associated with hazards from pathogens and also 
indicates the impact of interventions.  
 
The first steps in building a QMRA model involves the identification of hazards 
and the definition of production steps, and how they influence the hazard 
strength. The model input parameters are described in the form of probability 
distributions: continuous or discrete. In a continuous probability distribution         
a random variable can take any value in a finite or infinite range, while a discrete 
probability distribution describes a variable which can have a finite set of values. 
Examples of commonly used probability distributions in the calculation of risk in 
relation to food safety are: normal, lognormal (section 2.2.2.1 and 5.2.4.1), beta 
(section 2.2.2.2), BetaPert (section 5.2.4.1), uniform (section 5.2.4.1) or Poisson 
(section 5.2.4.3). Simple simulations can be conducted in commonly used 
spreadsheets (e.g. Microsoft Excel). For more complex models, a number of 
Microsoft Excel add-in routines, based on stochastic simulation algorithms, have 
been developed, e.g. @RISK (www.palisade.com), Crystal Ball 
(www.oracle.com) and ModelRisk (www.vosesoftware.com). Alternative methods 
of constructing probabilities in QMRA models are influence diagrams (using e.g. 
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Analytica (www.lumina.com) or Bayesian Belief Networks (www.hugin.com)), 
event trees, decision trees, fault trees or discrete event simulations (Vose, 2008). 
 
Recently, the number of publications that describe QMRA models has increased. 
Some models are from food safety authorities, international organisations, 
academia and industry, and they have been developed for a range of 
microorganisms and food products. Examples are shown in Table 5.2. Due to 
serious health consequences and commercial implications several risk 
assessments for non-proteolytic C. botulinum in minimally heated chilled foods 
have been conducted previously (see section 1). Nevertheless, these models do 
not take account of variability arising from strain behaviour. 
 
Product Microorganism Reference* 
Dairy Staphylococcus aureus 
Barker and Goméz-Tomé 
(2013) 
Egg and egg products Salmonella enteritidis EFSA (2010) 
Ready-to-eat food Listeria monocytogenes Ross et al. (2009) 
Seafood Vibrio parahaemolyticus  WHO/FAO (2011) 
Poultry meat Campylobacter spp. WHO/FAO (2009) 
Water Cryptosporidium Pintar et al. (2012) 
Table 5.2 Examples of quantitative microbial risk assessment models for 
different microorganisms and food products 
* More published risk assessments are available on www.foodrisk.org 
 
5.1.8 Scope of the risk assessment 
This chapter describes an example quantitative risk assessment for hazards 
arising from spores of non-proteolytic C. botulinum. The assessment concerns   
a model dairy-based product, but with realistic parameters. The assessment 
includes a detailed analysis of spore loads in raw materials, thermal inactivation 
of spores during manufacture, distribution of spores into individual retail units 
and spore germination and growth during multi-stage storage. Dose-response 
modelling falls outside the scope of this model, as the presence of any botulinum 
neurotoxin is considered unacceptable. The chemical environment within the 
food is considered in the model (i.e. assumed to be optimal for growth). The 
purpose of this risk assessment is to estimate the risk from toxicity for a single 
retail unit of a chilled dairy product at the point of consumption. Additionally, the 
impact of strain variability (as a function of growth) of non-proteolytic                  
C. botulinum on the calculated risk has been included. The assessment includes 
quantification of uncertainties and identification of sensitivity. 
 218 
5.2 Methods 
The risk assessment has been conducted and presented according to CAC 
(1999) principles and structure for microbiological risk assessment.                     
A probabilistic approach was chosen for the QMRA model, and developed using 
@Risk simulation software (@Risk version 5.5.1, Palisade Corporation, Ithaca, 
USA). The @Risk tool performs risk analysis using Monte Carlo simulation as an 
add-in for Microsoft Excel (2010).  
 
The model was structured according to a modular process risk model (MPRM) 
(Nauta, 2001). According to this approach factors influencing the risk, and 
effectivness of potential interventions, follow the food pathway, which is 
separated into smaller units (modules). In this QMRA for a model dairy-based 
product, four modules were considered: product formation, non-isothermal 
heating process, packing into retail units and multi-stage storage. In terms of 
hazards arising from non-proteolytic C. botulinum spores, these steps 
corresponds to: spore load in raw materials, thermal inactivation of spores, 
distribution of spores in individual product units, spore germination and 
outgrowth. A schematic diagram of the QMRA modules is presented in Figure 
5.4. The following process can be neutral or contribute to a reduction or an 
increase of risk arising from non-proteolytic C. botulinum strains. The model 
input parameters and distribution functions are provided in Table 5.3 and they 
are derived from experimental data, literature review and/or expert elicitation. 
The model allows for changing the input parameters (except the temperature of 
storage) to examine their effect on estimated risk.  
 
Probability distributions were generated from 1000000 interations using a Monte 
Carlo (section 5.1.4) simulation method with Latin hypercube sampling (LHS) to 
predict the impact of model parameters on the level of non-proteolytic                
C. botulinum in a model chilled dairy-based product. In this situation LHS is an 
effective method of generating random numbers for probability distributions that 
include tails. 
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Input parameter description Value Distribution Source 
Spore load, Sbatch (spores kg
-1)  Lognormal (<S>, σS) 
Mean load, <S> (spores kg-1)  BetaPert  
(<S>min, <S>mod, <S>max) 
 <SA>min 0.0001  Expert opinion 
 <SA>mod 0.1  Expert opinion 
 <SA>max 10.0  Expert opinion 
 <SB>min 0.001  Assumed 
 <SB>mod 1  Assumed 
 <SB>max 100  Assumed 
Standard deviation for load σS 
(spores kg-1) 
 Uniform [σSmin, σSmax] 
   min 5.6  Expert opinion 
   max 562  Expert opinion 
Decimal reduction time, D(T) (min) Lognormal (<D(T)>, σD) 
 <D(80)>-LYS 2.23  Chapter 2 
 σD -LYS 4.44  Chapter 2 
 <D(80)>+LYS 245  Chapter 2 
 σD +LYS 423  Chapter 2 
z-value (°C)  Beta (a, c, α1, α2) 
 a-LYS 3.7  Chapter 2 
 c-LYS 16.5  Chapter 2 
 α1-LYS 2.9  Chapter 2 
 α2-LYS 9.6  Chapter 2 
 a-LYS 4.0  Chapter 2 
 c-LYS 19.6  Chapter 2 
 α1-LYS 3.1  Chapter 2 
 α2-LYS 6.0  Chapter 2 
Spore load in volume, V, s (spores/unit) Poisson (sV)  
 V (kg) 0.1   
Time preceding the observation of growth, 
 tmin (hrs) 
Normal (<tmin>, σtmin) 
Mean time preceding observation of growth, <tmin> (hrs) 
Variable for strains in clusters 1 – 4  Table 
5.4 
 Chapter 3 
Coefficient of variation for spore expected 
growth, σtmin/<σtmin> (hrs) 
Uniform [(σtmin/<σtmin>)min, 
(σtmin/<σtmin>)max] 
 (σtmin/<σtmin>)min 0.06  Chapter 3 
 (σtmin/<σtmin>)max 0.21  Chapter 3 
Table 5.3 Model specification and parameterization for calculation of risk 
associated with non-proteolytic C. botulinum in a model dairy-based food product 
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Figure 5.4 A risk assessment scheme for hazards arising from spores of non-
proteolytic C. botulinum in a model dairy-based chilled food product 
The diagram shows stages of product manufacture considered in the model with 
corresponding inputs and parameters. At each stage the level of non-proteolytic           
C. botulinum spores is calculated. Colours of boxes indicate the impact of manufacture 
phase on the loading of non-proteolytic C. botulinum spores: neutral (white colour), 
decrease (blue colour), increase (red colour) 
 
This QMRA model for non-proteolytic C. botulinum includes for the first time 
estimates of the impact of strain variability and also lytic enzyme activity on the 
calculated risk. The variability of non-proteolytic C. botulinum strains is described 
by data generated in Chapters 2, 3 and 4. The response of the tested strains to 
environmental conditions is summarised in section 5.1.6 and indicates that 
variability is associated with the type of neurotoxin. In general, type E strains 
show the ability to utilize different carbohydrates compared to type B and F 
strains. Moreover, clustering of strains in terms of their growth at chill 
temperatures indicates that strains forming type E neurotoxin show more rapid 
growth compared with strains forming type B and F neurotoxin. Since time to 
growth is identified as a significant source of strain variability, the calculation of 
Product formation 
(mixing of ingredients)
Heat treatment
Packaging
Cooling
Cold storage at the 
factory
Retail cold storage
Consumer cold storage
Risk of toxic pack at the 
point of consumption 
Initial level of raw materials
contaminated with non-proteolytic
C. botulinum spores
Product formulation parameters 
(aw, pH) 
Material A: milk (90%)
Material B: cream (10%)
T1 = 20.0 C / t1 = 6 min
T2 = 84 C / t2 = 1 min
V = 100 g
T3 = 80 C / t3 = 1 min
T4 = 4.0 C / t4 = 1 min
Ts1 < 3.0 C / ts1 = 1 day
Ts2 = 6.0 C / ts2 = 2 days
Ts3 = 7.0 C / ts3 = 4 days
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probability of toxicity at the point of consumption is based on a classification of 
strains into the four clusters described in section 3.3.4 (Figure 3.9). Statistical 
analysis of data on heat resistance for non-proteolytic C. botulinum spores 
revealed that there is no significant difference in decimal reduction time for 
strains of different toxin types (section 2.3.2.2 – testing the dependence of the 
spore heat resistance on toxin type). Nevetheless, the same data indicated 
significantly greater D and z-values for spores recovered in the presence of 
lysozyme (section 2.3.2.3 – testing the similarity of +LYS HS and +LYS HR 
fractions). For comparison, the effect of heat treatment applied to the product 
with and without egg yolk is considered (egg yolk being potentially contaminated 
with egg white – a rich source of lysozyme). 
 
5.2.1 Hazard identification 
The risk assessment considers the risk posed by spores of non-proteolytic        
C. botulinum. Although botulism (the foodborne disease caused by consumption 
of preformed C. botulinum neurotoxin) occurs relatively rarely, it has a high 
impact on consumer safety, between 5 – 10% of cases are fatal. Full details of 
the hazard presented to consumers by non-proteolytic C. botulinum are 
summarised in section 1.1. In contrast to many other foodborne pathogens, the 
hazard arising from non-proteolytic C. botulinum is associated with the ability of 
dormant spores to survive in harsh conditions. Those spores are commonly 
present in the environment and can potentially enter the unprocessed food 
materials or a food product at any stage of the manufacturing process 
(particularly in manufacturing facilities where spore contaminated materials are 
handled). The heat treatment applied may not always be sufficient for 
inactivation of spores, and this can allow to subsequent germination, growth and 
botulinum neurotoxin formation, which is identified as a hazard. 
 
5.2.2 Exposure assessment 
Chilled food product sales in the UK have been summarised in detail in section 
1.2, based on data from the Chilled Food Association. It is estimated that 109 
packs are sold in the UK annually and sales of chilled foods continue to rise at 
an average of 10% per annum (Peck et al., 2008). The sale of chilled prepared 
desserts in 2012 was estimated to be worth £ ~0.7 billion pounds and it 
constituted 4.6% of the total chilled market (Figure 1.2). Consumer enthusiasm 
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to purchase and consume convenient and fresher foods with minimal 
preservatives makes it likely that the increase in consumption of minimally 
heated chilled foods can be expected to continue.  
 
There are very few data describing the frequency and concentration of non-
proteolytic C. botulinum spore contamination of dairy based chilled products. 
Nevertheless, since non-proteolytic C. botulinum spores are widely distributed in 
the environment (Dodds, 1993b; Lund and Peck, 2000; Carlin, 2011; Heyndrickx, 
2011) it can be assumed that any ingredient/food might be contaminated. 
Information regarding the spore load in dairy based products was derived from 
the literature and based on expert opinion. 
 
5.2.3 Hazard characterisation 
A description of clinical forms of botulism: incubation times, vehicles, symptoms, 
treatment and long term effects are summarised in section 1.1.2. There is no 
particular group identified at risk in terms of botulinum neurotoxin – the 
mechanism of action is similar irrespectively on victim’s gender, age or health 
conditions. Even a single spore of non-proteolytic C. botulinum can lead to 
growth, gas production and neurotoxin formation at chill temperatures (Chapter 
3). Lund and Peck (2000) considered that death can be caused by consumption 
of as little as 30 to 100 ng of botulinum neurotoxin, thus from a risk assessment 
perspective, any amount of toxin is considered as hazard, and this is the end 
point of concern. 
 
5.2.4 Risk characterisation 
An overview of the steps considered in the mathematical model is presented in 
Figure 5.4. The probabilistic modelling (with variables presented as probability 
distributions) was applied for evaluating: 1) spore load in raw materials (product 
formation), 2) thermal inactivation of spores (heat treatment), 3) distribution of 
spores in individual units (volume partition), and 4) germination and growth of 
non-proteolytic C. botulinum (storage).  
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Product description 
The model dairy-based chilled product is prepared from multiple materials in 
standard 10000 kg batches. All batches are assumed to be independent. The 
formulation includes two separate components – milk (material A) and cream 
(material B) constituted in a single vessel (at ambient temperature of ~20.0°C) 
(an alternative product contains egg yolk). Following cooking at 84°C for 1 min 
the batches are transferred to a filling line and hot filled into ~100000 x 100 g 
sealed cartons. The sealed units are cooled and stored before distribution into 
the retail and consumer chain. Values for water activity and pH throughout the 
process step are constant, aw = 0.997 and pH ~6.65. The same procedure and 
parameters are applied to a product with added egg yolk. Throughout the 
calculations the following notation is applied: -LYS – product without added egg 
yolk and assumed not to contain lysozyme; and +LYS – product with added egg 
yolk and associated lysozyme. 
 
5.2.4.1 Spore load in raw material 
Knowledge of spore concentration variability in raw materials is essential to 
quantify hazards, as it affects the strength of treatment required to ensure 
product safety.  
 
This model assumes a clear separation of variability and uncertainty in spore 
load. The spore concentration in a batch of raw materials, Sbatch, spores kg
-1, is 
assumed to have a lognormal distribution (equation 2.11), to allow for small 
probabilities of large loads. The variability in the concentration of spores is 
parameterized by mean value <S>, and by the standard deviation, σs, of Sbatch. 
The parameters are uncertain and reflect the lack of precise knowledge on the 
number of spores present in the raw materials used to make dairy-based 
desserts. The uncertainty in the mean concentration, <S>, is represented by       
a BetaPert distribution, a special form of the beta distribution (equation 2.15), 
which is commonly used for representing expert opinions. The BetaPert 
distribution requires three parameters: minimum, modal and maximum values for 
the expected mean concentration of spores (<S>min, <S>mod and <S>max).  
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A uniform probability distribution defined by range values σSmin and σSmax, is 
chosen to represent uncertainty in the standard deviation for Sbatch 
 
        
 
            
 5.1 
 
where                   . The uniform distribution expresses an equal 
probability of occurrence for every value in the range, and in many cases is used 
when limited information is available. 
 
The spore concentration is the sum of the defined component concentrations 
weighted by their volume fraction. In this assessment, 90% of material is type A, 
and 10% of material is type B. A group of experts were used to provide estimates 
for parameters of the uncertainty distribution for the mean concentration of 
spores, <S>, in type A material, and 95% UCL and LCL of spore concentration, 
Sbatch, (Appendix 6). The 95% UCL and LCL were used to estimate the   . Spore 
loads are insensitive to any parameters that describe the loads in egg yolk. 
 
Expert opinion established values <SA>min   0.0001, <SA>mod   0.1 and <SA>max 
  10 spores kg-1 for type A material. These values are consistent with values 
published by the ACMSF (2005) for spore loads of C. botulinum in infant formula. 
Previous published studies by Hussong and Hammer (1930), Fooladi et al. 
(2010) and Meshref (2013) indicated that cream is more contaminated with 
microorganisms than milk. Thus in this risk assessment for a model dairy-based 
chilled dessert it is assumed that the concentration of spores in type B material is 
ten times greater than in material A. A single value of      56 (calculated from 
elicited 95% UCL and LCL for Sbatch) was used to estimate the uncertainty 
distribution for   , completed by   min = 
  
  
 and   max =     . It is assumed that 
the standard deviation of the spore concentration is independent of the material. 
For a complex product with many components a similar distribution could be 
constructed. 
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5.2.4.2 Thermal inactivation of spores 
A thermal process is the primary method for reduction of spore numbers in food 
products, therefore it is an important component of the risk assessment model. It 
is assumed that for each batch of dairy-based dessert all ingredients are mixed 
and heat treated in a single vessel (the materials are not considered to be 
preheated before mixing). During the heat treatment the thermal inactivation of 
spores is assumed to be uniform through the volume. In the model product the 
temperature of the system varies with time during heating and cooling phases. 
Initially the temperature of the product rises from ambient temperature T1 = 
20.0°C, towards a holding temperature T2 = 84°C. During this period (Δt1 ~6 min) 
the temperature of product increases uniformly. After reaching T2, the cooking 
phase has duration Δt2 = 1 min. Following cooking the product is hot filled into 
sealed cartons with a final temperature, T3 = 80°C, this process takes time Δt3 ~1 
min (the time to fill a complete batch of units). Finally a cooling phase reduces 
the temperature to T4 = 4.0°C over a period Δt4 ~1 min (Figure 5.5). 
 
 
Figure 5.5 Parameterised schematic for the thermal history of model dairy-based 
chilled dessert 
 
As summarised in section 2.1.2, the bacterial heat resistance can be described 
by first order reaction kinetics (equation 2.3), which in terms of spore D-value 
can be expressed as 
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          5.2 
 
It is assumed that the D-value does not vary between batches. Nevertheless, 
different D and z-values are applied when the presence of lytic enzymes is 
considered in the product. The uncertainty concerning the D-value at 
temperature T is represented by a lognormal distribution, parameterized by <D> 
and σD (see section 2.2.2.1). 
 
A reduction of the number of spores in a batch corresponds to a non-isothermal 
process equivalent to a corresponding “effective” isothermal process, at              
a reference temperature, Tref, for an effective time, teff(Tref). When the 
temperature variation is linear (straight line) the effective heating time is 
 
      (    )  
 
    
 
  
  
    
       
    
       
   5.3 
 
where         ,          (T1, T2, t1 and t2 are the initial and final heating 
temperature and time) (G. C. Barker, personal communication). 
 
A beta distribution (see section 2.2.2.2), parameterized by extreme values         
a, c and shape parameters α1 and α2, was used to represent uncertainty 
concerning the z-value. Reference temperature, Tref = 80°C (a commonly applied 
temperature in a manufacturing of the chilled products) was used.  
 
Each batch with a particular number of spores has an uncertain D-value. The 
range of D-values for non-proteolytic C. botulinum spores in different laboratory 
media and food matrices, obtained from a literature review, is presented in 
Figure 2.14 in Chapter 2. The parameters (mean and standard deviation) for 
lognormal distribution of D-value at reference temperature Tref = 80°C, are 
respectively <Dˈ(80)> = 2.23 min and σDˈ(80) = 4.44 min (for -LYS data), and 
<Dˈ(80)> = 245 min and σDˈ(80) = 423 min (for +LYS data) (Figure 2.24). 
 
The temperature profile for dairy-based chilled product is created from a set of 
time-temperature slopes with a high temperature isothermal hold for 1 min. 
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Transformation of uncertain knowledge of z-value (with parameters a = 3.7, c = 
16.5, α1 = 2.9, α2 = 9.6 (for -LYS) and a = 4.0, c = 19.6, α1 = 3.1, α2 = 6.0 (for 
+LYS)) into uncertainty about equivalent heating time, teff at reference 
temperature (Tref = 80°C) using the relationship between teff and real time, gives 
uncertainty for effective time with <teff> = 6.99 and σteff = 1.95 for the product 
without lysozyme activity and <teff> = 5.02 and σteff = 1.25 for the product with 
egg yolk added. Two distributions for teff corresponding to the presence and 
absence of lytic enzyme activity are illustrated in Figure 5.6. 
 
 
Figure 5.6 Distributions representing belief concerning the effective heating time, 
teff(80), for batches of dairy-based dessert 
Distributions obtained using uncertain z-values (represented by beta distribution) for 
dairy-based dessert without added egg yolk; a = 3.7, c = 16.5, α1 = 2.9, α2 = 9.6 (blue 
line) and for dairy-based dessert in presence of egg yolk; a = 4.0, c = 19.6, α1 = 3.1, α2 = 
6.0 (red line) 
 
Combining beliefs for the effective heating time and for decimal reduction time 
for spores of non-proteolytic C. botulinum, gives beliefs concerning the 
logarithmic population reduction achieved by the thermal process for the model 
dairy-based chilled dessert 
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5.2.4.3 Distribution of spores in individual units 
Following the heating process the product is transferred to a filling step, hot filled 
and sealed, into individual 100 g sealed cartons. The partitioning process is an 
important step in QMRA that redistributes spores over the units of food product. 
Considering a batch consists of 105 units, the distribution of spores can be either 
regular – in which each individual unit contains the same number of spores, 
clustered – meaning that the remaining spore load in post-processed batch of 
dairy-based dessert may be contained in a single unit and all the other units are 
free of contamination, or random – where some units may be spore free and 
some can contain variable number. A random distribution of spores within 
independent units, sunit, is assumed in the model and is described by a Poisson 
process 
 
        |   
      
  
 5.5 
 
where sunit is the number of spores and λ is the expected number of spores in the 
individual unit. The exposure of product to the air during dispensing process is 
not considered as a potential contamination source. 
 
5.2.4.4 Germination and growth of non-proteolytic C. botulinum during 
multi-stage storage 
Following volume partition the model dairy-based dessert is stored within the 
factory facilities under controlled conditions at low temperature Ts1 < 3.0°C for 
time t1 ~1 day prior to distribution. Subsequently the product is transferred to 
retailers at temperature Ts2 = 6.0°C for a maximal period t2 ~2 days. The final 
stage of the product pathway is consumer storage. This is the most variable 
storage phase during the product lifetime, and there are very limited data 
available regarding time-temperature history of food during consumer storage. 
George et al. (2010) indicated that the dominant mean operating temperature of 
domestic fridges in the UK is 7.0°C (see section 3.1) and this temperature Ts3, for 
a period of t3 ~4 days is used to represent consumer storage. The fluctuations 
due to transport conditions and due to variable fridge temperatures in different 
parts of a fridge are not considered in the model. In this assessment it is 
assumed that the pH and the water activity of the dairy-based chilled product are 
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optimal (pH = 6.65 and aw = 0.997) and constant during the total period of 
storage. 
 
In the case of C. botulinum in food growth can be uncertain (Barker et al., 2005b) 
and initiated from a very low spore concentration, even from a single spore but it 
can be variable within a population of spores (Ikawa et al., 1986; Jensen et al., 
1987; Stringer et al., 2009). The food unit is considered to be free of hazard 
before any individual germinated spore has entered the growth phase that may 
lead to subsequent neurotoxin formation (this is very often referred to as a delay 
time (Malakar et al., 2011)). The evaluation of the time, before a spore has 
entered the growth phase is of primary interest in assessment of foodborne 
botulism. It depends on the storage temperature and chemical composition of 
food matrices, and can be highly variable and uncertain (Stringer et al., 2005; 
Stringer et al., 2011).  
 
In the model, the assessment of time, during which the product is free of hazard 
is based on results summarised in Chapter 3. The calculated   parameter, used 
to indicate variable growth of non-proteolytic C. botulinum strains at chill 
temperatures (see section 3.2.8), is used to calculate tmin, the time preceding 
observation of growth at temperatures 6.0°C (storage at retailer) and 7.0°C 
(consumer storage). The relationship between the    parameter and tmin is 
expressed in equation 3.3. As presented in section 3.3.2.1, during 90 days of 
incubation at 3.0°C, growth from non-proteolytic C. botulinum spores was not 
observed, therefore this stage is not considered in the calculation of risk. 
Previously Graham et al. (1997) reported growth at 3.0°C, and these data could 
be added to an updated risk assessment. 
 
For the purpose of this assessment the normal distribution (see section 3.2.8) 
with mean, <tmin>, and coefficient of variation,      /<tmin>, is used to 
parameterise the variability distribution of the time preceding observation of 
growth from a small population of spores, tmin, at chill temperatures. A uniform 
distribution, defined by extreme values (     /< tmin>)min, (     /< tmin>)max, is used 
to represent uncertainty in the coefficient of variation for tmin.  
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The value of <tmin> at 6.0°C for a small population of spores (s = 100, 10 and 1 
spores tube-1) is obtained from extrapolation of <tmin> calculated from measured 
  for large population of spores (s = 106, 105 and 104 spores tube-1) (Figure 5.7). 
The value of <tmin> is calculated for the four clusters of non-proteolytic               
C. botulinum strains (see Figure 3.9 for strain classification based on parameter 
 ). Extrapolation is used because not all strains tested in Chapter 3 show growth 
from low spore concentrations (Appendix 4). The extrapolation of <tmin> is 
validated by comparison of the values with those calculated for the subset of 
strains that show growth from small concentration of spores (marked as red 
points in Figure 5.7).  
 
 
Figure 5.7 Calculated mean time preceding observation of growth <tmin> (in 
days) for non-proteolytic C. botulinum at 6.0°C from large population of spores 
and corresponding <tmin> at small concentration of spores obtained by 
extrapolation  
The figure presents <tmin> for four clusters of non-proteolytic C. botulinum strains. <tmin> 
measured (full symbols) extrapolated (open symbols) for strains assigned to cluster 1: 
(●) and ( ), cluster 2: (▲) and ( ), cluster 3: (♦) and ( ), cluster 4: (■) and ( ). The red 
coloured marks values calculated for <tmin> for strains which show growth from low 
concentration of spores (see Chapter 3) and symbols for clusters 1 – 4 
 
Figure 5.7 indicates that the extrapolated value for <tmin> takes smaller values 
than <tmin> obtained from measurements. Thus extrapolation ensures                 
a conservative approach for estimation of time preceding observation of growth, 
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tmin. The value for <tmin> at 7.0°C is extrapolated using the same gradient as the 
line obtained at 6.0°C. The values of <tmin> (hrs) for strains assigned to clusters 
1, 2, 3 and 4 at 6.0°C and 7.0°C from a low number of spores (s = 100, 10 and 1 
spores unit-1) are summarised in Table 5.4. 
 
Cluster 
<tmin> at 6.0°C (hrs) <tmin> at 7.0°C (hrs) 
s = 100 s = 10 s = 1 s = 100 s = 10 s = 1 
1 375 419 464 318 362 407 
2 490 556 622 460 526 592 
3 255 279 303 239 263 287 
4 181 191 201 163 173 183 
Average 325 361 397 295 331 367 
Table 5.4 Extrapolated mean value of tmin for a low number of spores of non-
proteolytic C. botulinum at 6.0°C and 7.0°C 
 
The range of calculated <tmin> values quantifies the uncertainty in the variability 
of shortest time when any growth could be expected with (     /<tmin>)min = 0.06 
and (     /<tmin>)max = 0.21. The      /<tmin> value is considered to be 
independent of growth conditions and is calculated from the average standard 
deviation of tmin at 6.0°C over all clusters.  
 
The impact of multiple sequential periods of isothermal storage (   at Ti i = 1,3) 
on tmin is expressed by considering exhausted fractions    
  
        
 where tmin is 
the time preceding observation of growth, at temperature Ti and    is incubation 
time for the isothermal storage period. It is assumed that a spore exceeds the 
time preceding observation when the cumulative fraction,   ∑  , for a spore is 
greater than one (Malakar et al., 2011). 
 
By combining the probability for a finite number of spores in single retail unit with 
the probability of spores exceeding tmin (i.e. f > 1) the probability of a hazardous 
pack is calculated, as a product, and this is the main measure of risk used for 
risk characterisation. 
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5.3  Results 
All factors affecting the risk of intoxication from consumption of dairy-based 
chilled products are incorporated into a mathematical model. Its implementation 
is presented in Figure 5.4 and values for a probabilistic representation of the 
parameters used are summarised in Table 5.3. The probabilistic model was built 
using a Monte Carlo simulation tool (Figure 5.8) with 1000000 interations for 
products with and without egg yolk added.The simulation process was repeated 
five times and the calculated risk is an average of all simulations. The average 
and standard deviation of the risk estimate was calculated. 
 
 
Figure 5.8 A screen-shot presenting a mathematical model for calculation of 
risks associated with non-proteolytic C. botulinum in dairy-based chilled product 
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The product, consisting of raw materials from different sources, may contain 
large number of spores, S. Distributions representing the spore loads for non-
proteolytic C. botulinum in both materials and in the mixed product (90% of A 
and 10% of B) based on the parameterizations (Table 5.3), are illustrated in 
Figure 5.9. 
 
 
Figure 5.9 Distributions representing belief concerning spore loads, for non-
proteolytic C. botulinum, in raw materials of type A and type B materials, and 
mixed material 
material A – milk (dash) and material B – cream (dotted line), mixed material – 90% of A 
and 10% of B (solid line) 
 
It was assumed in the model that cream was more contaminated than milk, and 
that it could be the major source of spores in model dairy-based product, but the 
total spore load, Sbatch, in the mixed product is dependent on the proportion of the 
ingredients. Figure 5.10 illustrates the distribution of batch spore loads in mixed 
product, with expected value ~5 x 104 spores, prior to heat treatment and the 
sensitivity of this distribution with respect to the <SA>max parameter. 
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Figure 5.10 The cumulative probability of the spore load for a batch of dairy 
dessert (prior to heat treatment) 
The full, dotted and broken lines corresponds to parameter values <SA>max = 1000, 100 
and 10 spores kg-1 
 
Belief concerning the population reduction achieved by the heat treatment 
process is represented in Figure 5.11. It is apparent from the graph that the 
effect of heat treatment on reduction of spores, largely depends on the 
composition of the product. The model predicts that effective heating time teff = 
6.99 min and <Dˈ(80)> = 2.23 min, assumed for product without egg yolk, 
provides at least 0.2 order of magnitude population reduction and there is           
a probability ~0.54 for batches to receive a heat treatment that is stronger than   
a 6 log kill. There is also ~0.38 probability that the reduction of spores exceeds 
10 orders of magnitude. The effective heating time teff = 5.02 min and <Dˈ(80)> = 
245 min, assumed for product with added egg yolk, would provide only one order 
of magnitude reduction of spores with probability ~0.99. There are very small 
probabilities, ~3.0 x 10-3, ~4.0 x 10-4 and ~1.2 x 10-4 that a batch experiences     
a two, three or four orders of magnitude in population reduction. Use of a single 
D-value Dˈ(80)~1.29 min (see section 2.3.2.3 on practical application of heat 
treatment parameters) gives a probability ~0.85 that the population reduction 
exceeds six orders of magnitude. 
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Figure 5.11 Reduction of non-proteolytic C. botulinum spores, achieved by the 
thermal process applied to model dairy-based dessert 
The bars corresponds to distinct belief concerning the D and z-values for dessert without 
egg yolk (<Dˈ(80)>-LYS = 2.23 min; p(z) with parameters a = 3.7, c = 16.5, α1 = 2.9, α2 = 
9.6) (blue bars), and with egg yolk (<Dˈ(80)>+LYS = 245 min; p(z) with parameters a = 
4.0, c = 19.6, α1 = 3.1, α2 = 6) (red bars). The insert graph represents the distribution for 
reduction of spores corresponding to less than five orders of magnitude 
 
The heat treatment applied to the dairy-based dessert reduces the spore load, 
but this is only significant in the absence of egg yolk in the product. Lysozyme 
activity provides protection to spores, and there is a probability ~0.99 that           
a pasteurized batch is not spore free, with expected value of the spore load, 
Sbatch ~9600. For batches of dessert without egg yolk with <Dˈ(80)> = 2.23 and 
σD'(80) = 4.44 the probability that processed batches contain finite numbers of 
non-proteolytic C. botulinum spores is ~0.18 with a mean load Sbatch ~244 spores 
in an occupied batch. The batch spore load is very sensitive to parameters for 
Dˈ(80) (Table 5.5) and it is essential to take into account the variability 
associated with D-value. A single value for Dˈ(80) = 1.29 increased the 
probability of a spore free batch (~0.96) with expected spore load Sbatch ~2. 
Slightly greater standard deviation or mean value for the D-value decreases the 
probability that a pasteurised batch is spore free and the corresponding spore 
concentration of contaminated batches. 
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<D'(80)>* σD'(80)* 
Expected load 
(spore batch
-1
) 
Sbatch 
97.5% load 
(spore batch
-1
) 
Sbatch 
Probability of 
spore free 
batch 
Probability 
batch load 
exceeds 10 
spores 
Probability 
batch load 
exceeds 100 
spores 
2.23 4.44 395 404 0.82 0.11 0.05 
2.76 4.90 332 688 0.78 0.13 0.06 
1.87 2.50 206 229 0.84 0.09 0.04 
2.26 2.70 149 383 0.79 0.12 0.05 
1.29 - 0.57 2 0.96 0.01 0.00 
Table 5.5 Distribution of spore loads of non-proteolytic C. botulinum in heat 
treated batches of dairy-based chilled dessert (-LYS) 
*Mean and standard deviation of D-values derived from literature review on spore heat 
resistance summarised in Table 2.31 
 
The probability that a processed retail unit contains spores is very small and 
clearly depends on the expected spore concentration in a pasteurised batch. The 
details of the distribution of spore loads for non-proteolytic C. botulinum in units, 
sunit, of the chilled dairy-based dessert are illustrated in Figure 5.12. The insert 
graph presents a distribution corresponding to non-zero spore load.  
 
 
Figure 5.12 Belief concerning probability distribution of the number of spores of 
non-proteolytic C. botulinum in a heat treated retail unit of model dairy-based 
dessert. 
A dairy-based chilled dessert units without addition of egg yolk (blue bars) and with 
addition of egg yolk (red bars). An insert graphs represent distribution for non-zero spore 
load (numeric values are added for clarity) 
 
The greatest contribution to risk arises from a unit with a single spore, which for  
-LYS is ~1.9 x 10-3 (with the <Dˈ(80)> = 2.23 and σD'(80) = 4.44) and for +LYS   
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~8.1 x 10-2. Probabilities decrease for higher unit loads. Unit spore loads higher 
than one are very rare with probability ~1.8 x 10-6 for a product without egg yolk. 
Addition of egg yolk to a product increases the probability of more than one 
spore in a retail unit to ~3.7 x 10-3. These probabilities indicate an expectation 
that 180 and 3700 units in one batch (1 batch = 100000 units) of a chilled dairy-
based dessert carry finite loads of non-proteolytic C. botulinum. If the mean and 
standard deviation for the decimal reduction time is reduced <Dˈ(80)> = 1.87 and 
σD'(80) = 2.50, the probability of finite unit loads is reduced to ~8.9 x 10
-4 for          
(-LYS), and for a single D-value with Dˈ(80) = 1.29 the probability of a unit with   
a single spore is reduced by three orders of magnitude (~5.0 x 10-6). In this case 
approximately 99% of individual units of chilled dessert are free from spores of 
non-proteolytic C. botulinum. The probability of finite spore loads in individual 
units of dairy-based chilled dessert is also sensitive to the <SA>max parameter. 
For <SA>max = 1000 spores kg
-1 with <Dˈ(80)> = 2.23 and σDˈ(80) = 4.44 min, the 
probability of non-zero spore loads increases to ~3.4 x 10-1. Table 5.6 indicates 
the sensitivity of probability for a finite number of spores with respect to thermal 
inactivation parameters and spore load of material A. 
 
Process 
parameters 
Probability 
unit is non-
zero 
Probability 
unit load 
exceeds 
1 spore 
Process 
parameters 
Probability 
unit is non-
zero 
Probability 
unit load 
exceeds 
1 spore 
Dˈ(80) 2.23 
2.0 x 10
-3
 1.8 x 10
-6
 
Dˈ(80) 1.87 
8.9 x 10
-4
 4.0 x 10
-7
 σDˈ(80) 4.44 σDˈ(80) 2.5 
<SA>max 10 <SA>max 10 
Dˈ(80) 2.23 
3.7 x 10
-2
 6.9 x 10
-4
 
Dˈ(80) 1.87 
2.0 x 10
-2
 2.0 x 10
-4
 σDˈ(80) 4.44 σDˈ(80) 2.5 
<SA>max 100 <SA>max 100 
Dˈ(80) 2.23 
3.4 x 10
-1
 6.5 x 10
-2
 
Dˈ(80) 1.87 
2.3 x 10
-1
 2.7 x 10
-2
 σDˈ(80) 4.44 σDˈ(80) 2.5 
<SA>max 1000 <SA>max 1000 
Dˈ(80) 2.79 
2.4 x 10
-3
 2.8 x 10
-6
 
Dˈ(80) 1.29 
5.0 x 10
-6
 1.3 x 10
-11
 σDˈ(80) 4.9 σDˈ(80)  
<SA>max 10 <SA>max 10 
Dˈ(80) 2.79 
4.0 x 10
-2
 8.0x 10
-4
 
Dˈ(80) 1.29 
8.0 x 10
-5
 3.2 x 10
-9
 σDˈ(80) 4.9 σDˈ(80)  
<SA>max 100 <SA>max 100 
Dˈ(80) 2.79 
4.5x 10
-1
 1.2 x 10
-1
 
Dˈ(80) 1.29 
1.0 x 10
-3
 5.4 x 10
-7
 σDˈ(80) 4.9 σDˈ(80)  
<SA>max 1000 <SA>max 1000 
Table 5.6 Sensitivity to process parameters of distribution of spore loads in 
individual units of dairy-based chilled dessert without added egg yolk 
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An important component of this risk assessment is the probability of the time 
preceding observation of growth from spores of non-proteolytic C. botulinum, tmin 
during multi-stage storage. It was shown in Chapter 3 that growth at chill 
temperatures is highly variable and is associated with strain toxin type. At 6.0°C, 
the time preceding observation of growth, tmin, from a single spore ranges from 
~8 – 26 days (with expectation tmin ~17 days). This time is smaller for increasing 
concentration of spores (Table 5.4 and Figure 5.13).  
 
 
Figure 5.13 Distributions representing belief concerning time preceding 
observation of growth, tmin from a single spore of non-proteolytic C. botulinum at 
Ts2 = 6.0°C 
A distribution of tmin for strains belonging to cluster 1 (pink line), cluster 2 (green line), 
cluster 3 (violet line), cluster 4 (black line), average value of <tmin> for all clusters (Table 
5.4) (red dashed line). Dashed lines indicate the expected value for probability 
distribution for tmin from s = 10 spores tube
-1 (colours for clusters 1 – 4) 
 
For isothermal storage at 7.0°C, typical domestic storage fridge temperature, 
time preceding the observation of growth is in a similar range (~8 – 25 days) but 
with smaller expectation <tmin> ~15 days. The classification of non-proteolytic    
C. botulinum strains based on   parameter, produced homogeneous clusters of 
strains in terms of the growth properties at chill temperatures. The biggest tmin is 
calculated for strains belonging to cluster 2: ~26 and ~25 days and cluster 1: ~19 
and ~17 days, whereas shorter times are estimated for strains in cluster 3: ~13 
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and ~12 days (for each cluster the values are calculated at temperatures at 
6.0°C and 7.0°C). Growth from strains belonging to cluster 4 is expected to be 
the shortest: ~8 days at both temperatures. 
 
From the cumulative distributions of tmin it is possible to estimate the probability 
when a spore will exceed the time preceding the observation of growth. Table 
5.7 shows that the probability varies across clusters and it increases with time 
and number of spores.  
 
t 
(days) 
Cluster 1 Cluster 2 Cluster 3 Cluster 4 
s=1 s=10 s=100 s=1 s=10 s=100 s=1 s=10 s=100 s=1 s=10 s=100 
0 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
1 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
2 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
3 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 
4 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.002 0.003 0.005 
5 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.012 0.019 0.034 
6 0.000 0.000 0.001 0.000 0.000 0.000 0.001 0.003 0.005 0.060 0.102 0.175 
7 0.000 0.001 0.002 0.000 0.000 0.000 0.005 0.009 0.021 0.251 0.406 0.608 
8 0.001 0.002 0.006 0.000 0.000 0.000 0.014 0.030 0.073 0.666 0.817 0.911 
9 0.002 0.005 0.016 0.000 0.000 0.001 0.039 0.088 0.216 0.914 0.961 0.985 
10 0.005 0.013 0.041 0.000 0.001 0.002 0.105 0.235 0.516 0.983 0.994 0.998 
11 0.011 0.030 0.099 0.000 0.001 0.004 0.254 0.514 0.803 0.997 0.999 1.000 
12 0.023 0.065 0.220 0.001 0.002 0.008 0.513 0.783 0.934 1.000 1.000 1.000 
13 0.047 0.137 0.439 0.002 0.005 0.015 0.766 0.919 0.981 1.000 1.000 1.000 
14 0.093 0.272 0.687 0.003 0.009 0.030 0.904 0.973 0.995 1.000 1.000 1.000 
15 0.177 0.479 0.855 0.006 0.017 0.055 0.964 0.992 0.999 1.000 1.000 1.000 
Table 5.7 The probability that a number of spores s = 1, s = 10, s = 100 spores 
tube-1 will exceed the time preceding observation of growth during isothermal 
storage for time t (days) at Ts3 = 7.0°C 
 
The probability distributions for tmin (Figure 5.13 and Table 5.7) indicate that at 
certain storage conditions germination and growth from non-proteolytic              
C. botulinum is possible, and strain variability is an important factor in the 
estimate of risk associated with a product that is stored at chill temperatures.  
 
Risks associated with non-proteolytic C. botulinum are considered when the 
storage period exceeds the time preceding the observation of growth. This is 
expressed in a form of a cumulative fraction of time preceding observation of 
growth, tmin, consumed by three storage regimes (Ts1 = 3.0°C, Ts2 = 6.0°C, Ts3 = 
7.0°C for a period of ts1 = 1, ts2 = 2 and ts3 = 4 days). The fraction can take the 
values from 0 to infinity, but values below one are considered as safe 
“boundary”. In another words, if the exhausted fraction of the time preceding 
observation of growth is less than one, the population of spores is still in the time 
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prior to growth. Figure 5.14 shows the cumulative probability distribution for the 
fraction of the time preceding observation of growth for a single spore during      
a non-isothermal storage regime with Ts1 = 3.0°C, Ts2 = 6.0°C and Ts3 = 7.0°C 
and ts1 = 1 day, ts2 = 2 days, ts3 = 4 days. Coloured lines correspond to strains 
belonging to four clusters. It is apparent from the figure that the greatest risk 
arises from strains that belong to cluster four. Interestingly, a common 
assumption of many published risk assessments, that treat strains as                  
a homogeneous population, would not indicate hazards arising from some 
regimes that are appropriated for dairy-based desserts. 
 
 
Figure 5.14 The cumulative probability of the fraction of time preceding 
observation of growth, tmin, from s = 1 spore tube
-1 during non-isothermal storage 
at temperatures Ts1 = 3.0°C, Ts2 = 6.0°C and Ts3 = 7.0°C for a period of ts1 = 1 
day, ts2 = 2 days, ts3 = 4 days  
A distribution of fraction for strains belonging to cluster 1 (pink line), cluster 2 (green 
line), cluster 3 (violet line), cluster 4 (black line). The red dotted line indicates fraction of 
the time preceding observation of growth equal to 1 
 
Storage regimes can be variable (due to temperature elevation, time abuse) 
during the product’s lifetime which can affect product safety. Table 5.8 lists         
a series of storage regimes which represent three isothermal periods. The first 
isothermal period, with temperature Ts1 < 3.0°C is considered as neutral to 
product safety for any duration t1. Therefore the effect of storage period for two 
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remaining regimes, ts2 and ts3 (retail and consumer storage) on exhaustion of 
time preceding observation of growth from three inocula s = 1, 10 and 100 
spores tube-1 was considered. In each regime, the fluctuation of the time 
preceding observation of growth that is exhausted by the storage in the presence 
of strain variability is expressed and added to the cumulative value. Additionally, 
Table 5.8 lists the probability that the storage time will exceed the time preceding 
observation of growth, p(f > 1), and the maximum value of the exhausted fraction 
of time preceding observation of growth for a variable population of strains, fmax. 
 
Spore concentration 
(spores tube
-1
) 
s = 1 s = 10 s = 100 
Regime 
Ts  ts  
C
lu
s
te
r 
<f> p(f > 1) fmax <f> p(f > 1) fmax <f> p(f > 1) fmax 
°C day 
Factory 3 1 1 0.35 0.00 1.00 0.39 0.00 0.83 0.44 0.00 0.98 
Retail 6 2 2 0.24 0.00 0.48 0.27 0.00 0.76 0.31 0.00 0.73 
Consumer 7 4 3 0.50 1.8 x 10
-4
 1.08 0.55 4.7 x 10
-4
 1.55 0.60 1.8 x 10
-3
 1.63 
   4 0.78 2.6 x 10
-2
 1.76 0.82 4.4 x 10
-2
 2.19 0.87 9.2 x 10
-2
 1.97 
Factory 3 1 1 0.57 9.6 x 10
-4
 1.25 0.64 2.6 x 10
-3
 1.51 0.72 0.00 2.38 
Retail 6 4 2 0.41 0.00 0.81 0.46 2.8 x 10
-5
 1.03 0.52 2.0 x 10
-4
 1.27 
Consumer 7 6 3 0.84 5.1 x 10
-2
 1.61 0.91 1.4 x 10
-1
 2.57 1.00 4.4 x 10
-1
 2.73 
   4 1.29 9.9 x 10
-1
 2.51 1.37 9.9 x 10
-1
 3.29 1.45 1.00 2.87 
Factory 3 1 1 0.17 0.00 0.41 0.19 8.1 x 10
-6
 1.05 0.22 0.00 0.58 
Retail 6 1 2 0.12 0.00 0.33 0.14 0.00 0.30 0.16 0.00 0.38 
Consumer 7 2 3 0.25 0.00 0.76 0.27 2.3 x 10
-5
 1.13 0.30 0.00 0.53 
   4 0.39 0.00 0.97 0.41 0.00 0.94 0.44 0.00 0.99 
Table 5.8 The exhaustion of the time preceding observation of growth, tmin, from 
s = 1, s = 10 and s = 100 spore tube-1 during multi-stage isothermal storage 
 
At certain storage conditions a single spore for strains belonging to clusters 3 
and 4 give a high probability of exhaustion of the time preceding observation of 
growth ~0.05 and ~0.99 (Ts2 = 6.0°C, ts2 = 4 days and Ts2 = 7.0°C, ts2 = 6 days). 
As expected the probability for a hazard increases with increasing number of 
spores. The development of the probability that a single spore will exceed the 
time preceding the observation of growth as a function of time is presented in 
Figure 5.15. The example includes fixed conditions for factory and retail storage 
and shows the progression of the exhaustion probability, p(f > 1), as a function of 
consumer storage time at 7.0°C. After times ~3 days the probability for strains 
belonging to cluster 4 increases rapidly from ~0.02 (on day 4) to 1.0 (on day 9), 
with the most rapid rise between day 5 and 7. For some strains (cluster 2) the 
exhausted probability p(f > 1) does not increase significantly before 14 days of 
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storage. Clearly the total time for which the probability that a single spore 
exceeds the time preceding observation of growth can be reduced by extending 
storage in factory or by the retailer. 
 
 
Figure 5.15 The probability for a single spore to exceed the time preceding 
observation of growth during non-isothermal storage  
The storage regime includes ts1 = 1 day at Ts1 < 3.0°C (factory), ts2 = 2 days at Ts2 = 
6.0°C (retail) and a variable duration for consumer storage for ts3 at Ts3 = 7.0°C 
Bars colours corresponds to strains belonging to cluster 1 (pink bar), cluster 2 (green 
line), cluster 3 (violet line), cluster 4 (black line) 
 
From Table 5.8 and Figure 5.15 is clear that spore variability is an important 
factor in the determination of storage regimes and consequently product shelf-
life. Clearly, use of predictive models in estimation of the period preceding 
growth and toxin production would treat the population of spores as a uniform, 
and may under estimate those strains for which growth can be expected faster. 
The end point measure for non-proteolytic C. botulinum in dairy-based chilled 
dessert is a product of two independent probabilities: the probability for a finite 
number of spores in a retail unit and the probability that spores of non-proteolytic 
C. botulinum will exceed the time preceding observation of growth during multi-
stage storage period. The values listed in Table 5.8 are sensitive to product 
composition (addition of egg yolk) and strain variability. The sensitivity was 
summarised by evaluating the exhausted fraction of the time preceding 
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observation of growth for different consumer storage duration (Table 5.10). The 
model for the time preceding observation of growth from a given number of 
spores includes a dependency on spore population size after heat treatment (in 
general larger populations exhaust time preceding observation of growth 
quicker). Nevertheless, the dominant hazard arises from retails units containing  
a single spore (Table 5.9). 
 
C
lu
s
te
r Product without added egg yolk Product with added egg yolk 
s = 1 s = 10 s = 100 s = 1 s = 10 s = 100 
Hazard probability* 
1 
1.42 x 10
-8
  
(1.53 x 10
-8
) 
6.11 x 10
-11
 
(5.30 x 10
-11
) 0.00 
5.33 x 10
-7 
(5.58 x 10
-7
) 
9.82 x 10
-8 
(8.24 x 10
-8
) 
1.49 x 10
-21 
(2.99 x 10
-21
) 
2 0.00 0.00 0.00 0.00 0.00 0.00 
3 
4.96 x 10
-7 
 
 (1.45 x 10
-7
) 
1.05 x 10
-9
 
(5.31 x 10
-10
) 0.00 
1.98 x 10
-5 
(4.35 x 10
-6
) 
1.79 x 10
-6 
(6.49 x 10
-7
) 
3.73 x 10
-20 
(7.45 x 10
-20
) 
4 
4.85 x 10
-5
 
(8.61 x 10
-6
) 
9.24 x 10
-8
 
(3.10 x 10
-8
) 0.00 
1.94 x 10
-3 
(1.10 x 10
-4
) 
1.61 x 10
-4 
(2.52 x 10
-5
) 
2.47 x 10
-18 
(4.94 x 10
-18
) 
Table 5.9 Probabilities for end point measures in a quantitative risk assessment 
of model dairy-based chilled dessert 
The results indicate the probability for the multi-stage storage time (ts1 = 1 day at Ts1 < 
3.0°C (factory), ts2 = 2 days at Ts2 = 6.0°C (retail) and ts3 = 4 days at Ts3 = 7.0°C) to 
exceed time preceding observation of growth * data given as mean (standard deviation 
of five simulations) 
 
Table 5.10 indicates the end point measures, for non-proteolytic C. botulinum 
with the parameters corresponding to Table 5.3 and an additional period of 
consumer storage with duration up to 21 days. For the smallest periods of 
domestic storage strains belonging to cluster 2 will not make a contribution to the 
end point measure. The main hazard arises from strains belonging to clusters 3 
and 4. Additional storage for a period of 21 day increases the hazard which 
becomes uniform across all clusters. 
 
C
lu
s
te
r Product without added egg yolk Product with added egg yolk 
Hazard probability 
ts3 = 5 ts3 = 7 ts3 = 14 ts3 = 21 ts3 = 5 ts3 = 7 ts3 = 14 ts3 = 21 
1 1.59 x 10
-7
 1.63 x 10
-6
 5.52 x 10
-4
 2.28 x 10
-3
 4.14 x 10
-6
 5.39 x 10
-5
 2.11 x 10
-2
 8.91 x 10
-2
 
2 0.00 8.60 x 10
-8
 1.43 x 10
-5
 6.06 x 10
-4
 0.00 2.83 x 10
-6
 5.46 x 10
-4
 2.36 x 10
-2
 
3 3.58 x 10
-6
 5.26 x 10
-5
 2.09 x 10
-3
 2.30 x 10
-3
 9.34 x 10
-5
 1.74 x 10
-3
 7.99 x 10
-2
 8.97 x 10
-2
 
4 5.16 x 10
-4
 2.22 x 10
-3
 2.11 x 10
-3
 2.30 x 10
-3
 1.32 x 10
-2
 7.32 x 10
-2
 8.04 x 10
-2
 8.97 x 10
-2
 
Table 5.10 Probabilities for end point measures in a quantitative risk assessment 
of model dairy-based chilled dessert (s = 1 spore tube-1) 
The results indicate the probability for the multi-stage storage time that includes ts1 = 1 
day at Ts1 < 3.0°C (factory), ts2 = 2 days at Ts2 = 6.0°C (retail) and a variable duration for 
consumer storage for ts3 at Ts3 = 7.0°C 
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5.4 Discussion 
This assessment considered hazards associated with non-proteolytic                
C. botulinum in a model dairy-based minimally heated chilled dessert. The 
assessment is based on data summarised in chapters 2, 3 and 4 with 
implementation of Monte Carlo simulation. The strength of the hazard depends 
on spore loads in raw materials, on thermal properties of spores and on the 
definition of tmin, time that represents a period before non-proteolytic C. botulinum 
can produce toxin. The quantification of time tmin was based on a   parameter 
(determined in predictive models for the probability of growth). The assessment 
explicitly includes an evaluation of strain variability associated with time 
preceding the observation of growth. 
 
The assessment is quantitative and represents the probability that a product’s 
storage time, does not exceed the time preceding observation of growth from 
spore inocula in a retail units of dairy-based dessert. For a model corresponding 
to the parameters given in Table 5.3 and storage with Ts2 = 6.0°C for ts2 = 2 days 
and Ts3 = 7.0°C for t2 = 4 days, the probabilities for exceeding the time preceding 
observation of growth are very small for strains belonging to clusters 1 and 2, 2.6 
x 10-2 for strains from cluster 3 and ~1.8 x 10-4 for strains belonging to cluster 4. 
The combined end point measure ranges from 0 to 4.85 x 10-5 (s = 1 spore tube-
1), from 0 to 9.24 x 10-8 (s = 10 spores tube-1) and very small for s = 100 spore 
tube-1. These results relate to strains 1 – 4 (no egg) and show that the dominant 
contribution to risk is associated with single spore occupancy. In the presence of 
egg yolk the values are increased and range from 5.33 x 10-7 to 1.94 x 10-3 (s = 1 
spore tube-1), from 1.61 x 10-4 to 9.82 x 10-8 (s = 10 spore tube-1) and very small 
for s = 100 spore tube-1. Longer periods of storage add to the values of the end 
point measures.  
 
The statistical analysis performed on the model variables measured the 
correlation coefficient between the input variables and the end point measure. 
Figure 5.16 shows a tornado chart of the Spearman rank correlation of the main 
uncertain input parameters and the end point measure. In this model D-value 
(that determines the heat treatment applied) is the main control measure for 
ensuring a safe product. The D-value chosen influences one of two components 
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of end point measure – a probability that an individual unit of dairy-based chilled 
dessert contains a finite number of spores. A big value for σD leads to an end 
point measure, for non-proteolytic C. botulinum that is bigger than the one in the 
model, whereas use of single D-value leads to smaller end point measure. The 
product that contains egg yolk can be protective to spores of non-proteolytic     
C. botulinum, due to activity of lytic enzymes, leading to increase in the number 
of spores that survive heating. The information summarised in chapter 2 on 
spore inactivation kinetics in the presence of lysozyme, indicates a 100-fold 
greater heating required to reduce population of spores, compared to spores 
heated in the absence of lysozyme.  
 
 
Figure 5.16 Spearman rank correlation coefficients of uncertain input variables 
with toxicity of a dairy-based chilled dessert 
The length of the bar indicates the impact of particular input variable on the analysed 
output. A positive coefficient (bar extending to the right – the input has a positive impact, 
bar extending to the left – the input has a negative impact, e.g. increase the input will 
reduce the output) 
 
Variable risk for non-proteolytic C. botulinum was based on identification of 
appropriate clusters of strains as a function of growth at chilled temperatures – 
one of the crucial elements for the end point measure. The strain variability in 
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relation to growth is consistent with variability in carbohydrate utilisation and that 
is associated with toxin type.  
 
The risk of a toxic pack at the point of preparation for a model dairy-based chilled 
dessert is almost two orders of magnitude higher for strains belonging to cluster 
4 (4.85 x 10-5) – type E strains, than strains belonging to cluster 3 (4.96 x 10-7), 
three orders of magnitude higher than strains in cluster 1 (1.42 x 10-8) and much 
higher than for strains in cluster 2 (for which risk is very small) – mainly type B 
strains. The output of this risk assessment is consistent with epidemiology for 
non-proteolytic C. botulinum summarised in Table 1.2 which shows many more 
reported outbreaks of botulism associated with non-proteolytic C. botulinum type 
E compared to non-proteolytic C. botulinum type B. Nevertheless, it should be 
noted that non-proteolytic type B cases are under reported, since in many cases 
investigators fail to distinguish between proteolytic and non-proteolytic               
C. botulinum type B hazards. A majority of type B outbreaks associated with 
canned foods are probably associated with proteolytic type B, while some type B 
outbreaks in Europe are associated with non-proteolytic C. botulinum type B 
(Lücke, 1984; Hauschild, 1993; Peck, 2006). An additional contributory factor for 
greater incidence of outbreaks associated with strains of type E might be that 
type E strains are more common in the environment than non-proteolytic           
C. botulinum type B strains (Dodds, 1993b).  
 
Despite this, the development of a probabilistic risk assessment model, that 
includes integration of strain variability and associated effects can be used by 
product manufacturers to define an acceptable level of risk and to distinguish 
different hazards. The assessment is modular and therefore can be adopted to 
addition of more raw materials, different products and alternative process 
parameters.  
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5.5 Conclusions 
The main challenge for this risk assessment of model dairy-based chilled 
desserts was the inclusion of information regarding strain variability of non-
proteolytic C. botulinum summarised in this thesis. This approach reflects the 
variability of strain response to different factors present in their environment and 
therefore helps to give a better representation of the hazard. 
Additionally, the calculation of risk allowed the following conclusions: 
i. The inherent high level of phenotypic variability observed between non-
proteolytic C. botulinum strains has an important impact on calculated risk 
for minimally heated dairy-based chilled dessert 
ii. Strains forming type E neurotoxin present greater hazard for minimally-
heated chilled dessert, than strains forming type B and F neurotoxins 
iii. The results of risk assessment for non-proteolytic C. botulinum are 
consistent with foodborne botulism outbreaks (more cases reported due to 
non-proteolytic C. botulinum type E strains) 
iv. Extended storage time decreases the impact of strain variability on 
estimated risk 
v. The probability of spores in post-pasteurized retail units of model dairy-
based dessert is sensitive to spore heat resistance, given by a D-value 
and in consequence to product ingredients e.g. lysozyme 
vi. A single spore is the dominant hazard in the calculation of risk presented 
by a model dairy-based chilled dessert 
vii. Strain variability makes a considerable impact on the assessment of the 
time preceding observation of growth 
 
The model product chosen for this assessment includes relatively simple 
composition, a minimal heat process and storage regime dominantly at two 
temperatures. Each of these elements could be expanded, and could include 
more details, within the current model framework. In this case additional data 
supplies, such as growth at 5.0°C or 8.0°C, would be required to reduce 
corresponding uncertainty. Although additional elements in the process model 
would change the numeric values of the end point measure, the conclusions 
which point to an ability to quantify the hazard and identify variability associated 
with strain types would remain unchanged. The estimate of end point value could 
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be enhanced by improved description of spore loads in raw materials, by taking 
into account spore damage, by including temperature fluctuations for the 
consumer storage period and transport and by integration of information 
regarding carbohydrate fermentation e.g. ability of type B and F strains but not 
type E strains to utilise amylose, amylopectin (two components of starch) or 
glycogen. Moreover, the model could be improved by modification of the 
assumption regarding the product’s physico-chemical characteristics e.g. optimal 
and constant pH and aw or by inclusion of information on the effects of 
preservatives that inhibit growth of non-proteolytic C. botulinum. 
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6. Summary and conclusions 
The ability of non-proteolytic C. botulinum to survive moderate heat treatments 
and the ability for growth and neurotoxin formation at refrigeration temperatures 
makes this pathogen a major safety concern for minimally heated chilled foods. 
Although outbreaks of foodborne poisoning associated with the presence of 
botulinum neurotoxin in commercially manufactured products are rare, their 
serious consequences for consumers and food manufacturers requires use of 
the most sophisticated methods to assess and  control the risk. One suitable 
method is Quantitative Microbial Risk Assessment (QMRA), and one way to 
make a QMRA for non-proteolytic C. botulinum in minimally heated chilled foods 
more sophisticated is to take account of the effect of strain variability. Based on 
their physiological properties (growth at chill temperatures and growth on 
different carbohydrate source) and their phylogenetic relationship, strains of non-
proteolytic C. botulinum can be separated into distinct two groups, one of strains 
that form type B or type F neurotoxin, and one of strains that form type E 
neurotoxin. Account has been taken of strain variability in a QMRA for non-
proteolytic C. botulinum in a model minimally heated chilled dairy-based dessert.  
 
One of the factors important in controlling non-proteolytic C. botulinum in 
minimally heated chilled foods is heat treatment. Chapter 2 of this thesis 
presents the main findings of an extensive systematic literature review on the 
heat resistance of spores of non-proteolytic C. botulinum. The survey yielded 48 
eligible sources from which 880 D and 528 z-values were extracted. Analysis of 
the kinetic inactivation parameters indicated that: (i) activity of lytic enzymes is 
an important factor when applying a heat treatment, as it significantly affects the 
thermal properties of non-proteolytic C. botulinum spores; (ii) two D-values were 
identified <Dˈ(80)> = 2.23 min (for spores recovered in absence of lysozyme in 
recovery media) and <Dˈ(80)> = 245 min (for product in presence of lysozyme in 
recovery media); (iii) two z-values should be considered: z = 7.0°C (for product 
without lytic enzyme activity) and z = 9.0°C (for product with lytic enzyme 
activity); (iv) there was no relationship between spore heat resistance and toxin 
type, and strains forming exceptionally heat resistant spores were not identified; 
(v) the survey provided valuable information regarding the variability of D and    
z-values that is suitable for use in QMRA, and this has been used in the 
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quantification of risk for a model dairy-based minimally heated chilled product 
(Chapter 5). Moreover, the outputs of this review have been applied by 
companies producing chilled foods in the SUSSLE project (CFA, 2013). It is 
planned to publish the major findings as a review on spore heat resistance of 
non-proteolytic C. botulinum. 
 
Another major factor important in controlling non-proteolytic C. botulinum in 
minimally heated chilled foods is effective chilled storage. Chapter 3 of this thesis 
focuses on the variability in growth between different strains of non-proteolytic  
C. botulinum at chill temperatures. The variability of 42 strains was assessed in 
respect of two independent variables: incubation temperature and spore 
inoculum concentration. In the first experiment, the variable response of 40 
strains was tested at 3.0 – 10.0°C (using one spore concentration s = 106 spores 
tube-1), whereas in the second experiment, 24 strains were tested at one 
incubation temperature (6.0°C) from seven spore inocula concentrations (from    
s = 106 to 100 spores tube-1). These two independent experiments produced 
similar results. A clustering technique indicated an extensive variation in 
response among non-proteolytic C. botulinum strains, and most interestingly, the 
variability in growth was associated with type of neurotoxin formed, with type E 
strains generally showing more rapid growth at chilled temperatures than type B 
and F strains. Based on their growth response at chilled temperatures, strains of 
non-proteolytic C. botulinum were assigned to one of four clusters. Probabilistic 
models were developed that described the variability in growth response within 
these four clusters, and these were used in a risk assessment for a model dairy-
based minimally heated chilled dessert. It is planned to publish the major findings 
of this Chapter. 
 
Carbohydrates are the major source of carbon and energy for strains of non-
proteolytic C. botulinum. Chapter 4 describes tests to determine the ability of 33 
strains of non-proteolytic C. botulinum to utilize 54 different carbohydrates. 
Growth was determined by acidification of the culture medium, turbidity and gas 
formation. Most carbohydrates were either fermented or not fermented by all 
strains. However, a number of important differences were identified, and strains 
could be classified into three groups, with each group fermenting different 
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carbohydrates. Interestingly, strain classification was associated with type of 
neurotoxin formed. Strain clustering appeared to be consistent with the clustering 
pattern obtained in growth tests at chill temperatures, therefore these data 
support the validity of the classification pattern for non-proteolytic C. botulinum. 
The major findings of this chapter have been included in a publication on the 
genomic and physiological variability within non-proteolytic C. botulinum (Stringer 
et al., 2013). One unexpected finding was that in this test system observations of 
growth were not correlated with the presence of neurotoxin. Tests conducted in     
a fermenter system indicated that strains of non-proteolytic C. botulinum seemed 
able to degrade toxin that they had previously formed. This observation is worthy 
of further study. 
 
Generated and collected information in Chapters 2, 3 and 4 on strain variability 
of non-proteolytic C. botulinum were used as input information to the quantitative 
microbial risk assessment model for minimally heated chilled foods. The modular 
process risk model described in Chapter 5 considers hazards arising from raw 
materials, spore inactivation during thermal processing (based on a distribution 
for parameters D and z obtained in Chapter 2), distribution of spores in retail 
units and variability of strains during multi-stage storage regimes (based on 
strain variability tested in Chapter 3). The model is constructed using a Monte 
Carlo simulation technique and calculates the risk of a toxic retail unit of dairy 
dessert at point of preparation. The assessment includes the following findings: 
(i) inclusion of information on strain variability of non-proteolytic C. botulinum has 
an important impact on calculated risk; (ii) the greater hazard for model 
minimally-heated chilled dessert was associated with type E strains rather than 
those of type B and F; (iii) the output of the risk assessment agreed with the 
epidemiology of non-proteolytic C. botulinum, were more outbreaks are 
associated with type E strains; (iv) heat treatment parameters are significant 
elements of QMRA model and should be precisely defined when the activity of 
lytic enzymes in manufactured product is considered. The results of this risk 
assessment can be used for example when estimating the risks associated with 
food products originating from distinct geographical locations (e.g. with higher 
prevalence of type E strains). Information regarding the effect of carbohydrate 
source on variability of growth and neurotoxin formation by strains of non-
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proteolytic C. botulinum were not directly implemented into the QMRA model. 
Nevertheless, this information strongly supports the variability between strains of 
non-proteolytic C. botulinum that is associated with the type of neurotoxin 
formed. This information can be also used in a future risk assessment for 
products that contain e.g. starch (that appeared in tests to be utilized by B and F 
strains but not by type E strains). The main observations of this chapter will be 
published as a model risk assessment.  
 
The present study was designed to determine the impact of strain variability on 
risks presented by non-proteolytic C. botulinum in chilled foods. The data 
obtained in two independent experiments (growth at chill temperatures and 
carbohydrate utilisation) indicated a significant variability between strains of 
types B and F and those of type E, and this appeared to have an impact on 
calculated risk. Nevertheless, additional research could be undertaken in order to 
test whether strain variability is related with combination of factors including the 
toxin formed. These could include: (i) testing the spore heat resistance of strains 
used in experiments described in Chapters 3 and 4 in well-controlled manner; (ii) 
tests different NaCl concentrations; (iii) tests the effect of pH and water activity 
on heat resistance; (iv) testing the strain variability as a function of the combined 
effect of heat treatment and storage at chill temperatures. Although the particular 
risk assessment presented in Chapter 5 is limited by model process, the QMRA 
technique and implementation can be extended to other, more realistic 
situations. The QMRA results clearly show the ability to encapsulate complexities 
that are associated with strain variability for non-proteolytic C. botulinum. In 
addition the QMRA illustrates opportunities for progression and future work 
concerning improved appreciation of C. botulinum hazards that includes partition 
of the hazards according to cluster of strains and potential complex behaviour 
involving toxin degradation in the presence of glucose.  
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Appendix 1 Brief summary of included studies on heat 
resistance of non-proteolytic C. botulinum spores 
 
Studies of recovery in absence of lysozyme (-LYS) [ordered alphabetically] 
 
Alderman et al. (1972)  
Toxin type E 
No. of strains tested 2 
Temperature
 a)
 83°C 
Heating menstruum autoclaved chub fish and egg white, raw egg white,  
No. of D/z-values
b) 
4/-/- 
Notes The influence of moist and dry environment on spore heat 
resistance was tested. Spores heated in raw fish had 
significantly greater D-value than those heated in autoclaved 
fish. The same finding was observed using egg white (which 
coagulates rapidly at high temperatures). Authors concluded 
that the physical state of the menstruum is important in the 
heat tolerance of spores. Lower aw increases the resistance of 
spores. 
Quality 
 High 
Quality criteria not met 
 
 
Angelotti (1970) 
Toxin type E 
No. of strains tested 4 
Temperature 80°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 4/4/4 
Notes The paper summaries current state of knowledge on heat 
resistance of type E strains. Four D-values originate from the 
experiment performed by another author (that could not be 
retrieved) and there is no detailed description of the system.  
Quality 
 Medium 
Quality criteria not met 
f, k, l, n, o, p 
 
Appleyard and Gaze (1993) 
Toxin type E 
No. of strains tested 1 
Temperature 70°C 
Heating menstruum tomato homogenates 
No. of D/z-values 37/-/- 
Notes Heat resistance was determined following a range of sublethal 
heat treatments. The sublethal heating (heat shock) at all 
conditions (except one: 60 min/40°C) increased the D-value. 
Simultaneously the influence of conditions at which the 
heating menstruum was kept before determining the D-value 
was examined. The D-value obtained immediately after heat 
treatment was the highest (to compare to those obtained after 
holding the samples for 4h/room temp. and 24h/6°C). 
Sublethal heating activates spores and induces higher spore 
heat resistance (which might have a crucial role in food that is 
heat treated slowly with long come up time). 
Quality 
 High 
Quality criteria not met 
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Bohrer et al. (1973) 
Toxin type E 
No. of strains tested 4 
Temperature 70, 72, 73, 75, 77, 79, 80, 81, 82°C 
Heating menstruum 0.07M and 0.067M phosphate buffer, corn brine, crabmeat, 
milk (evaporated), peas, salmon, sardines (in tomato 
sauce), shrimp, tuna (in oil) 
No. of D/z-values 53/12/51 
Notes The heat resistance of only one strain, Saratoga, was 
tested in food. As a reference heating menstruum 
phosphate buffer was used, where at 80°C a D-value of 1.1 
minute was calculated. Much higher values were obtained 
in tuna, sardines, crabmeat, peas and corn, which show 
that food is more protective to heat than buffer. Authors 
also presented the percentage composition of tested food. 
There was no correlation in heat resistance and content of 
carbohydrates in food. Tuna – high in protein and fat 
content gave the highest D-value. Sardines in tomato 
sauce – high in fat in protein content – gave second 
highest D-value. Both tuna and sardines are low 
percentage of water. Shrimp – low in fat and high in protein 
gave little protection from heat. A comparison of heat 
resistance of 4 strains was conducted in phosphate buffer, 
and it was difficult to distinguish the most heat resistant 
strain, since it varied with T. The most heat resistant strain 
at 70°C was Alaska, at 73°C and 75°C Saratoga, at 77°C 
Beluga and 80°C 1304E. 
Quality 
 High 
Quality criteria not met 
 
 
Bucknavage et al. (1990) 
Toxin type E 
No. of strains tested 1 
Temperature 50, 55, 60, 70, 80°C 
Heating menstruum oyster homogenates 
No. of D/z-values 20/4/20 
Notes Initially the heat resistance of 5 strains was tested, of which 
Beluga was the most heat resistant. The impact of addition 
of salt and/or potassium sorbate (KS) to heating 
menstruum was tested. Salt increased the D-value only at 
certain T (50, 70 and 80°C). KS had no effect on heat 
resistance of spores. Authors calculated z-values for two 
different temperatures range according to better fit found. 
The z-values calculated for the curve between 70°C and 
80°C ranged from 6.9°C to 7.6°C, while z-value calculated 
between 55°C and 70°C were 12.1 to 14.7°C. In the 
analysis the z-values were calculated for all temperatures. 
(50 – 80°C), and ranged from 7.7°C to 7.9°C. 
Quality 
 High 
Quality criteria not met 
o 
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Chai and Liang (1992) 
Toxin type E 
No. of strains tested 5 
Temperature 74, 75, 77, 79, 82°C 
Heating menstruum oyster homogenates 
No. of D/z-values 52/10/52 
Notes From 5 strains tested the most heat resistant was strain 
Minnesota. Authors calculated z-values using two different 
methods (TDT curve and survivor curve). The z-values 
were higher when determined from TDT curve as 
compared to survivor curve. Although authors gave 21 D-
values, 52 were noted, since for each D-value two z-values 
were calculated, which is important when all D-values are 
converted to D'(80). 
Quality 
 High 
Quality criteria not met 
 
 
Crisley et al. (1968) 
Toxin type E 
No. of strains tested 5 
Temperature 80°C 
Heating menstruum whitefish chubs 
No. of D/z-values 6/6/6  
Notes The test was conducted at four T. Data were presented as 
TDT was converted to D-value, with strain Alaska showing 
the highest heat resistance. 
Quality 
 High 
Quality criteria not met 
 
 
De Pantoja (1986) 
Toxin type E 
No. of strains tested 1 
Temperature 80, 85, 90, 95°C 
Heating menstruum crawfish paste 
No. of D/z-values 2/1/2 
Notes D-values calculated by three methods (Stumbo, 1948; 
Stumbo et al., 1950; Schmidt, 1957) were inconsistent, 
causing a variation in z-values. Since D-values at 80 and 
95°C did not confirm earlier findings of other researchers, the 
author excluded them from further analysis. Only the D-value 
calculated by the method of Stumbo (1948) gave the z-value 
consistent with results of previous studies therefore these 
data were included in database. The author observed that 
heat resistance of spores seemed to be greater at higher T. 
This might be attributed to: possible activation of more heat 
resistant spores present in population or problems with the 
experimental procedure itself - sedimentation of crawfish 
paste along sides of the test tubes - providing “dry” 
environment or loss of water, that might occur during heating 
at high T due to evaporation. 
Quality 
 High 
Quality criteria not met 
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Duh and Ren (1995) 
Toxin type E 
No. of strains tested 1 
Temperature 70, 80, 90°C 
Heating menstruum fine carrot 
No. of D/z-values 3/1/3 
Notes The paper was written in Chinese. The publication was 
translated by visiting student in IFR.  
Quality 
 High 
Quality criteria not met 
f 
 
Eklund et al. (1967a) 
Toxin type F 
No. of strains tested 2 
Temperature 70, 80, 90°C 
Heating menstruum physiological saline 
No. of D/z-values 6/2/6 
Notes The heat resistance was included in tests examining the 
properties of a type F strain. The D and z-values were not 
given in the publication and parameters were calculated 
from TDT data. 
Quality 
 High 
Quality criteria not met 
f 
 
Fernandez and Peck (1997) 
Toxin type mixed strains (3 type B, 3 type E and 2 type F) 
No. of strains tested mixture of 8 strains 
Temperature 70, 75, 80, 85°C 
Heating menstruum meat medium 
No. of D/z-values 3/1/3 
Notes The purpose of this study was to develop a predictive 
model that described the effect of heating and incubation 
on growth and toxin production by C.botulinum strains. The 
D-values were not given by authors. MPN results were 
used to fit the best straight line and calculated the 
parameters of heat treatment. It was impossible to 
calculate the D-value at 90°C since rapid death. The D-
value at 70°C was excluded from analysis. The low z-value 
(5.9°C) might be a result of including the D-value in a range 
of 70-85°C, since it gave better fit that the D-values in a 
range 75 – 85°C. 
Quality 
 High 
Quality criteria not met 
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Gaze and Brown (1990) 
Toxin type B and E 
No. of strains tested 2 
Temperature 70, 75, 80, 85, 90, 92°C 
Heating menstruum cod and carrot homogenates 
No. of D/z-values 20/4/20 
Notes This study is a basis for ACMSF recommendation (heat 
treatment of 10 minutes at 90°C) to deliver a 6D reduction 
of C. botulinum spores. Precisely, authors recommended 
heating of “sous-vide” products at 90°C for 7 minutes with 
z-value equal to 9.84°C. 
For both strains at all measured temp. D-values were 
higher in cod than in carrot homogenate. There was no 
significant difference in heat resistance of different toxin 
type strains within the same heating menstruum.  
Quality 
 High 
Quality criteria not met 
 
 
Graikoski and Kempe (1964) 
Toxin type E 
No. of strains tested 6 
Temperature 65, 70, 85°C 
Heating menstruum phosphate buffer,  
No. of D/z-values 6/-/- 
Notes This vast report summarises the resistance of spores to 
heat and radiation. The authors conducted a comparison of 
five counting media (beef-infusion broth, pork-infusion 
agar, Mossel’s media, pork-pea extract and peptone 
media). As a result, beef infusion agar was used for spore 
count in further tests. Two techniques of spores heating 
were employed (open tube and sealed ampules). In case of 
two strains (Forks and Nanaimo), using the open tube 
technique heated at 70°C and 75°C, slightly higher viable 
count was obtained compared to two other strains – those 
strains were stored for several weeks after preparation. 
Authors suggested that this might be attributed to spore 
aging due to storage. With both techniques a tailing effect 
was observed. Spores surviving heating were tested for the 
ability to produce toxin. The results showed that it varies 
across different strains and different temperatures. In the 
database only results of 6 tests were included due to tailing 
effect. The tailing effect could be a consequence of error 
associated with technique: only 1/3 of the top of the tubes 
were immersed in a water bath, tubes were inoculated 
before they reached the test temperature. In few cases 
there was less than 1 log reduction of initial number of 
spores during heat resistance. therefore these data were 
not included in database 
Quality 
 High 
Quality criteria not met 
f 
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Grecz and Tang (1970) 
Toxin type E 
No. of strains tested 5 
Temperature 75°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 1/-/- 
Notes The publication describes a correlation between the spore 
heat resistance and content of dipicolinic acid (DPA). 
Authors tested type A, B and E strains (but only results of 
type E strains were included in database) and concluded 
that there was no correlation between the DPA-content of 
spores and their heat resistance, but a correlation was 
observed between the rate of loss of spore viability and the 
rate of loss of DPA.  
Quality 
 High 
Quality criteria not met 
f, l 
 
Ito et al. (1967) 
Toxin type E 
No. of strains tested 4 
Temperature 77°C 
Heating menstruum 0.03M phosphate buffer 
No. of D/z-values 4/-/- 
Notes The paper presents the study of thermal and chlorine 
resistance of spores. Authors concluded that there is a 
good correlation between heat resistance and chlorine 
resistance. Comparison of heat resistance of proteolytic 
type A, B strains and non-proteolytic type E toxins revealed 
that type A and B spores appears to be generally more 
chlorine resistant than type E strains. 
Quality 
 High 
Quality criteria not met 
f 
 
Ito et al. (1970) 
Toxin type E 
No. of strains tested 4 
Temperature 70, 73, 75, 80°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 16/4/16 
Notes The paper summaries the state of knowledge regarding the 
heat resistance of C. botulinum spores and specifies 
factors influencing the D-value. Additionally the authors 
present results on heat treatment type E strains. From all 
four strains the most heat resistant at 70°C appeared to be 
strain Alaska, at 73 and 75°C strain Saratoga and at 80°C 
strain 1304E. 
Quality 
 Medium 
Quality criteria not met 
f, k, l, n, o, p 
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Kralovic (1973) 
Toxin type E 
No. of strains tested not specified 
Temperature 80°C 
Heating menstruum not specified  
No. of D/z-values 1/-/- 
Notes The data were derived from an abstract of the annual 
meeting of ASM. The test was designed to investigate the 
influence of lysozyme treatment on HR of spores. Since, it 
was not clear if the lysozyme was added to the recovery 
media or heating menstruum, only the control (no 
lysozyme) test was included in the analysis.  
Quality 
 Medium 
Quality criteria not met 
f, h, l, n, o, p, r 
 
Licciardello (1983) 
Toxin type E 
No. of strains tested 2 
Temperature 66, 71, 77, 82, 88, 93°C 
Heating menstruum 0.067M phosphate buffer, clam liquor, haddock slurry 
No. of D/z-values 18/5/18 
Notes The author compares z-values determined by two different 
methods. The z-value calculated from TDT curve for 
spores in clam liquor was higher than the z-value 
determined from plotting survivor curves. The author 
explained that this could be caused by the difference in 
incubation time or medium used during the recovery of 
spores. The author only gives the z-value. D-values were 
not given; therefore they were read from survivor curve and 
TDT curve. The parameter was higher in experiments, 
where food was used as heating medium, rather than 
phosphate buffer. 
Quality 
 High 
Quality criteria not met 
f, o 
 
Lynt et al. (1977) 
Toxin type E 
No. of strains tested 5 
Temperature 74, 77, 79, 82, 85 °C 
Heating menstruum blue crabmeat 
No. of D/z-values 28/6/26 
Notes A comparison of two methods of z-value calculation was 
conducted. TDT curve and survival curve were obtained by 
plotting the log of D-value, and show different slopes for 
the same strain. The greater slope was found for the D-
curve data; therefore the z-value was smaller. This was 
particularly notable for strain Beluga. The most resistant 
strain at all tested T was Beluga.  
Quality 
 High 
Quality criteria not met 
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Lynt et al. (1979) 
Toxin type F 
No. of strains tested 3 
Temperature 71, 74, 77, 79, 82, 85°C 
Heating menstruum 0.067M phosphate buffer, crabmeat 
No. of D/z-values 36/8/36 
Notes Similarly, as in the previous paper (Lynt et al., 1977), the 
authors compared the methods of z-value calculation. TDT 
curve and survival curve obtained by plotting the log of D-
value. It shows different slopes for the same strain. The 
greater slope was found for the D-curve data; therefore the 
z-value was smaller. The study also reported that the heat 
resistance of type F strains was similar to type E strains, 
but with some differences (the slope of TDT and D-curves 
are steeper). Strains 190 and 202 had similar heat 
resistance patterns. The most resistant strain at all 
temperatures was 610 with the greatest z-value. At all 
temperature the crabmeat presented protection to spores 
of all type F strains tested. 
Quality 
 High 
Quality criteria not met 
 
 
Lynt et al. (1983) 
Toxin type E and F 
No. of strains tested 6 
Temperature 71, 74, 77, 79, 82, 85°C 
Heating menstruum 0.067M phosphate buffer, crabmeat 
No. of D/z-values 31/8/31 
Notes The effect of delayed germination by heat damaged spores 
on estimates of heat resistance of type E and F spores was 
determined. The D-values were calculated for all strains 
during different periods of incubation. Parameters extracted 
to the database were calculated at the final period. The 
lowest delays in germination were reported for two type E 
strains (Alaska and Beluga). The delay was greater for the 
type F strains (190, 202 and 610). The delayed incubation 
influences the measured heat resistance of spores. Both 
type E and F showed an apparent increase in D-values 
during the incubation period, with type F more clearly 
reflecting the delayed germination. The D-value of those 
strains measured in phosphate buffer increased from 2- to 
4-fold. As reported previously (Lynt et al., 1979) crabmeat 
offered greater protection to spores. The z-value of type F 
strains showed a slight increase over the period of 
incubation. 
Quality 
 High 
Quality criteria not met 
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Mann (1966) 
Toxin type E 
No. of strains tested 1 
Temperature 71°C 
Heating menstruum distilled water, tuna 
No. of D/z-values 2/2/2 
Notes The data were presented in abstract of a thesis; therefore 
much information regarding the heating procedure is 
missing. Nevertheless, D and z-values given by author 
were added to database.  
Quality 
 
Medium 
Quality criteria not met 
f, i, j, k, l, n, o, p 
 
Membrè and McClure (2006) 
Toxin type mixed strains 
No. of strains tested 6 (type B), 15 (type E), 3 (type F) 
Temperature 80°C 
Heating menstruum TPG, TYD 
No. of D/z-values 38/-/- 
Notes The report was the most recent literature review in the 
given field. Data were obtained by other authors; therefore 
information regarding heating method and recovery 
conditions are missing. The original data could not be 
retrieved from their original studies. 
Quality 
 
Medium 
Quality criteria not met 
f, i, l, n, o, p 
 
Murrell and Scott (1966) 
Toxin type E 
No. of strains tested 1 
Temperature 70, 80°C 
Heating menstruum 0.05M phosphate buffer 
No. of D/z-values 3/-/- 
Notes The heat resistance of spores of six bacterial species at 
various aw was tested. The D-value was not given by 
authors – it was calculated from survivor curves. Authors 
concluded that the heat resistance of spores increases as 
the aw value decreases.  
Quality 
 
Medium 
Quality criteria not met 
f, k, l 
 
NCA (1966) 
Toxin type E 
No. of strains tested 2 
Temperature 70, 75, 80°C 
Heating menstruum 0.017M phosphate buffer 
No. of D/z-values 5/2/5 
Notes Two strains were heated in phosphate buffer at three 
temperature regimes. At 75 and 80°C strain Beluga 
appeared to more heat resistant. 
Quality 
 
High 
Quality criteria not met 
f, l 
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Ohye and Scott (1957) 
Toxin type E 
No. of strains tested 2 
Temperature 70, 75, 80°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 6/2/6 
Notes The paper is one of the first publications showing studies in 
physiology of type E strains. The heat resistance of spores 
was tested among other properties, such us: temperature 
of growth, toxin production and heat resistance of toxin. 
Strain 103 was more heat resistant than strain 108, 
simultaneously showing lower heat resistance in 
comparison with proteolytic C. botulinum type A and B 
strains. 
Quality 
 High 
Quality criteria not met 
f, i, o 
 
Rhodehamel et al. (1991) 
Toxin type E 
No. of strains tested mixture of five strains 
Temperature 74, 77, 79, 82°C 
Heating menstruum menhaden Surimi 
No. of D/z-values 4/1/4 
Notes The incidence of type E spores in menhadeb surimi was 
determined. The results shown that the incidence is 
relatively low (1.2%). Reported D-value at 74 and 77°C 
agreed with values reported by other authors. At 79 and 
82°C values were slightly higher for those previously 
reported. A slightly higher z-value compared with other 
reported for type E, could be a result of high protein 
content of a surimi or inclusion in spore “cocktail” strain of 
unknown heat resistance properties. 
Quality 
 High 
Quality criteria not met 
f 
 
Roberts et al. (1965) 
Toxin type E 
No. of strains tested 9 
Temperature 80°C 
Heating menstruum water 
No. of D/z-values 9/9/9 
Notes The most resistant was strain 1957/61. The heat resistance 
of remaining strains appeared to be very similar. The most 
heat sensitive strain was 16/63. The D-values were given 
by the authors, but it was not clear what method of heat 
treatment was used for the specified D-values. 
Quality 
 High 
Quality criteria not met 
f, i, o 
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Schmidt (1964) 
Toxin type E 
No. of strains tested 1 
Temperature 80°C 
Heating menstruum TPB broth, 0.067M phosphate buffer 
No. of D/z-values 2/2/2 
Notes The thesis summaries updated knowledge about the heat 
resistance of type E strains. One of the main conclusions is 
that spores of proteolytic C. botulinum types A and B are 
more heat resistant that spores of type E. Two D-values 
were given by the author, but there is very little information 
about the experiment. 
Quality 
 Medium 
Quality criteria not met 
f, i, k, l, n, o 
 
Scott and Bernard (1982) 
Toxin type B and E 
No. of strains tested 7 
Temperature 77, 82°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 9/5/7 
Notes Spores of type B strains had greater thermal resistance 
than type E strains and less than of proteolytic                  
C. botulinum type B strains. Authors noted differences in 
heat resistance obtained in their study from data reported 
by other researchers, e.g. for strain Saratoga and 
Minnesota. Nevertheless the authors commented that their 
results were not consistent, and might be possibly caused 
by different batches of recovery media and age of spore 
Quality 
 High 
Quality criteria not met 
o 
 
Solomon et al. (1977) 
Toxin type E 
No. of strains tested 1 
Temperature 82°C 
Heating menstruum crabmeat, TPGY broth  
No. of D/z-values 2/-/- 
Notes The purpose of the experiment was to investigate the effect 
of low temperatures on growth of C. botulinum in a 
autoclaved creabmeat. The D-values were not given by 
authors, but were calculated from the initial and final spore 
concentration given in publication. 
Quality 
 High 
Quality criteria not met 
l, m 
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Stringer et al. (1999) 
Toxin type B 
No. of strains tested 1 
Temperature 80°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 1/-/- 
Notes The D-value was not given by the authors; it was 
calculated from given data. The purpose of the study was 
to test growth from spores of non-proteolytic C. botulinum 
in heated vegetable juice. Unheated spores were able to 
growth in all tested juices (broccoli, spring green, turnip, 
potato, helda bean) but the probability of growth was lower 
than in PYGS or PYGSL broth. A greater probability of 
growth in bean or broccoli juice than in culture media was 
observed after heating spores at 80°C for 10 minutes 
(incubation in heated media). Heating at 80°C for 100 
minutes prevented the growth of spores both in juices and 
culture media. Nevertheless, the shortest time leading to 
growth was observed in PYGS broth (incubated at 30°C). 
Vegetable juice heated at 75°C for 10 min gave counts 
similar to those obtained with unheated juice; therefore 
heating increased the measured heat resistance of the 
spores, despite the fact that no lysozyme activity was 
detected.  
Quality 
 High 
Quality criteria not met 
m 
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Studies of recovery in presence of lysozyme [+LYS] [ordered alphabetically]  
 
Alderton et al. (1974) 
Toxin type E 
No. of strains tested 1 
Temperature 79, 91, 93°C 
Heating menstruum distilled water, phosphate buffer 
Nr. of D/z-values 5/1/2 
Notes No data regarding inoculum size and heating method was 
given. The D-value was not calculated for the heat 
sensitive fraction. This part of survivor curve was ignored. 
The heat resistance of proteolytic and non-proteolytic C. 
botulinum was compared in a presence of lysozyme. 
Addition of enzyme to recovery media increases heat 
resistance both type A and type E strains, but with a 
greater impact on heat resistance of type E strains. 
Lysozyme also affected the colony outgrowth time of type 
A strains - shortening it by approximately half. This 
phenomenon was not observed in case of type E strains. 
Authors stated also, that the magnitude of D-values 
depended on individual batches of recovery medium. 
Quality 
 High 
Quality criteria not met 
f, i 
 
Institute of Food Research (IFR), 1980-2011  
Toxin type B, E, F and mixed strains 
No. of strains tested 9 [11] 
Temperature 75, 78, 80, 82, 85, 88, 92°C 
Heating menstruum 0.067M phosphate buffer, PY broth, béchamel sauce, 
bolognaise sauce, broccoli puree, cooked pasta potato 
puree,  
No. of D/z-values 108/6/24 [96/9/27] 
Notes The data are a summary of manual search of laboratory 
books. Experiments were conducted in different heating 
menstruum with recovery media in absence and presence 
of lysozyme, HEWL or vegetable juices in varius media. In 
most cases the parameters were not given, therefore they 
were obtained by fitting the best straight line. Majority of 
the data were collected at 90°C and the resistance of 
strains depended on heating menstruum used. The most 
resistant strains of heat sensitive and heat resistant fraction 
at 80 and 90°C were Foster B96 and Eklund 17B. In case 
of -LYS tests the most resistant strain at 75 and 80° was 
Eklund 17B. 
Quality 
 High 
Quality criteria not met 
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Juneja and Eblen (1995) 
Toxin type B 
No. of strains tested 9 
Temperature 75, 80, 85, 90°C 
Heating menstruum turkey slurry 
No. of D/z-values 24/6/24 
Notes The Authors determined the effect of salt in turkey slurry 
and recovery medium on the heat resistance of spores. 
They concluded that increasing concentration of salt both 
in heating menstruum and recovery medium reduced the 
heat resistance. There were no kinetic data presented, 
therefore it was impossible to verify, whether the tailing 
effect in spore recovery was observed.  
Quality 
  
Quality criteria not met 
f, o, r 
 
Juneja et al. (1995a) 
Toxin type B and E 
No. of strains tested 7 
Temperature 70, 75, 80, 85, 90°C 
Heating menstruum 0.1M phosphate buffer, turkey slurry 
No. of D/z-values 33/33/33 [12/12/12] 
Notes The data showed that the D-value obtained in turkey slurry 
was higher than in phosphate buffer and that the heat 
resistance of spores is higher in media +LYS to compare to 
-LYS. The most resistant strains at 70°C in a phosphate 
buffer at 75°C were CBW25 and KapB5, at 80 and 85°C – 
Saratoga. There were no kinetic data presented, therefore 
it was impossible to verify, whether the tailing effect in 
spore recovery was observed.  
Quality 
  
Quality criteria not met 
o, r 
 
Juneja et al. (1995b) 
Toxin type B, E 
No. of strains tested mixture of six strains 
Temperature 70, 75, 80, 85, 90°C 
Heating menstruum turkey slurry 
No. of D/z-values 45/7/19 
Notes The authors examined the effect and interactions of 
heating temperature, pH, sodium chloride and sodium 
pyrophosphate on the heat resistance of C. botulinum. The 
data suggested that a lower pH resulted in a greater heat 
resistance, particularly at high temperatures. The 
parameters of heat resistance can be reduced by 
combining all four factors. There were no kinetic data 
presented, therefore it was impossible to verify, whether 
the tailing effect in spore recovery was observed. 
Quality 
  
Quality criteria not met 
o, r 
 
 
 291 
Lindström et al. (2003) 
Toxin type E 
No. of strains tested 1 
Temperature 75, 81, 85, 90, 93°C 
Heating menstruum rainbow trout, whitefish 
No. of D/z-values 10/2/5 
Notes The authors estimated that the heat resistant fraction 
constitutes of approximately 0.1% of spores.  
Quality 
 High 
Quality criteria not met 
 
 
Notermans et al. (1990) 
Toxin type B and E 
No. of strains tested 3 
Temperature 70, 80, 90°C 
Heating menstruum 0.07M phosphate buffer, different media 
No. of D/z-values 7/1/30 
Notes The authors concluded that spores of non-proteolytic        
C. botulinum can lead to growth and toxin production in 
REPFEDs, but heating at 90°C for 4 minutes was sufficient 
to provide a 5D safety factor. Strains CDI-1 and CDI-2 
presented a very similar heat resistance pattern both at 70 
and 80°C. There are no example kinetic data; therefore it 
was impossible to state if tailing effect was observed.  
Quality 
  
Quality criteria not met 
f, n, r 
 
Peck et al. (1992a) 
Toxin type B 
No. of strains tested 1 
Temperature 85°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 3/-/- 
Notes The effect of recovery medium on the heat resistance of 
spores was tested. The authors shown that inclusion of as 
little as 0.1µl lysozyme ml-1 is sufficient to increases the 
number of surviving spores. The maximum spore recovery 
was achieved at a concentration of 5 – 10 µg/ml of 
lysozyme. The D-values were not given by authors and 
they were extrapolated from survivor curve given only for 
one strain. The authors estimate also that 0.1 – 1.0% of 
heated spores are permeable to lysozyme. 
Quality 
 High 
Quality criteria not met 
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Peck et al. (1992b)  
Toxin type B and E 
No. of strains tested 2 
Temperature 85°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 6/-/- 
Notes All strains had a higher D-value in +LYS media compared 
with the control. The effect of alkaline thioglycolate 
treatment of heated spores on their inactivation kinetics 
was tested. Spores of Eklund 17B untreated with alkaline 
thioglycolate before plating gave an estimated 4.1 decimal 
kill in 120 min. Treatment of spores gave an estimated 1.6 
decimal kill in 120 min. The authors suggested that a 
marked increase in the number of heated spores recovered 
on +LYS medium was due to their increased permeability 
to lysozyme. 
Quality 
 
High 
Quality criteria not met 
 
 
Peck et al. (1993)  
Toxin type B and E 
No. of strains tested 2 
Temperature 75, 85, 90, 95°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 15/2/15 
Notes In +LYS media, spores of strain Beluga were more 
sensitive to heating than those of strain Eklund 17B. 
Heated spores of a further 10 strains (type E and F) at 
85°C and recovered in +LYS, resulted in D-values of 29 – 
53 min (heat resistant fraction). Within those 10 strains 
there was no relationship between toxin type and D-value. 
The authors estimated that 0.2 – 1.4% of heated spores 
were permeable to lysozyme with temperature having little 
effect on its size. The effect of alkaline thioglycolate 
treatment of heated spores on their inactivation kinetics 
was tested. Similar curves for the heat resistant fraction 
were obtained for spores both treated/untreated with 
alkaline thioglycolate. 
Quality 
 
High 
Quality criteria not met 
 
 
Peterson et al. (1997) 
Toxin type mixed strains 
No. of strains tested 3 
Temperature 89, 91, 92, 93, 94°C 
Heating menstruum crabmeat 
No. of D/z-values 11/1/11 
Notes The authors showed that recovery of spores in a medium 
containing crabmeat increased the D-value, suggesting 
that crabmeat provide protection to the spores against the 
heat. The effect of two methods determination (TDT and 
survivor curve) of D-value on its magnitude was explained.  
Quality 
 
 
Quality criteria not met 
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Scott and Bernard (1985) 
Toxin type B and E 
No. of strains tested 5 
Temperature 85°C 
Heating menstruum 0.067M phosphate buffer 
No. of D/z-values 5/-/- [5/-/-] 
Notes The D-values were given by authors; unfortunately they did 
not agree with presented graphs for z-values. Therefore D-
values extracted to the database were read directly from 
graphs. The authors concluded that the effect of lysozyme 
on the heat resistance of spores varied for different strains. 
The heat resistance of strain ATCC 17844 was about 60-
fold higher for spores recovered without lysozyme, but this 
difference was smaller at higher temperatures. The 
difference in heat resistance of strain Eklund 17B in 
medium with and without lysozyme was significant, but it 
was not the case for strain 2129B. The higher heat 
resistance due to lysozyme of type B strains was similar to 
type E strains. D-values obtained in this study varied from 
values reported by other authors, which could be the result 
of different medium used. 
Quality 
  
Quality criteria not met 
f, l, o, r 
 
Smelt (1980) 
Toxin type B and E 
No. of strains tested 2 
Temperature 78, 80, 83, 85, 88, 90°C 
Heating menstruum 0.067M phosphate buffer, 0.1M citrate buffer, 0.1M citrate 
buffer + 30% (w/w) sucrose 
No. of D/z-values 31/6/24 
Notes The heat resistance of spores of type B and E strains at 
neutral and low pH were tested. The survival curves spores 
heated in citrate buffer or phosphate buffer showed tailing. 
The author dispute the theory that tailing is caused by 
clumping of spores. In the case of the two tested strains, 
the pH of heating medium had little effect on the heat 
resistance of the heat sensitive fraction. At a higher pH 
there was a greater D-value of the heat resistant fraction, 
which was very noticeable for strain Eklund 17B. The 
thermal destruction of spores of strain Beluga was different 
in neutral phosphate buffer and citrate buffer. The biphasic 
curve was not observed. When spores were heated in the 
presence of glucose+fructose or glucose alone survival 
curves were characterised by a shoulder, the length of 
which depends on temperature and carbohydrate 
concentration (D-values not calculated by author). 
Quality 
 High 
Quality criteria not met 
f 
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Stringer and Peck (1997) 
Toxin type B 
No. of strains tested 1 
Temperature 75, 90°C 
Heating menstruum PY broth 
No. of D/z-values 10/-/- [2/-/-] 
Notes The effect of sodium chloride on the recovery of heat 
treated spores was tested. Heat treatment at 75°C had little 
effect on the heat resistance of spores, when recovered in 
media containing 1.4%, 3.0% or 4.0% NaCl at 10°C. In the 
presence of lysozyme in the recovery medium the D-value 
increased with an increasing concentration of NaCl (both 
for heat sensitive and heat resistant fractions). Incubation 
of inoculated heated broths at 10°C for 147 days, or for 
further 28 days at 30°C resulted in additional growth. 
Quality 
 High 
Quality criteria not met 
m 
 
Stringer and Peck (1996) 
Toxin type B 
No. of strains tested 1 
Temperature 85°C 
Heating menstruum PY broth 
No. of D/z-values 18/-/- 
Notes The effect of vegetable juices in the plating medium on 
recovery of heated spores was tested. The results showed 
that turnip, swede, potato, flat bean or cabbage juice 
increased the measured heat resistance of spores – 
resulting in biphasic curve. The D-values were not given by 
authors. 
Quality 
 High 
Quality criteria not met 
m 
 
Stringer et al. (1997) 
Toxin type B and E 
No. of strains tested mixture of six strains 
Temperature 90°C 
Heating menstruum PY broth 
No. of D/z-values 2/-/- 
Notes The D-values were not given in the paper. Heating at 90°C 
resulted in a rapid fall in the first 2 min. of heating. Further 
heat treatment gave less rapid decline.  
Quality 
 High 
Quality criteria not met 
m 
a)
 Temperatures from which D-values were extracted to the database and analysed 
b)  
the D and z-values are presented in a form of three numbers (a/b/c), where: 
i. total number of D-values extracted to the database from a given source 
ii. z-values originating from the particular test (e.g. the same strain, the same inoculum size, 
recovery conditions, at particular temperature range) 
iii. total number of z-values that were used to calculate the D'(80) (this could be due e.g. two 
different methods of z-value calculation conducted by authors) 
Data in [ ] the –LYS data 
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Appendix 2 Details of collected D and z-values for non-proteolytic C. botulinum spores 
 
HS
HR
1 Nanaimo E 0.067M phosphate buffer7.0 70 36.00 1.56 3.11 Survivor curve 9.4 TDT tubes in water bath counts PIT 25°C/14 days Ohye and Scott, 1957
2 Nanaimo E 0.067M phosphate buffer7.0 75 10.00 1.00 2.94 Survivor curve 9.4 TDT tubes in water bath counts PIT 25°C/14 days Ohye and Scott, 1957
3 Nanaimo E 0.067M phosphate buffer7.0 80 3.30 0.52 3.30 Survivor curve 9.4 TDT tubes in water bath counts PIT 25°C/14 days Ohye and Scott, 1957
4 Vancouver HerringE 0.067M phosphate buffer7.0 70 7.80 0.89 0.41 Survivor curve 7.8 TDT tubes in water bath counts PIT 25°C/14 days Ohye and Scott, 1957
5 Vancouver HerringE 0.067M phosphate buffer7.0 75 3.10 0.49 0.71 Survivor curve 7.8 TDT tubes in water bath counts PIT 25°C/14 days Ohye and Scott, 1957
6 Vancouver HerringE 0.067M phosphate buffer7.0 80 0.40 -0.40 0.40 Survivor curve 7.8 TDT tubes in water bath counts PIT 25°C/14 days Ohye and Scott, 1957
7 Eklund 17B B cod 6.8 75 53.90 1.73 14.13 Survivor curve 8.6 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
8 Eklund 17B B cod 6.8 80 18.30 1.26 18.30 Survivor curve 8.6 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
9 Eklund 17B B cod 6.8 85 4.00 0.60 15.26 Survivor curve 8.6 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
10 Eklund 17B B cod 6.8 90 1.10 0.04 16.00 Survivor curve 8.6 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
11 Eklund 17B B cod 6.8 92 0.62 -0.21 15.41 Survivor curve 8.6 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
12 ATCC 9564 E cod 6.8 75 58.50 1.77 14.61 Survivor curve 8.3 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
13 ATCC 9564 E cod 6.8 80 15.10 1.18 15.10 Survivor curve 8.3 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
14 ATCC 9564 E cod 6.8 85 4.75 0.68 19.02 Survivor curve 8.3 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
15 ATCC 9564 E cod 6.8 90 0.79 -0.10 12.66 Survivor curve 8.3 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
16 ATCC 9564 E cod 6.8 92 0.56 -0.25 15.63 Survivor curve 8.3 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
17 Eklund 17B B carrot homogenates 5.7 75 19.39 1.29 5.99 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
18 Eklund 17B B carrot homogenates 5.7 80 4.24 0.63 4.24 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
19 Eklund 17B B carrot homogenates 5.7 85 1.57 0.20 5.08 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
20 Eklund 17B B carrot homogenates 5.7 90 0.43 -0.37 4.51 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
21 Eklund 17B B carrot homogenates 5.7 92 0.36 -0.44 6.04 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
22 ATCC 9564 E carrot homogenates 5.7 70 32.80 1.52 3.13 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
23 ATCC 9564 E carrot homogenates 5.7 75 18.05 1.26 5.58 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
24 ATCC 9564 E carrot homogenates 5.7 80 4.33 0.64 4.33 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
25 ATCC 9564 E carrot homogenates 5.7 85 0.73 -0.14 2.36 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
26 ATCC 9564 E carrot homogenates 5.7 90 0.48 -0.32 5.03 Survivor curve 9.8 bottles in water bath counts EA+0.1% starch30°C/6 days Gaze and Brown, 1990
27 Beluga E oyster Homogenates 6.2 50 7943.00 3.90 1.27 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
28 Beluga E oyster Homogenates 6.2 0.13% KS 50 7413.00 3.87 1.06 Survivor curve 7.8 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
29 Beluga E oyster Homogenates 6.2 1.0 % NaCl 50 23990.00 4.38 3.05 Survivor curve 7.7 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
30 Beluga E oyster Homogenates 6.2 1.0% NaCl + 0.13% KS 50 6607.00 3.82 1.05 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
31 Beluga E oyster Homogenates 6.2 55 1259.00 3.10 0.86 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
32 Beluga E oyster Homogenates 6.2 0.13% KS 55 1202.00 3.08 0.75 Survivor curve 7.8 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
33 Beluga E oyster Homogenates 6.2 1.0 % NaCl 55 1047.00 3.02 0.59 Survivor curve 7.7 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
34 Beluga E oyster Homogenates 6.2 1.0% NaCl + 0.13% KS 55 1023.00 3.01 0.70 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
35 Beluga E oyster Homogenates 6.2 60 776.00 2.89 2.28 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
36 Beluga E oyster Homogenates 6.2 0.13% KS 60 912.00 2.96 2.49 Survivor curve 7.8 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
37 Beluga E oyster Homogenates 6.2 1.0 % NaCl 60 692.00 2.84 1.75 Survivor curve 7.7 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
38 Beluga E oyster Homogenates 6.2 1.0% NaCl + 0.13% KS 60 776.00 2.89 2.28 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
39 Beluga E oyster Homogenates 6.2 70 72.00 1.86 3.90 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
40 Beluga E oyster Homogenates 6.2 0.13% KS 70 72.00 1.86 3.76 Survivor curve 7.8 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
41 Beluga E oyster Homogenates 6.2 1.0 % NaCl 70 100.00 2.00 5.03 Survivor curve 7.7 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
42 Beluga E oyster Homogenates 6.2 1.0% NaCl + 0.13% KS 70 79.00 1.90 4.28 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
43 Beluga E oyster Homogenates 6.2 80 0.78 -0.11 0.78 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
44 Beluga E oyster Homogenates 6.2 0.13% KS 80 0.63 -0.20 0.63 Survivor curve 7.8 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
Reference
Heating 
technique
Recovery 
conditions
Recovery 
method
Recovery 
media
z -value 
(oC)
D'(80)Strain
Toxin                
type
Heating menstruum pH
Addition of 
(aw)
No.
logD 
(min)
T(oC)
D -value 
(min)
Method of D-
value calculation
SH
 296 
 
45 Beluga E oyster Homogenates 6.2 1.0 % NaCl 80 1.00 0.00 1.00 Survivor curve 7.7 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
46 Beluga E oyster Homogenates 6.2 1.0% NaCl + 0.13% KS 80 0.55 -0.26 0.55 Survivor curve 7.9 flasks in water bath counts PYG 30°C/2 days Bucknavage et al., 1990
47 Alaska E oyster Homogenates 74 7.56 0.88 0.48 TDT/Schmidt(1957) 5.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
48 Alaska E oyster Homogenates 74 7.56 0.88 0.27 TDT/Schmidt(1957) 4.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
49 Minnesota E oyster Homogenates 74 8.96 0.95 1.07 TDT/Schmidt(1957) 6.6 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
50 Minnesota E oyster Homogenates 74 8.96 0.95 0.96 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
51 Crab G21-5 E oyster Homogenates 74 5.23 0.72 0.72 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
52 Crab G21-5 E oyster Homogenates 74 5.23 0.72 0.41 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
53 Crab 25 V-1 E oyster Homogenates 74 7.13 0.85 0.88 TDT/Schmidt(1957) 6.7 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
54 Crab 25 V-1 E oyster Homogenates 74 7.13 0.85 0.55 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
55 Crab 25 V-2 E oyster Homogenates 74 2.00 0.30 0.21 TDT/Schmidt(1957) 6.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
56 Crab 25 V-2 E oyster Homogenates 74 2.00 0.30 0.18 TDT/Schmidt(1957) 5.9 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
57 Alaska E oyster Homogenates 75 3.85 0.59 0.40 TDT/Schmidt(1957) 5.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
58 Minnesota E oyster Homogenates 75 5.28 0.72 0.92 TDT/Schmidt(1957) 6.6 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
59 Minnesota E oyster Homogenates 75 5.28 0.72 0.85 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
60 Crab G21-5 E oyster Homogenates 75 2.38 0.38 0.47 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
61 Crab G21-5 E oyster Homogenates 75 2.38 0.38 0.29 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
62 Crab 25 V-1 E oyster Homogenates 75 3.40 0.53 0.61 TDT/Schmidt(1957) 6.7 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
63 Crab 25 V-2 E oyster Homogenates 75 1.28 0.11 0.20 TDT/Schmidt(1957) 6.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
64 Crab 25 V-1 E oyster Homogenates 75 3.40 0.53 0.42 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
65 Crab 25 V-2 E oyster Homogenates 75 1.28 0.11 0.18 TDT/Schmidt(1957) 5.9 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
66 Alaska E oyster Homogenates 75 3.85 0.59 0.25 TDT/Schmidt(1957) 4.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
67 Alaska E oyster Homogenates 77 1.53 0.18 0.34 TDT/Schmidt(1957) 5.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
68 Alaska E oyster Homogenates 77 1.53 0.18 0.25 TDT/Schmidt(1957) 4.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
69 Minnesota E oyster Homogenates 77 2.69 0.43 0.85 TDT/Schmidt(1957) 6.6 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
70 Crab G21-5 E oyster Homogenates 77 1.01 0.00 0.35 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
71 Crab 25 V-1 E oyster Homogenates 77 1.42 0.15 0.46 TDT/Schmidt(1957) 6.7 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
72 Crab 25 V-1 E oyster Homogenates 77 1.42 0.15 0.36 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
73 Crab 25 V-2 E oyster Homogenates 77 0.73 -0.14 0.21 TDT/Schmidt(1957) 6.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
74 Crab 25 V-2 E oyster Homogenates 77 0.73 -0.14 0.20 TDT/Schmidt(1957) 5.9 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
75 Alaska E oyster Homogenates 79 0.41 -0.39 0.31 TDT/Schmidt(1957) 5.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
76 Minnesota E oyster Homogenates 77 2.69 0.43 0.81 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
77 Minnesota E oyster Homogenates 79 1.03 0.01 0.73 TDT/Schmidt(1957) 6.6 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
78 Crab G21-5 E oyster Homogenates 77 1.01 0.00 0.29 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
79 Crab G21-5 E oyster Homogenates 79 0.29 -0.54 0.21 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
80 Crab G21-5 E oyster Homogenates 79 0.29 -0.54 0.19 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
81 Crab 25 V-1 E oyster Homogenates 79 0.58 -0.24 0.47 TDT/Schmidt(1957) 6.7 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
82 Crab 25 V-1 E oyster Homogenates 79 0.58 -0.24 0.45 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
83 Alaska E oyster Homogenates 79 0.41 -0.39 0.30 TDT/Schmidt(1957) 4.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
84 Alaska E oyster Homogenates 82 0.07 -1.15 0.19 TDT/Schmidt(1957) 5.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
85 Minnesota E oyster Homogenates 79 1.03 0.01 0.83 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
86 Minnesota E oyster Homogenates 82 0.43 -0.37 0.93 TDT/Schmidt(1957) 6.6 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
87 Crab G21-5 E oyster Homogenates 82 0.11 -0.96 0.22 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
88 Crab 25 V-1 E oyster Homogenates 82 0.20 -0.70 0.43 TDT/Schmidt(1957) 6.7 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
89 Crab 25 V-1 E oyster Homogenates 82 0.20 -0.70 0.50 TDT/Schmidt(1957) 5.5 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
90 Crab 25 V-2 E oyster Homogenates 79 0.25 -0.60 0.20 TDT/Schmidt(1957) 6.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
91 Crab G21-5 E oyster Homogenates 82 0.11 -0.96 0.22 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
92 Crab G21-5 E oyster Homogenates 79 0.27 -0.57 0.22 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/14 days Chai and Liang, 1992
93 Alaska E oyster Homogenates 82 0.07 -1.15 0.23 TDT/Schmidt(1957) 4.2 TDT tubes in water bathTDT TPGYT 28°C/14 days Chai and Liang, 1992
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94 Minnesota E oyster Homogenates 82 0.43 -0.37 0.96 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGYT 28°C/14 days Chai and Liang, 1992
95 Crab G21-5 E oyster Homogenates 79 0.27 -0.57 0.22 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGYT 28°C/14 days Chai and Liang, 1992
96 Crab 25 V-2 E oyster Homogenates 79 0.25 -0.60 0.20 TDT/Schmidt(1957) 5.9 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
97 Crab 25 V-2 E oyster Homogenates 82 0.08 -1.10 0.18 TDT/Schmidt(1957) 6.2 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
98 Crab 25 V-2 E oyster Homogenates 82 0.08 -1.10 0.19 TDT/Schmidt(1957) 5.9 TDT tubes in water bathTDT TPGYT 28°C/62 days Chai and Liang, 1992
99 Beluga E crabmeat 74 12.97 1.11 2.39 TDT/Schmidt(1957) 8.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
100 Beluga E crabmeat 77 4.07 0.61 1.63 TDT/Schmidt(1957) 8.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
101 Beluga E crabmeat 79 1.65 0.22 1.40 TDT/Schmidt(1957) 8.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
102 Beluga E crabmeat 82 0.74 -0.13 1.36 TDT/Schmidt(1957) 8.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
103 Beluga E crabmeat 85 0.29 -0.54 1.16 TDT/Schmidt(1957) 8.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
104 Beluga E crabmeat 74 12.97 1.11 1.55 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
105 Beluga E crabmeat 77 4.07 0.61 1.26 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
106 Beluga E crabmeat 79 1.65 0.22 1.33 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
107 Beluga E crabmeat 82 0.74 -0.13 1.61 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
108 Beluga E crabmeat 85 0.29 -0.54 1.70 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
109 Alaska E crabmeat 74 10.39 1.02 1.40 TDT/Schmidt(1957) 7.0 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
110 Alaska E crabmeat 77 3.04 0.48 1.03 TDT/Schmidt(1957) 7.0 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
111 Alaska E crabmeat 79 1.35 0.13 1.11 TDT/Schmidt(1957) 7.0 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
112 Alaska E crabmeat 82 0.51 -0.29 1.05 TDT/Schmidt(1957) 7.0 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
113 Alaska E crabmeat 74 10.39 1.02 1.04 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
114 Alaska E crabmeat 77 3.04 0.48 0.87 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
115 Alaska E crabmeat 79 1.35 0.13 1.08 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
116 Alaska E crabmeat 82 0.51 -0.29 1.17 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
117 Crab G21-5 E crabmeat 74 6.80 0.83 1.31 TDT/Schmidt(1957) 8.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
118 Crab G21-5 E crabmeat 77 2.38 0.38 0.96 TDT/Schmidt(1957) 8.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
119 Crab G21-5 E crabmeat 79 1.10 0.04 0.93 TDT/Schmidt(1957) 8.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
120 Crab G21-5 E crabmeat 82 0.63 -0.20 1.15 TDT/Schmidt(1957) 8.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
121 Crab G21-5 E crabmeat 74 6.80 0.83 0.97 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
122 Crab G21-5 E crabmeat 77 2.38 0.38 0.82 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
123 Crab G21-5 E crabmeat 79 1.10 0.04 0.91 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
124 Crab G21-5 E crabmeat 82 0.63 -0.20 1.29 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
125 Crab 25 V-1 E crabmeat 82 0.62 -0.21 1.29 TDT/Schmidt(1957) TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
126 Crab 25 V-2 E crabmeat 82 0.49 -0.31 1.02 TDT/Schmidt(1957) TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1977
127 190 F 0.067M phosphate buffer7.0 71 31.08 1.49 0.85 TDT/Schmidt(1957) 5.7 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
128 190 F 0.067M phosphate buffer7.0 74 9.07 0.96 0.77 TDT/Schmidt(1957) 5.7 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
129 190 F 0.067M phosphate buffer7.0 77 1.66 0.22 0.44 TDT/Schmidt(1957) 5.7 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
130 190 F 0.067M phosphate buffer7.0 79 1.03 0.01 0.81 TDT/Schmidt(1957) 5.7 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
131 190 F 0.067M phosphate buffer7.0 82 0.25 -0.60 0.61 TDT/Schmidt(1957) 5.7 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
132 190 F 0.067M phosphate buffer7.0 71 31.08 1.49 0.70 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
133 190 F 0.067M phosphate buffer7.0 74 9.07 0.96 0.67 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
134 190 F 0.067M phosphate buffer7.0 77 1.66 0.22 0.41 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
135 190 F 0.067M phosphate buffer7.0 79 1.03 0.01 0.80 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
136 190 F 0.067M phosphate buffer7.0 82 0.25 -0.60 0.64 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
137 202 F 0.067M phosphate buffer7.0 71 42.41 1.63 1.24 TDT/Schmidt(1957) 5.8 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
138 202 F 0.067M phosphate buffer7.0 74 12.68 1.10 1.13 TDT/Schmidt(1957) 5.8 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
139 202 F 0.067M phosphate buffer7.0 77 4.29 0.63 1.16 TDT/Schmidt(1957) 5.8 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
140 202 F 0.067M phosphate buffer7.0 79 0.93 -0.03 0.73 TDT/Schmidt(1957) 5.8 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
141 202 F 0.067M phosphate buffer7.0 82 0.33 -0.48 0.79 TDT/Schmidt(1957) 5.8 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
142 202 F 0.067M phosphate buffer7.0 71 42.41 1.63 0.89 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
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143 202 F 0.067M phosphate buffer7.0 74 12.68 1.10 0.90 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
144 202 F 0.067M phosphate buffer7.0 77 4.29 0.63 1.02 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
145 202 F 0.067M phosphate buffer7.0 79 0.93 -0.03 0.72 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
146 202 F 0.067M phosphate buffer7.0 82 0.33 -0.48 0.86 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
147 Craig 610 F 0.067M phosphate buffer7.0 77 6.64 0.82 2.63 TDT/Schmidt(1957) 8.2 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
148 Craig 610 F 0.067M phosphate buffer7.0 79 2.12 0.33 1.79 TDT/Schmidt(1957) 8.2 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
149 Craig 610 F 0.067M phosphate buffer7.0 82 0.84 -0.08 1.56 TDT/Schmidt(1957) 8.2 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
150 Craig 610 F 0.067M phosphate buffer7.0 85 0.37 -0.43 1.51 TDT/Schmidt(1957) 8.2 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
151 Craig 610 F 0.067M phosphate buffer7.0 77 6.64 0.82 1.99 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
152 Craig 610 F 0.067M phosphate buffer7.0 79 2.12 0.33 1.70 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
153 Craig 610 F 0.067M phosphate buffer7.0 82 0.84 -0.08 1.88 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
154 Craig 610 F 0.067M phosphate buffer7.0 85 0.37 -0.43 2.30 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
155 202 F crabmeat 7.0 77 9.50 0.98 3.45 TDT/Schmidt(1957) 7.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
156 202 F crabmeat 7.0 79 3.55 0.55 2.95 TDT/Schmidt(1957) 7.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
157 202 F crabmeat 7.0 82 1.16 0.06 2.28 TDT/Schmidt(1957) 7.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
158 202 F crabmeat 7.0 85 0.53 -0.28 2.46 TDT/Schmidt(1957) 7.5 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
159 202 F crabmeat 7.0 77 9.50 0.98 2.90 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
160 202 F crabmeat 7.0 79 3.55 0.55 2.86 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
161 202 F crabmeat 7.0 82 1.16 0.06 2.56 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
162 202 F crabmeat 7.0 85 0.53 -0.28 3.20 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/14 days Lynt et al.,  1979
163 Beluga E rainbow trout 6.6 75 4.60 0.66 0.99 HS Survivor curve metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
164 Beluga E rainbow trout 6.6 75 255.00 2.41 84.29 HR Survivor curve 10.4 metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
165 Beluga E rainbow trout 6.6 85 2.00 0.30 9.28 HS Survivor curve metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
166 Beluga E rainbow trout 6.6 85 98.00 1.99 296.48 HR Survivor curve 10.4 metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
167 Beluga E rainbow trout 6.6 93 0.40 -0.40 21.65 HS Survivor curve metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
168 Beluga E rainbow trout 6.6 93 4.20 0.62 74.69 HR Survivor curve 10.4 metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
169 Beluga E whitefish 7.0 81 1.90 0.28 2.58 HS Survivor curve metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
170 Beluga E whitefish 7.0 81 55.00 1.74 69.08 HR Survivor curve 10.1 metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
171 Beluga E whitefish 7.0 90 1.00 0.00 21.54 HS Survivor curve metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
172 Beluga E whitefish 7.0 90 7.10 0.85 69.40 HR Survivor curve 10.1 metal cap tubes in water bathcounts + LYS TPGY + LYS 30°/90 days Lindström et al., 2003
173 Mixed strains (Beluga, Birmingham Salmon, 070, G21-5, MS - 272)E menhaden Surimi 74 8.66 0.94 2.07 TDT/Schmidt(1957) 9.8 TDT tubes in water bathTDT TPGY 26°C/14 days Rhodehamel et a l, 1991
174 Mixed strains (Beluga, Birmingham Salmon, 070, G21-5, MS - 272)E menhaden Surimi 77 3.49 0.54 1.61 TDT/Schmidt(1957) 9.8 TDT tubes in water bathTDT TPGY 26°C/14 days Rhodehamel et a l, 1991
175 Mixed strains (Beluga, Birmingham Salmon, 070, G21-5, MS - 272)E menhaden Surimi 79 2.15 0.33 1.87 TDT/Schmidt(1957) 9.8 TDT tubes in water bathTDT TPGY 26°C/14 days Rhodehamel et a l, 1991
176 Mixed strains (Beluga, Birmingham Salmon, 070, G21-5, MS - 272)E menhaden Surimi 82 1.22 0.09 2.05 TDT/Schmidt(1957) 9.8 TDT tubes in water bathTDT TPGY 26°C/14 days Rhodehamel et a l, 1991
177 Alaska E water 80 0.60 -0.22 0.60 Survivor curve 5.8 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
178 Beluga E water 80 0.75 -0.12 0.75 Survivor curve 5.3 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
179 Iwanai E water 80 1.00 0.00 1.00 Survivor curve 5.6 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
180 Minneapolis E water 80 0.87 -0.06 0.87 Survivor curve 5.8 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
181 8E E water 80 0.80 -0.10 0.80 Survivor curve 4.1 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
182 1957/61 E water 80 1.25 0.10 1.25 Survivor curve 6.0 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
183 1537/62 E water 80 0.83 -0.08 0.83 Survivor curve 6.0 counts RCM 25°C/5-7 days Roberts and Ingram, 1965
184 16/63 E water 80 0.33 -0.48 0.33 Survivor curve 5.0 counts RCA 25°C/5-7 days Roberts and Ingram, 1965
185 4318/63 E water 80 0.66 -0.18 0.66 Survivor curve 5.6 counts RCA 25°C/5-7 days Roberts and Ingram, 1965
186 Eklund 17B B 0.067M phosphate buffer7.0 75 283.00 2.45 62.21 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
187 Eklund 17B B 0.067M phosphate buffer7.0 85 73.60 1.87 334.79 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
188 Eklund 17B B 0.067M phosphate buffer7.0 Alkaline thioglycolate after heating 85 79.00 1.90 359.35 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
189 Eklund 17B B 0.067M phosphate buffer7.0 85 90.00 1.95 409.39 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
190 Eklund 17B B 0.067M phosphate buffer7.0 Alkaline thioglycolate after heating 85 111.00 2.05 504.91 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
191 Eklund 17B B 0.067M phosphate buffer7.0 90 18.10 1.26 374.51 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
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192 Eklund 17B B 0.067M phosphate buffer7.0 Alkaline thioglycolate after heating 90 19.40 1.29 401.41 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
193 Eklund 17B B 0.067M phosphate buffer7.0 95 4.57 0.66 430.13 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
194 Eklund 17B B 0.067M phosphate buffer7.0 Alkaline thioglycolate after heating 95 4.23 0.63 398.13 HR Survivor curve 7.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
195 Beluga E 0.067M phosphate buffer7.0 85 48.30 1.68 193.36 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
196 Beluga E 0.067M phosphate buffer7.0 Alkaline thioglycolate after heating 85 42.80 1.63 171.34 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
197 Beluga E 0.067M phosphate buffer7.0 90 12.60 1.10 201.92 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
198 Beluga E 0.067M phosphate buffer7.0 90 11.00 1.04 176.28 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
199 Beluga E 0.067M phosphate buffer7.0 95 3.17 0.50 203.37 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
200 Beluga E 0.067M phosphate buffer7.0 95 2.34 0.37 150.12 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30° Peck et al.,  1993
201 Mixed strains (Ham, Kapchunka, 17B)crabmeat 89 12.90 1.11 139.79 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
202 Mixed strains (Ham, Kapchunka, 17B)crabmeat 89 11.10 1.05 138.99 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
203 Mixed strains (Ham, Kapchunka, 17B)crabmeat 90 9.50 0.98 138.20 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
204 Mixed strains (Ham, Kapchunka, 17B)crabmeat 91 8.20 0.91 140.08 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
205 Mixed strains (Ham, Kapchunka, 17B)crabmeat 91 7.10 0.85 139.03 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
206 Mixed strains (Ham, Kapchunka, 17B)crabmeat 92 6.10 0.79 138.77 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
207 Mixed strains (Ham, Kapchunka, 17B)crabmeat 92 5.30 0.72 138.96 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
208 Mixed strains (Ham, Kapchunka, 17B)crabmeat 93 4.50 0.65 137.80 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
209 Mixed strains (Ham, Kapchunka, 17B)crabmeat 93 3.90 0.59 138.38 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
210 Mixed strains (Ham, Kapchunka, 17B)crabmeat 94 3.40 0.53 140.15 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
211 Mixed strains (Ham, Kapchunka, 17B)crabmeat 94 2.90 0.46 137.03 TDT/Stumbo(1948) 8.6 packaged samples in water bathTDT+crabmeat TPGY + crabmeat27°/21 days Peterson et al.,  1997
212 Beluga E 0.07M phosphate buffer 7.2 70 20.00 1.30 2.00 Survivor curve 10.0 metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
213 Beluga E 0.07M phosphate buffer 7.2 80 1.70 0.23 1.70 Survivor curve 10.0 metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
214 Beluga E 0.07M phosphate buffer 7.2 90 0.20 -0.70 2.00 Survivor curve 10.0 metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
215 CDI-1 B different media 80 5.20 0.72 5.20 Survivor curve metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
216 CDI-1 B different media 90 0.60 -0.22 4.52 Survivor curve metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
217 CDI-2 B different media 80 5.10 0.71 5.10 Survivor curve metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
218 CDI-2 B different media 90 0.60 -0.22 4.52 Survivor curve metal cap tubes in water bathcounts + egg yolkFEM + egg yolk 30°C/5 days Notermans et al. , 1990
219 8E E 0.03M phosphate buffer 7.0 77 0.77 -0.11 0.28 TDT/Stumbo(1950) TDT tubes in water bathTDT Liver broth with meat particles30°C Ito et al.,  1967
220 1304E E 0.03M phosphate buffer 7.0 77 1.23 0.09 0.45 TDT/Stumbo(1950) TDT tubes in water bathTDT Liver broth with meat particles30°C Ito et al.,  1967
221 Minneapolis E 0.03M phosphate buffer 7.0 77 1.55 0.19 0.57 TDT/Stumbo(1950) TDT tubes in water bathTDT Liver broth with meat particles30°C Ito et al.,  1967
222 Saratoga E 0.03M phosphate buffer 7.0 77 1.95 0.29 0.72 TDT/Stumbo(1950) TDT tubes in water bathTDT Liver broth with meat particles30°C Ito et al.,  1967
223 CBW25 B 0.1M phosphate buffer 7.0 70 46.03 1.66 3.14 Survivor curve 8.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
224 CBW25 B 0.1M phosphate buffer 7.0 80 1.90 0.28 1.90 Survivor curve 10.0 screw-capped vials in water bathcounts RCM 28°C/6 days Juneja et al.,  1995a
225 CBW25 B 0.1M phosphate buffer 7.0 80 4.09 0.61 4.09 Survivor curve 8.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
226 CBW25 B 0.1M phosphate buffer 7.0 80 0.96 -0.02 0.96 Survivor curve 8.2 screw-capped vials in water bathcounts TSA 28°C/6 days Juneja et al.,  1995a
227 CBW25 B 0.1M phosphate buffer 7.0 80 3.73 0.57 3.73 Survivor curve 8.6 screw-capped vials in water bathcounts + LYS TSA + LYS 28°C/6 days Juneja et al.,  1995a
228 Eklund 17B B 0.1M phosphate buffer 7.0 70 27.16 1.43 2.11 Survivor curve 9.0 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
229 Eklund 17B B 0.1M phosphate buffer 7.0 75 5.45 0.74 1.52 Survivor curve 9.0 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
230 Eklund 17B B 0.1M phosphate buffer 7.0 80 0.60 -0.22 0.60 Survivor curve 8.4 screw-capped vials in water bathcounts RCM 28°C/6 days Juneja et al.,  1995a
231 Eklund 17B B 0.1M phosphate buffer 7.0 80 3.22 0.51 3.22 Survivor curve 9.0 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
232 Eklund 17B B 0.1M phosphate buffer 7.0 80 0.67 -0.17 0.67 Survivor curve 8.6 screw-capped vials in water bathcounts TSA 28°C/6 days Juneja et al.,  1995a
233 Eklund 17B B 0.1M phosphate buffer 7.0 80 3.22 0.51 3.22 Survivor curve 8.9 screw-capped vials in water bathcounts + LYS TSA + LYS 28°C/6 days Juneja et al.,  1995a
234 Eklund 17B B 0.1M phosphate buffer 7.0 85 0.41 -0.39 1.47 Survivor curve 9.0 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
235 Kap B5 B 0.1M phosphate buffer 7.0 75 27.42 1.44 6.91 Survivor curve 8.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
236 Kap B5 B 0.1M phosphate buffer 7.0 80 1.53 0.18 1.53 Survivor curve 9.1 screw-capped vials in water bathcounts RCM 28°C/6 days Juneja et al.,  1995a
237 Kap B5 B 0.1M phosphate buffer 7.0 80 4.31 0.63 4.31 Survivor curve 8.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
238 Kap B5 B 0.1M phosphate buffer 7.0 80 2.25 0.35 2.25 Survivor curve 9.3 screw-capped vials in water bathcounts TSA 28°C/6 days Juneja et al.,  1995a
239 Kap B5 B 0.1M phosphate buffer 7.0 80 2.53 0.40 2.53 Survivor curve 8.5 screw-capped vials in water bathcounts + LYS TSA + LYS 28°C/6 days Juneja et al.,  1995a
240 Kap B5 B 0.1M phosphate buffer 7.0 85 0.89 -0.05 3.53 Survivor curve 8.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
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241 Kap B5 B 0.1M phosphate buffer 7.0 90 0.46 -0.34 7.25 Survivor curve 8.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
242 Whitefish E 0.1M phosphate buffer 7.0 70 25.50 1.41 2.32 Survivor curve 9.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
243 Whitefish E 0.1M phosphate buffer 7.0 80 0.39 -0.41 0.39 Survivor curve 9.1 screw-capped vials in water bathcounts RCM 28°C/6 days Juneja et al.,  1995a
244 Whitefish E 0.1M phosphate buffer 7.0 80 1.03 0.01 1.03 Survivor curve 9.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
245 Whitefish E 0.1M phosphate buffer 7.0 80 0.39 -0.41 0.39 Survivor curve 9.6 screw-capped vials in water bathcounts TSA 28°C/6 days Juneja et al.,  1995a
246 Whitefish E 0.1M phosphate buffer 7.0 80 0.98 -0.01 0.98 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS TSA + LYS 28°C/6 days Juneja et al.,  1995a
247 Whitefish E 0.1M phosphate buffer 7.0 85 0.68 -0.17 2.26 Survivor curve 9.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
248 Saratoga E 0.1M phosphate buffer 7.0 70 44.58 1.65 4.34 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
249 Saratoga E 0.1M phosphate buffer 7.0 80 3.61 0.56 3.61 Survivor curve 9.9 screw-capped vials in water bathcounts RCM 28°C/6 days Juneja et al.,  1995a
250 Saratoga E 0.1M phosphate buffer 7.0 80 4.51 0.65 4.51 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
251 Saratoga E 0.1M phosphate buffer 7.0 80 3.77 0.58 3.77 Survivor curve 10.1 screw-capped vials in water bathcounts TSA 28°C/6 days Juneja et al.,  1995a
252 Saratoga E 0.1M phosphate buffer 7.0 80 3.80 0.58 3.80 Survivor curve 9.8 screw-capped vials in water bathcounts + LYS TSA + LYS 28°C/6 days Juneja et al.,  1995a
253 Saratoga E 0.1M phosphate buffer 7.0 85 1.03 0.01 3.30 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
254 Alaska E 0.1M phosphate buffer 7.0 70 30.63 1.49 3.12 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
255 Alaska E 0.1M phosphate buffer 7.0 80 3.91 0.59 3.91 Survivor curve 10.0 screw-capped vials in water bathcounts RCM 28°C/6 days Juneja et al.,  1995a
256 Alaska E 0.1M phosphate buffer 7.0 80 4.35 0.64 4.35 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
257 Alaska E 0.1M phosphate buffer 7.0 80 2.60 0.41 2.60 Survivor curve 10.7 screw-capped vials in water bathcounts TSA 28°C/6 days Juneja et al.,  1995a
258 Alaska E 0.1M phosphate buffer 7.0 80 4.31 0.63 4.31 Survivor curve 10.8 screw-capped vials in water bathcounts + LYS TSA + LYS 28°C/6 days Juneja et al.,  1995a
259 Alaska E 0.1M phosphate buffer 7.0 85 0.80 -0.10 2.51 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
260 Alaska E turkey slurry 70 51.89 1.72 5.07 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
261 Alaska E turkey slurry 75 18.06 1.26 5.65 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
262 Alaska E turkey slurry 80 13.37 1.13 13.37 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
263 Alaska E turkey slurry 85 1.18 0.07 3.78 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
264 Kap B5 B turkey slurry 75 32.53 1.51 9.60 Survivor curve 9.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
265 Kap B5 B turkey slurry 80 15.21 1.18 15.21 Survivor curve 9.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
266 Kap B5 B turkey slurry 85 4.85 0.69 16.44 Survivor curve 9.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
267 Kap B5 B turkey slurry 90 0.80 -0.10 9.19 Survivor curve 9.4 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995a
268 Beluga E 0.017M phosphate buffer7.0 70 26.10 1.42 0.93 TDT/Stumbo(1948) 6.9 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
269 Beluga E 0.017M phosphate buffer7.0 73 11.60 1.06 1.05 TDT/Stumbo(1948) 6.9 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
270 Beluga E 0.017M phosphate buffer7.0 75 5.00 0.70 0.94 TDT/Stumbo(1948) 6.9 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
271 Beluga E 0.017M phosphate buffer7.0 80 1.00 0.00 1.00 TDT/Stumbo(1948) 6.9 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
272 Saratoga E 0.017M phosphate buffer7.0 70 81.60 1.91 1.34 TDT/Stumbo(1948) 5.6 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
273 Saratoga E 0.017M phosphate buffer7.0 73 26.20 1.42 1.36 TDT/Stumbo(1948) 5.6 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
274 Saratoga E 0.017M phosphate buffer7.0 75 11.20 1.05 1.43 TDT/Stumbo(1948) 5.6 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
275 Saratoga E 0.017M phosphate buffer7.0 80 1.10 0.04 1.10 TDT/Stumbo(1948) 5.6 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
276 Alaska E 0.067M phosphate buffer7.0 70 37.50 1.57 1.21 TDT/Stumbo(1948) 6.7 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
277 Alaska E 0.067M phosphate buffer7.0 73 11.80 1.07 0.99 TDT/Stumbo(1948) 6.7 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
278 Alaska E 0.067M phosphate buffer7.0 75 5.30 0.72 0.95 TDT/Stumbo(1948) 6.7 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
279 Alaska E 0.067M phosphate buffer7.0 77 2.70 0.43 0.87 TDT/Stumbo(1948) 6.7 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
280 Alaska E 0.067M phosphate buffer7.0 80 1.60 0.20 1.60 TDT/Stumbo(1948) 6.7 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
281 Beluga E 0.067M phosphate buffer7.0 70 29.30 1.47 1.53 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
282 Beluga E 0.067M phosphate buffer7.0 73 8.00 0.90 0.96 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
283 Beluga E 0.067M phosphate buffer7.0 75 5.10 0.71 1.17 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
284 Beluga E 0.067M phosphate buffer7.0 77 4.60 0.66 1.74 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
285 Beluga E 0.067M phosphate buffer7.0 80 1.40 0.15 1.40 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
286 Saratoga E 0.067M phosphate buffer7.0 70 33.80 1.53 1.38 TDT/Stumbo(1948) 7.2 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
287 Saratoga E 0.067M phosphate buffer7.0 73 13.10 1.12 1.31 TDT/Stumbo(1948) 7.2 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
288 Saratoga E 0.067M phosphate buffer7.0 75 8.20 0.91 1.66 TDT/Stumbo(1948) 7.2 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
289 Saratoga E 0.067M phosphate buffer7.0 77 4.10 0.61 1.43 TDT/Stumbo(1948) 7.2 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
 301 
290 Saratoga E 0.067M phosphate buffer7.0 80 1.40 0.15 1.40 TDT/Stumbo(1948) 7.2 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
291 1304E E 0.067M phosphate buffer7.0 70 29.60 1.47 1.55 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
292 1304E E 0.067M phosphate buffer7.0 73 10.60 1.03 1.27 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
293 1304E E 0.067M phosphate buffer7.0 75 5.60 0.75 1.28 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
294 1304E E 0.067M phosphate buffer7.0 77 3.70 0.57 1.53 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
295 1304E E 0.067M phosphate buffer7.0 80 1.80 0.26 1.80 TDT/Stumbo(1948) 7.8 TDT tubes in water bathTDT W & F 29.4°C/21 days Bohrer et al.,  1973
296 Saratoga E tuna (in oil) 72 226.50 2.36 11.92 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT tuna (in oil) 29.4°C/168-336 daysBohrer et al.,  1973
297 Saratoga E tuna (in oil) 77 40.90 1.61 13.18 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT tuna (in oil) 29.4°C/168-336 daysBohrer et al.,  1973
298 Saratoga E tuna (in oil) 79 17.10 1.23 11.29 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT tuna (in oil) 29.4°C/168-336 daysBohrer et al.,  1973
299 Saratoga E tuna (in oil) 80 10.50 1.02 10.50 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT tuna (in oil) 29.4°C/168-336 daysBohrer et al.,  1973
300 Saratoga E tuna (in oil) 81 7.50 0.88 11.36 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT tuna (in oil) 29.4°C/168-336 daysBohrer et al.,  1973
301 Saratoga E tuna (in oil) 82 6.60 0.82 15.14 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT tuna (in oil) 29.4°C/168-336 daysBohrer et al.,  1973
302 Saratoga E crabmeat 80 4.40 0.64 4.40 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT crabmeat 29.4°C/168-336 daysBohrer et al.,  1973
303 Saratoga E crabmeat 81 2.10 0.32 3.14 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT crabmeat 29.4°C/168-336 daysBohrer et al.,  1973
304 Saratoga E crabmeat 82 1.90 0.28 4.25 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT crabmeat 29.4°C/168-336 daysBohrer et al.,  1973
305 Saratoga E corn brine 77 11.20 1.05 3.61 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT corn brine 29.4°C/168-336 daysBohrer et al.,  1973
306 Saratoga E corn brine 80 3.20 0.51 3.20 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT corn brine 29.4°C/168-336 daysBohrer et al.,  1973
307 Saratoga E corn brine 81 1.70 0.23 2.57 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT corn brine 29.4°C/168-336 daysBohrer et al.,  1973
308 Saratoga E corn brine 82 1.30 0.11 2.98 TDT/Stumbo(1948) 6.1 TDT cans in water bathTDT corn brine 29.4°C/168-336 daysBohrer et al.,  1973
309 Saratoga E milk (evaporated) 77 6.40 0.81 2.14 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT milk (evaporated)29.4°C/168-336 daysBohrer et al.,  1973
310 Saratoga E milk (evaporated) 80 1.90 0.28 1.90 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT milk (evaporated)29.4°C/168-336 daysBohrer et al.,  1973
311 Saratoga E milk (evaporated) 81 1.10 0.04 1.64 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT milk (evaporated)29.4°C/168-336 daysBohrer et al.,  1973
312 Saratoga E milk (evaporated) 82 0.80 -0.10 1.79 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT milk (evaporated)29.4°C/168-336 daysBohrer et al.,  1973
313 Saratoga E sardines (in tomato sauce) 77 20.00 1.30 6.68 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT sardines (in tomato sauce)29.4°C/168-336 daysBohrer et al.,  1973
314 Saratoga E sardines (in tomato sauce) 80 4.50 0.65 4.50 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT sardines (in tomato sauce)29.4°C/168-336 daysBohrer et al.,  1973
315 Saratoga E sardines (in tomato sauce) 81 3.40 0.53 5.08 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT sardines (in tomato sauce)29.4°C/168-336 daysBohrer et al.,  1973
316 Saratoga E sardines (in tomato sauce) 82 2.90 0.46 6.48 TDT/Stumbo(1948) 6.3 TDT cans in water bathTDT sardines (in tomato sauce)29.4°C/168-336 daysBohrer et al.,  1973
317 Saratoga E shrimp 80 1.90 0.28 1.90 TDT/Stumbo(1948) TDT cans in water bathTDT shrimp 29.4°C/168-336 daysBohrer et al.,  1973
318 Saratoga E peas 77 18.60 1.27 3.87 TDT/Stumbo(1948) 4.4 TDT cans in water bathTDT peas 29.4°C/168-336 daysBohrer et al.,  1973
319 Saratoga E peas 80 3.30 0.52 3.30 TDT/Stumbo(1948) 4.4 TDT cans in water bathTDT peas 29.4°C/168-336 daysBohrer et al.,  1973
320 Saratoga E salmon 80 2.90 0.46 2.90 TDT/Stumbo(1948) TDT cans in water bathTDT salmon 29.4°C/168-336 daysBohrer et al.,  1973
321 ATCC 17786 E tomato homogenates 4.1 70 6.50 0.81 0.23 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
322 ATCC 17786 E tomato homogenates 4.1 Immediate 40oC/60 min7 4.61 0.66 0.16 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
323 ATCC 17786 E tomato homogenates 4.1 Immediate 40oC/120 min7 20.00 1.30 0.71 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
324 ATCC 17786 E tomato homogenates 4.1 Immediate 40oC/180 min7 38.81 1.59 1.38 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
325 ATCC 17786 E tomato homogenates 4.1 Immediate 45oC/60 min70 16.80 1.23 0.60 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
326 ATCC 17786 E tomato homogenates 4.1 Immediate 45oC/120 min70 17.50 1.24 0.62 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
327 ATCC 17786 E tomato homogenates 4.1 Immediate 45oC/180 min70 11.90 1.08 0.42 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
328 ATCC 17786 E tomato homogenates 4.1 Immediate 50oC/60 min7 43.80 1.64 1.56 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
329 ATCC 17786 E tomato homogenates 4.1 Immediate 50oC/120 min7 43.00 1.63 1.53 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
330 ATCC 17786 E tomato homogenates 4.1 Immediate 50oC/180 min7 11.80 1.07 0.42 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
331 ATCC 17786 E tomato homogenates 4.1 Immediate 55oC/60 min70 20.20 1.31 0.72 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
332 ATCC 17786 E tomato homogenates 4.1 Immediate 55oC/120 min70 22.60 1.35 0.80 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
333 ATCC 17786 E tomato homogenates 4.1 Immediate 55oC/180 min70 21.50 1.33 0.76 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
334 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 40oC/60 min70 29.40 1.47 1.04 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
335 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 40oC/120 min70 2 .90 1.34 0.78 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
336 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 40oC/180 min70 13.50 1.13 0.48 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
337 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 45oC/60 min70 28.60 1.46 1.02 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
338 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 45oC/120 min70 18.24 1.26 0.65 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
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339 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 45oC/180 min70 15.95 1.20 0.57 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
340 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 50oC/60 min70 32.80 1.52 1.17 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
341 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 50oC/120 min70 13.60 1.13 0.48 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
342 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 50oC/180 min70 12. 4 1.08 0.43 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
343 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 55oC/60 min70 11.70 1.07 0.42 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
344 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 55oC/120 min70 13.12 1.12 0.47 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
345 ATCC 17786 E tomato homogenates 4.1 4 h at ambient 55oC/180 min70 15.15 1.18 0.54 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
346 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 40oC/60 min70 15.60 1.19 0.55 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
347 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 40oC/120 min70 10.60 1.03 0.38 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
348 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 40oC/180 min70 20.80 1.32 0.74 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
349 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 45oC/60 min70 16.10 1.21 0.57 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
350 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 45oC/120 min70 12.80 1.11 0.45 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
351 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 45oC/180 min70 17.30 1.24 0.61 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
352 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 50oC/60 min70 22.40 1.35 0.80 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
353 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 50oC/120 min70 28.20 1.45 1.00 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
354 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 50oC/180 min70 15.18 1.18 0.54 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
355 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 55oC/60 min70 17.70 1.25 0.63 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
356 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 55oC/120 min70 12.20 1.09 0.43 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
357 ATCC 17786 E tomato homogenates 4.1 24 h hold at 6oC 55oC/180 min70 25.80 1.41 0.92 Survivor curve bottles in water bathcounts EA+0.1% starch37°C/5 days Appleyard and Gaze, 1993
358 Eklund 17B B 0.067M phosphate buffer7.0 82 16.70 1.22 36.41 TDT/Stumbo(1950) 6.5 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
359 Eklund 17B B 0.067M phosphate buffer7.0 82 0.83 -0.08 1.81 TDT/Stumbo(1950) 6.5 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
360 CBW25 B 0.067M phosphate buffer7.0 82 1.49 0.17 2.74 TDT/Stumbo(1950) 8.3 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
361 2129B B 0.067M phosphate buffer7.0 82 32.30 1.51 54.45 TDT/Stumbo(1950) 9.7 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
362 ATCC 17844 B 0.067M phosphate buffer7.0 82 4.17 0.62 5.67 TDT/Stumbo(1950) 16.5 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
363 Minnesota E 0.067M phosphate buffer7.0 82 0.52 -0.28 1.08 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
364 Whitefish E 0.067M phosphate buffer7.0 82 0.40 -0.40 0.83 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
365 Saratoga E 0.067M phosphate buffer7.0 82 0.33 -0.48 0.59 TDT/Stumbo(1950) 8.7 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
366 Saratoga E 0.067M phosphate buffer7.0 77 1.44 0.16 2.58 TDT/Stumbo(1950) 8.7 TDT tubes in water bathTDT APPA 30°C/168 days Scott and Bernard, 1982
367 CBW25 B 0.067M phosphate buffer7.0 85 0.65 -0.19 3.45 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA Scott and Bernard, 1985
368 CBW25 B 0.067M phosphate buffer7.0 85 30.00 1.48 82.36 TDT/Stumbo(1950) TDT tubes in water bathTDT + LYS APPA + LYS Scott and Bernard, 1985
369 2129B B 0.067M phosphate buffer7.0 85 15.00 1.18 79.57 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA Scott and Bernard, 1985
370 2129B B 0.067M phosphate buffer7.0 85 25.00 1.40 68.63 TDT/Stumbo(1950) TDT tubes in water bathTDT + LYS APPA + LYS Scott and Bernard, 1985
371 ATCC 17844 B 0.067M phosphate buffer7.0 85 3.00 0.48 15.91 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA Scott and Bernard, 1985
372 ATCC 17844 B 0.067M phosphate buffer7.0 85 100.00 2.00 274.53 TDT/Stumbo(1950) TDT tubes in water bathTDT + LYS APPA + LYS Scott and Bernard, 1985
373 Eklund 17B B 0.067M phosphate buffer7.0 85 0.25 -0.60 1.33 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA Scott and Bernard, 1985
374 Eklund 17B B 0.067M phosphate buffer7.0 85 85.00 1.93 233.35 TDT/Stumbo(1950) TDT tubes in water bathTDT + LYS APPA + LYS Scott and Bernard, 1985
375 Saratoga E 0.067M phosphate buffer7.0 85 0.15 -0.82 0.80 TDT/Stumbo(1950) TDT tubes in water bathTDT APPA Scott and Bernard, 1985
376 Saratoga E 0.067M phosphate buffer7.0 85 15.00 1.18 41.18 TDT/Stumbo(1950) TDT tubes in water bathTDT + LYS APPA + LYS Scott and Bernard, 1985
377 1304E E 0.067M phosphate buffer7.0 79 1.30 0.11 1.08 Survivor curve counts T-Best agar 30°C/21 days Alderton et al., 1974
378 1304E E 0.067M phosphate buffer7.0 91 13.50 1.13 1079.04 HR Survivor curve 5.6 counts + LYS T-Best agar + LYS30°C/14 days Alderton et al., 1974
379 1304E E 0.067M phosphate buffer7.0 93 3.80 0.58 958.49 HR Survivor curve 5.6 counts + LYS T-Best agar + LYS30°C/14 days Alderton et al., 1974
380 1304E E distilled water 79 0.60 -0.22 0.49 Survivor curve counts T-Best agar 30°C/21 days Alderton et al., 1974
381 1304E E distilled water 91 5.00 0.70 62.95 HR Survivor curve counts + LYS T-Best agar + LYS30°C/14 days Alderton et al., 1974
382 Mixed strains: B (Colworth 151, Eklund 17B), E (Beluga, Sebald P34), F (Eklund 202F, Craig 610)PY broth 6.8 90 0.58 - .24 12.50 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/28 days Stringer et al., 1997
383 Mixed strains: B (Colworth 151, Eklund 17B), E (Beluga, Sebald P34), F (Eklund 202F, Craig 610)PY broth 6.8 90 27.25 1.44 299.94 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/28 days Stringer et al., 1997
384 Eklund 17B B PY broth 6.8 75 30.00 1.48 5.66 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/28 days IFR unpublished data
385 Eklund 17B B PY broth 6.8 90 0.69 -0.16 14.87 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/28 days Stringer and Peck 1997
386 Eklund 17B B PY broth 6.8 90 8.92 0.95 98.18 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/28 days Stringer and Peck 1997
387 Eklund 17B B PY broth 6.8 90 0.78 -0.11 16.80 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days Stringer and Peck 1997
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388 Eklund 17B B PY broth 6.8 90 27.70 1.44 304.89 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days Stringer and Peck 1997
389 Eklund 17B B PY broth 6.8 3.0 % NaCl 75 28.39 1.45 5.35 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
390 Eklund 17B B PY broth 6.8 4.0 % NaCl 75 13.00 1.11 2.45 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
391 Eklund 17B B PY broth 6.8 1.5 % NaCl 90 0.81 -0.09 304.89 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
392 Eklund 17B B PY broth 6.8 1.5 % NaCl 90 8.30 0.92 17.45 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
393 Eklund 17B B PY broth 6.8 3.0 % NaCl 90 1.39 0.14 91.36 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
394 Eklund 17B B PY broth 6.8 3.0 % NaCl 90 13.35 1.13 29.95 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
395 Eklund 17B B PY broth 6.8 4.0 % NaCl 90 1.08 0.03 146.94 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
396 Eklund 17B B PY broth 6.8 4.0 % NaCl 90 35.59 1.55 23.27 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/147 days then 30
°C/28 daysStringer and Peck 1997
397 Eklund 17B B 0.067M phosphate buffer7.0 85 0.09 -1.05 391.74 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C Peck et al., 1992a
398 Eklund 17B B 0.067M phosphate buffer7.0 85 9.31 0.97 30.89 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C Peck et al., 1992a
399 Eklund 17B B 0.067M phosphate buffer7.0 85 0.18 -0.74 0.95 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C Peck et al., 1992a
400 Eklund 17B B 0.067M phosphate buffer7.0 2 M sodium thioglycolate after heating85 84.92 1.93 281.74 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days Peck et al., 1992b
401 Eklund 17B B 0.067M phosphate buffer7.0 85 3.85 0.59 17.87 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days Peck et al., 1992b
402 Eklund 17B B 0.067M phosphate buffer7.0 85 70.42 1.85 233.63 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days Peck et al., 1992b
403 Beluga E 0.067M phosphate buffer7.0 2 M sodium thioglycolate after heating85 41.15 1.61 136.52 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days Peck et al., 1992b
404 Beluga E 0.067M phosphate buffer7.0 85 11.48 1.06 53.29 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days Peck et al., 1992b
405 Beluga E 0.067M phosphate buffer7.0 85 50.76 1.71 168.40 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days Peck et al., 1992b
406 Alaska E whitefish chubs 80 4.30 0.63 4.30 TDT 7.3 TDT tubes in water bathTDT NVB 30°/7 days & 25°C/186 daysrisley, et al., 1968
407 Beluga E whitefish chubs 80 2.10 0.32 2.10 TDT 7.3 TDT tubes in water bathTDT NVB 30°/7 days & 25°C/186 daysrisley, et al., 1968
408 8E E whitefish chubs 80 1.80 0.26 1.80 TDT 5.7 TDT tubes in water bathTDT NVB 30°/7 days & 25°C/186 daysrisley, et al., 1968
409 Iwanai E whitefish chubs 80 1.60 0.20 1.60 TDT 7.6 TDT tubes in water bathTDT NVB 30°/7 days & 25°C/186 daysrisley, et al., 1968
410 Tenno E whitefish chubs 80 1.60 0.20 1.60 TDT 7.3 TDT tubes in water bathTDT NVB 30°/7 days & 25°C/186 daysrisley, et al., 1968
411 Minneapolis E TPB broth 80 1.80 0.26 1.80 TDT 7.8 TDT tubes in water bathTDT Schmidt, 1964 
412 Minneapolis E 0.067M phosphate buffer7.0 80 2.30 0.36 2.30 TDT 8.3 TDT tubes in water bathTDT Schmidt, 1964 
413 Tenno E 0.067M phosphate buffer7.0 80 0.80 -0.10 0.80 5.3 Crisley, et al.,  1968
414 Minnesota E autoclaved chub fish 83 2.50 0.40 5.76 TDT TDT tubes in water bathTDT TPGY 25°C/7 days Alderman et al.,  1972
415 Alaska E autoclaved chub fish 83 3.50 0.54 8.06 TDT TDT tubes in water bathTDT TPGY 25°C/7 days Alderman et al.,  1972
416 Alaska E raw egg white 83 14.16 1.15 32.61 TDT TDT tubes in water bathTDT TPGY 25°C/7 days Alderman et al.,  1972
417 Alaska E pre-coagulated egg white 83 1.16 0.06 2.67 TDT TDT tubes in water bathTDT TPGY 25°C/7 days Alderman et al.,  1972
418 8E E 0.067M phosphate buffer7.0 66 70.00 1.85 0.13 Survivor curve 5.1 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
419 8E E 0.067M phosphate buffer7.0 71 5.20 0.72 0.09 Survivor curve 5.1 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
420 8E E 0.067M phosphate buffer7.0 77 0.50 -0.30 0.13 Survivor curve 5.1 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
421 8E E clam liquor 66 550.00 2.74 1.12 Survivor curve 5.2 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
422 8E E clam liquor 71 40.00 1.60 0.74 Survivor curve 5.2 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
423 8E E clam liquor 77 2.90 0.46 0.77 Survivor curve 5.2 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
424 8E E clam liquor 82 0.30 -0.52 0.73 Survivor curve 5.2 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
425 8E E haddock slurry 66 500.00 2.70 0.79 Survivor curve 5.0 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
426 8E E haddock slurry 71 32.00 1.51 0.51 Survivor curve 5.0 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
427 8E E haddock slurry 77 3.00 0.48 0.75 Survivor curve 5.0 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
428 8E E haddock slurry 82 0.20 -0.70 0.50 Survivor curve 5.0 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
429 Detroit E clam liquor 66 700.00 2.85 0.63 Survivor curve 4.6 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
430 Detroit E clam liquor 77 2.40 0.38 0.53 Survivor curve 4.6 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
431 Detroit E clam liquor 82 0.20 -0.70 0.54 Survivor curve 4.6 sealed capillaries in oil bathc unts MAM 30°C/2 days Licciardello, 1983
432 Detroit E clam liquor 77 36.76 1.57 17.63 TDT 9.4 sealed capillaries in oil bathTDT TPG broth 30°C/14 days Licciardello, 1983
433 Detroit E clam liquor 82 7.95 0.90 12.98 TDT 9.4 sealed capillaries in oil bathTDT TPG broth 30°C/14 days Licciardello, 1983
434 Detroit E clam liquor 88 1.71 0.23 12.14 TDT 9.4 sealed capillaries in oil bathTDT TPG broth 30°C/14 days Licciardello, 1983
435 Detroit E clam liquor 93 0.69 -0.16 16.67 TDT 9.4 sealed capillaries in oil bathTDT TPG broth 30°C/14 days Licciardello, 1983
436 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min75 42.10 1.62 13.44 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
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437 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min80 17.10 1.23 17.10 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
438 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min85 7.80 0.89 24.44 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
439 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min90 1.10 0.04 10.80 Survivor curve 10.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
440 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min75 25.70 1.41 6.97 Survivor curve 8.8 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
441 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min80 15.10 1.18 15.10 Survivor curve 8.8 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
442 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min85 5.50 0.74 20.29 Survivor curve 8.8 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
443 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min90 0.60 -0.22 8.16 Survivor curve 8.8 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
444 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min75 17.70 1.25 4.55 Survivor curve 8.5 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
445 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min80 13.10 1.12 13.10 Survivor curve 8.5 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
446 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min85 3.20 0.51 12.46 Survivor curve 8.5 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
447 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min90 0.50 -0.30 7.58 Survivor curve 8.5 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja and Eblen, 1995
448 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min75 27.40 1.44 8.52 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS + 1% NaCl28°C/6 days Juneja and Eblen, 1995
449 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min80 13.20 1.12 13.20 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS + 1% NaCl28°C/6 days Juneja and Eblen, 1995
450 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min85 5.00 0.70 16.07 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS + 1% NaCl28°C/6 days Juneja and Eblen, 1995
451 Kap B5 B turkey slurry 1% NaCl 60˚C/10 min90 0.80 -0.10 8.27 Survivor curve 9.9 screw-capped vials in water bathcounts + LYS RCM + LYS + 1% NaCl28°C/6 days Juneja and Eblen, 1995
452 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min75 19.90 1.30 5.70 Survivor curve 9.2 screw-capped vials in water bathcounts + LYS RCM + LYS + 2% NaCl28°C/6 days Juneja and Eblen, 1995
453 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min80 12.60 1.10 12.60 Survivor curve 9.2 screw-capped vials in water bathcounts + LYS RCM + LYS + 2% NaCl28°C/6 days Juneja and Eblen, 1995
454 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min85 4.30 0.63 15.01 Survivor curve 9.2 screw-capped vials in water bathcounts + LYS RCM + LYS + 2% NaCl28°C/6 days Juneja and Eblen, 1995
455 Kap B5 B turkey slurry 2% NaCl 60˚C/10 min90 0.40 -0.40 4.87 Survivor curve 9.2 screw-capped vials in water bathcounts + LYS RCM + LYS + 2% NaCl28°C/6 days Juneja and Eblen, 1995
456 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min75 16.90 1.23 5.04 Survivor curve 9.5 screw-capped vials in water bathcounts + LYS RCM + LYS + 3% NaCl28°C/6 days Juneja and Eblen, 1995
457 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min80 8.20 0.91 8.20 Survivor curve 9.5 screw-capped vials in water bathcounts + LYS RCM + LYS + 3% NaCl28°C/6 days Juneja and Eblen, 1995
458 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min85 2.60 0.41 8.72 Survivor curve 9.5 screw-capped vials in water bathcounts + LYS RCM + LYS + 3% NaCl28°C/6 days Juneja and Eblen, 1995
459 Kap B5 B turkey slurry 3% NaCl 60˚C/10 min90 0.30 -0.52 3.38 Survivor curve 9.5 screw-capped vials in water bathcounts + LYS RCM + LYS + 3% NaCl28°C/6 days Juneja and Eblen, 1995
460 Mixed strains B,E turkey slurry 5.0 70 45.10 1.65 14.34 Survivor curve 20.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
461 Mixed strains B,E turkey slurry 5.0 1.5% NaCl + 0.15% Sodium phyrophosphate70 33.80 1.53 9.80 Survivor curve 18.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
462 Mixed strains B,E turkey slurry 6.0 70 51.30 1.71 6.81 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
463 Mixed strains B,E turkey slurry 6.0 0.3% Sodium phyrophosphate70 33.90 1.53 4.50 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
464 Mixed strains B,E turkey slurry 6.0 1.5% NaCl + 0.15% Sodium phyrophosphate70 38.60 1.59 12.96 Survivor curve 21.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
465 Mixed strains B,E turkey slurry 6.0 3.0% NaCl 70 31.10 1.49 4.13 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
466 Mixed strains B,E turkey slurry 6.5 70 57.70 1.76 7.66 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
467 Mixed strains B,E turkey slurry 6.5 1.5% NaCl + 0.15% Sodium phyrophosphate70 40.10 1.60 5.32 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
468 Mixed strains B,E turkey slurry 7.0 1.5% NaCl + 0.15% Sodium phyrophosphate70 44.10 1.64 5.85 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
469 Mixed strains B,E turkey slurry 5.0 1.5% NaCl + 0.15% Sodium phyrophosphate75 28.90 1.46 15.56 Survivor curve 18.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
470 Mixed strains B,E turkey slurry 5.5 1% NaCl + 0.10% Sodium phyrophosphate75 36.10 1.56 16.32 Survivor curve 14.5 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
471 Mixed strains B,E turkey slurry 5.5 1% NaCl + 0.20% Sodium phyrophosphate75 28.50 1.45 13.82 Survivor curve 15.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
472 Mixed strains B,E turkey slurry 5.5 2% NaCl + 0.1% Sodium phyrophosphate75 28.70 1.46 10.45 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
473 Mixed strains B,E turkey slurry 5.5 2% NaCl + 0.2% Sodium phyrophosphate75 20.90 1.32 7.61 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
474 Mixed strains B,E turkey slurry 6.0 1.5% NaCl + 0.15% Sodium phyrophosphate75 36.40 1.56 21.09 Survivor curve 21.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
475 Mixed strains B,E turkey slurry 6.25 1% NaCl + 0.10% Sodium phyrophosphate75 39.10 1.59 22.95 Survivor curve 21.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
476 Mixed strains B,E turkey slurry 6.25 1% NaCl + 0.20% Sodium phyrophosphate75 32.90 1.52 19.77 Survivor curve 22.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
477 Mixed strains B,E turkey slurry 6.25 2% NaCl + 0.1% Sodium phyrophosphate75 38.70 1.59 14.10 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
478 Mixed strains B,E turkey slurry 6.25 2% NaCl + 0.2% Sodium phyrophosphate75 30.40 1.48 11.07 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
479 Mixed strains B,E turkey slurry 5.0 1.5% NaCl + 0.15% Sodium phyrophosphate80 13.50 1.13 13.50 Survivor curve 18.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
480 Mixed strains B,E turkey slurry 6.0 0.15% Sodium phyrophosphate80 32.10 1.51 32.10 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
481 Mixed strains B,E turkey slurry 6.0 1.5% NaCl 80 26.20 1.42 26.20 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
482 Mixed strains B,E turkey slurry 6.0 1.5% NaCl + 0.15% Sodium phyrophosphate80 23.00 1.36 23.00 Survivor curve 21.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
483 Mixed strains B,E turkey slurry 6.0 1.5% NaCl + 0.3% Sodium phyrophosphate80 21.00 1.32 21.00 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
484 Mixed strains B,E turkey slurry 6.0 3% NaCl + 0.15% Sodium phyrophosphate80 25.10 1.40 25.10 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
485 Mixed strains B,E turkey slurry 6.5 1.5% NaCl + 0.15% Sodium phyrophosphate80 28.20 1.45 28.20 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
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486 Mixed strains B,E turkey slurry 5.0 1.5% NaCl + 0.15% Sodium phyrophosphate85 7.00 0.85 13.00 Survivor curve 18.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
487 Mixed strains B,E turkey slurry 5.5 1% NaCl + 0.10% Sodium phyrophosphate85 7.40 0.87 16.37 Survivor curve 14.5 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
488 Mixed strains B,E turkey slurry 5.5 1% NaCl + 0.20% Phosphate85 6.70 0.83 13.82 Survivor curve 15.9 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
489 Mixed strains B,E turkey slurry 5.5 2% NaCl + 0.1% Sodium phyrophosphate85 7.40 0.87 20.32 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
490 Mixed strains B,E turkey slurry 5.5 2% NaCl + 0.2% Sodium phyrophosphate85 4.00 0.60 10.98 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
491 Mixed strains B,E turkey slurry 6.25 1% NaCl + 0.10% Sodium phyrophosphate85 13.50 1.13 23.00 Survivor curve 21.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
492 Mixed strains B,E turkey slurry 6.25 1% NaCl + 0.20% Sodium phyrophosphate85 11.90 1.08 19.81 Survivor curve 22.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
493 Mixed strains B,E turkey slurry 6.25 2% NaCl + 0.2% Sodium phyrophosphate85 9.70 0.99 26.63 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
494 Mixed strains B,E turkey slurry 5.0 90 5.00 0.70 15.72 Survivor curve 20.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
495 Mixed strains B,E turkey slurry 5.0 1.5% NaCl + 0.15% Sodium phyrophosphate90 3.10 0.49 10.69 Survivor curve 18.6 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
496 Mixed strains B,E turkey slurry 6.0 90 8.80 0.94 66.32 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
497 Mixed strains B,E turkey slurry 6.0 0.3% Sodium phyrophosphate90 5.40 0.73 40.70 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
498 Mixed strains B,E turkey slurry 6.0 1.5% NaCl + 0.15% Sodium phyrophosphate90 4.80 0.68 14.29 Survivor curve 21.1 screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
499 Mixed strains B,E turkey slurry 6.0 3% NaCl 90 5.60 0.75 42.21 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
500 Mixed strains B,E turkey slurry 6.25 2% NaCl + 0.2% Sodium phyrophosphate90 3.50 0.54 26.38 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
501 Mixed strains B,E turkey slurry 6.50 90 9.30 0.97 70.09 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
502 Mixed strains B,E turkey slurry 6.50 1.5% NaCl + 0.15% Sodium phyrophosphate90 7.30 0.86 55.02 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
503 Mixed strains B,E turkey slurry 6.5 70 53.30 1.73 7.07 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
504 Mixed strains B,E turkey slurry 5.0 70 49.50 1.69 6.57 Survivor curve screw-capped vials in water bathcounts + LYS RCM + LYS 28°C/6 days Juneja et al.,  1995b
505 Vancouver HerringE 0.067M phosphate buffer7.0 75 9.00 0.95 1.70 Survivor curve screw-cap tube in a water bathcounts ESBA Grecz and Tang, 1970
506 Saratoga E 0.017M phosphate buffer7.0 70 98.00 1.99 1.17 TDT 5.2 TDT tubes in water bathTDT W & F NCA, 1966
507 Saratoga E 0.017M phosphate buffer7.0 75 13.89 1.14 1.52 TDT 5.2 TDT tubes in water bathTDT W & F NCA, 1966
508 Saratoga E 0.017M phosphate buffer7.0 80 1.21 0.08 1.21 TDT 5.2 TDT tubes in water bathTDT W & F NCA, 1966
509 Beluga E 0.017M phosphate buffer7.0 75 6.39 0.81 0.94 TDT 6.0 TDT tubes in water bathTDT W & F NCA, 1966
510 Beluga E 0.017M phosphate buffer7.0 80 0.93 -0.03 0.93 TDT 6.0 TDT tubes in water bathTDT W & F NCA, 1966
511 Eklund 17B B PY broth 6.8 85 0.49 -0.31 2.60 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/8 days Stringer and Peck, 1996
512 Eklund 17B B PY broth 6.8 85 0.09 -1.05 0.42 HS Survivor curve screw-cap tube in a water bathcounts + courgettePYGS + courgette30°C/8 days Stringer and Peck, 1996
513 Eklund 17B B PY broth 6.8 85 0.38 -0.42 1.76 HS Survivor curve screw-cap tube in a water bathcounts + carrot PYGS + carrot 30°C/8 days Stringer and Peck, 1996
514 Eklund 17B B PY broth 6.8 85 0.39 -0.41 1.81 HS Survivor curve screw-cap tube in a water bathcounts + mung bean sproutPYGS + mung bean sprout30°C/8 days Stringer and Peck, 1996
515 Eklund 17B B PY broth 6.8 85 0.34 -0.47 1.58 HS Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + potato juice & HEWL30°C/8 days Stringer and Peck, 1996
516 Eklund 17B B PY broth 6.8 85 23.81 1.38 78.99 HR Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + potato juice & HEWL30°C/8 days Stringer and Peck, 1996
517 Eklund 17B B PY broth 6.8 85 0.31 -0.51 1.44 HS Survivor curve screw-cap tube in a water bathcounts + turnip juicePYGS + turnip juice30°C/8 days Stringer and Peck, 1996
518 Eklund 17B B PY broth 6.8 85 15.63 1.19 51.86 HR Survivor curve screw-cap tube in a water bathcounts + turnip juicePYGS + turnip juice30°C/8 days Stringer and Peck, 1996
519 Eklund 17B B PY broth 6.8 85 0.21 -0.68 0.97 HS Survivor curve screw-cap tube in a water bathcounts + swede juicePYGS + swede juice30°C/8 days Stringer and Peck, 1996
520 Eklund 17B B PY broth 6.8 85 12.58 1.10 41.74 HR Survivor curve screw-cap tube in a water bathcounts + swede juicePYGS + swede juice30°C/8 days Stringer and Peck, 1996
521 Eklund 17B B PY broth 6.8 85 0.19 -0.72 0.88 HS Survivor curve screw-cap tube in a water bathcounts + swede juicePYGS + swede juice30°C/8 days Stringer and Peck, 1996
522 Eklund 17B B PY broth 6.8 85 11.23 1.05 37.26 HR Survivor curve screw-cap tube in a water bathcounts + swede juicePYGS + swede juice30°C/8 days Stringer and Peck, 1996
523 Eklund 17B B PY broth 6.8 85 0.20 -0.70 0.93 HS Survivor curve screw-cap tube in a water bathcounts + flat bean juicePYGS + flat bean juice30°C/8 days Stringer and Peck, 1996
524 Eklund 17B B PY broth 6.8 85 10.06 1.00 33.38 HR Survivor curve screw-cap tube in a water bathcounts + flat bean juicePYGS + flat bean juice30°C/8 days Stringer and Peck, 1996
525 Eklund 17B B PY broth 6.8 85 0.19 -0.72 0.88 HS Survivor curve screw-cap tube in a water bathcounts + red cabbage juicePYGS + red cabbage juice30°C/8 days Stringer and Peck, 1996
526 Eklund 17B B PY broth 6.8 85 7.59 0.88 25.18 HR Survivor curve screw-cap tube in a water bathcounts + red cabbage juicePYGS + red cabbage juice30°C/8 days Stringer and Peck, 1996
527 Eklund 17B B PY broth 6.8 85 0.31 -0.51 1.44 HS Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + 10 µg HEWL ml-130°C/8 days Stringer and Peck, 1996
528 Eklund 17B B PY broth 6.8 85 34.48 1.54 114.39 HR Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + 10 µg HEWL ml-130°C/8 days Stringer and Peck, 1996
529 Eklund 17B B PY broth 6.8 85 0.32 -0.49 1.49 HS Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + 100 µg HEWL ml-130°C/7 days IFR unpublished data
530 Eklund 17B B PY broth 6.8 85 34.48 1.54 114.39 HR Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + 100 µg HEWL ml-130°C/7 days IFR unpublished data
531 Eklund 17B B PY broth 6.8 85 0.35 -0.46 1.62 HS Survivor curve screw-cap tube in a water bathcounts + HEWL PYGS + 1µg HEWL ml-130°C/7 days IFR unpublished data
532 ATCC 9564 E 0.05M phosphate buffer 7.0 1.00 70 10.00 1.00 0.36 Survivor curve pyrex test tube counts Murrell and Scott, 1966
533 ATCC 9564 E 0.90 80 25.84 1.41 25.84 Survivor curve pyrex test tube counts Murrell and Scott, 1966
534 ATCC 9564 E 0.05M phosphate buffer 7.0 1.00 80 0.32 -0.50 0.32 Survivor curve pyrex test tube counts Murrell and Scott, 1966
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535 Alaska E crabmeat 74 10.05 1.00 1.01 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
536 Alaska E crabmeat 77 2.82 0.45 0.81 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
537 Alaska E crabmeat 79 1.49 0.17 1.19 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
538 Alaska E crabmeat 82 0.71 -0.15 1.63 TDT/Schmidt(1957) 6.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
539 Beluga E crabmeat 74 11.22 1.05 1.29 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
540 Beluga E crabmeat 77 2.94 0.47 0.91 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
541 Beluga E crabmeat 79 1.19 0.08 0.96 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
542 Beluga E crabmeat 82 0.84 -0.08 1.83 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
543 Beluga E crabmeat 85 0.33 -0.48 1.94 TDT/Schmidt(1957) 6.5 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
544 Crab G21-5 E crabmeat 74 6.15 0.79 0.85 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
545 Crab G21-5 E crabmeat 77 1.70 0.23 0.58 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
546 Crab G21-5 E crabmeat 79 1.09 0.04 0.90 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
547 Crab G21-5 E crabmeat 82 0.51 -0.29 1.04 TDT/Schmidt(1957) 7.1 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
548 Crab G21-5 E crabmeat 71 31.88 1.50 0.72 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/70 days Lynt et al.,  1983
549 190 F 0.067M phosphate buffer7.0 74 9.07 0.96 0.67 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
550 190 F 0.067M phosphate buffer7.0 77 1.66 0.22 0.41 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
551 190 F 0.067M phosphate buffer7.0 79 1.03 0.01 0.80 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
552 190 F 0.067M phosphate buffer7.0 82 0.25 -0.60 0.64 TDT/Schmidt(1957) 5.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
553 202 F 0.067M phosphate buffer7.0 71 42.41 1.63 0.89 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
554 202 F 0.067M phosphate buffer7.0 74 12.68 1.10 0.90 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
555 202 F 0.067M phosphate buffer7.0 77 4.29 0.63 1.02 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
556 202 F 0.067M phosphate buffer7.0 79 0.93 -0.03 0.72 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
557 202 F 0.067M phosphate buffer7.0 82 0.33 -0.48 0.86 TDT/Schmidt(1957) 5.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
558 Craig 610 F 0.067M phosphate buffer7.0 77 6.64 0.82 1.99 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
559 Craig 610 F 0.067M phosphate buffer7.0 79 2.12 0.33 1.70 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
560 Craig 610 F 0.067M phosphate buffer7.0 82 0.84 -0.08 1.88 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
561 Craig 610 F 0.067M phosphate buffer7.0 85 0.37 -0.43 2.30 TDT/Schmidt(1957) 6.3 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
562 202 F crabmeat 77 9.50 0.98 2.90 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
563 202 F crabmeat 79 3.64 0.56 2.93 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
564 202 F crabmeat 82 1.20 0.08 2.65 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
565 202 F crabmeat 85 0.53 -0.28 3.20 TDT/Schmidt(1957) 6.4 TDT tubes in water bathTDT TPGY 26°C/182 days Lynt et al.,  1983
566 Mixed strains (Colworth 230, ATCC 23387, Colworth 195, Colworth 151, Eklund 17B)B PY broth 6.8 90 0.51 -0.29 10.99 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days IFR unpublished data
567 Mixed strains (Colworth 230, ATCC 23387, Colworth 195, Colworth 151, Eklund 17B)B PY broth 6.8 90 23.20 1.37 255.36 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days IFR unpublished data
568 Mixed strains (Colworth 230, ATCC 23387, Colworth 195, Colworth 151, Eklund 17B)B PY broth 6.8 90 0.58 -0.24 12.50 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days IFR unpublished data
569 Mixed strains (Colworth 230, ATCC 23387, Colworth 195, Colworth 151, Eklund 17B)B PY broth 6.8 90 31.55 1.50 347.27 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days IFR unpublished data
570 Eklund 17B B 0.067M phosphate buffer7.0 75 14.81 1.17 1.35 Survivor curve 4.8 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
571 Eklund 17B B broccoli puree 5.8 75 10.70 1.03 1.42 Survivor curve 5.7 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
572 Eklund 17B B broccoli puree 5.8 75 6.60 0.82 0.48 Survivor curve 4.4 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
573 Eklund 17B B potato puree 5.9 75 10.07 1.00 0.96 Survivor curve 4.9 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
574 Eklund 17B B potato puree 5.9 75 4.34 0.64 0.54 Survivor curve 5.5 screw-cap tube in a water bathcounts Potato agar 30°C/5 days IFR unpublished data
575 Eklund 17B B 0.067M phosphate buffer7.0 78 3.03 0.48 1.16 Survivor curve 4.8 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
576 Eklund 17B B broccoli puree 5.8 78 3.17 0.50 1.41 Survivor curve 5.7 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
577 Eklund 17B B broccoli puree 5.8 78 1.16 0.06 0.41 Survivor curve 4.4 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
578 Eklund 17B B potato puree 5.9 78 3.17 0.50 1.24 Survivor curve 4.9 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
579 Eklund 17B B potato puree 5.9 78 1.07 0.03 0.46 Survivor curve 5.5 screw-cap tube in a water bathcounts Potato agar 30°C/5 days IFR unpublished data
580 Eklund 17B B 0.067M phosphate buffer7.0 80 1.26 0.10 1.26 Survivor curve 4.8 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
581 Eklund 17B B broccoli puree 5.8 80 1.46 0.16 1.46 Survivor curve 5.7 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
582 Eklund 17B B broccoli puree 5.8 80 0.50 -0.30 0.50 Survivor curve 4.4 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
583 Eklund 17B B potato puree 5.9 80 0.94 -0.03 0.94 Survivor curve 4.9 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
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584 Eklund 17B B potato puree 5.9 80 0.47 -0.33 0.47 Survivor curve 5.5 screw-cap tube in a water bathcounts Potato agar 30°C/5 days IFR unpublished data
585 Kap B2 B 0.067M phosphate buffer7.0 78 2.23 0.35 0.74 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
586 Kap B2 B 0.067M phosphate buffer7.0 78 70.42 1.85 40.30 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
587 Kap B2 B broccoli puree 5.8 78 3.18 0.50 1.06 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
588 Kap B2 B broccoli puree 5.8 78 47.17 1.67 33.10 HR Survivor curve 13.0 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
589 Kap B2 B broccoli puree 5.8 78 0.93 -0.03 0.34 Survivor curve 4.6 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
590 Kap B2 B potato puree 5.9 78 3.41 0.53 1.24 HS Survivor curve 4.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
591 Kap B2 B potato puree 5.9 78 48.78 1.69 30.01 HR Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
592 Kap B2 B potato puree 5.9 78 0.56 -0.25 0.29 Survivor curve 7.1 screw-cap tube in a water bathcounts Potato agar 30°C/5 days IFR unpublished data
593 Kap B2 B 0.067M phosphate buffer7.0 75 19.23 1.28 1.22 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
594 Kap B2 B 0.067M phosphate buffer7.0 75 192.30 2.28 47.63 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
595 Kap B2 B broccoli puree 5.8 75 18.73 1.27 1.21 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
596 Kap B2 B broccoli puree 5.8 75 77.52 1.89 31.97 HR Survivor curve 13.0 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
597 Kap B2 B broccoli puree 5.8 75 6.95 0.84 0.57 Survivor curve 4.6 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
598 Kap B2 B potato puree 5.9 75 18.01 1.26 1.45 HS Survivor curve 4.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
599 Kap B2 B potato puree 5.9 75 78.12 1.89 23.19 HR Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
600 Kap B2 B potato puree 5.9 75 2.28 0.36 0.45 Survivor curve 7.1 screw-cap tube in a water bathcounts Potato agar 30°C/5 days IFR unpublished data
601 Kap B2 B 0.067M phosphate buffer7.0 80 1.09 0.04 1.09 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
602 Kap B2 B 0.067M phosphate buffer7.0 80 36.63 1.56 36.63 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
603 Kap B2 B broccoli puree 5.8 80 1.11 0.05 1.11 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
604 Kap B2 B broccoli puree 5.8 80 30.67 1.49 30.67 HR Survivor curve 13.0 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
605 Kap B2 B broccoli puree 5.8 80 0.46 -0.34 0.46 Survivor curve 4.6 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
606 Kap B2 B potato puree 5.9 80 2.30 0.36 2.30 HS Survivor curve 4.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
607 Kap B2 B potato puree 5.9 80 20.58 1.31 20.58 HR Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
608 Kap B2 B 0.067M phosphate buffer7.0 82 0.37 -0.43 1.12 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
609 Kap B2 B 0.067M phosphate buffer7.0 82 28.65 1.46 50.07 HR Survivor curve 8.3 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
610 Kap B2 B broccoli puree 5.8 82 0.39 -0.41 1.17 HS Survivor curve 4.2 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
611 Kap B2 B broccoli puree 5.8 82 22.83 1.36 32.54 HR Survivor curve 13.0 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
612 Kap B2 B broccoli puree 5.8 82 0.19 -0.72 0.52 Survivor curve 4.6 screw-cap tube in a water bathcounts Broccoli agar 30°C/5 days IFR unpublished data
613 Kap B2 B potato puree 5.9 82 0.52 -0.28 1.42 HS Survivor curve 4.6 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
614 Kap B2 B potato puree 5.9 82 15.77 1.20 25.63 HR Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/5 days IFR unpublished data
615 Kap B2 B potato puree 5.9 82 0.22 -0.66 0.42 Survivor curve 7.1 screw-cap tube in a water bathcounts Potato agar 30°C/5 days IFR unpublished data
616 Eklund 17B B 0.067M phosphate buffer7.0 75 1.15 0.06 0.22 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/3 days IFR unpublished data
617 Eklund 17B B 0.067M phosphate buffer7.0 75 1.24 0.09 0.23 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
618 Eklund 17B B 0.067M phosphate buffer7.0 90 0.64 -0.19 13.79 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/3 days IFR unpublished data
619 Eklund 17B B 0.067M phosphate buffer7.0 90 34.13 1.53 375.67 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/3 days IFR unpublished data
620 Eklund 17B B 0.067M phosphate buffer7.0 90 0.65 -0.19 14.00 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/6 days IFR unpublished data
621 Eklund 17B B 0.067M phosphate buffer7.0 90 36.50 1.56 401.75 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/6 days IFR unpublished data
622 Eklund 17B B PY broth 6.8 75 1.48 0.17 0.28 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/2 days IFR unpublished data
623 Eklund 17B B PY broth 6.8 75 1.90 0.28 0.36 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/21 days IFR unpublished data
624 Eklund 17B B PY broth 6.8 75 1.29 0.11 0.24 Survivor curve screw-cap tube in a water bathcounts PYGS + 0.1% NaCl30°C/1 day IFR unpublished data
625 Eklund 17B B PY broth 6.8 75 1.54 0.19 0.29 Survivor curve screw-cap tube in a water bathcounts PYGS + 1.5% NaCl30°C/1 day IFR unpublished data
626 Eklund 17B B PY broth 6.8 75 0.63 -0.20 0.12 Survivor curve screw-cap tube in a water bathcounts PYGS + 3% NaCl30°C/1 day IFR unpublished data
627 Eklund 17B B PY broth 6.8 90 0.68 -0.17 14.65 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/3 days IFR unpublished data
628 Eklund 17B B PY broth 6.8 90 15.65 1.19 172.26 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/3 days IFR unpublished data
629 Eklund 17B B PY broth 6.8 90 0.68 -0.17 14.65 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/6 days IFR unpublished data
630 Eklund 17B B PY broth 6.8 90 15.65 1.19 172.26 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/6 days IFR unpublished data
631 Eklund 17B B PY broth 6.8 80 4.31 0.63 4.31 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/6 days IFR unpublished data
632 Eklund 17B B PY broth 6.8 90 0.71 -0.15 15.30 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/4 days IFR unpublished data
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633 Eklund 17B B PY broth 6.8 90 40.16 1.60 442.04 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/4 days IFR unpublished data
634 Eklund 17B B PY broth 6.8 80 4.01 0.60 4.01 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
635 Eklund 17B B PY broth 6.8 80 6.02 0.78 6.02 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
636 Eklund 17B B PY broth 6.8 90 0.77 -0.11 16.59 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/4 days IFR unpublished data
637 Eklund 17B B PY broth 6.8 90 19.42 1.29 213.75 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/4 days IFR unpublished data
638 Eklund 17B B PY broth 6.8 80 5.03 0.70 5.03 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/7 days IFR unpublished data
639 Eklund 17B B PY broth 6.8 80 2.59 0.41 2.59 Survivor curve screw-cap tube in a water bathcounts PYGS under 10% H2, 5%CO2, 85% N210°C/ 6 days IFR unpublished data
640 Eklund 17B B PY broth 6.8 80 2.68 0.43 2.68 Survivor curve screw-cap tube in a water bathcounts PYGS under 10% H2, 90% N210°C/56 days IFR unpublished data
641 Eklund 17B B PY broth 6.8 80 3.22 0.51 3.22 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% N210°C/56 days IFR unpublished data
642 Eklund 17B B PY broth 6.8 80 1.45 0.16 1.45 Survivor curve screw-cap tube in a water bathcounts PYGS under 50% CO2, 50% N210°C/56 days IFR unpublished data
643 Eklund 17B B PY broth 6.8 80 2.66 0.42 2.66 Survivor curve screw-cap tube in a water bathcounts PYGS under 2% O2, 98% N210°C/56 days IFR unpublished data
644 Eklund 17B B PY broth 6.8 75 4.95 0.69 0.93 Survivor curve screw-cap tube in a water bathcounts PYGS under 100 N210°C/160 days IFR unpublished data
645 Eklund 17B B PY broth 6.8 75 7.51 0.88 1.42 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% CO210° /160 days IFR unpublished data
646 Eklund 17B B PY broth 6.8 75 7.84 0.89 1.48 Survivor curve screw-cap tube in a water bathcounts PYGS under 50% CO2, 50% N210°C/160 days IFR unpublished data
647 Eklund 17B B PY broth 6.8 75 8.86 0.95 1.67 Survivor curve screw-cap tube in a water bathcounts PYGS under 80% CO2, 20% N210°C/16  days IFR unpublished data
648 Eklund 17B B PY broth 6.8 75 8.97 0.95 1.69 Survivor curve screw-cap tube in a water bathcounts PYGS under 50% Ar, 50% N210°C/160 days IFR unpublished data
649 Eklund 17B B PY broth 6.8 90 1.13 0.05 24.35 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 10% H2, 5%CO2, 85% N2 + Lys10°C/49 days IFR unpublished data
650 Eklund 17B B PY broth 6.8 90 45.25 1.66 498.06 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 10% H2, 5%CO2, 85% N2 + Lys10°C/49 days IFR unpublished data
651 Eklund 17B B PY broth 6.8 90 2.15 0.33 46.32 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 10% H2, 90% N2 + Lys10°C/49 days IFR unpublished data
652 Eklund 17B B PY broth 6.8 90 16.95 1.23 186.57 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 10% H2, 90% N2 + Lys10°C/49 days IFR unpublished data
653 Eklund 17B B PY broth 6.8 90 1.79 0.25 38.56 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% N2 + Lys10°C/49 days IFR unpublished data
654 Eklund 17B B PY broth 6.8 90 22.52 1.35 247.88 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% N2 + Lys10°C/49 days IFR unpublished data
655 Eklund 17B B PY broth 6.8 90 1.27 0.10 27.36 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 50% CO2, 50% N2 + Lys10°C/49 days IFR unpublished data
656 Eklund 17B B PY broth 6.8 90 22.52 1.35 247.88 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 50% CO2, 50% N2 + Lys10°C/49 days IFR unpublished data
657 Eklund 17B B PY broth 6.8 90 2.45 0.39 68.94 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 2% O2, 98% N2 + Lys10°C/49 days IFR unpublished data
658 Eklund 17B B PY broth 6.8 90 0.83 -0.08 17.88 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% N2 + Lys10°C/140 days IFR unpublished data
659 Eklund 17B B PY broth 6.8 90 26.59 1.42 292.67 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% N2 + Lys10°C/140 days IFR unpublished data
660 Eklund 17B B PY broth 6.8 90 0.93 -0.03 20.04 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% Ar + Lys10°C/140 days IFR unpublished data
661 Eklund 17B B PY broth 6.8 90 27.93 1.45 307.42 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% Ar + Lys10°C/140 days IFR unpublished data
662 Eklund 17B B PY broth 6.8 90 1.05 0.02 22.62 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 80%CO2, 20% N2 + Lys10°C/14  days IFR unpublished data
663 Eklund 17B B PY broth 6.8 90 26.88 1.43 295.87 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 80%CO2, 20% N2 + Lys10°C/14  days IFR unpublished data
664 Eklund 17B B PY broth 6.8 90 6.13 0.79 172.48 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 50% Ar + 50% N2 + Lys10°C/14  days IFR unpublished data
665 Eklund 17B B PY broth 6.8 90 0.99 0.00 21.33 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/7 days IFR unpublished data
666 Eklund 17B B PY broth 6.8 90 16.50 1.22 181.61 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/7 days IFR unpublished data
667 Eklund 17B B PY broth 6.8 90 0.78 -0.11 16.80 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/7 days IFR unpublished data
668 Eklund 17B B PY broth 6.8 90 10.29 1.01 113.26 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 10°C/7 days IFR unpublished data
669 Eklund 17B B PY broth 6.8 80 3.74 0.57 3.74 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
670 Eklund 17B B PY broth 6.8 80 2.01 0.30 2.01 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/21 days IFR unpublished data
671 Eklund 17B B 0.067M phosphate buffer6.8 80 2.42 0.38 2.42 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/8 days Stringer et al. , 1999
672 Eklund 17B B 0.067M phosphate buffer7.0 80 4.07 0.61 4.07 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/8 days IFR unpublished data
673 Eklund 17B B 0.067M phosphate buffer7.0 80 82.64 1.92 82.64 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/8 days IFR unpublished data
674 Eklund 17B B 0.067M phosphate buffer7.0 80 3.15 0.50 3.15 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/98 days IFR unpublished data
675 Eklund 17B B 0.067M phosphate buffer7.0 80 27.93 1.45 27.93 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/98 days IFR unpublished data
676 Eklund 17B B PY broth 6.8 80 0.97 -0.01 0.97 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/8 days IFR unpublished data
677 Eklund 17B B PY broth 6.8 80 111.11 2.05 111.11 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/8 days IFR unpublished data
678 Eklund 17B B PY broth 6.8 80 2.00 0.30 2.00 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/7 days IFR unpublished data
679 Eklund 17B B PY broth 6.8 80 0.80 -0.10 0.80 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% CO2 + Lys10° /49 da IFR unpublished data
680 Eklund 17B B PY broth 6.8 80 0.69 -0.16 0.69 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% CO2 + Lys10° /49 da IFR unpublished data
681 Eklund 17B B PY broth 6.8 80 0.86 -0.07 0.86 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% Ar + Lys10°C/49 days IFR unpublished data
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682 Eklund 17B B PY broth 6.8 80 15.38 1.19 15.38 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS under 100% Ar + Lys10°C/49 days IFR unpublished data
683 Eklund 17B B PY broth 6.8 80 2.33 0.37 2.33 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% N2O10°C/21 days IFR unpublished data
684 Eklund 17B B PY broth 6.8 80 3.98 0.60 3.98 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% N210°/4  days IFR unpublished data
685 Eklund 17B B PY broth 6.8 80 4.00 0.60 4.00 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% CO210°/42 days IFR unpublished data
686 Eklund 17B B PY broth 6.8 80 2.11 0.32 2.11 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% He10°/42 days IFR unpublished data
687 Eklund 17B B PY broth 6.8 80 1.33 0.12 1.33 Survivor curve screw-cap tube in a water bathcounts PYGS under 100% N2O10°/4  days IFR unpublished data
688 Eklund 17B B PY broth 6.8 80 2.23 0.35 2.23 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/119 days IFR unpublished data
689 Eklund 17B B PY broth 6.8 80 3.44 0.54 3.44 Survivor curve screw-cap tube in a water bathcounts PYGS + 0.01M Acetate10°C/119 days IFR unpublished data
690 Eklund 17B B PY broth 6.8 80 3.84 0.58 3.84 Survivor curve screw-cap tube in a water bathcounts PYGS + 0.01M Lactate10°C/119 days IFR unpublished data
691 Eklund 17B B PY broth 6.8 80 2.91 0.46 2.91 Survivor curve screw-cap tube in a water bathcounts PYGS + 0.01M Citrate10°C/119 days IFR unpublished data
692 Eklund 17B B PY broth 6.8 75 6.99 0.84 1.32 Survivor curve screw-cap tube in a water bathcounts PYGS 10°C/147 days IFR unpublished data
693 Eklund 17B B PY broth 6.8 75 4.58 0.66 0.86 Survivor curve screw-cap tube in a water bathcounts PYGS (pH 5.5) 10°C/147 days IFR unpublished data
694 Eklund 17B B PY broth 6.8 90 0.71 -0.15 15.30 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + Lys 10°C/21 days IFR unpublished data
695 Eklund 17B B PY broth 6.8 90 18.38 1.26 202.31 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + Lys 10°C/21 days IFR unpublished data
696 Eklund 17B B PY broth 6.8 90 2.81 0.45 60.54 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS (pH 6.0) + LYS10°C/21 days IFR unpublished data
697 Eklund 17B B PY broth 6.8 90 10.76 1.03 118.43 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS (pH 6.0) + LYS10°C/21 days IFR unpublished data
698 Eklund 17B B PY broth 6.8 90 4.81 0.68 135.34 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS (pH 5.6) + LYS10°C/21 days IFR unpublished data
699 Eklund 17B B PY broth 6.8 90 0.71 -0.15 15.30 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + Lys 10°/42 days IFR unpublished data
700 Eklund 17B B PY broth 6.8 90 19.38 1.29 213.31 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + Lys 10°/42 days IFR unpublished data
701 Eklund 17B B PY broth 6.8 90 1.22 0.09 26.28 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS (pH 6.0) + LYS10°/42 days IFR unpublished data
702 Eklund 17B B PY broth 6.8 90 23.92 1.38 263.29 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS (pH 6.0) + LYS10°/42 days IFR unpublished data
703 Eklund 17B B PY broth 6.8 90 2.39 0.38 67.25 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS (pH 5.6) + LYS10°/42 days IFR unpublished data
704 Eklund 17B B PY broth 6.8 75 4.45 0.65 0.84 Survivor curve screw-cap tube in a water bathcounts PYGS + 3% NaCl10°C/28 days IFR unpublished data
705 Eklund 17B B PY broth 6.8 75 3.56 0.55 0.67 Survivor curve screw-cap tube in a water bathcounts PYGS + 4% NaCl10°C/28 days IFR unpublished data
706 Eklund 17B B PY broth 6.8 75 0.59 -0.23 0.11 Survivor curve screw-cap tube in a water bathcounts PYGS + 3% NaCl10°C/14 days IFR unpublished data
707 Eklund 17B B PY broth 6.8 90 4.29 0.63 92.43 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + 0.1% NaCl + Lys10°C/161 days IFR unpublished data
708 Eklund 17B B PY broth 6.8 90 26.81 1.43 295.10 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + 0.1% NaCl + Lys10°C/161 days IFR unpublished data
709 Eklund 17B B PY broth 6.8 90 0.87 -0.06 18.74 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + 1.5% NaCl + Lys10°C/161 days IFR unpublished data
710 Eklund 17B B PY broth 6.8 90 22.52 1.35 247.88 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + 1.5% NaCl + Lys10°C/161 days IFR unpublished data
711 Eklund 17B B PY broth 6.8 90 1.53 0.18 32.96 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + 3% NaCl + Lys10°C/161 days IFR unpublished data
712 Eklund 17B B PY broth 6.8 90 26.38 1.42 290.36 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + 3% NaCl + Lys10°C/161 days IFR unpublished data
713 Eklund 17B B 0.067M phosphate buffer7.0 80 0.42 -0.38 0.42 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
714 2129B B 0.067M phosphate buffer7.0 80 2.47 0.39 2.47 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
715 Kap B2 B 0.067M phosphate buffer7.0 80 2.57 0.41 2.57 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
716 Kap B5 B 0.067M phosphate buffer7.0 80 2.62 0.42 2.62 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
717 Beluga E 0.067M phosphate buffer7.0 80 0.42 -0.38 0.42 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
718 Foster B96 E 0.067M phosphate buffer7.0 80 0.59 -0.23 0.59 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
719 Eklund 202F F 0.067M phosphate buffer7.0 80 0.59 -0.23 0.59 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
720 Craig 610 F 0.067M phosphate buffer7.0 80 0.75 -0.12 0.75 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/4 days IFR unpublished data
721 Eklund 17B B 0.067M phosphate buffer7.0 75 14.81 1.17 1.21 Survivor curve 4.6 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
722 Eklund 17B B 0.067M phosphate buffer7.0 78 3.03 0.48 1.11 Survivor curve 4.6 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
723 Eklund 17B B 0.067M phosphate buffer7.0 80 4.64 0.67 4.64 Survivor curve 4.6 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
724 Kap B2 B 0.067M phosphate buffer7.0 80 1.09 0.04 1.09 Survivor curve 4.2 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
725 Kap B2 B 0.067M phosphate buffer7.0 82 0.37 -0.43 1.11 Survivor curve 4.2 screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
726 Eklund 17B B 0.067M phosphate buffer7.0 85 2.53 0.40 5.61 HS Survivor curve 14.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
727 Eklund 17B B 0.067M phosphate buffer7.0 85 51.00 1.71 128.96 HR Survivor curve 12.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
728 Eklund 17B B 0.067M phosphate buffer7.0 88 1.50 0.18 4.95 HS Survivor curve 14.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
729 Eklund 17B B 0.067M phosphate buffer7.0 88 24.00 1.38 96.51 HR Survivor curve 12.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
730 Eklund 17B B 0.067M phosphate buffer7.0 90 0.40 -0.40 1.96 HS Survivor curve 14.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
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731 Eklund 17B B 0.067M phosphate buffer7.0 90 8.30 0.92 53.07 HR Survivor curve 12.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
732 Eklund 17B B 0.1M citrate buffer 3.5 88 0.99 0.00 9.90 HS Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
733 Eklund 17B B 0.1M citrate buffer 3.5 88 4.90 0.69 26.12 HR Survivor curve 10.3 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
734 Beluga E 0.067M phosphate buffer7.0 80 1.24 0.09 1.24 HS Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
735 Beluga E 0.067M phosphate buffer7.0 80 36.00 1.56 36.00 HR Survivor curve 11.8 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
736 Beluga E 0.067M phosphate buffer7.0 83 0.53 -0.28 0.97 HS Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
737 Beluga E 0.067M phosphate buffer7.0 83 23.60 1.37 38.52 HR Survivor curve 11.8 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
738 Beluga E 0.067M phosphate buffer7.0 85 0.30 -0.52 1.01 HS Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
739 Beluga E 0.067M phosphate buffer7.0 85 10.40 1.02 27.71 HR Survivor curve 11.8 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
740 Beluga E 0.067M phosphate buffer7.0 88 0.15 -0.82 0.92 HS Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
741 Beluga E 0.067M phosphate buffer7.0 88 6.10 0.79 26.52 HR Survivor curve 11.8 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
742 Eklund 17B B 0.1M citrate buffer 3.5 78 2.39 0.38 1.11 HS Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
743 Eklund 17B B 0.1M citrate buffer 3.5 78 40.00 1.60 22.90 HR Survivor curve 10.3 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
744 Eklund 17B B 0.1M citrate buffer 4.4 78 3.42 0.53 1.59 HS Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
745 Eklund 17B B 0.1M citrate buffer 4.4 78 52.00 1.72 29.77 HR Survivor curve 10.3 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
746 Eklund 17B B 0.067M phosphate buffer7.0 78 3.98 0.60 2.67 HS Survivor curve 14.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
747 Eklund 17B B 0.067M phosphate buffer7.0 78 103.00 2.01 64.77 HR Survivor curve 12.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
748 Beluga E 0.1M citrate buffer 3.5 78 1.77 0.25 0.82 HS Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
749 Beluga E 0.1M citrate buffer 3.5 78 19.30 1.29 10.60 HR Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
750 Beluga E 0.1M citrate buffer 4.4 78 2.12 0.33 0.98 HS Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
751 Beluga E 0.1M citrate buffer 4.4 78 30.00 1.48 16.47 HR Survivor curve screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
752 Beluga E 0.067M phosphate buffer7.0 78 1.52 0.18 0.83 HS Survivor curve 9.5 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
753 Beluga E 0.067M phosphate buffer7.0 78 38.00 1.58 23.28 HR Survivor curve 11.8 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
754 Beluga E 0.1M citrate buffer + 30% (w/w) sucrose3.8 80 5.84 0.77 5.84 Survivor curve 8.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
755 Beluga E 0.1M citrate buffer + 30% (w/w) sucrose3.8 83 3.01 0.48 5.98 Survivor curve 8.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
756 Beluga E 0.1M citrate buffer + 30% (w/w) sucrose3.8 85 1.48 0.17 5.84 Survivor curve 8.4 screw-cap tube in a water bathcounts + LYS TPG + egg yolk 25°C/3-4 days Smelt, 1980
757 Eklund 17B B 0.067M phosphate buffer7.0 90 0.65 -0.19 14.03 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
758 Eklund 17B B 0.067M phosphate buffer7.0 90 18.28 1.26 201.22 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
759 ATCC 9564 E 0.067M phosphate buffer7.0 90 0.77 -0.11 16.58 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
760 ATCC 9564 E 0.067M phosphate buffer7.0 90 11.44 1.06 125.94 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
761 ATCC 9564 E 0.067M phosphate buffer7.0 75 0.90 -0.05 0.17 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
762 Hobbs FT50 B 0.067M phosphate buffer7.0 90 0.83 -0.08 17.81 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
763 Hobbs FT50 B 0.067M phosphate buffer7.0 90 28.17 1.45 310.05 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
764 Hobbs FT50 B 0.067M phosphate buffer7.0 75 1.25 0.10 0.24 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
765 Beluga E 0.067M phosphate buffer7.0 75 1.63 0.21 0.31 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
766 Beluga E 0.067M phosphate buffer7.0 90 0.78 -0.11 16.88 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
767 Beluga E 0.067M phosphate buffer7.0 90 14.18 1.15 156.13 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
768 Foster B96 E 0.067M phosphate buffer7.0 75 1.56 0.19 0.29 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
769 Foster B96 E 0.067M phosphate buffer7.0 90 2.11 0.32 45.46 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
770 Foster B96 E 0.067M phosphate buffer7.0 90 28.41 1.45 312.71 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
771 Craig 610 F 0.067M phosphate buffer7.0 75 1.55 0.19 0.26 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
772 Craig 610 F 0.067M phosphate buffer7.0 90 0.60 -0.22 12.93 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
773 Craig 610 F 0.067M phosphate buffer7.0 90 24.87 1.40 273.74 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
774 Eklund 202F F 0.067M phosphate buffer7.0 90 0.65 -0.19 13.92 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
775 Eklund 202F F 0.067M phosphate buffer7.0 90 21.46 1.33 236.20 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
776 CBW25 B 0.067M phosphate buffer7.0 90 1.05 0.02 22.72 HS Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
777 CBW25 B 0.067M phosphate buffer7.0 90 28.25 1.45 310.93 HR Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/2-3 days IFR unpublished data
778 CBW25 B 0.067M phosphate buffer7.0 75 3.06 0.49 0.58 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
779 Eklund 202F F 0.067M phosphate buffer7.0 75 4.91 0.69 0.84 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
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780 Eklund 17B B 0.067M phosphate buffer7.0 75 17.00 1.23 3.20 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/5 days IFR unpublished data
781 Crab G21-5 E crabmeat 82 3.00 0.48 6.25 TDT TDT tubes in water bathTDT TPGY 26°C/6 days Solmon et al. , 1977
782 Crab G21-5 E TPGY broth 82 1.50 0.18 3.13 TDT TDT tubes in water bathTDT TPGY Solmon et al. , 1977
783 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)bechamel sauce 6.49 0.989 80 7.21 0.86 7.21 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
784 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)bechamel sauce 6.49 0.989 85 2.20 0.34 12.27 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
785 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)bechamel sauce 6.49 0.989 92 0.26 -0.59 16.07 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
786 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)bolognaise sauce 5.37 0.987 80 9.27 0.97 9.27 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
787 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)bolognaise sauce 5.37 0.987 85 2.16 0.33 12.04 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
788 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)bolognaise sauce 5.37 0.987 92 0.22 -0.66 13.60 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
789 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)cooked pasta 6.74 0.99 85 2.18 0.34 12.15 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
790 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)cooked pasta 6.74 0.99 88 1.24 0.09 19.38 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
791 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)cooked pasta 6.74 0.99 92 0.52 -0.28 32.14 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
792 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)0.067M phosphate buffer7.0 92 0.06 -1.22 3.71 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
793 Mixed strains: B (Eklund 17B, CWB 25, CDC 3815, Kapchunka B2), E (Dolma VH, CB-K-38E)0.067M phosphate buffer7.0 92 0.47 -0.33 29.05 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
794 Eloise E 0.067M phosphate buffer7.0 70 15.29 1.18 0.54 Survivor curve unsealed tubes in water bathcounts Beef-Infusion agar33°C/2 days Graikoski and Kempe, 1964
795 Detroit E 0.067M phosphate buffer7.0 65 400.00 2.60 2.68 Survivor curve unsealed tubes in water bathcounts Beef-Infusion agar33°C/2 days Graikoski and Kempe, 1964
796 Minneapolis E 0.067M phosphate buffer7.0 70 14.81 1.17 0.53 Survivor curve sealed tubes in water bathcounts Beef-Infusion agar33°C/2 days Graikoski and Kempe, 1964
797 Iwanai E 0.067M phosphate buffer7.0 65 66.67 1.82 0.45 Survivor curve unsealed tubes in water bathcounts Beef-Infusion agar33°C/2 days Graikoski and Kempe, 1964
798 E-74 E 0.067M phosphate buffer7.0 85 7.05 0.85 37.40 Survivor curve unsealed tubes in water bathcounts Beef-Infusion agar33°C/2 days Graikoski and Kempe, 1964
799 Vancouver HerringE 0.067M phosphate buffer7.0 85 6.12 0.79 32.46 Survivor curve unsealed tubes in water bathcounts Beef-Infusion agar33°C/2 days Graikoski and Kempe, 1964
800 Not specified strainE distilled water 71 62.90 1.80 1.17 5.2 Mann, 1966
801 Not specified strainE tuna 71 84.10 1.92 1.02 4.7 Mann, 1966
802 Saratoga E 0.067M phosphate buffer7.0 70 33.80 1.53 1.38 7.2 TDT tubes in water bathTDT Ito et al.,  1970
803 Saratoga E 0.067M phosphate buffer7.0 73 13.10 1.12 1.31 7.2 TDT tubes in water bathTDT Ito et al.,  1970
804 Saratoga E 0.067M phosphate buffer7.0 75 8.20 0.91 1.66 7.2 TDT tubes in water bathTDT Ito et al.,  1970
805 Saratoga E 0.067M phosphate buffer7.0 80 1.40 0.15 1.40 7.2 TDT tubes in water bathTDT Ito et al.,  1970
806 Beluga E 0.067M phosphate buffer7.0 70 29.30 1.47 1.53 7.8 TDT tubes in water bathTDT Ito et al.,  1970
807 Beluga E 0.067M phosphate buffer7.0 73 8.00 0.90 0.96 7.8 TDT tubes in water bathTDT Ito et al.,  1970
808 Beluga E 0.067M phosphate buffer7.0 75 5.10 0.71 1.17 7.8 TDT tubes in water bathTDT Ito et al.,  1970
809 Beluga E 0.067M phosphate buffer7.0 80 1.40 0.15 1.40 7.8 TDT tubes in water bathTDT Ito et al.,  1970
810 Alaska E 0.067M phosphate buffer7.0 70 37.50 1.57 1.96 7.8 TDT tubes in water bathTDT Ito et al.,  1970
811 Alaska E 0.067M phosphate buffer7.0 73 11.80 1.07 1.41 7.8 TDT tubes in water bathTDT Ito et al.,  1970
812 Alaska E 0.067M phosphate buffer7.0 75 5.30 0.72 1.21 7.8 TDT tubes in water bathTDT Ito et al.,  1970
813 Alaska E 0.067M phosphate buffer7.0 80 1.60 0.20 1.60 7.8 TDT tubes in water bathTDT Ito et al.,  1970
814 1304E E 0.067M phosphate buffer7.0 70 29.60 1.47 1.85 8.3 TDT tubes in water bathTDT Ito et al.,  1970
815 1304E E 0.067M phosphate buffer7.0 73 10.60 1.03 1.44 8.3 TDT tubes in water bathTDT Ito et al.,  1970
816 1304E E 0.067M phosphate buffer7.0 75 5.60 0.75 1.40 8.3 TDT tubes in water bathTDT Ito et al.,  1970
817 1304E E 0.067M phosphate buffer7.0 80 1.80 0.26 1.80 8.3 TDT tubes in water bathTDT Ito et al.,  1970
818 Saratoga E 0.067M phosphate buffer7.0 80 1.17 0.07 1.17 7.1 TDT tubes in water bathTDT Angelotti, 1970
819 Beluga E 0.067M phosphate buffer7.0 80 1.10 0.04 1.10 8.3 TDT tubes in water bathTDT Angelotti, 1970
820 Alaska E 0.067M phosphate buffer7.0 80 1.35 0.13 1.35 7.8 TDT tubes in water bathTDT Angelotti, 1970
821 1304E E 0.067M phosphate buffer7.0 80 1.45 0.16 1.45 8.1 TDT tubes in water bathTDT Angelotti, 1970
822 Minnesota E crawfish paste 85 8.81 0.94 37.15 TDT/Stumbo(1948) 8.0 TDT tubes in water bathTDT crawfish paste 30°C/14 days DePantoja, 1986
823 Minnesota E crawfish paste 90 2.46 0.39 43.75 TDT/Stumbo(1948) 8.0 TDT tubes in water bathTDT crawfish paste 30°C/14 days DePantoja, 1986
824 Mixed strains: B (CDC 5900, Kapchunka B2, CB-R-25, Sebald P34, CB-K-18E, CB-K-38E)0.067M phosphate buffer7.0 80 5.45 0.74 5.45 Survivor curve screw-cap tube in a water bathcounts PYGS 30°C/7 days IFR unpublished data
825 Mixed strains: B (CDC 5900, Kapchunka B2, CB-R-25, Sebald P34, CB-K-18E, CB-K-38E)0.067M phosphate buffer7.0 80 5.76 0.76 5.76 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 30°C/7 days IFR unpublished data
826 Mixed strains: B (CDC 5900, Kapchunka B2, CB-R-25, Sebald P34, CB-K-18E, CB-K-38E)0.067M phosphate buffer7.0 80 5.24 0.72 5.24 Survivor curve screw-cap tube in a water bathcounts PYGS 25°C/14 days IFR unpublished data
827 Mixed strains: B (CDC 5900, Kapchunka B2, CB-R-25, Sebald P34, CB-K-18E, CB-K-38E)0.067M phosphate buffer7.0 80 6.51 0.81 6.51 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 25°C/14 days IFR unpublished data
828 Mixed strains: B (CDC 5900, Kapchunka B2, CB-R-25, Sebald P34, CB-K-18E, CB-K-38E)0.067M phosphate buffer7.0 80 7.90 0.90 7.90 Survivor curve screw-cap tube in a water bathcounts PYGS 25°C/21 days IFR unpublished data
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829 Mixed strains: B (CDC 5900, Kapchunka B2, CB-R-25, Sebald P34, CB-K-18E, CB-K-38E)0.067M phosphate buffer7.0 80 7.90 0.90 7.90 Survivor curve screw-cap tube in a water bathcounts + LYS PYGS + LYS 25°C/21 days IFR unpublished data
831 202 F physiological saline 80 4.90 0.69 4.00 TDT 9.2 sealed ampules in water bathTDT CMM 25˚C/35 days Eklund et al., 1967
832 202 F physiological saline 90 0.56 -0.25 3.82 TDT 9.2 sealed ampules in water bathTDT CMM 25˚C/35 days Eklund et al., 1967
834 288 F physiological saline 80 5.60 0.75 4.00 TDT 8.7 sealed ampules in water bathTDT CMM 25˚C/35 days Eklund et al., 1967
835 288 F physiological saline 90 0.56 -0.25 4.59 TDT 8.7 sealed ampules in water bathTDT CMM 25˚C/35 days Eklund et al., 1967
836 Mixed strains TPG 80 0.80 -0.10 0.80 Survivor curve counts TPG Membre and McClure, 2006
837 Mixed strains TPG 80 1.40 0.15 1.40 Survivor curve counts TPG Membre and McClure, 2006
838 Mixed strains TPG 80 1.70 0.23 1.70 Survivor curve counts TPG Membre and McClure, 2006
839 Mixed strains TPG 80 1.80 0.26 1.80 Survivor curve counts TPG Membre and McClure, 2006
840 Mixed strains TPG 80 3.20 0.51 3.20 Survivor curve counts TPG Membre and McClure, 2006
841 Mixed strains TPG 80 0.20 -0.70 0.20 Survivor curve counts TPG Membre and McClure, 2006
842 Mixed strains TPG 80 0.30 -0.52 0.30 Survivor curve counts TPG Membre and McClure, 2006
843 Mixed strains TPG 80 0.30 -0.52 0.30 Survivor curve counts TPG Membre and McClure, 2006
844 Mixed strains TPG 80 0.30 -0.52 0.30 Survivor curve counts TPG Membre and McClure, 2006
845 Mixed strains TPG 80 0.30 -0.52 0.30 Survivor curve counts TPG Membre and McClure, 2006
846 Mixed strains TPG 80 0.60 -0.22 0.60 Survivor curve counts TPG Membre and McClure, 2006
847 Mixed strains TPG 80 0.60 -0.22 0.60 Survivor curve counts TPG Membre and McClure, 2006
848 Mixed strains TPG 80 0.60 -0.22 0.60 Survivor curve counts TPG Membre and McClure, 2006
849 Mixed strains TPG 80 0.60 -0.22 0.60 Survivor curve counts TPG Membre and McClure, 2006
850 Mixed strains TPG 80 0.70 -0.15 0.70 Survivor curve counts TPG Membre and McClure, 2006
851 Mixed strains TPG 80 0.70 -0.15 0.70 Survivor curve counts TPG Membre and McClure, 2006
852 Mixed strains TPG 80 0.80 -0.10 0.80 Survivor curve counts TPG Membre and McClure, 2006
853 Mixed strains TPG 80 0.90 -0.05 0.90 Survivor curve counts TPG Membre and McClure, 2006
854 Mixed strains TPG 80 1.20 0.08 1.20 Survivor curve counts TPG Membre and McClure, 2006
855 Mixed strains TPG 80 1.40 0.15 1.40 Survivor curve counts TPG Membre and McClure, 2006
856 Mixed strains TPG 80 1.30 0.11 1.30 Survivor curve counts TPG Membre and McClure, 2006
857 Mixed strains TYD 80 0.20 -0.70 0.20 Survivor curve counts TPG Membre and McClure, 2006
858 Mixed strains TYD 80 0.20 -0.70 0.20 Survivor curve counts TPG Membre and McClure, 2006
859 Mixed strains TYD 80 0.60 -0.22 0.60 Survivor curve counts TPG Membre and McClure, 2006
860 Mixed strains TYD 80 1.00 0.00 1.00 Survivor curve counts TPG Membre and McClure, 2006
861 Mixed strains TYD 80 5.11 0.71 5.11 Survivor curve counts TPG Membre and McClure, 2006
862 Mixed strains TYD 80 0.40 -0.40 0.40 Survivor curve counts TPG Membre and McClure, 2006
863 Mixed strains TYD 80 0.40 -0.40 0.40 Survivor curve counts TPG Membre and McClure, 2006
864 Mixed strains TYD 80 0.50 -0.30 0.50 Survivor curve counts TPG Membre and McClure, 2006
865 Mixed strains TYD 80 0.70 -0.16 0.70 Survivor curve counts TPG Membre and McClure, 2006
866 Mixed strains TYD 80 0.70 -0.16 0.70 Survivor curve counts TPG Membre and McClure, 2006
867 Mixed strains TYD 80 0.80 -0.10 0.80 Survivor curve counts TPG Membre and McClure, 2006
868 Mixed strains TYD 80 0.90 -0.05 0.90 Survivor curve counts TPG Membre and McClure, 2006
869 Mixed strains TYD 80 0.90 -0.05 0.90 Survivor curve counts TPG Membre and McClure, 2006
870 Mixed strains TYD 80 1.00 0.00 1.00 Survivor curve counts TPG Membre and McClure, 2006
871 Mixed strains TYD 80 0.30 -0.52 0.30 Survivor curve counts TPG Membre and McClure, 2006
872 Mixed strains TYD 80 0.40 -0.40 0.40 Survivor curve counts TPG Membre and McClure, 2006
873 Mixed strains TYD 80 1.00 0.00 1.00 Survivor curve counts TPG Membre and McClure, 2006
874 ATCC 9564 E fine carot 70 31.41 1.50 1.58 Survivor curve 7.7 counts TPGY 30˚C/2 days Duh and Ren, 1995
875 ATCC 9564 E fine carot 80 1.80 0.26 1.80 Survivor curve 7.7 counts TPGY 30˚C/2 days Duh and Ren, 1995
876 ATCC 9564 E fine carot 90 0.08 -1.10 1.59 Survivor curve 7.7 counts TPGY 30˚C/2 days Duh and Ren, 1995
877 Not specified strainE 80 1.51 0.18 1.51 TDT TDT tubes in water bathTDT W & F Kralovic, 1973 
878 Mixed strains(Eklund 2B, Eklund 17B, Hazen 36208, Hobbs FT50, Beluga, Foster, Eklund 202F, Craig 610)meat medium 75 274.76 2.44 39.04 Survivor curve 5.9 screw-cap tube in a water bathcounts PYGS 25˚C/90 days Fernandez and Peck, 1997
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APPA – Anderson’s pork-pea agar, aw – water activity, CMM – cooked meat medium, D-value – decimal reduction time (min), EA – Eugon agar, 
ESBA – extract-starch-biocarbonate agar, FEM – fortified egg-meat medium, HR – heat resistant fraction, HS – heat sensitive fraction, MAM – 
Molten agar medium, NVB – Noyes veal-broth medium, PIT – pork-infusion-thioglycollate-starch agar, PYG – peptone-yeast-glucose agar, 
PYGS – peptone-yeast-glucose-starch medium, RCA – reinforced clostridial agar, RCM – reinforced clostridial medium, SH – sublethal heating, 
T – temperature (°C), TDT – thermal death time, TPG – tripticase-peptone-glucose agar, TPGY – trypticase-peptone-glucose yeast agar, 
TPGYT – trypticase-peptone-glucose yeast + 0.1% tripsin, TSA – tryptic-soy agar, TYD – tryptone-yeast dextrose, W & F – Wynne and Foster’s 
pork infusion broth, z-value – a change of temperature (°C), for which the D-value is reduced/increased by a factor of 10 
 
879 Mixed strains(Eklund 2B, Eklund 17B, Hazen 36208, Hobbs FT50, Beluga, Foster, Eklund 202F, Craig 610)meat medium 80 4.24 0.63 4.24 Survivor curve 5.9 screw-cap tube in a water bathcounts PYGS 25˚C/90 days Fernandez and Peck, 1997
880 Mixed strains(Eklund 2B, Eklund 17B, Hazen 36208, Hobbs FT50, Beluga, Foster, Eklund 202F, Craig 610)meat medium 85 8.85 0.95 62.29 Survivor curve 5.9 screw-cap tube in a water bathcounts PYGS 25˚C/90 days Fernandez and Peck, 1997
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Appendix 3 Experiment one: Time to visible growth (days) from 106 spores tube-1 of non-proteolytic       
C. botulinum strains at ten refrigeration temperatures (Stringer and Webb, unpublished data) 
Toxin Strain 4.0°C 5.0°C 5.5°C 6.0°C 6.5°C 7.0°C 8.0°C 9.0°C 10.0°C 
T
y
p
e
 B
 
81-23 >90 >90 >90 >90 >90 >90 >90 >90 >90 >90 >90 >90 42 49 39 25 25 25 14 14 14 8 7 7 5 5 5 
81-30 >90 >90 >90 >90 >90 77 46 39 39 25 25 25 18 18 21 14 14 18 8 8 8 7 7 7 5 5 5 
83-01 >90 >90 >90 74 81 42 32 32 39 18 25 21 18 14 18 14 11 14 8 8 8 6 6 6 5 5 5 
86-17 >90 >90 >90 >90 >90 >90 39 28 32 18 18 18 14 14 18 11 11 11 8 8 8 6 6 6 4 4 4 
87-02 >90 >90 >90 >90 >90 >90 >90 35 >90 21 25 25 14 18 18 11 11 11 8 8 7 6 6 6 5 5 5 
90-04 >90 >90 >90 >90 >90 >90 >90 >90 >90 28 32 32 21 18 21 14 14 14 11 11 11 7 8 7 6 6 5 
93-06 >90 >90 >90 32 >90 39 25 25 28 18 18 18 11 11 11 8 8 8 5 6 6 5 5 5 4 4 4 
93-10 >90 >90 >90 42 42 39 25 28 25 14 14 14 11 11 11 11 11 11 6 7 7 6 6 6 5 5 5 
93-11 >90 >90 >90 60 46 39 28 28 25 18 14 14 11 11 11 11 11 11 7 7 7 5 5 5 4 4 4 
02-50 >90 >90 >90 74 49 42 21 25 21 18 18 18 14 14 11 11 11 11 7 7 7 5 6 6 4 4 4 
02-51 >90 >90 >90 >90 >90 >90 >90 >90 56 25 25 25 14 18 14 14 11 11 11 11 11 6 6 6 5 5 5 
05-20 >90 >90 >90 35 >90 >90 25 25 25 18 18 18 14 14 14 11 11 11 11 8 11 6 6 6 5 5 5 
05-25 >90 >90 >90 >90 46 >90 >90 >90 70 21 25 25 14 14 14 11 11 11 7 7 7 6 5 6 5 5 5 
05-29 >90 >90 >90 >90 >90 >90 35 >90 >90 35 32 25 14 18 14 14 11 11 8 8 7 6 6 6 5 5 5 
T
y
p
e
 E
 
81-26 >90 >90 >90 >90 74 67 32 35 32 18 18 18 18 18 18 14 11 14 8 8 8 6 6 6 5 5 5 
81-31 >90 >90 >90 >90 >90 >90 >90 >90 >90 >90 >90 X >90 >90 >90 >90 >90 >90 28 25 28 14 14 14 14 11 11 
86-21 >90 >90 >90 25 25 28 18 18 18 14 14 11 11 11 11 11 11 11 6 6 6 5 5 5 4 4 4 
87-01 >90 >90 >90 >90 >90 >90 35 49 49 18 21 21 14 14 14 14 14 14 8 8 8 6 6 7 5 5 5 
93-07 >90 >90 >90 >90 >90 >90 >90 >90 >90 21 35 25 18 18 18 11 11 11 7 7 7 5 6 6 4 4 4 
93-08 >90 >90 >90 28 32 32 14 18 18 14 11 14 11 11 8 8 8 8 7 7 6 5 6 6 4 4 4 
02-06 >90 >90 >90 >90 >90 >90 25 25 25 14 18 18 11 11 14 11 11 11 8 8 8 5 6 6 5 5 5 
02-09 >90 >90 >90 63 56 74 21 25 25 14 14 14 11 11 11 11 11 11 7 7 7 5 5 5 5 5 5 
02-13 >90 >90 >90 32 35 32 14 18 18 11 11 11 11 8 8 8 8 8 7 7 7 5 5 5 4 4 4 
02-14 >90 >90 >90 >90 >90 >90 >90 >90 >90 49 >90 56 18 18 18 11 14 14 7 8 7 6 6 6 4 4 4 
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02-15 >90 67 67 21 21 21 18 18 14 11 14 14 11 11 11 8 8 8 6 6 6 5 5 5 4 4 4 
02-21 >90 >90 >90 >90 74 39 28 28 39 11 14 14 11 11 11 8 8 8 6 6 6 5 5 5 4 4 4 
02-22 >90 >90 >90 >90 >90 >90 >90 >90 >90 >90 42 35 18 14 14 11 11 11 6 7 6 6 5 6 4 4 4 
02-24 >90 >90 >90 >90 >90 >90 >90 >90 46 25 25 25 14 14 14 11 11 11 7 6 7 5 6 5 4 4 4 
02-25 >90 >90 >90 >90 >90 >90 32 39 56 14 14 18 11 11 11 8 11 11 7 7 7 5 5 5 4 4 4 
02-26 >90 >90 >90 >90 81 >90 56 39 39 25 21 25 14 14 14 11 11 11 8 8 8 5 5 5 5 5 6 
02-29 >90 >90 >90 28 25 25 21 21 21 14 11 14 11 11 11 11 11 11 6 6 7 5 5 5 4 4 4 
02-32 >90 >90 >90 32 32 32 21 21 21 14 14 14 11 11 11 11 11 11 7 7 7 5 5 5 4 4 4 
02-33 >90 >90 >90 32 32 32 21 21 21 14 14 14 11 11 11 11 11 11 7 7 8 5 5 6 5 5 5 
02-35 >90 >90 >90 42 42 39 21 21 21 14 14 14 11 11 11 8 8 11 7 7 8 5 5 5 5 4 4 
02-47 >90 >90 >90 >90 >90 >90 >90 >90 >90 18 21 18 11 11 11 11 11 11 7 7 6 5 5 5 4 4 4 
T
y
p
e
 F
 
86-32 >90 >90 >90 42 >90 >90 35 49 49 21 25 25 18 18 18 14 11 11 7 7 7 5 6 5 5 5 5 
86-33 >90 >90 >90 >90 53 53 28 32 35 18 18 18 14 14 14 11 11 11 6 6 6 5 5 5 4 4 4 
86-34 >90 >90 >90 >90 >90 >90 35 39 39 21 21 21 18 18 18 11 11 11 6 6 6 5 5 5 4 4 4 
06-01 >90 >90 >90 >90 >90 >90 39 53 >90 25 32 28 21 18 18 14 14 14 8 7 8 6 6 6 5 5 5 
06-05 >90 >90 >90 >90 >90 >90 >90 42 42 28 25 39 18 21 28 14 18 18 8 8 8 6 6 6 5 5 5 
X – tubes broken 
Tests were also carried out at 3.0°C, but growth was not observed in 90 days 
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Appendix 4 Experiment two: Time to visible growth (days) from different spore concentrations of non-
proteolytic C. botulinum strains at 6.0°C 
Toxin Type B Type E Type F 
Strain/spore 
concentration 8
1
-2
3
 
8
1
-3
0
 
8
3
-0
1
 
8
6
-1
7
 
8
7
-0
2
 
8
7
-0
4
 
9
3
-0
6
 
9
3
-1
1
 
0
2
-5
1
 
0
5
-2
0
 
0
5
-2
5
 
8
1
-3
1
 
8
6
-2
1
 
8
7
-0
1
 
0
2
-0
7
 
0
2
-0
9
 
0
2
-1
5
 
0
2
-2
5
 
0
2
-2
6
 
0
2
-2
9
 
8
6
-3
2
 
8
6
-3
3
 
8
6
-3
4
 
0
6
-0
5
 
S = 10
6
 
spores  
tube
-1
 
37 16 12 12 12 16 12 11 20 11 17 40 11 11 11 11 11 11 11 11 12 16 13 17 
59 16 12 12 13 16 12 11 20 11 17 
 
11 11 11 11 11 11 11 11 12 16 14 18 
>60 16 14 13 14 16 13 11 21 11 17 >60 11 11 11 11 11 11 11 11 16 16 14 18 
>60 17 14 13 14 16 13 11 23 11 18 >60 11 11 11 11 11 11 11 11 16 17 14 19 
>60 17 14 13 14 16 13 11 24 11 18 >60 11 11 11 11 11 11 11 11 16 17 16 20 
S = 10
5
 
spores  
tube
-1
 
>60 17 14 14 16 20 16 12 59 12 18 59 11 12 11 11 11 11 11 11 14 17 17 20 
>60 18 14 14 16 20 17 13 >60 12 18 
 
11 12 11 11 11 11 11 11 16 18 18 20 
>60 18 14 14 17 21 18 13 >60 13 19 >60 11 12 11 11 11 11 11 11 18 18 18 20 
>60 20 14 16 23 21 18 13 >60 13 19 >60 11 12 11 11 11 11 11 11 18 18 18 24 
>60 20 16 >60 30 23 19 13 >60 14 19 >60 11 13 11 12 11 11 11 11 19 19 20 24 
S = 10
4
 
spores  
tube
-1
 
>60 20 17 17 21 24 18 14 60 16 20 40 12 13 12 12 12 12 14 11 19 19 19 23 
>60 20 17 17 23 25 19 14 >60 16 23 
 
12 14 12 12 12 12 14 11 19 23 20 24 
>60 23 18 18 24 25 19 16 >60 16 23 >60 12 14 12 12 12 12 14 11 20 23 20 30 
>60 25 19 18 34 32 20 16 >60 18 23 >60 12 16 12 12 12 12 14 11 26 25 21 34 
>60 32 19 18 48 34 23 16 >60 19 24 >60 12 >60 12 12 12 12 14 11 30 31 21 
 
S = 10
3
 
spores  
tube
-1
 
>60 25 20 23 28 30 18 16 >60 20 23 >60 13 16 14 13 14 13 16 14 20 20 23 26 
>60 25 20 23 28 32 18 16 >60 20 23 >60 13 16 14 14 14 13 16 14 20 20 23 34 
>60 25 21 24 30 44 19 17 >60 20 25 >60 14 16 14 14 14 13 17 14 23 21 25 >60 
>60 26 21 30 54 44 20 18 >60 25 27 >60 14 16 14 14 14 13 17 14 24 23 25 >60 
>60 27 25 48 >60 >60 20 18 >60 25 37 >60 14 17 14 14 16 14 18 14 28 >60 26 >60 
S = 10
2
 
spores  
tube
-1
 
>60 25 23 30 26 34 23 17 >60 23 25 >60 16 17 16 16 16 16 21 16 27 23 25 >60 
>60 30 23 30 37 37 23 19 >60 25 30 >60 16 18 16 16 16 16 23 16 28 25 27 >60 
>60 30 26 31 37 >60 23 19 >60 27 40 >60 16 18 16 16 16 16 23 16 30 25 31 >60 
>60 31 30 32 48 >60 24 20 >60 30 40 >60 16 18 16 16 16 16 23 16 31 25 >60 >60 
>60 34 37 37 54 >60 25 20 >60 31 44 >60 17 18 16 16 16 16 28 16 32 
 
>60 >60 
S = 10
1
 
spores  
tube
-1
 
>60 31 24 37 28 >60 24 19 >60 25 >60 >60 18 19 17 18 18 17 26 18 23 25 32 >60 
>60 34 26 40 28 >60 27 19 >60 37 >60 >60 18 19 18 18 19 17 30 19 23 
 
>60 >60 
>60 37 30 42 28 >60 28 23 >60 40 >60 >60 18 19 19 18 19 18 30 19 23 >60 >60 >60 
>60 >60 30 48 30 >60 >60 23 >60 48 >60 >60 19 20 20 18 20 18 40 20 
 
>60 >60 >60 
>60 >60 30 54 54 >60 >60 24 >60 51 >60 >60 20 25 >60 19 20 19 42 20 >60 >60 >60 >60 
S = 10
0
 
spores  
tube
-1
 
>60 
 
37 34 28 >60 >60 >60 >60 32 >60 >60 18 20 21 20 19 18 54 20 26 37 >60 >60 
>60 >60 42 40 >60 >60 >60 >60 >60 48 >60 >60 20 21 >60 20 20 19 59 21 >60 >60 >60 >60 
>60 >60 >60 >60 >60 >60 >60 >60 >60 48 >60 >60 21 23 >60 21 20 19 >60 23 >60 >60 >60 >60 
>60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 21 >60 >60 21 21 19 >60 >60 >60 >60 >60 >60 
>60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 >60 24 >60 20 >60 >60 >60 >60 >60 >60 
Pink colour indicates that tube content turned aerobic and has been excluded from the analysis 
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Appendix 5 Initial experiment: Carbohydrate utilization test by strains of non-proteolytic C. botulinum 
types B, E and F 
Carbohydrate/Strain 81-23 81-26 81-30 81-31* 83-01 86-17* 86-21 86-32 86-33 87-02 93-07 02-25* 05-2*5 06-01* 08-02 
Control 6.53 6.10 6.39 6.30 6.33 6.37 6.42 6.59 6.40 6.41 6.29 6.43 6.36 6.41 6.43 
Glycerol 5.47 5.57 5.33 5.68 5.41 5.39 6.13 5.84 5.26 5.62 5.53 5.61 5.49 5.89 6.28 
Erythritol 6.23 6.31 6.51 6.31 6.40 6.35 6.53 6.61 6.29 6.39 6.27 6.26 6.39 6.38 6.39 
D-arabinose 6.41 6.39 6.27 6.27 6.34 6.32 6.36 6.55 6.32 6.33 6.30 6.22 6.35 6.34 6.45 
L-arabinose 6.41 6.27 6.41 6.17 6.38 6.31 6.34 6.54 6.34 6.28 6.21 6.25 6.42 6.33 6.28 
D-ribose 5.11 5.15 5.14 4.88 5.07 5.06 4.95 5.29 5.38 5.38 5.24 5.13 5.55 5.18 5.15 
D-xylose 6.27 6.25 6.37 6.19 6.35 6.24 6.24 6.32 6.33 6.34 6.30 6.18 6.44 6.28 6.31 
L-xylose 6.41 6.37 6.52 6.33 6.40 6.38 6.47 6.43 6.41 6.40 6.36 6.27 6.55 6.33 6.50 
D-adonitol 6.09 5.88 5.77 6.00 5.83 5.28 5.52 5.35 5.61 5.92 5.61 5.79 5.99 5.60 5.70 
Methyl-βD-
xylopyranoside 
6.58 6.52 6.55 6.48 6.39 6.43 6.47 6.55 6.44 6.47 6.42 6.33 6.50 6.51 6.46 
D-galactose 6.46 6.28 6.23 6.02 6.26 6.20 6.22 6.47 6.41 6.52 6.27 6.25 6.34 6.26 6.23 
D-glucose 5.20 5.06 4.83 4.90 5.07 4.96 4.83 5.12 5.33 5.30 5.15 5.15 5.41 5.21 5.02 
D-fructose 5.20 5.05 5.06 4.81 5.01 4.92 4.94 5.16 5.28 5.38 5.16 5.12 5.34 5.21 4.96 
D-mannose 5.08 5.07 5.02 4.94 5.00 5.00 4.92 5.29 5.34 5.36 5.26 5.18 5.83 5.14 5.26 
L-sorbose 6.41 6.12 6.39 6.13 6.30 6.29 6.16 6.43 6.40 6.63 6.22 6.17 6.43 6.38 6.18 
L-rhamnose 6.55 6.42 6.56 6.27 6.35 6.50 6.35 6.46 6.36 6.45 6.38 6.37 6.53 6.40 6.42 
Dulcitol 6.69 6.41 6.58 6.37 6.42 6.49 6.33 6.38 6.40 6.48 6.38 6.43 6.44 6.49 6.37 
Inositol 6.01 5.48 6.57 5.92 5.24 5.75 5.38 5.13 5.74 6.08 5.38 5.18 5.82 6.21 5.18 
D-mannitol 6.60 6.31 6.48 6.29 6.42 6.36 5.32 6.30 6.40 6.41 6.22 6.30 6.49 6.25 6.34 
D-sorbitol 5.48 5.29 5.16 5.03 5.13 5.23 4.89 5.00 5.31 5.32 5.37 5.35 5.40 5.17 5.16 
Methyl-αD-
mannopyranoside 
6.56 6.35 6.41 6.19 6.58 6.40 6.38 6.30 6.40 6.54 6.23 6.25 6.55 6.47 6.54 
Methyl-αD-
glucopyranoside 
6.34 5.84 5.89 5.92 6.22 5.97 6.14 6.20 6.34 5.94 5.81 6.11 6.45 6.17 6.13 
N-
acetylglucosamine 
5.39 5.28 5.00 5.14 5.57 5.16 5.08 5.47 5.45 5.40 5.30 5.31 5.47 5.37 5.39 
Amygdalin 6.58 6.09 6.10 6.23 6.42 6.20 6.21 6.38 6.46 6.54 6.31 6.30 6.53 6.28 6.29 
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Arbutin 6.80 6.19 6.42 6.31 6.16 6.35 6.39 6.42 6.59 6.66 6.38 6.30 6.19 6.38 6.46 
Esculin ferric citrate 6.78 6.63 6.55 6.51 6.59 6.59 6.54 6.69 6.74 6.61 6.51 6.55 6.57 6.57 6.68 
Salicin 6.62 6.26 6.49 6.35 6.30 6.31 6.43 6.43 6.40 6.44 6.39 6.31 6.61 6.31 6.43 
D-cellobiose 6.57 6.21 6.40 6.27 6.31 6.26 6.27 6.31 6.41 6.48 6.25 6.26 6.51 6.35 6.31 
D-maltose 6.19 5.12 5.25 4.97 5.09 5.42 4.85 5.24 5.35 5.24 5.21 5.24 5.38 5.21 5.21 
D-lactose (bovine 
origin) 
6.35 6.21 6.43 6.19 6.59 6.36 6.42 6.35 6.34 6.38 6.26 6.31 6.59 6.34 6.77 
D-melibiose 6.35 6.41 6.60 6.18 6.55 6.41 6.46 6.36 6.40 6.56 6.31 6.26 6.61 6.33 6.89 
D-saccharose 5.24 5.09 4.98 4.96 5.18 5.12 5.04 5.27 5.26 5.47 5.29 5.14 6.11 5.30 5.08 
D-trehalose 5.22 5.18 5.25 5.28 5.25 5.29 5.13 5.26 5.35 5.42 5.25 5.28 5.57 5.35 5.07 
Inulin 6.37 6.33 6.69 6.24 6.48 6.43 6.40 6.38 6.42 6.56 6.28 6.24 6.67 6.39 6.13 
D-melezitose 6.57 5.39 6.59 5.05 6.16 6.28 6.46 6.27 6.46 6.46 5.22 5.22 6.57 6.39 5.20 
D-raffinose 6.43 6.58 6.44 6.31 6.54 6.45 6.65 6.38 6.48 6.48 6.34 6.38 6.60 6.41 6.33 
Amidon (starch) 5.14 6.60 4.90 6.41 4.95 5.13 6.66 5.09 5.43 5.44 6.40 6.16 5.57 5.26 5.18 
Glycogen 5.15 6.73 4.99 6.41 4.96 5.02 6.52 5.26 5.31 5.37 6.39 6.40 5.39 5.28 6.51 
Xylitol 6.31 6.67 5.28 6.39 5.16 5.06 6.51 6.49 6.31 6.51 5.32 6.44 6.52 6.44 6.39 
Gentiobiose 6.41 6.57 6.48 6.35 6.36 6.44 6.54 6.44 6.49 6.63 6.41 6.42 6.54 6.56 6.66 
D-turanose 5.13 5.22 5.33 5.29 5.30 5.31 5.03 5.10 5.38 5.64 5.25 5.40 5.41 5.23 5.21 
D-lyxose 6.36 6.48 6.60 6.27 6.37 6.47 6.42 6.41 6.44 6.56 6.33 6.31 6.50 6.33 6.43 
D-tagatose 6.63 6.61 6.69 6.38 6.55 6.65 6.55 6.54 6.57 6.65 6.48 6.43 6.61 6.43 6.64 
D-fucose 6.48 6.67 6.62 6.43 6.57 6.61 6.81 6.50 6.60 6.70 6.51 6.45 6.59 6.46 6.59 
L-fucose 6.43 6.61 6.69 6.40 6.51 6.63 6.62 6.42 6.63 6.67 6.57 6.44 6.60 6.50 6.75 
D-arabitol 6.54 6.73 6.79 6.53 6.52 6.58 6.58 6.48 6.74 6.69 6.62 6.64 6.64 6.59 6.70 
L-arabitol 6.45 6.67 6.87 6.48 6.60 6.67 6.69 6.55 6.57 6.74 6.56 6.53 6.66 6.63 6.82 
Potassium 
gluconate 
6.83 6.73 7.57 6.58 7.30 7.20 6.78 6.67 6.70 7.27 6.73 6.63 6.68 6.75 6.74 
Potassium 2-
ketogluconate 
7.08 7.27 7.13 7.18 7.09 7.14 7.17 7.21 7.39 7.23 7.20 7.21 7.21 7.27 7.28 
Potassium 5-
ketogluconate 
6.53 6.76 6.37 6.45 6.52 6.53 6.47 6.68 6.60 6.68 6.56 6.52 6.67 6.60 6.64 
The pH is shown at the end of the incubation period 
* results present the average of two independent pH measurements 
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Appendix 6 Expert opinion questioner regarding the 
concentration of C. botulinum spores in batch of milk 
 
Dear Expert - 
As part of my project I am exploring different type of data sources that can be 
used in risk assessments. 
I hope you can help me with an example by using expertise to estimate a few 
parameter values.  
 
My problem centres on spores of C. botulinum, in fresh cows’ milk. I am 
considering large batches of milk each with a volume ~10000 litres.  
 
 
Based on a large number of batches there will be a single mean value for the 
number of spores per batch.  
Can you estimate the largest value of the mean and the smallest value of the 
mean that are consistent with your belief concerning the number of spores in 
fresh milk? 
 
Smallest mean = …………………………………………… (spores per 10000 litres) 
Largest mean = ……………………………………….…… (spores per 10000 litres) 
 
 
 
In a large number of batches each batch will have a different spore load. 
Based on your experience what range of spore load would include 95% of all the 
spore loads in the batches of milk. 
 
The smallest load of the 95% interval = ………………… (spores per 10000 litres) 
The largest load of the 95% interval = …………………... (spores per 10000 litres) 
 
 
 
This is a very informal exercise. 
None of these values will be used in a real safety assessment. 
The values you give will only be used anonymously and will never be 
attributable. 
 
 
 
Thank you for your response. 
 
